WorldWideScience

Sample records for neutron therapy assembly

  1. Design of a boron neutron capture enhanced fast neutron therapy assembly

    Energy Technology Data Exchange (ETDEWEB)

    Wang, Zhonglu [Georgia Inst. of Technology, Atlanta, GA (United States)

    2006-12-01

    The use of boron neutron capture to boost tumor dose in fast neutron therapy has been investigated at several fast neutron therapy centers worldwide. This treatment is termed boron neutron capture enhanced fast neutron therapy (BNCEFNT). It is a combination of boron neutron capture therapy (BNCT) and fast neutron therapy (FNT). It is believed that BNCEFNT may be useful in the treatment of some radioresistant brain tumors, such as glioblastoma multiform (GBM). A boron neutron capture enhanced fast neutron therapy assembly has been designed for the Fermilab Neutron Therapy Facility (NTF). This assembly uses a tungsten filter and collimator near the patient's head, with a graphite reflector surrounding the head to significantly increase the dose due to boron neutron capture reactions. The assembly was designed using Monte Carlo radiation transport code MCNP version 5 for a standard 20x20 cm2 treatment beam. The calculated boron dose enhancement at 5.7-cm depth in a water-filled head phantom in the assembly with a 5x5 cm2 collimation was 21.9% per 100-ppm 10B for a 5.0-cm tungsten filter and 29.8% for a 8.5-cm tungsten filter. The corresponding dose rate for the 5.0-cm and 8.5-cm thick filters were 0.221 and 0.127 Gy/min, respectively; about 48.5% and 27.9% of the dose rate of the standard 10x10 cm2 fast neutron treatment beam. To validate the design calculations, a simplified BNCEFNT assembly was built using four lead bricks to form a 5x5 cm2 collimator. Five 1.0-cm thick 20x20 cm2 tungsten plates were used to obtain different filter thicknesses and graphite bricks/blocks were used to form a reflector. Measurements of the dose enhancement of the simplified assembly in a water-filled head phantom were performed using a pair of tissue-equivalent ion chambers. One of the ion chambers is loaded with 1000-ppm natural boron (184-ppm 10B) to measure dose due to boron neutron capture. The

  2. Optimal Neutron Source and Beam Shaping Assembly for Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Vujic, J.; Greenspan, E.; Kastenber, W.E.; Karni, Y.; Regev, D.; Verbeke, J.M.; Leung, K.N.; Chivers, D.; Guess, S.; Kim, L.; Waldron, W.; Zhu, Y.

    2003-01-01

    There were three objectives to this project: (1) The development of the 2-D Swan code for the optimization of the nuclear design of facilities for medical applications of radiation, radiation shields, blankets of accelerator-driven systems, fusion facilities, etc. (2) Identification of the maximum beam quality that can be obtained for Boron Neutron Capture Therapy (BNCT) from different reactor-, and accelerator-based neutron sources. The optimal beam-shaping assembly (BSA) design for each neutron source was also to e obtained. (3) Feasibility assessment of a new neutron source for NCT and other medical and industrial applications. This source consists of a state-of-the-art proton or deuteron accelerator driving and inherently safe, proliferation resistant, small subcritical fission assembly

  3. Evaluation of moderator assemblies for use in an accelerator-based neutron source for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Woollard, J.E.; Blue, T.E.; Gupta, N.; Gahbauer, R.A.

    1998-01-01

    The neutron fields produced by several moderator assemblies were evaluated using both in-phantom and in-air neutron field assessment parameters. The parameters were used to determine the best moderator assembly, from among those evaluated, for use in the accelerator-based neutron source for boron neutron capture therapy. For a 10-mA proton beam current and the specified treatment parameters, a moderator assembly consisting of a BeO moderator and a Li 2 CO 3 reflector was found to be the best moderator assembly whether the comparison was based on in-phantom or in-air neutron field assessment parameters. However, the parameters were discordant regarding the moderator thickness. The in-phantom neutron field assessment parameters predict 20 cm of BeO as the best moderator thickness, whereas the in-air neutron field assessment parameters predict 25 cm of BeO as the best moderator thickness

  4. Neutron therapy

    International Nuclear Information System (INIS)

    Riesler, Rudi

    1995-01-01

    Standard radiotherapy uses Xrays or electrons which have low LET (linear energy transfer); in contrast, particles such as neutrons with high LET have different radiobiological responses. In the late 1960s, clinical trials by Mary Catterall at the Hammersmith Hospital in London indicated that fast neutron radiation had clinical advantages for certain malignant tumours. Following these early clinical trials, several cyclotron facilities were built in the 1980s for fast neutron therapy, for example at the University of Washington, Seattle, and at UCLA. Most of these newer machines use extracted cyclotron proton beams in the range 42 to 66 MeV with beam intensities of 15 to 60 microamps. The proton beams are transported to dedicated therapy rooms, where neutrons are produced from beryllium targets. Second-generation clinical trials showed that accurate neutron beam delivery to the tumour site is more critical than for photon therapy. In order to achieve precise beam geometries, the extracted proton beams have to be transported through a gantry which can rotate around the patient and deliver beams from any angle; also the neutron beam outline (''field shape'') must be adjusted to extremely irregular shapes using a flexible collimation system. A therapy procedure has to be appropriately organized, with physicians, radiotherapists, nurses, medical physicists and other staff in attendance; other specialized equipment, such as CT or MRI scanners and radiation simulators must be made available. Neutron therapy is usually performed only in radiation oncology departments of major medical centres

  5. Neutron detector assembly

    International Nuclear Information System (INIS)

    Hanai, Koi; Shirayama, Shinpei.

    1978-01-01

    Purpose: To prevent gamma-ray from leaking externally passing through the inside of a neutron detector assembly. Constitution: In a neutron detector assembly having a protection pipe formed with an enlarged diameter portion which serves also as a spacer, partition plates with predetermined width are disposed at the upper and the lower portions in this expanded portion. A lot of metal particles are filled into spaces formed by the partition plates. In such a structure, the metal particles well-absorb the gamma-rays from above and convert them into heat to provide shielding for the gamma-rays. (Horiuchi, T.)

  6. Experimental and Simulated Characterization of a Beam Shaping Assembly for Accelerator- Based Boron Neutron Capture Therapy (AB-BNCT)

    International Nuclear Information System (INIS)

    Burlon, Alejandro A.; Valda, Alejandro A.; Girola, Santiago; Minsky, Daniel M.; Kreiner, Andres J.

    2010-01-01

    In the frame of the construction of a Tandem Electrostatic Quadrupole Accelerator facility devoted to the Accelerator-Based Boron Neutron Capture Therapy, a Beam Shaping Assembly has been characterized by means of Monte-Carlo simulations and measurements. The neutrons were generated via the 7 Li(p, n) 7 Be reaction by irradiating a thick LiF target with a 2.3 MeV proton beam delivered by the TANDAR accelerator at CNEA. The emerging neutron flux was measured by means of activation foils while the beam quality and directionality was evaluated by means of Monte Carlo simulations. The parameters show compliance with those suggested by IAEA. Finally, an improvement adding a beam collimator has been evaluated.

  7. Compact D-D Neutron Source-Driven Subcritical Multiplier and Beam-Shaping Assembly for Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Ganda, Francesco; Vujic, Jasmina; Greenspan, Ehud; Leung, Ka-Ngo

    2010-01-01

    This work assesses the feasibility of using a small, safe, and inexpensive keff 0.98 subcritical fission assembly [subcritical neutron multiplier (SCM)] to amplify the treatment neutron beam intensity attainable from a compact deuterium-deuterium (D-D) fusion neutron source delivering [approximately]1012 n/s. The objective is to reduce the treatment time for deep-seated brain tumors to [approximately]1 h. The paper describes the optimal SCM design and two optimal beam-shaping assemblies (BSAs) - one designed to maximize the dose rate and the other designed to maximize the total dose that can be delivered to a deep-seated tumor. The neutron beam intensity amplification achieved with the optimized SCM and BSA results in an increase in the treatment dose rate by a factor of 18: from 0.56 Gy/h without the SCM to 10.1 Gy/h. The entire SCM is encased in an aluminum structure. The total amount of 20% enriched uranium required for the SCM is 8.5 kg, and the cost (not including fabrication) is estimated to be less than $60,000. The SCM power level is estimated at 400 W when driven by a 1012 n/s D-D neutron source. This translates into consumption of only [approximately]0.6% of the initially loaded 235U atoms during 50 years of continuous operation and implies that the SCM could operate continuously for the entire lifetime of the facility without refueling. Cooling the SCM does not pose a challenge; it may be accomplished by natural circulation as the maximum heat flux is only 0.034 W/cm2.

  8. Neutron Therapy Facility

    Data.gov (United States)

    Federal Laboratory Consortium — The Neutron Therapy Facility provides a moderate intensity, broad energy spectrum neutron beam that can be used for short term irradiations for radiobiology (cells)...

  9. SU-F-T-183: Design of a Beam Shaping Assembly of a Compact DD-Based Boron Neutron Capture Therapy System

    Energy Technology Data Exchange (ETDEWEB)

    Hsieh, M; Liu, Y; Nie, L [Purdue University, West Lafayette, Indiana (United States)

    2016-06-15

    Purpose: To design a beam shaping assembly (BSA) to shape the 2.45-MeV neutrons produced by a deuterium-deuterium (DD) neutron generator and to optimize the beam output for boron neutron capture therapy of brain tumors Methods: MCNP is used for this simulation study. The simulation model consists of a neutron surface source that resembles an actual DD source and is surrounded by a BSA. The neutron source emits 2.45-MeV neutrons isotropically. The BSA is composed of a moderator, reflector, collimator and filter. Various types of materials and geometries are tested for each component to optimize the neutron output. Neutron characteristics are measured with an 2×2×2-cm{sup 3} air-equivalent cylinder at the beam exit. The ideal BSA is determined by evaluating the in-air parameters, which include epithermal neutron per source neutron, fast neutron dose per epithermal neutron, and photon dose per epithermal neutron. The parameter values are compared to those recommended by the IAEA. Results: The ideal materials for reflector and thermal neutron filter were lead and cadmium, respectively. The thickness for reflector was 43 cm and for filter was 0.5 mm. At present, the best-performing moderator has 25 cm of AlF{sub 3} and 5 cm of MgF{sub 2}. This layout creates a neutron spectrum that has a peak at approximately 10 keV and produces 1.35E-4 epithermal neutrons per source neutron per cm{sup 2}. Additional neutron characteristics, fast neutrons per epithermal neutron and photon per epithermal neutron, are still under investigation. Conclusion: Working is ongoing to optimize the final layout of the BSA. The neutron spectrum at the beam exit window of the final configuration will have the maximum number of epithermal neutrons and limited photon and fast neutron contaminations within the recommended values by IAEA. Future studies will also include phantom experiments to validate the simulation results.

  10. Neutron beams for therapy

    International Nuclear Information System (INIS)

    Kuplenikov, Eh.L.; Dovbnya, A.N.; Telegin, Yu.N.; Tsymbal, V.A.; Kandybej, S.S.

    2011-01-01

    It was given the analysis and generalization of the study results carried out during some decades in many world countries on application of thermal, epithermal and fast neutrons for neutron, gamma-neutron and neutron-capture therapy. The main attention is focused on the practical application possibility of the accumulated experience for the base creation for medical research and the cancer patients effective treatment.

  11. Neutron irradiation therapy machine

    International Nuclear Information System (INIS)

    1980-01-01

    Conventional neutron irradiation therapy machines, based on the use of cyclotrons for producing neutron beams, use a superconducting magnet for the cyclotron's magnetic field. This necessitates complex liquid He equipment and presents problems in general hospital use. If conventional magnets are used, the weight of the magnet poles considerably complicates the design of the rotating gantry. Such a therapy machine, gantry and target facilities are described in detail. The use of protons and deuterons to produce the neutron beams is compared and contrasted. (U.K.)

  12. Gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Akine, Yasuyuki; Tokita, Nobuhiko; Tokuuye, Koichi; Satoh, Michinao; Churei, Hisahiko

    1993-01-01

    Gadolinium neutron capture therapy makes use of photons and electrons produced by nuclear reactions between gadolinium and lower-energy neutrons which occur within the tumor. The results of our studies have shown that its radiation effect is mostly of low LET and that the electrons are the significant component in the over-all dose. The dose from gadolinium neutron capture reactions does not seem to increase in proportion to the gadolinium concentration, and the Gd-157 concentration of about 100 μg/ml appears most optimal for therapy. Close contact between gadolinium and the cell is not necessarily required for cell inactivation, however, the effect of electrons released from intracellular gadolinium may be significant. Experimental studies on tumor-bearing mice and rabbits have shown that this is a very promising modality though further improvements in gadolinium delivery to tumors are needed. (author)

  13. Calculated characteristics of subcritical assembly with anisotropic transport of neutrons

    International Nuclear Information System (INIS)

    Gorin, N.V.; Lipilina, E.N.; Lyutov, V.D.; Saukov, A.I.

    2003-01-01

    There was considered possibility of creating enough sub-critical system that multiply neutron fluence from a primary source by many orders. For assemblies with high neutron tie between parts, it is impossible. That is why there was developed a construction consisting of many units (cascades) having weak feedback with preceding cascades. The feedback attenuation was obtained placing layers of slow neutron absorber and moderators between the cascades of fission material. Anisotropy of fast neutron transport through the layers was used. The system consisted of many identical cascades aligning one by another. Each cascade consists of layers of moderator, fissile material and absorber of slow neutrons. The calculations were carried out using the code MCNP.4a with nuclear data library ENDF/B5. In this construction neutrons spread predominantly in one direction multiplying in each next fissile layer, and they attenuate considerably in the opposite direction. In a calculated construction, multiplication factor of one cascade is about 1.5 and multiplication factor of whole construction composed of n cascades is 1.5 n . Calculated keff value is 0.9 for one cascade and does not exceed 0.98 for a system containing any number of cascades. Therefore the assembly is always sub-critical and therefore it is safe in respect of criticality. There was considered using such a sub-critical assembly to create a powerful neutron fluence for neutron boron-capturing therapy. The system merits and demerits were discussed. (authors)

  14. Some neutronics of innovative subcritical assembly with fast neutron spectrum

    International Nuclear Information System (INIS)

    Kiyavitskaya, H.; Fokov, Yu.; Rutkovskaya, Ch.; Sadovich, S.; Kasuk, D.; Gohar, Y.; Bolshinsky, I.

    2013-01-01

    Conclusion: • New assembly can be used to: • develop the experimental techniques and adapt the existing ones for monitoring the sub-criticality level, neutron spectra measurements, etc; • study the spatial kinetics of sub-critical and critical systems with fast neutron spectra; • measure the transmutation reaction rates of minor-actinides etc

  15. Neutron capture therapy

    International Nuclear Information System (INIS)

    Jun, B. J.

    1998-11-01

    The overall state of the art related with neutron capture therapy(NCT) is surveyed. Since the field related with NCT is very wide, it is not intended to survey all related subjects in depth. The primary objective of this report is to help those working for the installation of a NCT facility and a PGNAA(prompt gamma ray neutron activation analysis) system for the boron analysis understand overall NCT at Hanaro. Therefore, while the parts of reactor neutron source and PGNAA are dealt in detail, other parts are limited to the level necessary to understand related fields. For example, the subject of chemical compound which requires intensive knowledge on chemistry, is not dealt as a separated item. However, the requirement of a compound for NCT, currently available compounds, their characteristics, etc. could be understood through this report. Although the subject of cancer treated by NCT is out of the capability of the author, it is dealt focussing its characteristics related with the success of NCT. Each detailed subject is expected to be dealt more detail by specialists in future. This report would be helpful for the researchers working for the NCT to understand related fields. (author). 128 refs., 3 tabs., 12 figs

  16. Feasibility of sealed D-T neutron generator as neutron source for liver BNCT and its beam shaping assembly.

    Science.gov (United States)

    Liu, Zheng; Li, Gang; Liu, Linmao

    2014-04-01

    This paper involves the feasibility of boron neutron capture therapy (BNCT) for liver tumor with four sealed neutron generators as neutron source. Two generators are placed on each side of the liver. The high energy of these emitted neutrons should be reduced by designing a beam shaping assembly (BSA) to make them useable for BNCT. However, the neutron flux decreases as neutrons pass through different materials of BSA. Therefore, it is essential to find ways to increase the neutron flux. In this paper, the feasibility of using low enrichment uranium as a neutron multiplier is investigated to increase the number of neutrons emitted from D-T neutron generators. The neutron spectrum related to our system has a proper epithermal flux, and the fast and thermal neutron fluxes comply with the IAEA recommended values. Copyright © 2014 Elsevier Ltd. All rights reserved.

  17. Iodine neutron capture therapy

    Science.gov (United States)

    Ahmed, Kazi Fariduddin

    A new technique, Iodine Neutron Capture Therapy (INCT) is proposed to treat hyperthyroidism in people. Present thyroid therapies, surgical removal and 131I treatment, result in hypothyroidism and, for 131I, involve protracted treatment times and excessive whole-body radiation doses. The new technique involves using a low energy neutron beam to convert a fraction of the natural iodine stored in the thyroid to radioactive 128I, which has a 24-minute half-life and decays by emitting 2.12-MeV beta particles. The beta particles are absorbed in and damage some thyroid tissue cells and consequently reduce the production and release of thyroid hormones to the blood stream. Treatment times and whole-body radiation doses are thus reduced substantially. This dissertation addresses the first of the several steps needed to obtain medical profession acceptance and regulatory approval to implement this therapy. As with other such programs, initial feasibility is established by performing experiments on suitable small mammals. Laboratory rats were used and their thyroids were exposed to the beta particles coming from small encapsulated amounts of 128I. Masses of 89.0 mg reagent-grade elemental iodine crystals have been activated in the ISU AGN-201 reactor to provide 0.033 mBq of 128I. This activity delivers 0.2 Gy to the thyroid gland of 300-g male rats having fresh thyroid tissue masses of ˜20 mg. Larger iodine masses are used to provide greater doses. The activated iodine is encapsulated to form a thin (0.16 cm 2/mg) patch that is then applied directly to the surgically exposed thyroid of an anesthetized rat. Direct neutron irradiation of a rat's thyroid was not possible due to its small size. Direct in-vivo exposure of the thyroid of the rat to the emitted radiation from 128I is allowed to continue for 2.5 hours (6 half-lives). Pre- and post-exposure blood samples are taken to quantify thyroid hormone levels. The serum T4 concentration is measured by radioimmunoassay at

  18. The MARVEL assembly for neutron multiplication

    Energy Technology Data Exchange (ETDEWEB)

    David L. Chichester; Mathew T. Kinlaw

    2013-10-01

    A new multiplying test assembly is under development at Idaho National Laboratory to support research, validation, evaluation, and learning. The item is comprised of three stacked, highly-enriched uranium (HEU) cylinders, each 11.4 cm in diameter and having a combined height of up to 11.7 cm. The combined mass of all three cylinders is 20.3 kg of HEU. Calculations for the bare configuration of the assembly indicate a multiplication level of >3.5 (keff=0.72). Reflected configurations of the assembly, using either polyethylene or tungsten, are possible and have the capability of raising the assembly's multiplication level to greater than 10. This paper describes simulations performed to assess the assembly's multiplication level under different conditions and describes the resources available at INL to support the use of these materials. We also describe some preliminary calculations and test activities using the assembly to study neutron multiplication.

  19. Neutron therapy: The historical background

    International Nuclear Information System (INIS)

    Svensson, H.; Landberg, T.

    1994-01-01

    Neutron therapy was first introduced by Stone et al. in 1938, i.e. more than 10 years earlier than electron beam therapy and only 6 years after the discovery of neutrons. In spite of the impressive accomplishment in generating an adequate therapy beam, time was also found for careful radiobiological studies of neutron beams. However, it was not considered that for a certain early reaction the late effects were much greater with neutrons than with X-rays. The severe late sequelae in proportion to the few good results motivated the closure of this therapy. Neutron therapy was again introduced in Hammersmith hospital at the end of the 1960's. The major reason seems to have been to overcome the oxygen effect. Encouraging results were reported. It was argued that the very favourable statistics on local tumour control were obtained at the expense of more frequent and more severe complications. A clinical trial in Edinburgh seemed to indicate this, but it was not proved in the end as the two trials differed regarding fractionation. Today about 16000 patients have been treated with neutrons. The neutron beams now used differ significantly, both regarding dose distributions and microdosimetrical properties, from those utilized earlier. The advantage of neutrons is still, however, controversial. There are indications that neutron treatment may be favourable for some tumours. A careful cost-benefit study ought to be performed before the creation of a neutron therapy centre in Sweden as the group of patients suitable for neutrons is limited, and there may be new possibilities for improvement of photon and electron treatment with much smaller resources. (orig.)

  20. A shielding design for an accelerator-based neutron source for boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Hawk, A.E.; Blue, T.E. E-mail: blue.1@osu.edu; Woollard, J.E

    2004-11-01

    Research in boron neutron capture therapy (BNCT) at The Ohio State University Nuclear Engineering Department has been primarily focused on delivering a high quality neutron field for use in BNCT using an accelerator-based neutron source (ABNS). An ABNS for BNCT is composed of a proton accelerator, a high-energy beam transport system, a {sup 7}Li target, a target heat removal system (HRS), a moderator assembly, and a treatment room. The intent of this paper is to demonstrate the advantages of a shielded moderator assembly design, in terms of material requirements necessary to adequately protect radiation personnel located outside a treatment room for BNCT, over an unshielded moderator assembly design.

  1. Neutron dosimetry in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Miola, U.J.; Ettinger, K.V.

    1981-01-01

    The recent development of various borated compounds and the utilization of one of these (Na 2 B 12 H 11 SH) to treat brain tumors in clinical studies in Japan has renewed interest in neutron capture therapy. In these procedures thermal neutrons interact with 10 B in boron containing cells through the 10 B(n,α) 7 Li reaction producing charged particles with a maximum range of approx. 10μm in tissue. Borated analogs of chlorpromazine, porphyrin, thiouracil and deoxyuridine promise improved tumor uptake and blood clearance. The therapy beam from the Medical Research Reactor in Brookhaven contains neutrons from a modified and filtered fission spectrum and dosimetric consequences of the use of the above mentioned compounds in conjunction with thermal and epithermal fluxes are discussed in the paper. One of the important problems of radiation dosimetry in capture therapy is determination of the flux profile and, hence, the dose profile in the brain. This has been achieved by constructing a brain phantom made of TE plastic. The lyoluminescence technique provides a convenient way of monitoring the neutron flux distributions; the detectors for this purpose utilize 6 Li and 10 B compounds. Such compounds have been synthesized specially for the purpose of dosimetry of thermal and epithermal beams. In addition, standard lyoluminescent phosphors, like glutamine, could be used to determine the collisional component of the dose as well as the contribution of the 14 N(n,p) 14 C reaction. Measurements of thermal flux were compared with calculations and with measurements done with activation foils

  2. The MARVEL assembly for neutron multiplication.

    Science.gov (United States)

    Chichester, David L; Kinlaw, Mathew T

    2013-10-01

    A new multiplying test assembly is under development at Idaho National Laboratory to support research, validation, evaluation, and learning. The item is comprised of three stacked, highly-enriched uranium (HEU) cylinders, each 11.4 cm in diameter and having a combined height of up to 11.7 cm. The combined mass of all three cylinders is 20.3 kg of HEU. Calculations for the bare configuration of the assembly indicate a multiplication level of >3.5 (k(eff)=0.72). Reflected configurations of the assembly, using either polyethylene or tungsten, are possible and have the capability of raising the assembly's multiplication level to greater than 10. This paper describes simulations performed to assess the assembly's multiplication level under different conditions and describes the resources available at INL to support the use of these materials. We also describe some preliminary calculations and test activities using the assembly to study neutron multiplication. Copyright © 2013 Elsevier Ltd. All rights reserved.

  3. Middle Atlantic neutron therapy trail

    International Nuclear Information System (INIS)

    Rogers, C.

    1975-01-01

    A consortium of therapeutic radiologists in the Middle Atlantic States and physicists at the Naval Research Laboratory has been established to investigate the use of fast neutron beams in the control of some tumors. Many radiobiology experiments have indicated that neutron beams may have an advantage in the control of local tumors over that of conventional forms of radiotherapy. In preparation for clinical radiotherapy trials, extensive measurements have quantified the various physical characteristics of the NRL cyclotron-produced neutron beam. Techniques have been developed for the absolute determination of delivered dose at depth in tissue for this beam, accounting for the relatively small component of dose delivered by gamma rays, as well as that by the neutrons. A collimator system has been designed to allow the precise field definition necessary for optimum therapy treatment planning. A dose control and monitor unit has been engineered and has demonstrated a reproducibility of 0.2 percent. The relative biological effectiveness of this neutron bean has been studied with several biological systems to aid in determining proper radiotherapeutic dose levels. The objective of these studies is a full-scale clinical radiotherapy trial to test neutron effectiveness as compared to that of conventional radiotherapy, after a pilot study in man

  4. Towards gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Stalpers, L.; Kuipers, S.; Vroegindeweij, C.; Stecher-Rasmussen, F.; Slotman, B.

    2000-01-01

    As glioblastoma multiforme has macroscopic areas with poor vascularisation, and thereby poor uptake of an NCT-agent, the long-range γ-rays from GdNCT might enhance dose deposition compared to BNCT and to conformal photon therapy. Multicellular spheroids from a human glioblastoma cell line (Gli-6) were irradiated with conventional X-rays, with neutrons only (from the NRG Argonaut Reactor, LFR), and with neutrons (from the LFR) + 157 Gd-DTPA (240 ppm 157 Gd). Preliminary results demonstrate that after neutron irradiation in the presence of 157 Gd, the spheroids showed growth arrest. By 3D treatment planning calculations on MRI's from patients with brain tumours, dose volume histograms (DVH) for GdNCT were compared to DVH for conventional conformal radiotherapy. The calculations indicate that GdNCT on patients with large, deep-seated tumours yields better tumour/brain dose distribution than conformal radiotherapy. (author)

  5. Radiobiology of boron neutron capture therapy

    International Nuclear Information System (INIS)

    Bond, V.P.

    1986-01-01

    The author addresses the question of single session versus protracted therapy in the application of boron neutron therapy to tumors. As background he discusses the reasoning behind the current use of fractionated therapy with conventional low-LET radiations and difference which may obtain for neutron therapy. Several aspects of dose rates and dose levels are then addressed

  6. Workshop on neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Fairchild, R.G.; Bond, V.P. (eds.)

    1986-01-01

    Potentially optimal conditions for Neutron Capture Therapy (NCT) may soon be in hand due to the anticipated development of band-pass filtered beams relatively free of fast neutron contaminations, and of broadly applicable biomolecules for boron transport such as porphyrins and monoclonal antibodies. Consequently, a number of groups in the US are now devoting their efforts to exploring NCT for clinical application. The purpose of this Workshop was to bring these groups together to exchange views on significant problems of mutual interest, and to assure a unified and effective approach to the solutions. Several areas of preclinical investigation were deemed to be necessary before it would be possible to initiate clinical studies. As neither the monomer nor the dimer of sulfhydryl boron hydride is unequivocally preferable at this time, studies on both compounds should be continued until one is proven superior.

  7. Workshop on neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Bond, V.P.

    1986-01-01

    Potentially optimal conditions for Neutron Capture Therapy (NCT) may soon be in hand due to the anticipated development of band-pass filtered beams relatively free of fast neutron contaminations, and of broadly applicable biomolecules for boron transport such as porphyrins and monoclonal antibodies. Consequently, a number of groups in the US are now devoting their efforts to exploring NCT for clinical application. The purpose of this Workshop was to bring these groups together to exchange views on significant problems of mutual interest, and to assure a unified and effective approach to the solutions. Several areas of preclinical investigation were deemed to be necessary before it would be possible to initiate clinical studies. As neither the monomer nor the dimer of sulfhydryl boron hydride is unequivocally preferable at this time, studies on both compounds should be continued until one is proven superior

  8. Absorbing rods for nuclear fast neutron reactor absorbing assembly

    International Nuclear Information System (INIS)

    Aji, M.; Ballagny, A.; Haze, R.

    1986-01-01

    The invention proposes a neutron absorber rod for neutron absorber assembly of a fast neutron reactor. The assembly comprises a bundle of vertical rods, each one comprising a stack of pellets made of a neutron absorber material contained in a long metallic casing with a certain radial play with regard to this casing; this casing includes traps for splinters from the pellets which may appear during reactor operation, at the level of contact between adjacent pellets. The present invention prevents the casing from rupture involved by the disintegration of the pellets producing pieces of boron carbide of high hardness [fr

  9. Neutron capture therapy with thermal neutrons at IRT MIFI

    International Nuclear Information System (INIS)

    Zajtsev, K.N.; Portnov, A.A.; Savkin, V.A.; Kulakov, V.N.; Khokhlov, V.F.; Shejno, I.N.; Vajnson, A.A.; Kozlovskaya, N.G.; Meshcherikova, V.V.; Mitin, V.N.; Yarmonenko, S.P.

    2001-01-01

    Combined preclinical investigations into neutron capture therapy are conducted. Malignant melanoma was adopted as the line of investigation; boron-containing and gadolinium-containing preparations were used during the neutron capture therapy working off. Preparations produce secondary varying radiations when used in tumor. Dogs with spontaneous melanoma were used for the experiments. Procedures for the irradiation of dogs by neutron beam as the stage before use for the treatment of oncology patients were finished off; efficiency of neutron beam influence on normal tissues during the irradiation of dogs with melanoma (and without it) in antitumor and side effect sense was estimated [ru

  10. Neutron capture therapy for melanoma

    Energy Technology Data Exchange (ETDEWEB)

    Coderre, J.A.; Glass, J.D.; Micca, P.; Fairchild, R.G.

    1988-01-01

    The development of boron-containing compounds which localize selectively in tumor may require a tumor-by-tumor type of approach that exploits any metabolic pathways unique to the particular type of tumor. Melanin-producing melanomas actively transport and metabolize aromatic amino acids for use as precursors in the synthesis of the pigment melanin. It has been shown that the boron-containing amino acid analog p-borono-phenylalanine (BPA) is selectively accumulated in melanoma tissue, producing boron concentrations in tumor that are within the range estimated to be necessary for successful boron neutron capture therapy (BNCT). We report here the results of therapy experiments carried out at the Brookhaven Medical Research Reactor (BMRR). 21 refs., 5 figs., 3 tabs.

  11. Neutron capture therapy for melanoma

    International Nuclear Information System (INIS)

    Coderre, J.A.; Glass, J.D.; Micca, P.; Fairchild, R.G.

    1988-01-01

    The development of boron-containing compounds which localize selectively in tumor may require a tumor-by-tumor type of approach that exploits any metabolic pathways unique to the particular type of tumor. Melanin-producing melanomas actively transport and metabolize aromatic amino acids for use as precursors in the synthesis of the pigment melanin. It has been shown that the boron-containing amino acid analog p-borono-phenylalanine (BPA) is selectively accumulated in melanoma tissue, producing boron concentrations in tumor that are within the range estimated to be necessary for successful boron neutron capture therapy (BNCT). We report here the results of therapy experiments carried out at the Brookhaven Medical Research Reactor (BMRR). 21 refs., 5 figs., 3 tabs

  12. Utilizing horizontal reactors channels for neutron therapy

    International Nuclear Information System (INIS)

    Stankovsky, E.Yu.; Kurachenko, Yu.A.

    2000-01-01

    Two experimental heterogeneous reactors have been considered. The reactors may be applied in neutron capture therapy and in a conventional manner. The channel out of the core serves as the neutron source. At each of these facilities, both fast and epithermal neutron fluxes for BNCT research, human clinical trials, and characterized common computational techniques have been evaluated. (authors)

  13. Accelerator based neutron source for neutron capture therapy

    International Nuclear Information System (INIS)

    Salimov, R.; Bayanov, B.; Belchenko, Yu.; Belov, V.; Davydenko, V.; Donin, A.; Dranichnikov, A.; Ivanov, A.; Kandaurov, I; Kraynov, G.; Krivenko, A.; Kudryavtsev, A.; Kursanov, N.; Savkin, V.; Shirokov, V.; Sorokin, I.; Taskaev, S.; Tiunov, M.

    2004-01-01

    Full text: The Budker Institute of Nuclear Physics (Novosibirsk) and the Institute of Physics and Power Engineering (Obninsk) have proposed an accelerator based neutron source for neutron capture and fast neutron therapy for hospital. Innovative approach is based upon vacuum insulation tandem accelerator (VITA) and near threshold 7 Li(p,n) 7 Be neutron generation. Pilot accelerator based neutron source for neutron capture therapy is under construction now at the Budker Institute of Nuclear Physics, Novosibirsk, Russia. In the present report, the pilot facility design is presented and discussed. Design features of facility components are discussed. Results of experiments and simulations are presented. Complete experimental tests are planned by the end of the year 2005

  14. Neutron Collar Evolution and Fresh PWR Assembly Measurements with a New Fast Neutron Passive Collar

    Energy Technology Data Exchange (ETDEWEB)

    Menlove, Howard Olsen [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Geist, William H. [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Root, Margaret A. [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Rael, Carlos D. [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Belian, Anthony P. [Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

    2017-11-02

    The passive neutron collar approach removes the effect of poison rods when using a 1mm Gd liner. This project sets out to solve the following challenges: BWR fuel assemblies have less mass and less neutron multiplication than PWR; and effective removal of cosmic ray spallation neutron bursts needed via QC tests.

  15. Pulsed neutron source based on accelerator-subcritical-assembly

    Energy Technology Data Exchange (ETDEWEB)

    Inoue, Makoto; Noda, Akira; Iwashita, Yoshihisa; Okamoto, Hiromi; Shirai, Toshiyuki [Kyoto Univ., Uji (Japan). Inst. for Chemical Research

    1997-03-01

    A new pulsed neutron source which consists of a 300MeV proton linac and a nuclear fuel subcritical assembly is proposed. The proton linac produces pulsed spallation neutrons, which are multipied by the subcritical assembly. A prototype proton linac that accelerates protons up to 7MeV has been developed and a high energy section of a DAW structure is studied with a power model. Halo formations in high intensity beam are also being studied. (author)

  16. Monte Carlo codes use in neutron therapy

    International Nuclear Information System (INIS)

    Paquis, P.; Mokhtari, F.; Karamanoukian, D.; Pignol, J.P.; Cuendet, P.; Iborra, N.

    1998-01-01

    Monte Carlo calculation codes allow to study accurately all the parameters relevant to radiation effects, like the dose deposition or the type of microscopic interactions, through one by one particle transport simulation. These features are very useful for neutron irradiations, from device development up to dosimetry. This paper illustrates some applications of these codes in Neutron Capture Therapy and Neutron Capture Enhancement of fast neutrons irradiations. (authors)

  17. Nuclear data needed for neutron therapy

    International Nuclear Information System (INIS)

    Okamoto, K.

    1988-03-01

    This is the summary report of the First Research Co-ordination Meeting of the IAEA Co-ordinated Research Programme (CRP) on Nuclear Data Needed for Neutron Therapy, convened by the IAEA Nuclear Data Section in Vienna, from 17 to 20 November 1987. The main objectives of the CRP are to improve the present state of nuclear data for neutron therapy. (author)

  18. Neutron therapy in the 21. century

    International Nuclear Information System (INIS)

    Kroc, Thomas K.; Welsh, James S.

    2015-01-01

    The question of whether or not neutron therapy works has been answered. It is a qualified yes, as is the case with all of radiation therapy. But, neutron therapy has not kept pace with the rest of radiation therapy in terms of beam delivery techniques. Modern photon and proton based external beam radiotherapy routinely implements image-guidance, beam intensity-modulation and 3-dimensional treatment planning. The current iteration of fast neutron radiotherapy does not. Addressing these deficiencies, however, is not a matter of technology or understanding, but resources. The future of neutron therapy lies in better understanding the interaction processes of radiation with living tissue. A combination of radiobiology and computer simulations is required in order to optimise the use of neutron therapy. The questions that need to be answered are: Can we connect the macroscopic with the microscopic? What is the optimum energy? What is the optimum energy spectrum? Can we map the sensitivity of the various tissues of the human body and use that knowledge to our advantage? And once we gain a better understanding of the above radiobiological issues will we be able to capitalise on this understanding by precisely and accurately delivering fast neutrons in a manner comparable to what is now possible with photons and protons? This presentation will review the accomplishments to date. It will then lay out the questions that need to be answered for neutron therapy to truly be a 21. century therapy. (authors)

  19. Neutron Detector Signal Processing to Calculate the Effective Neutron Multiplication Factor of Subcritical Assemblies

    Energy Technology Data Exchange (ETDEWEB)

    Talamo, Alberto [Argonne National Lab. (ANL), Argonne, IL (United States). Nuclear Engineering Division; Gohar, Yousry [Argonne National Lab. (ANL), Argonne, IL (United States). Nuclear Engineering Division

    2016-06-01

    This report describes different methodologies to calculate the effective neutron multiplication factor of subcritical assemblies by processing the neutron detector signals using MATLAB scripts. The subcritical assembly can be driven either by a spontaneous fission neutron source (e.g. californium) or by a neutron source generated from the interactions of accelerated particles with target materials. In the latter case, when the particle accelerator operates in a pulsed mode, the signals are typically stored into two files. One file contains the time when neutron reactions occur and the other contains the times when the neutron pulses start. In both files, the time is given by an integer representing the number of time bins since the start of the counting. These signal files are used to construct the neutron count distribution from a single neutron pulse. The built-in functions of MATLAB are used to calculate the effective neutron multiplication factor through the application of the prompt decay fitting or the area method to the neutron count distribution. If the subcritical assembly is driven by a spontaneous fission neutron source, then the effective multiplication factor can be evaluated either using the prompt neutron decay constant obtained from Rossi or Feynman distributions or the Modified Source Multiplication (MSM) method.

  20. Neutron Detector Signal Processing to Calculate the Effective Neutron Multiplication Factor of Subcritical Assemblies

    International Nuclear Information System (INIS)

    Talamo, Alberto; Gohar, Yousry

    2016-01-01

    This report describes different methodologies to calculate the effective neutron multiplication factor of subcritical assemblies by processing the neutron detector signals using MATLAB scripts. The subcritical assembly can be driven either by a spontaneous fission neutron source (e.g. californium) or by a neutron source generated from the interactions of accelerated particles with target materials. In the latter case, when the particle accelerator operates in a pulsed mode, the signals are typically stored into two files. One file contains the time when neutron reactions occur and the other contains the times when the neutron pulses start. In both files, the time is given by an integer representing the number of time bins since the start of the counting. These signal files are used to construct the neutron count distribution from a single neutron pulse. The built-in functions of MATLAB are used to calculate the effective neutron multiplication factor through the application of the prompt decay fitting or the area method to the neutron count distribution. If the subcritical assembly is driven by a spontaneous fission neutron source, then the effective multiplication factor can be evaluated either using the prompt neutron decay constant obtained from Rossi or Feynman distributions or the Modified Source Multiplication (MSM) method.

  1. Fast Neutron Emission Tomography of Used Nuclear Fuel Assemblies

    Science.gov (United States)

    Hausladen, Paul; Iyengar, Anagha; Fabris, Lorenzo; Yang, Jinan; Hu, Jianwei; Blackston, Matthew

    2017-09-01

    Oak Ridge National Laboratory is developing a new capability to perform passive fast neutron emission tomography of spent nuclear fuel assemblies for the purpose of verifying their integrity for international safeguards applications. Most of the world's plutonium is contained in spent nuclear fuel, so it is desirable to detect the diversion of irradiated fuel rods from an assembly prior to its transfer to ``difficult to access'' storage, such as a dry cask or permanent repository, where re-verification is practically impossible. Nuclear fuel assemblies typically consist of an array of fuel rods that, depending on exposure in the reactor and consequent ingrowth of 244Cm, are spontaneous sources of as many as 109 neutrons s-1. Neutron emission tomography uses collimation to isolate neutron activity along ``lines of response'' through the assembly and, by combining many collimated views through the object, mathematically extracts the neutron emission from each fuel rod. This technique, by combining the use of fast neutrons -which can penetrate the entire fuel assembly -and computed tomography, is capable of detecting vacancies or substitutions of individual fuel rods. This paper will report on the physics design and component testing of the imaging system. This material is based upon work supported by the U.S. Department of Energy, Office of Defense Nuclear Nonproliferation Research and Development within the National Nuclear Security Administration, under Contract Number DE-AC05-00OR22725.

  2. The Edinburgh experience of fast neutron therapy

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Orr, J.A.; Kerr, G.R.

    1982-01-01

    The Edinburgh experience is based on a d(15 + Be) neutron beam generated by a compact CS 30 Cyclotron. Neutron therapy alone given in 20 daily fractions over four weeks has been compared with photon therapy given in the same fractionation schedule. Since clinical studies began in March, 1977, over 500 patients have been treated by fast neutrons. Almost all patients are now admitted to randomly controlled trials. In the head and neck trial conducted in collaboration with collegues in Amsterdam and Essen, 192 patients are available for analysis. Most patients had T3 lesions and about 50% had involved nodes. The cumulative regression rate at six months is similar after neutrons and photons (75%). Later recurrence rates (36%) are also similar. The early radiation morbidity is similar in both groups, but the late reactions are greater after neutrons (15%) than photons (6%). Overall survival is better after photon therapy. A trial of patients with glioblastoma has also shown a better survival after photon therapy. Neutron therapy was associated with demyelinization in three of 18 patients. Patients with transitional cell cancer of the bladder have also been the subject of study. Local tumor control was similar (53%) after neutrons and photons. Late radiation morbidity was much greater after neutrons (20%), compared with photons (2%). In a trial of advanced carcinoma of the rectum, the local tumor control was also similar after neutrons and photons (30%), but morbidity was greater after neutrons. Soft tissue sarcomas have shown response rates (37%) that may be expected after photon therapy. Salivary gland tumors have shown a similar experience, although slow growing tumors such as adenoid cystic carcinoma may respond better to neutrons

  3. Proton linacs for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Lennox, A.J.

    1993-08-01

    Recent advances in the ability to deliver boron-containing drugs to brain tumors have generated interest in ∼4 MeV linacs as sources of epithermal neutrons for radiation therapy. In addition, fast neutron therapy facilities have been studying methods to moderate their beams to take advantage of the high cross section for epithermal neutrons on boron-10. This paper describes the technical issues involved in each approach and presents the motivation for undertaking such studies using the Fermilab linac. the problems which must be solved before therapy can begin are outlined. Status of preparatory work and results of preliminary measurements are presented

  4. Neutronics assessment of thorium-based fuel assembly in SCWR

    International Nuclear Information System (INIS)

    Liu, Shichang; Cai, Jiejin

    2013-01-01

    Highlights: • A novel thorium-based fuel assembly for SCWR has been introduced and investigated. • Neutronic properties of three thorium fuels have been studied, compared with UO 2 fuel. • The thorium-based fuel has advantages on fuel utilization and lower MAs generation. -- Abstract: Aiming to take advantage of neutron spectrum of SCWR, a novel thorium-based fuel assembly for SCWR is introduced in this paper. The neutronic characteristics of the introduced fuel assembly with three different thorium fuel types have been investigated using the “dragon” codes. The parameters in different working conditions, such as infinite multiplication factors, radial power peaking factor, temperature coefficient of reactivity and their relation with the operation period have been assessed by comparing with conventional uranium assembly. Moreover, the moderator-to-fuel ratio (MFR) was changed in order to investigate its influence on the neutronic characteristics of fuel assembly. Results show that the thorium-based fuel has advantages on both efficient fuel utilization and lower minor actinide generation, with some similar neutronic properties to the uranium fuel

  5. Preclinical studies on gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Akine, Yasuyuki

    1994-01-01

    Gadolinium neutron capture therapy is based on radiations (photons and electrons) produced in the tumor by a nuclear reaction between gadolinium and lower-energy neutrons. Studies with Chinese hamster cells have shown that the radiation effect resulting from gadolinium neutron capture reactions is mostly of low LET and that released electrons are the significant component in the over-all dose. Biological dosimetry revealed that the dose does not seem to increase in proportion to the gadolinium concentration, leading to a conclusion that there is a range of gadolinium concentrations most efficient for gadolinium neutron capture therapy. The in vivo studies with transplantable tumors in mice and rabbits have revealed that close contact between gadolinium and the cell is not necessarily required for cell inactivation and that gadolinium delivery selective to tumors is crucial. The results show that the potential of gadolinium neutron capture therapy as a therapeutic modality appears very promising. (author)

  6. Nuclear reactor, fuel assembly and neutron measuring system

    International Nuclear Information System (INIS)

    Chaki, Masao; Murase, Michio; Zukeran, Atsushi; Moriya, Kimiaki

    1998-01-01

    The present invention provides a BWR type reactor improved with the efficiency of used fuels and fuel economy by increasing a rated power and reducing exchange fuels. Namely, in a BWR type reactor at present, a thermal limit value is determined by conducting nuclear calculation of the reactor core based on data of reactor flow rate measurement and data of neutron flux measurement. However, since the neutron calculation of the reactor core is based on fuel assemblies while the points for the neutron measurement are present at the outside of the fuel assemblies, errors are caused. A margin including the errors has been used as a thermal limit value during operation. In the present invention, neutron fluxes in the fuel assembly as a base of the nuclear calculation can be measured by the same number of neutron detector tubes, but the number of the measuring points is increased to four times. With such procedures, errors caused by the difference of the neutron calculation and values at neutron measuring points can be reduced. As a result, a margin of the thermal limit value is reduced to increase the degree of freedom of reactor operation. Then, the economical property of the reactor operation can be improved. (N.H.)

  7. The Edinburgh experience of fast neutron therapy

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Orr, J.A.; Kerr, G.R.

    1982-01-01

    The Edinburgh experience is based on a d(15 + Be) neutron beam generated by a compact CS 30 Cyclotron. The facility has an iso-center treatment head providing 240 0 of rotation. The most important limitation of the beam is its poor penetrating quality. We have compared neutron therapy alone given in 20 daily fractions over four weeks with photon therapy given in the same fractionation schedule. Since clinical studies began in March, 1977, over 500 patients have been treated by fast neutrons. Almost all patients are now admitted to randomly controlled trials. In the head and neck trial conducted in collaboraton with colleagues in Amsterdam and Essen, 92 patients are available for analysis. Most patients had T3 lesions and about 50% had involved nodes. The cumulative regression rate at six months is similar after neutrons and photons (75%). Later recurrence rates (36%) are also similar. The early radiation morbidity is similar in both groups, but the late reactions are greater after neutrons (15%) than photons (6%). Overall survival is better after photon therapy. A trial of patients with glioblastoma has also shown a better survival after photon therapy. Neutron therapy was associated with demelinization in three of 18 patients. Patients with transitional cell cancer of the bladder have also been the subject of study. Local tumor control was similar (53%) after neutrons and photons. Late radiation morbidity was much greater after neutrons (20%), compared with photons (2%). In a trial of advanced carcinoma of the rectum, the local tumor control was also similar after neutrons and photons (30%), but morbidity was greater after neutrons. Soft tissue sarcomas have shown response rates (37%) that may be expected after photon therapy

  8. Hyper-thermal neutron irradiation field for neutron capture therapy

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori; Kobayashi, Tooru; Kanda, Keiji

    1994-01-01

    The utilization of hyper-thermal neutrons, which have an energy spectrum of a Maxwell distribution higher than the room temperature of 300 K, has been studied in order to improve the thermal neutron flux distribution in a living body for a deep-seated tumor in neutron capture therapy (NCT). Simulation calculations using MCNP-V3 were carried out in order to investigate the characteristics of the hyper-thermal neutron irradiation field. From the results of simulation calculations, the following were confirmed: (i) The irradiation field of the hyper-thermal neutrons is feasible by using some scattering materials with high temperature, such as Be, BeO, C, SiC and ZrH 1.7 . Especially, ZrH 1.7 is thought to be the best material because of good characteristics of up-scattering for thermal neutrons. (ii) The ZrH 1.7 of 1200 K yields the hyper-thermal neutrons of a Maxwell-like distribution at about 2000 K and the treatable depth is about 1.5 cm larger comparing with the irradiation of the thermal neutrons of 300 K. (iii) The contamination by the secondary gamma-rays from the scattering materials can be sufficiently eliminated to the tolerance level for NCT through the bismuth layer, without the larger change of the energy spectrum of hyper-thermal neutrons. ((orig.))

  9. Neutron spectrum for neutron capture therapy in boron

    International Nuclear Information System (INIS)

    Medina C, D.; Soto B, T. G.; Baltazar R, A.; Vega C, H. R.

    2016-10-01

    Glioblastoma multiforme is the most common and aggressive of brain tumors and is difficult to treat by surgery, chemotherapy or conventional radiation therapy. One treatment alternative is the Neutron Capture Therapy in Boron, which requires a beam modulated in neutron energy and a drug with 10 B able to be fixed in the tumor. When the patients head is exposed to the neutron beam, they are captured by the 10 B and produce a nucleus of 7 Li and an alpha particle whose energy is deposited in the cancer cells causing it to be destroyed without damaging the normal tissue. One of the problems associated with this therapy is to have an epithermal neutrons flux of the order of 10 9 n/cm 2 -sec, whereby irradiation channels of a nuclear research reactor are used. In this work using Monte Carlo methods, the neutron spectra obtained in the radial irradiation channel of the TRIGA Mark III reactor are calculated when inserting filters whose position and thickness have been modified. From the arrangements studied, we found that the Fe-Cd-Al-Cd polyethylene filter yielded a ratio between thermal and epithermal neutron fluxes of 0.006 that exceeded the recommended value (<0.05), and the dose due to the capture gamma rays is lower than the dose obtained with the other arrangements studied. (Author)

  10. Chemical processes in neutron capture therapy

    International Nuclear Information System (INIS)

    Brown, B.J.

    1975-01-01

    Research into the radiation chemical effects of neutron capture therapy are described. In the use of neutron capture therapy for the treatment of brain tumours, compounds containing an activatable nuclide are selectively concentrated within tumour tissue and irradiated with neutrons. Target compounds for use in therapy must accumulate selectively in high concentrations in the tumour and must be non toxic to the patient. The most suitable of these are the boron hydrides. Radiation dosages, resulting from neutron capture in normal tissue constituents are tabulated. As part of the program to study the radiation-induced chemical processes undergone by boron target compounds, the radiolytic degredation of boron hydride and phenyl boric acid system was investigated. No direct dependence between the yield of the transient radiolytic species and the concentration of the B-compound was observed. (author)

  11. Self-powered neutron flux detector assembly

    International Nuclear Information System (INIS)

    Allan, C.J.; McIntyre, I.L.

    1980-01-01

    A self-powered neutron flux detector has both the central emitter electrode and its surrounding collector electrode made of inconel 600. The lead cables may also be made of inconel. Other nickel alloys, or iron, nickel, titamium, chromium, zirconium or their alloys may also be used for the electrodes

  12. The measurement of neutron and neutron induced photon spectra in fusion reactor related assemblies

    CERN Document Server

    Unholzer, S; Klein, H; Seidel, K

    2002-01-01

    The spectral neutron and photon fluence (or flux) measured outside and inside of assemblies related to fusion reactor constructions are basic quantities of fusion neutronics. The comparison of measured spectra with the results of MCNP neutron and photon transport calculations allows a crucial test of evaluated nuclear data as generally used in fusion applications to be carried out. The experiments concern mixed neutron/photon fields with about the same intensity of the two components. An NE-213 scintillation spectrometer, well described by response matrices for both neutrons and photons, is used as proton-recoil and Compton spectrometer. The experiments described here in more detail address the background problematic of two applications, an iron benchmark experiment with an ns-pulsed neutron source and a deep penetration mock-up experiment for the investigation of the ITER in-board shield system. The measured spectral neutron and photon fluences are compared with spectra calculated with the MCNP code on the b...

  13. Nuclear fuel assembly for fast neutron reactors

    International Nuclear Information System (INIS)

    Ilyunin, V.G.; Murogov, V.M.; Troyanov, M.F.; Rinejskij, A.A.; Ustinov, G.G.; Shmelev, A.N.

    1982-01-01

    The fuel assembly of a fast reactor consists of fuel elements comprising sections with fissionable and breeding material and tubes with hollows designed for entrapping gaseous fission products. Tubes joining up to the said sections are divided in a middle and a peripheral group such that at least one of the tube groups is placed in the space behind the coolant inlet ports. The configuration above allows reducing internal overpressure in the fuel assembly, thus reducing the volume of necessary structural elements in the core. (J.B.)

  14. Approach to magnetic neutron capture therapy

    International Nuclear Information System (INIS)

    Kuznetsov, Anatoly A.; Podoynitsyn, Sergey N.; Filippov, Victor I.; Komissarova, Lubov Kh.; Kuznetsov, Oleg A.

    2005-01-01

    Purpose: The method of magnetic neutron capture therapy can be described as a combination of two methods: magnetic localization of drugs using magnetically targeted carriers and neutron capture therapy itself. Methods and Materials: In this work, we produced and tested two types of particles for such therapy. Composite ultradispersed ferro-carbon (Fe-C) and iron-boron (Fe-B) particles were formed from vapors of respective materials. Results: Two-component ultradispersed particles, containing Fe and C, were tested as magnetic adsorbent of L-boronophenylalanine and borax and were shown that borax sorption could be effective for creation of high concentration of boron atoms in the area of tumor. Kinetics of boron release into the physiologic solution demonstrate that ultradispersed Fe-B (10%) could be applied for an effective magnetic neutron capture therapy. Conclusion: Both types of the particles have high magnetization and magnetic homogeneity, allow to form stable magnetic suspensions, and have low toxicity

  15. Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors.

    Science.gov (United States)

    Blue, Thomas E; Yanch, Jacquelyn C

    2003-01-01

    This paper reviews the development of low-energy light ion accelerator-based neutron sources (ABNSs) for the treatment of brain tumors through an intact scalp and skull using boron neutron capture therapy (BNCT). A major advantage of an ABNS for BNCT over reactor-based neutron sources is the potential for siting within a hospital. Consequently, light-ion accelerators that are injectors to larger machines in high-energy physics facilities are not considered. An ABNS for BNCT is composed of: (1) the accelerator hardware for producing a high current charged particle beam, (2) an appropriate neutron-producing target and target heat removal system (HRS), and (3) a moderator/reflector assembly to render the flux energy spectrum of neutrons produced in the target suitable for patient irradiation. As a consequence of the efforts of researchers throughout the world, progress has been made on the design, manufacture, and testing of these three major components. Although an ABNS facility has not yet been built that has optimally assembled these three components, the feasibility of clinically useful ABNSs has been clearly established. Both electrostatic and radio frequency linear accelerators of reasonable cost (approximately 1.5 M dollars) appear to be capable of producing charged particle beams, with combinations of accelerated particle energy (a few MeV) and beam currents (approximately 10 mA) that are suitable for a hospital-based ABNS for BNCT. The specific accelerator performance requirements depend upon the charged particle reaction by which neutrons are produced in the target and the clinical requirements for neutron field quality and intensity. The accelerator performance requirements are more demanding for beryllium than for lithium as a target. However, beryllium targets are more easily cooled. The accelerator performance requirements are also more demanding for greater neutron field quality and intensity. Target HRSs that are based on submerged-jet impingement and

  16. Neutron therapy of resistant thyroid gland cancer

    Science.gov (United States)

    Choynzonov, E. L.; Gribova, O. V.; Startseva, Zh. A.; Lisin, V. A.; Novikov, V. A.; Musabaeva, L. I.

    2017-09-01

    The purpose of this study was to analyze the results of the combined modality treatment and radiation therapy using 6.3 MeV fast neutrons c. The study included 45 patients with thyroid gland cancers who received the combined modality treatment and radiation therapy alone with the use of 6.3 MeV fast neutrons generated within U-120 cyclotron. The clinical trial of neutron-photon therapy used alone and in combination with the surgery for the patients with aggressive forms of thyroid cancer showed feasibility of increasing the effectiveness of treatment due to the reduction in the incidence of local recurrences. In addition, satisfactory treatment tolerance and absence of severe specific complications dictate the necessity of prospective studies to improve treatment outcomes.

  17. Nuclear data for neutron therapy: Status and future needs

    International Nuclear Information System (INIS)

    1997-12-01

    This report discusses the status and success of neutron therapy and some of the problems in clinical neutron dosimetry. Existing neutron interaction data, in particular results of kerma factor measurements and data evaluations, are reviewed. Nuclear data relevant for neutron source reactions, collimation, and shielding are also discussed. Finally, physical aspects of the variation of biological effectiveness of neutrons with neutron energy (radiation quality) are set out. Exchange of information between neutron therapy centers is essential, since only clinical experience can determine the optimal absorbed dose, fractionation, target volume, and clinical indications/contra-indications for neutron therapy

  18. Nuclear data for neutron therapy: Status and future needs

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-12-01

    This report discusses the status and success of neutron therapy and some of the problems in clinical neutron dosimetry. Existing neutron interaction data, in particular results of kerma factor measurements and data evaluations, are reviewed. Nuclear data relevant for neutron source reactions, collimation, and shielding are also discussed. Finally, physical aspects of the variation of biological effectiveness of neutrons with neutron energy (radiation quality) are set out. Exchange of information between neutron therapy centers is essential, since only clinical experience can determine the optimal absorbed dose, fractionation, target volume, and clinical indications/contra-indications for neutron therapy. Refs, 44 figs, 19 tabs.

  19. Benchmark experiment on vanadium assembly with D-T neutrons. Leakage neutron spectrum measurement

    Energy Technology Data Exchange (ETDEWEB)

    Kokooo; Murata, I.; Nakano, D.; Takahashi, A. [Osaka Univ., Suita (Japan); Maekawa, F.; Ikeda, Y.

    1998-03-01

    The fusion neutronics benchmark experiments have been done for vanadium and vanadium alloy by using the slab assembly and time-of-flight (TOF) method. The leakage neutron spectra were measured from 50 keV to 15 MeV and comparison were done with MCNP-4A calculations which was made by using evaluated nuclear data of JENDL-3.2, JENDL-Fusion File and FENDL/E-1.0. (author)

  20. Parallel processing of neutron transport in fuel assembly calculation

    International Nuclear Information System (INIS)

    Song, Jae Seung

    1992-02-01

    Group constants, which are used for reactor analyses by nodal method, are generated by fuel assembly calculations based on the neutron transport theory, since one or a quarter of the fuel assembly corresponds to a unit mesh in the current nodal calculation. The group constant calculation for a fuel assembly is performed through spectrum calculations, a two-dimensional fuel assembly calculation, and depletion calculations. The purpose of this study is to develop a parallel algorithm to be used in a parallel processor for the fuel assembly calculation and the depletion calculations of the group constant generation. A serial program, which solves the neutron integral transport equation using the transmission probability method and the linear depletion equation, was prepared and verified by a benchmark calculation. Small changes from the serial program was enough to parallelize the depletion calculation which has inherent parallel characteristics. In the fuel assembly calculation, however, efficient parallelization is not simple and easy because of the many coupling parameters in the calculation and data communications among CPU's. In this study, the group distribution method is introduced for the parallel processing of the fuel assembly calculation to minimize the data communications. The parallel processing was performed on Quadputer with 4 CPU's operating in NURAD Lab. at KAIST. Efficiencies of 54.3 % and 78.0 % were obtained in the fuel assembly calculation and depletion calculation, respectively, which lead to the overall speedup of about 2.5. As a result, it is concluded that the computing time consumed for the group constant generation can be easily reduced by parallel processing on the parallel computer with small size CPU's

  1. Microdosimetry for Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Maughan, R.L.; Kota, C.

    2000-01-01

    The specific aims of the research proposal were as follows: (1) To design and construct small volume tissue equivalent proportional counters for the dosimetry and microdosimetry of high intensity thermal and epithermal neutron beams used in BNCT, and of modified fast neutron beams designed for boron neutron capture enhanced fast neutron therapy (BNCEFNT). (2) To develop analytical methods for estimating the biological effectiveness of the absorbed dose in BNCT and BNCEFNT based on the measured microdosimetric spectra. (3) To develop an analytical framework for comparing the biological effectiveness of different epithermal neutron beams used in BNCT and BNCEFNT, based on correlated sets of measured microdosimetric spectra and radiobiological data. Specific aims (1) and (2) were achieved in their entirety and are comprehensively documented in Jay Burmeister's Ph.D. dissertation entitled ''Specification of physical and biologically effective absorbed dose in radiation therapies utilizing the boron neutron capture reaction'' (Wayne State University, 1999). Specific aim (3) proved difficult to accomplish because of a lack of sufficient radiobiological data

  2. Gadolinium atom on neutron capture therapy

    International Nuclear Information System (INIS)

    Oda, Y.; Takagaki, M.; Miyatake, S.; Kikuchi, H.

    1994-01-01

    This report describes our measurements of gadolinium concentrations in several brain tumors obtained from fresh surgical specimens, as compared with corresponding concentrations in the blood. Moreover we tried to find out if the gadolinium concentration is high enough to use this compound in the treatment of brain tumors by neutron capture therapy. (J.P.N.)

  3. Installation Test of Cold Neutron Soruce In-pool Assembly

    International Nuclear Information System (INIS)

    Lee, Kye Hong; Choi, J.; Wu, S. I.; Kim, Y. K.; Cho, Y. G.; Lee, C. H.; Kim, K. R.

    2006-04-01

    Before installation of the final cold neutron source in-pool assembly (IPA) in the vertical CN hole at the HANARO, the research reactor, the installation test of IPA has been conducted in the CN hole of the reactor using a full-scaled mock-up in-pool assembly. The well-known cold neutron sources, being safely operated or being now constructed, had been constructed together with each research reactor; therefore, there was little limitation to obtain the optimal cold neutron source since a cold neutron source had been decided to be installed in the reactor from the beginning of the design for the reactor construction. Unlikely, the HANARO has been operated for 10 years so that we have got lots of design limitation in terms of the decisions in the optimal shape, size, minimal light-water gap, and adhesion degree to the CN beam tube, IPA installation tools, etc. for the construction of the CNS. Accordingly, the main objective of this test is to understand any potential problem or interference happened inside the reactor by installing the mock-up IPA and installation bracket. The outcomes from this test is reflected on the finalizing process of the IPA detail design

  4. Description and performance characteristics for the neutron Coincidence Collar for the verification of reactor fuel assemblies

    International Nuclear Information System (INIS)

    Menlove, H.O.

    1981-08-01

    An active neutron interrogation method has been developed for the measurement of 235 U content in fresh fuel assemblies. The neutron Coincidence Collar uses neutron interrogation with an AmLi neutron source and coincidence counting the induced fission reaction neutrons from the 235 U. This manual describes the system components, operation, and performance characteristics. Applications of the Coincidence Collar to PWR and BWR types of reactor fuel assemblies are described

  5. Neutron therapy coupling brachytherapy and boron neutron capture therapy (BNCT) techniques

    International Nuclear Information System (INIS)

    Chaves, Iara Ferreira.

    1994-12-01

    In the present dissertation, neutron radiation techniques applied into organs of the human body are investigated as oncologic radiation therapy. The proposal treatment consists on connecting two distinct techniques: Boron Neutron Capture Therapy (BNCT) and irradiation by discrete sources of neutrons, through the brachytherapy conception. Biological and radio-dosimetrical aspects of the two techniques are considered. Nuclear aspects are discussed, presenting the nuclear reactions occurred in tumoral region, and describing the forms of evaluating the dose curves. Methods for estimating radiation transmission are reviewed through the solution of the neutron transport equation, Monte Carlo methodology, and simplified analytical calculation based on diffusion equation and numerical integration. The last is computational developed and presented as a quickly way to neutron transport evaluation in homogeneous medium. The computational evaluation of the doses for distinct hypothetical situations is presented, applying the coupled techniques BNTC and brachytherapy as an possible oncologic treatment. (author). 78 refs., 61 figs., 21 tabs

  6. Accelerator Based Neutron Beams for Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Yanch, Jacquelyn C.

    2003-01-01

    The DOE-funded accelerator BNCT program at the Massachusetts Institute of Technology has resulted in the only operating accelerator-based epithermal neutron beam facility capable of generating significant dose rates in the world. With five separate beamlines and two different epithermal neutron beam assemblies installed, we are currently capable of treating patients with rheumatoid arthritis in less than 15 minutes (knee joints) or 4 minutes (finger joints) or irradiating patients with shallow brain tumors to a healthy tissue dose of 12.6 Gy in 3.6 hours. The accelerator, designed by Newton scientific Incorporated, is located in dedicated laboratory space that MIT renovated specifically for this project. The Laboratory for Accelerator Beam Applications consists of an accelerator room, a control room, a shielded radiation vault, and additional laboratory space nearby. In addition to the design, construction and characterization of the tandem electrostatic accelerator, this program also resulted in other significant accomplishments. Assemblies for generating epithermal neutron beams were designed, constructed and experimentally evaluated using mixed-field dosimetry techniques. Strategies for target construction and target cooling were implemented and tested. We demonstrated that the method of submerged jet impingement using water as the coolant is capable of handling power densities of up to 6 x 10(sup 7) W/m(sup 2) with heat transfer coefficients of 10(sup 6)W/m(sup 2)-K. Experiments with the liquid metal gallium demonstrated its superiority compared with water with little effect on the neutronic properties of the epithermal beam. Monoenergetic proton beams generated using the accelerator were used to evaluate proton RBE as a function of LET and demonstrated a maximum RBE at approximately 30-40 keV/um, a finding consistent with results published by other researchers. We also developed an experimental approach to biological intercomparison of epithermal beams and

  7. Radiation therapy with fast neutrons: A review

    International Nuclear Information System (INIS)

    Jones, D.T.L.; Wambersie, A.

    2007-01-01

    Because of their biological effects fast neutrons are most effective in treating large, slow-growing tumours which are resistant to conventional X-radiation. Patients are treated typically 3-4 times per week for 4-5 weeks (sometimes in combination with X-radiation) for a variety of conditions such as carcinomas of the head and neck, salivary gland, paranasal sinus and breast; soft tissue, bone and uterine sarcomas and malignant melanomas. It is estimated that about 27,000 patients have undergone fast neutron therapy to date

  8. Recent advances in neutron capture therapy (NCT)

    International Nuclear Information System (INIS)

    Fairchild, R.G.

    1985-01-01

    The application of the 10 B(n,α) 7 Li reaction to cancer radiotherapy (Neutron Capture therapy, or NCT) has intrigued investigators since the discovery of the neutron. This paper briefly summarizes data describing recently developed boronated compounds with evident tumor specificity and extended biological half-lives. The implication of these compounds to NCT is evaluated in terms of Therapeutic Gain (TG). The optimization of NCT using band-pass filtered beams is described, again in terms of TG, and irradiation times with these less intense beams are estimated. 24 refs., 3 figs., 3 tabs

  9. Study on neutron streaming effect in large fast critical assembly

    International Nuclear Information System (INIS)

    Takeda, Toshikazu; Yamaoka, Mitsuaki; Sakurai, Shungo; Tanimoto, Koichi; Abe, Yuhei

    1981-03-01

    A cell calculation method taking into account the neutron leakage from a cell and a transport calculation method treating the neutron streaming have been developed, and their applicability has been investigated. In the cell calculation method, the neutron leakage in the perpendicular direction to plates was treated by introducing an albedo collision probability which is a first-flight collision probability incorporating albedos at cell boundaries, and that in the parallel direction was treated by the pseudo absorption method. The use of the albedo collision probability made it possible to calculate the flux tilt in a cell exactly. This cell calculation method was applied to two slab models where fuel drawers were stacked in perpendicular and parallel directions to plates. Cell averaged cross sections calculated by the proposed method agreed well with those obtained from exact transport calculations treating the plate-wise heterogeneity, while the infinite cell calculation and the conventional pseudo absorption method produced about 2% errors in the cell-averaged cross sections. The cell-averaging procedure for control-rod channels was also proposed, and this method was applied to the calculation of control-rod worths and control-rod position worths. A transport calculation method based on the response matrix method has been proposed to treat the neutron streaming in fast critical assemblies directly. A response matrix code in two dimensional XY geometry RES2D was made. The accuracy of response matrices obtained from the RES2D code was checked by applying it to a slab cell and by comparing cell-averaged cross sections and k-infinity with those from a reference cell calculation based on the collision probability. The agreement of the results was good, and it was found that the response matrix method is very promising for the treatment of the neutron streaming in fast critical assemblies. (author)

  10. Fast neutron therapy in advanced malignant tumour treatment

    International Nuclear Information System (INIS)

    Avinc, A.

    1998-01-01

    In this report the fast neutron therapy applications were examined by thoroughly consideration of the fast neutron sources and the interactions of the fast neutron by the medium. The efficacy of fast neutron radiotherapy with that of patients with locally advanced tumours were compared. Radiological data indicate that fast neutrons could bring benefit in the treatment of some tumour types especially salivary glands, paranasal sinuses, soft tissue sarcomas, prostatic adenocarcinomas, palliative treatment of melanoma and rectum. There is a significant improvement in local/regional control for the neutron group, but no improvement in the survival. The neutron therapy is suggested through which this benefit could be achieved

  11. Estimation of neutron production from accelerator head assembly of 15 MV medical LINAC using FLUKA simulations

    Energy Technology Data Exchange (ETDEWEB)

    Patil, B.J., E-mail: bjp@physics.unipune.ac.in [Department of Physics, University of Pune, Pune 411 007 (India); Chavan, S.T., E-mail: sharad@sameer.gov.in [SAMEER, IIT Powai Campus, Mumbai 400 076 (India); Pethe, S.N., E-mail: sanjay@sameer.gov.in [SAMEER, IIT Powai Campus, Mumbai 400 076 (India); Krishnan, R., E-mail: krishnan@sameer.gov.in [SAMEER, IIT Powai Campus, Mumbai 400 076 (India); Bhoraskar, V.N., E-mail: vnb@physics.unipune.ac.in [Department of Physics, University of Pune, Pune 411 007 (India); Dhole, S.D., E-mail: sanjay@physics.unipune.ac.in [Department of Physics, University of Pune, Pune 411 007 (India)

    2011-12-15

    For the production of a clinical 15 MeV photon beam, the design of accelerator head assembly has been optimized using Monte Carlo based FLUKA code. The accelerator head assembly consists of e-{gamma} target, flattening filter, primary collimator and an adjustable rectangular secondary collimator. The accelerators used for radiation therapy generate continuous energy gamma rays called Bremsstrahlung (BR) by impinging high energy electrons on high Z materials. The electron accelerators operating above 10 MeV can result in the production of neutrons, mainly due to photo nuclear reaction ({gamma}, n) induced by high energy photons in the accelerator head materials. These neutrons contaminate the therapeutic beam and give a non-negligible contribution to patient dose. The gamma dose and neutron dose equivalent at the patient plane (SSD = 100 cm) were obtained at different field sizes of 0 Multiplication-Sign 0, 10 Multiplication-Sign 10, 20 Multiplication-Sign 20, 30 Multiplication-Sign 30 and 40 Multiplication-Sign 40 cm{sup 2}, respectively. The maximum neutron dose equivalent is observed near the central axis of 30 Multiplication-Sign 30 cm{sup 2} field size. This is 0.71% of the central axis photon dose rate of 0.34 Gy/min at 1 {mu}A electron beam current.

  12. Neutron capture therapy. Principles and applications

    International Nuclear Information System (INIS)

    Sauerwein, Wolfgang A.G.; Moss, Raymond; Wittig, Andrea; Nakagawa, Yoshinobu

    2012-01-01

    State of the art report on neutron capture therapy. Summarizes the progress made in recent decades. Multidisciplinary approach. Written by the most experienced specialists Neutron capture therapy (NCT) is based on the ability of the non-radioactive isotope boron-10 to capture thermal neutrons with very high probability and immediately to release heavy particles with a path length of one cell diameter. This in principle allows for tumor cell-selective high-LET particle radiotherapy. NCT is exciting scientifically but challenging clinically, and a key factor in success is close collaboration among very different disciplines. This book provides a comprehensive summary of the progress made in NCT in recent years. Individual sections cover all important aspects, including neutron sources, boron chemistry, drugs for NCT, dosimetry, and radiation biology. The use of NCT in a variety of malignancies and also some non-malignant diseases is extensively discussed. NCT is clearly shown to be a promising modality at the threshold of wider clinical application. All of the chapters are written by experienced specialists in language that will be readily understood by all participating disciplines.

  13. Nuclear data needed for neutron therapy

    International Nuclear Information System (INIS)

    Okamoto, K.

    1989-03-01

    The Second Research Co-ordination Meeting (RCM) of the IAEA Co-ordinated Research Programme (CRP) on Nuclear Data Needed for Neutron Therapy was convened by the IAEA Nuclear Data Section, in Vienna, from 24 to 27 January 1989. The Summary Report of the First RCM was issued as INDC(NDS)-203/GZ (March 1988). Special emphasis was put on the discussion of the issue of the final publication of this CRP. (author). 36 refs, 8 tabs

  14. Evaluation of neutron flux in the Pool Critical Assembly

    International Nuclear Information System (INIS)

    Lippincott, E.P.; Ruddy, F.H.; Gold, R.; Kellogg, L.S.; Roberts, J.H.

    1984-09-01

    A recently completed series of experiments in the Pool Critical Assembly (PCA) at Oak Ridge National Laboratory (ORNL) provided extensive neutron flux characterization of a mockup pressure vessel configuration. Considerable effort has been made to understand the uncertainties of the various measurements made in the PCA and to resolve discrepancies in the data. Additional measurements are available for similar configurations in the Oak Ridge Reactor-Poolside Facility (ORR-PSF) at ORNL and in the NESDIP facility in the UK. Comparisons of these results, together with associated neutron field calculations, enable a better evaluation of the actual uncertainties and realistic limits of accuracy to be assessed. Such assessments are especially valuable when the accuracy improvements of benchmark referencing are to be included and extrapolations to new configurations are made

  15. Neutron Fluence Evaluation using an Am-Be Neutron Sources Assembly and P ADC Detectors

    International Nuclear Information System (INIS)

    Seddik, U.

    2008-01-01

    An assembly of four 241 Am-Be sources has been constructed at Nuclear Reactions Unit (NRU) of Nuclear Research Center (NRU) to perform analysis of different materials using thermal and fast neutrons. In the present paper, we measure the value of transmittance (T) in percentage of etched CR-39 detectors using a spectrophotometer at different neutron fluences ,to relate the transmittance of the detector with the neutron fluence values. The exposed samples to neutrons with accumulated fluence of order between 10 10 and 10 12 cm -2 were etched for 15 time intervals between 10-600 min in 6.25 N NaOH at 70 degree C. The etched samples were analyzed using Tech 8500 II spectrophotometer. A trend of the sample transmission and the etching time is observed which is different for each fluence value. A linear relation between the transmittance decay constant and the neutron fluence is observed which could be used as a calibration to determine unknown neutron fluence

  16. A novel detector assembly for detecting thermal neutrons, fast neutrons and gamma rays

    Energy Technology Data Exchange (ETDEWEB)

    Cester, D., E-mail: davide.cester@gmail.com [Dipartimento di Fisica ed Astronomia dell' Università di Padova, Via Marzolo 8, I-35131 Padova (Italy); Lunardon, M.; Moretto, S. [Dipartimento di Fisica ed Astronomia dell' Università di Padova, Via Marzolo 8, I-35131 Padova (Italy); INFN Sezione di Padova, Via Marzolo 8, I-35131 Padova (Italy); Nebbia, G. [INFN Sezione di Padova, Via Marzolo 8, I-35131 Padova (Italy); Pino, F. [Dipartimento di Fisica ed Astronomia dell' Università di Padova, Via Marzolo 8, I-35131 Padova (Italy); Sajo-Bohus, L. [Dipartimento di Fisica ed Astronomia dell' Università di Padova, Via Marzolo 8, I-35131 Padova (Italy); Laboratorio de Fisica Nuclear, Universidad Simon Bolivar, Apartado 89000, 1080 A Caracas (Venezuela, Bolivarian Republic of); Stevanato, L.; Bonesso, I.; Turato, F. [Dipartimento di Fisica ed Astronomia dell' Università di Padova, Via Marzolo 8, I-35131 Padova (Italy)

    2016-09-11

    A new composite detector has been developed by combining two different commercial scintillators. The device has the capability to detect gamma rays as well as thermal and fast neutrons; the signal discrimination between the three types is performed on-line by means of waveform digitizers and PSD algorithms. This work describes the assembled detector and its discrimination performance to be employed in the applied field.

  17. A novel detector assembly for detecting thermal neutrons, fast neutrons and gamma rays

    International Nuclear Information System (INIS)

    Cester, D.; Lunardon, M.; Moretto, S.; Nebbia, G.; Pino, F.; Sajo-Bohus, L.; Stevanato, L.; Bonesso, I.; Turato, F.

    2016-01-01

    A new composite detector has been developed by combining two different commercial scintillators. The device has the capability to detect gamma rays as well as thermal and fast neutrons; the signal discrimination between the three types is performed on-line by means of waveform digitizers and PSD algorithms. This work describes the assembled detector and its discrimination performance to be employed in the applied field.

  18. Effect of blanket assembly shuffling on LMR neutronic performance

    International Nuclear Information System (INIS)

    Khalil, H.; Fujita, E.K.

    1987-01-01

    Neutronic analyses of advanced liquid-metal reactors (LMRs) have generally been performed with assemblies in different batches scatter-loaded but not shuffled among the core lattice positions between cycles. While this refueling approach minimizes refueling time, significant improvements in thermal performance are believed to be achievable by blanket assembly shuffling. These improvements, attributable to mitigation of the early-life overcooling of the blankets, include reductions in peak clad temperatures and in the temperature gradients responsible for thermal striping. Here the authors summarize results of a study performed to: (1) assess whether the anticipated gains in thermal performance can be realized without sacrificing core neutronic performance, particularly the burnup reactivity swing rho/sub bu/, which determines the rod ejection worth; (2) determine the effect of various blanket shuffling operations on reactor performance; and (3) determine whether shuffling strategies developed for an equilibrium (plutonium-fueled) core can be applied during the transition from an initial uranium-fueled core as is being considered in the US advanced LMR program

  19. 21 CFR 892.5300 - Medical neutron radiation therapy system.

    Science.gov (United States)

    2010-04-01

    ... therapy system. (a) Identification. A medical neutron radiation therapy system is a device intended to... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Medical neutron radiation therapy system. 892.5300... analysis and display equipment, patient and equipment support, treatment planning computer programs...

  20. Measuring method for effective neutron multiplication factor upon containing irradiated fuel assembly

    International Nuclear Information System (INIS)

    Ueda, Makoto; Mitsuhashi, Ishi; Sasaki, Tomoharu.

    1993-01-01

    A portion of irradiated fuel assemblies at a place where a reactivity effect is high, that is, at a place where neutron importance is high is replaced with standard fuel assemblies having a known composition to measure neutron fluxes at each of the places. An effective composition at the periphery of the standard fuel assemblies is determined by utilizing a calibration curve determined separately based on the composition and neutron flux values of the standard assemblies. By using the calibration curve determined separately based on this composition and the known composition of the standard fuel assemblies, an effective neutron multiplication factor for the fuel containing portion containing the irradiated fuel assemblies is recognized. Then, subcriticality is ensured and critical safety upon containing the fuel assemblies can be secured quantitatively. (N.H.)

  1. Present status of fast neutron therapy for the malignant tumors

    Energy Technology Data Exchange (ETDEWEB)

    Tsunemoto, H; Morita, S; Honke, Y [National Inst. of Radiological Sciences, Chiba (Japan)

    1980-04-01

    Fast neutron therapy has been applied to the treatment of cancer of the head and the neck, prostatic cancer, osteosarcoma, and malignant melanoma, and the basic treatment schedule for this therapy for them has been almost established. The effectiveness of this therapy for squamous cell carcinoma of the uterus will be established by the results of future clinical application of this therapy. It is expected that postoperative irradiation of fast neutron will decrease local recurrence of adenocarcinoma of the uterus. Treatment schedule for fast neutron therapy for esophageal cancer and lung cancer must be established, and moreover, it is necessary to apply this therapy to the treatment of gastric and pancreatic cancer.

  2. Neutron spectrum for neutron capture therapy in boron; Espectro de neutrones para terapia por captura de neutrones en boro

    Energy Technology Data Exchange (ETDEWEB)

    Medina C, D.; Soto B, T. G. [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Programa de Doctorado en Ciencias Basicas, 98068 Zacatecas, Zac. (Mexico); Baltazar R, A. [Universidad Autonoma de Zacatecas, Unidad Academica de Ingenieria Electrica, Programa de Doctorado en Ingenieria y Tecnologia Aplicada, 98068 Zacatecas, Zac. (Mexico); Vega C, H. R., E-mail: dmedina_c@hotmail.com [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Cipres No. 10, Fracc. La Penuela, 98068 Zacatecas, Zac. (Mexico)

    2016-10-15

    Glioblastoma multiforme is the most common and aggressive of brain tumors and is difficult to treat by surgery, chemotherapy or conventional radiation therapy. One treatment alternative is the Neutron Capture Therapy in Boron, which requires a beam modulated in neutron energy and a drug with {sup 10}B able to be fixed in the tumor. When the patients head is exposed to the neutron beam, they are captured by the {sup 10}B and produce a nucleus of {sup 7}Li and an alpha particle whose energy is deposited in the cancer cells causing it to be destroyed without damaging the normal tissue. One of the problems associated with this therapy is to have an epithermal neutrons flux of the order of 10{sup 9} n/cm{sup 2}-sec, whereby irradiation channels of a nuclear research reactor are used. In this work using Monte Carlo methods, the neutron spectra obtained in the radial irradiation channel of the TRIGA Mark III reactor are calculated when inserting filters whose position and thickness have been modified. From the arrangements studied, we found that the Fe-Cd-Al-Cd polyethylene filter yielded a ratio between thermal and epithermal neutron fluxes of 0.006 that exceeded the recommended value (<0.05), and the dose due to the capture gamma rays is lower than the dose obtained with the other arrangements studied. (Author)

  3. Considerations for boron neutron capture therapy studies

    International Nuclear Information System (INIS)

    Faria Gaspar, P. de.

    1994-01-01

    Radiotherapy is indispensable as a mean to eradicate deeply or infiltrating tumor tissue that can not be removed surgically. Therefore, it is not selective and may also kill the surrounding health tissue. The principle of BNCT (Boron Neutron Capture Therapy) consist in targeting a tumor selectively with a boron-10 compound. This nuclide has a large capture cross section for thermal neutrons and the nuclear reaction and the delivered energy in locus will selective the tumor. Since its initial proposal in 1963 BNCT has made much progress, however it is not used in a routine treatment. In this work it was approached some complex procedures, as the obtention of selective boron compounds, the adequate set up of neutron beams, the biodistribution, the in vivo and in vitro studies, and also human patients treatments. This work provide fundamentals about BNCT to professional of different areas of knowledge since it comprises multidisciplinary study. It includes appendixes for the ones not related to the field for a better comprehension of the many aspects involved. It is also presented a glossary containing technical and basic aspects involved. It is also presented a glossary containing technical and basic terms referred in the work. (author). 174 refs, 1 fig, 12 apps

  4. Research needs for neutron capture therapy

    International Nuclear Information System (INIS)

    1995-01-01

    Key issues and questions addressed by the workshop related to optimization of Boron Neutron Capture Therapy (BNCT), in general, and to the possibility of success of the present BNCT trials at Brookhaven National Laboratory (BNL) and Massachusetts Institute of Technology (MIT), in particular. Both trials use nuclear fission reactors as neutron sources for BNCT of glioblastoma multiforme (BNL) and of deep seated melanoma (MIT). Presentations and discussions focussed on optimal boron-labeled compounds, mainly for brain tumors such as glioblastoma multiforme, and the best mode of compound delivery to the tumor. Also, optimizing neutron irradiation with dose delivery to the tumor cells and the issues of dosimetry of BNCT especially in the brain were discussed. Planning of treatment and of follow-up of patients, coordination of BNCT at various treatment sites, and the potential of delivering BNCT to various types of cancer with an appropriately tailored protocol were additional issues. The need for multicentric interdisciplinary cooperation among the different medical specialties was highlighted

  5. Development of In-pile Plug Assembly and Primary Shutter for Cold Neutron Guide System

    Energy Technology Data Exchange (ETDEWEB)

    Shin, Jin Won; Cho, Yeong Garp; Ryu, Jeong Soo; Lee, Jung Hee [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2008-12-15

    The HANARO, a 30 MW multi-purpose research reactor in Korea, will be equipped with a neutron guide system, in order to transport cold neutrons from the neutron source to the neutron scattering instruments in the neutron guide hall near the reactor building. The neutron guide system of HANARO consists of the in-pile plug assembly with in-pile guides, the primary shutter with in-shutter guides, the neutron guides in the guide shielding room with dedicated secondary shutters, and the neutron guides connected to the instruments in the neutron guide hall. The functions of the in-pile plug assembly are to shield the reactor environment from a nuclear radiation and to support the neutron guides and maintain them precisely oriented. The primary shutter is a mechanical device to be installed just after the in-pile plug assembly, which stops neutron flux on demand. This report describes the mechanical design, fabrication, and installation procedure of the in-pile plug assembly and the primary shutter for the neutron guide system at HANARO. A special tool and procedure for a replacement of in-pile plug and guide cassette is also presented with the interface condition in the reactor hall.

  6. Neutron studies of paramagnetic fullerenols’ assembly in aqueous solutions

    Science.gov (United States)

    Lebedev, V. T.; Szhogina, A. A.; Suyasova, M. V.

    2018-03-01

    Recent results on structural studies of aqueous solutions of water-soluble derivatives of endofullerenes encapsulating 4f- and 3d-elements have been presented. Neutron small angle scattering experiments allowed recognize subtle features of fullerenols assembly as dependent on chemical nature (atomic number) of interior atom, pH-factor and temperature of solutions. It was observed a fractal-type fullerenols’ ordering at the scale of correlation radii ∼ 10-20 nm when molecules with iron atoms are integrated into branched structures at low concentrations (C ≤ 1 % wt.) and organized into globular aggregates at higher amounts (C > 1 % wt.). On the other hand, for Lanthanides captured in carbon cages the supramolecular structures are mostly globular and have larger gyration radii ∼ 30 nm. They demonstrated a good stability in acidic (pH ∼ 3) and neutral (pH ∼ 7) media that is important for forthcoming medical applications.

  7. Fuel-assembly vibration-induced neutron noise in PWRs

    International Nuclear Information System (INIS)

    Sweeney, F.J.; Renier, J.P.

    1983-01-01

    Space-dependent reactor kinetics calculations were performed to interpret observed increases in the amplitude of pressurized water reactor (PWR), ex-core neutron detector noise with increasing fuel burnup and correspondingly decreasing soluble boron concentration. These noise amplitude increases have occurred at both low frequencies (< 1.0 Hz) and in the 2.0- to 4.0-Hz frequency range. The noise amplitude increases in the 2.0- to 4.0-Hz frequency range have usually been accompanied by a decrease in the fundamental mode fuel assembly resonant frequency from 3.5 to 2.5 Hz over a fuel cycle, which has also been attributed to grid spacer spring relaxation

  8. Experimental determination of the neutron source for the Argonauta reactor subcritical assembly

    Energy Technology Data Exchange (ETDEWEB)

    Renke, Carlos A.C.; Furieri, Rosanne C.A.A.; Pereira, Joao C.S.; Voi, Dante L.; Barbosa, Andre L.N., E-mail: renke@ien.gov.b [Instituto de Engenharia Nuclear (IEN/CNEN-RJ), Rio de Janeiro, RJ (Brazil)

    2011-07-01

    The utilization of a subcritical assembly for the determination of nuclear parameters in a multiplier medium requires a well defined neutron source to carry out the experiments necessary for the acquisition of the desired data. The Argonauta research reactor installed at the Instituto de Engenharia Nuclear has a subcritical assembly, under development, to be coupled at the upper part of the reactor core that will provide the needed neutrons emerging from its internal thermal column made of graphite. In order to perform neutronic calculations to compare with the experimental results, it is necessary a precise knowledge of the emergent neutron flux that will be used as neutron source in the subcritical assembly. In this work, we present the thermal neutron flux profile determined experimentally via the technique of neutron activation analysis, using dysprosium wires uniformly distributed at the top of the internal thermal neutron column of the Argonauta reactor and later submitted to a detection system using Geiger-Mueller detector. These experimental data were then compared with those obtained through neutronic calculation using HAMMER and CITATION codes in order to validate this calculation system and to define a correct neutron source distribution to be used in the subcritical assembly. This procedure avoids a coupled neutronic calculation of the subcritical assembly and the reactor core. It has also been determined the dimension of the graphite pedestal to be used in the bottom of the subcritical assembly tank in order to smooth the emergent neutron flux at the reactor top. Finally, it is estimated the thermal neutron flux inside the assembly tank when filled with water. (author)

  9. Thermal-hydraulic and neutron-physical characteristics of a new SCWR fuel assembly

    International Nuclear Information System (INIS)

    Liu, X.J.; Cheng, X.

    2009-01-01

    A new fuel assembly design for a thermal supercritical water cooled reactor (SCWR) core is proposed. Compared to the existing fuel assemblies, the present fuel assembly has two-rows of fuel rods between the moderator channels, to achieve a more uniform moderation for all fuel rod cells, and subsequently, a more uniform radial power distribution. In addition, a neutron-kinetics/thermal-hydraulics coupling method is developed, to analyze the neutron-physical and thermal-hydraulic behavior of the fuel assembly designs. This coupling method is based on the sub-channel analysis code COBRA-IV for thermal-hydraulics and the neutron-kinetics code SKETCH-N for neutron-physics. Both the COBRA-IV code and the SKETCH-N code are accordingly modified. An interface is established for the data transfer between these two codes. This coupling method is applied to both the one-row fuel assemblies (previous design) and the two-row fuel assemblies (present design). The performance of the two types of fuel assemblies is compared. The results show clearly that the two-row fuel assembly has more favorable neutron-physical and thermal-hydraulic characteristics than the one-row fuel assembly. The effect of various parameters on the fuel assembly performance is discussed. The coupling method is proven to be well suitable for further applications to SCWR fuel assembly design analysis

  10. Boron neutron capture therapy (BNCT) using fast neutrons: Effects in two human tumor cell lines

    International Nuclear Information System (INIS)

    Sauerwein, W.; Ziegler, W.; Szypniewski, H.; Streffer, C.

    1990-01-01

    The results demonstrate that the effect of fast neutrons on cell survival in cell culture can be enhanced by boron neutron capture reaction. Even with lower enhancement ratios, the concept of NCT assisted fast neutron therapy may successfully be applied for tumor treatment with the Essen cyclotron. (orig.)

  11. Neutron noise measurements at the Delphi subcritical assembly

    International Nuclear Information System (INIS)

    Szieberth, M.; Klujber, G.; Kloosterman, J. L.; De Haas, D.

    2012-01-01

    The paper presents the results and evaluations of a comprehensive set of neutron noise measurements on the Delphi subcritical assembly of the Delft Univ. of Technology. The measurements investigated the effect of different source distributions (inherent spontaneous fission and 252 Cf) and the position of the detectors applied (both radially and vertically). The evaluation of the measured data has been performed by the variance-to-mean ratio (VTMR, Feynman-α), the autocorrelation (ACF, Rossi-α) and the cross-correlation (CCF) methods. The values obtained for the prompt decay constant show a strong bias, which depends both on the detector position and on the source distribution. This is due to the presence of higher modes in the system. It has been observed that the α value fitted is higher when the detector is close to the boundary of the core or to the 252 Cf point-source. The higher alpha-modes have also been observed by fitting functions describing two alpha-modes. The successful set of measurement also provides a good basis for further theoretical investigations including the Monte Carlo simulation of the noise measurements and the calculation of the alpha-modes in the Delphi subcritical assembly. (authors)

  12. Neutron capture therapy: Years of experimentation---Years of reflection

    International Nuclear Information System (INIS)

    Farr, L.E.

    1991-01-01

    This report describes early research on neutron capture therapy over a number of years, beginning in 1950, speaking briefly of patient treatments but dwelling mostly on interpretations of our animal experiments. This work carried out over eighteen years, beginning over forty years ago. Yet, it is only fitting to start by relating how neutron capture therapy became part of Brookhaven's Medical Research Center program

  13. Current status of neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2001-05-01

    There are about 6000 new glioblastoma multiform brain tumours diagnosed each year in the United States of America alone. This cancer is usually fatal within six months of diagnosis even with current standard treatments. Research on boron neutron capture therapy (BNCT) has been considered as a method of potentially curing such cancers. There is a great interest at under-utilised research reactors institutions to identify new medical utilization, attractive to the general public. Neutron capture therapy is a true multidisciplinary topic with a large variety of individuals involved. This publication attempts to provide current information for all those thinking about being involved with NCT, based on the knowledge and experience of those who have pioneered the treatment. It covers the whole range of NCT from designing reactor conversions or new facilities, through to clinical trials and their effectiveness. However, since most work has been done with boron capture therapy for brain tumours using modified thermal research reactors, this tends to be the focus of the report. One of the factors which need to be addressed at the beginning is the timing of the further development of NCT facilities. It should be emphasised that all current work is still at the research stage. Many of those now involved believe that there is little need for many more research facilities until such time as the treatment shows more promising results. For this and other reasons discussed in the report, very serious consideration should be given by research reactor owners and operators before spending large sums of money converting their facilities for NCT.

  14. Current status of neutron capture therapy

    International Nuclear Information System (INIS)

    2001-05-01

    There are about 6000 new glioblastoma multiform brain tumours diagnosed each year in the United States of America alone. This cancer is usually fatal within six months of diagnosis even with current standard treatments. Research on boron neutron capture therapy (BNCT) has been considered as a method of potentially curing such cancers. There is a great interest at under-utilised research reactors institutions to identify new medical utilization, attractive to the general public. Neutron capture therapy is a true multidisciplinary topic with a large variety of individuals involved. This publication attempts to provide current information for all those thinking about being involved with NCT, based on the knowledge and experience of those who have pioneered the treatment. It covers the whole range of NCT from designing reactor conversions or new facilities, through to clinical trials and their effectiveness. However, since most work has been done with boron capture therapy for brain tumours using modified thermal research reactors, this tends to be the focus of the report. One of the factors which need to be addressed at the beginning is the timing of the further development of NCT facilities. It should be emphasised that all current work is still at the research stage. Many of those now involved believe that there is little need for many more research facilities until such time as the treatment shows more promising results. For this and other reasons discussed in the report, very serious consideration should be given by research reactor owners and operators before spending large sums of money converting their facilities for NCT

  15. Development of SiC Neutron Detector Assembly to Measure the Neutron Flux of the Reactor Core

    Energy Technology Data Exchange (ETDEWEB)

    Park, Se Hwan; Park, June Sic; Shin, Hee Sung; Kim, Ho Dong [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of); Kim, Yong Kyun [Hanyang University, Seoul (Korea, Republic of)

    2012-05-15

    At present, the conventional detector to measure the neutron at harsh environment is a Self Powered Neutron Detector (SPND). Rhodium(Rh)-103 is in the SPND. When neutron is incident on the Rhodium, the neutron capture reaction occurs, and the Rh-103 is converted to Rh-104. The Rh-104 is decayed to Pd-104 by {beta}-decay, and electrons are generated as the decay products. Because of the half life of Rh-104, approximately 5 minutes are required for the SPND output to reach the equilibrium condition. Therefore the on-line monitoring of the nuclear reactor state is limited if the neutron flux in the reactor core is monitored with the SPND. Silicon carbide (SiC) has the possibility to be developed as neutron detector at harsh environment, because the SiC can be operative at high temperature and high neutron flux conditions. Previously, the basic operation properties of the SiC detector were studied. Also, the radiation response of the SiC detector was studied at high neutron and gamma dose rate. The measurement results for an ex-core neutron flux monitor or a neutron flux monitor of the spent fuel were published. The SiC detector was also developed as neutron detector to measure the fissile material with active interrogation method. However, the studies about the development of SiC detector are still limited. In the present work, the radiation damage effect of the SiC detector was studied. The detector structure was determined based on the study, and a neutron detector assembly was made with the SiC detectors. The neutron and gamma-ray response of the detector assembly is presented in this paper. The detector assembly was positioned in the HANARO research reactor core, the performance test was done. The preliminary results are also included in this paper

  16. Using anisotropies in prompt fission neutron coincidences to assess the neutron multiplication of highly multiplying subcritical plutonium assemblies

    Energy Technology Data Exchange (ETDEWEB)

    Mueller, J.M., E-mail: jonathan_mueller@ncsu.edu; Mattingly, J.

    2016-07-21

    There is a significant and well-known anisotropy between the prompt neutrons emitted from a single fission event; these neutrons are most likely to be observed at angles near 0° or 180° relative to each other. However, the propagation of this anisotropy through different generations of a fission chain reaction has not been previously studied. We have measured this anisotropy in neutron–neutron coincidences from a subcritical highly-multiplying assembly of plutonium metal. The assembly was a 4.5 kg α-phase plutonium metal sphere composed of 94% {sup 239}Pu and 6% {sup 240}Pu by mass. Data were collected using two EJ-309 liquid scintillators and two EJ-299 plastic scintillators. The angular distribution of neutron–neutron coincidences was measured at 90° and 180° and found to be largely isotropic. Simulations were performed using MCNPX-PoliMi of similar plutonium metal spheres of varying sizes and a correlation between the neutron multiplication of the assembly and the anisotropy of neutron–neutron coincidences was observed. In principle, this correlation could be used to assess the neutron multiplication of an unknown assembly.

  17. Dose prescription in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gupta, N.M.S.; Gahbauer, R.A.; Blue, T.E.; Wambersie, A.

    1994-01-01

    The purpose of this paper is to address some aspects of the many considerations that need to go into a dose prescription in boron neutron capture therapy (BNCT) for brain tumors; and to describe some methods to incorporate knowledge from animal studies and other experiments into the process of dose prescription. Previously, an algorithm to estimate the normal tissue tolerance to mixed high and low linear energy transfer radiations in BNCT was proposed. The authors have developed mathematical formulations and computational methods to represent this algorithm. Generalized models to fit the central axis dose rate components for an epithermal neutron field were also developed. These formulations and beam fitting models were programmed into spreadsheets to simulate two treatment techniques which are expected to be used in BNCT: a two-field bilateral scheme and a single-field treatment scheme. Parameters in these spreadsheets can be varied to represent the fractionation scheme used, the 10 B microdistribution in normal tissue, and the ratio of 10 B in tumor to normal tissue. Most of these factors have to be determined for a given neutron field and 10 B compound combination from large animal studies. The spreadsheets have been programmed to integrate all of the treatment-related information and calculate the location along the central axis where the normal tissue tolerance is exceeded first. This information is then used to compute the maximum treatment time allowable and the maximum tumor dose that may be delivered for a given BNCT treatment. The effect of different treatment variables on the treatment time and tumor dose has been shown to be very significant. It has also been shown that the location of D max shifts significantly, depending on some of the treatment variables-mainly the fractionation scheme used. These results further emphasize the fact that dose prescription in BNCT is very complicated and nonintuitive. 11 refs., 6 figs., 3 tabs

  18. Boron thermal/epithermal neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.

    1982-01-01

    The development of various particle beams for radiotherapy represents an attempt to improve dose distribution, and to provide high LET radiations which are less sensitive to ambient physical and radiobiological factors such as oxygen tension, cell cycle, and dose rate. In general, a compromise is necessary as effective RBE is reduced in order to spread the dose distribution over the anticipated tumor volume. The approach of delivering stable non-toxic isotopes to tumor, and then activating these atoms subsequently via an external radiation beam has mator advantages; problems associated with high uptake of these isotopes in competing cell pools are obviated, and the general tumor volume can be included in the treatment field of the activating beam. As long as the normal tissues supporting tumor show a low uptake of the isotope to be activated, and as long as the range of the reaction products is short, dose will be restricted to tumor, with a consequent high therapeutic ratio. Neutron Capture Therapy (NCT) is generally carried out by activating boron-10 with low energy neutrons. The range of the high LET, low OER particles from the 10 B(n, α) 7 Li reaction is approx. 10μ, or one cell diameter, a situation that is optimal for cell killing. Significant advantages may be gained by using the NCT procedure in conjunction with improved tissue penetration provided with epithermal or filtered beams, and new compounds showing physiological binding to tumor

  19. Self-powered in-core neutron detector assembly with uniform perturbation characteristics

    International Nuclear Information System (INIS)

    Todt, W.H.; Playfoot, K.C.

    1979-01-01

    Disclosed is a self-powered in-core neutron detector assembly in which a plurality of longitudinally extending self-powered detectors have neutron responsive active portions spaced along a longitudinal path. A low neutron absorptive extension extends from the active portions of the spaced active portions of the detectors in symmetrical longitudinal relationship with the spaced active detector portions of each succeeding detector. The detector extension terminates with the detector assembly to provide a uniform perturbation characteristic over the entire assembly length

  20. Optimization of beam shaping assembly based on D-T neutron generator and dose evaluation for BNCT

    Science.gov (United States)

    Naeem, Hamza; Chen, Chaobin; Zheng, Huaqing; Song, Jing

    2017-04-01

    The feasibility of developing an epithermal neutron beam for a boron neutron capture therapy (BNCT) facility based on a high intensity D-T fusion neutron generator (HINEG) and using the Monte Carlo code SuperMC (Super Monte Carlo simulation program for nuclear and radiation process) is proposed in this study. The Monte Carlo code SuperMC is used to determine and optimize the final configuration of the beam shaping assembly (BSA). The optimal BSA design in a cylindrical geometry which consists of a natural uranium sphere (14 cm) as a neutron multiplier, AlF3 and TiF3 as moderators (20 cm each), Cd (1 mm) as a thermal neutron filter, Bi (5 cm) as a gamma shield, and Pb as a reflector and collimator to guide neutrons towards the exit window. The epithermal neutron beam flux of the proposed model is 5.73 × 109 n/cm2s, and other dosimetric parameters for the BNCT reported by IAEA-TECDOC-1223 have been verified. The phantom dose analysis shows that the designed BSA is accurate, efficient and suitable for BNCT applications. Thus, the Monte Carlo code SuperMC is concluded to be capable of simulating the BSA and the dose calculation for BNCT, and high epithermal flux can be achieved using proposed BSA.

  1. Evaluation of the U-Pu residual mass from spent fuel assemblies with passive and active neutronic methods

    International Nuclear Information System (INIS)

    Bignan, G.; Martin-Deidier, L.

    1991-01-01

    The interpretation of passive and active neutronic measurements to evaluate the U-Pu residual mass in spent fuel assemblies is presented as follows: passive neutron measurements are well correlated to the plutonium mass, active neutron measurements give information linked to the fissile mass content of the assembly ( 235 U + 239 Pu + 241 Pu) and, using the passive neutron measurement, lead to the 235 U mass content of the assemblies

  2. Neutron therapy for salivary and thyroid gland cancer

    Energy Technology Data Exchange (ETDEWEB)

    Gribova, O. V., E-mail: gribova79@mail.ru; Choynzonov, E. L., E-mail: nii@oncology.tomsk.ru [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation); National Research Tomsk Polytechnic University, Lenina Avenue 30, Tomsk, 634050 (Russian Federation); Musabaeva, L. I., E-mail: musabaevaLI@oncology.tomsk.ru; Lisin, V. A., E-mail: Lisin@oncology.tomsk.ru; Novikov, V. A., E-mail: dr.vanovikov@gmail.com [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation)

    2016-08-02

    The purpose of this study was to analyze the results of the combined modality treatment and radiation therapy using 6.3 MeV fast neutrons for salivary gland cancer and prognostically unfavorable thyroid gland cancer. The study group comprised 127 patients with salivary gland cancer and 46 patients with thyroid gland cancer, who received neutron therapy alone and in combination with surgery. The results obtained demonstrated that the combined modality treatment including fast neutron therapy led to encouraging local control in patients with salivary and thyroid gland cancers.

  3. Neutron collar calibration for assay of LWR [light-water reactor] fuel assemblies

    International Nuclear Information System (INIS)

    Menlove, H.O.; Pieper, J.E.

    1987-03-01

    The neutron-coincidence collar is used for the verification of the uranium content in light-water reactor fuel assemblies. An AmLi neutron source is used to give an active interrogation of the fuel assembly to measure the 235 U content, and the 238 U content is verified from a passive neutron-coincidence measurement. This report gives the collar calibration data of pressurized-water reactor and boiling-water reactor fuel assemblies. Calibration curves and correction factors are presented for neutron absorbers (burnable poisons) and different fuel assembly sizes. The data were collected at Exxon Nuclear, Franco-Belge de Fabrication de Combustibles, ASEA-Atom, and other nuclear fuel fabrication facilities

  4. Design and fabrication of self-powered in-core neutron flux monitor assembly

    International Nuclear Information System (INIS)

    Chung, M.K.; Cho, S.W.; Kang, H.D.; Cho, K.K.; Cho, B.S.; Kang, S.S.

    1980-01-01

    This is the final report on the prototypical fabrication of an in-core neutron flux monitor detector assembly for a specific power reactor conducted by KAERI from July 1, 1978 to December 31, 1979. It is well known that power reactors require a large number of in-core neutron flux detector for reactor regulation and the structures of detector assemblies are different from reactor to reactor. Therefore, from the nature of this project, it should be noted here that the target model of the prototypical farbrication of an in-core neutron flux monitor detector assembly is a VFD-2 System for Wolsung CANDU. It is concluded that fabrication of in-core neutron flux monitor detector assembly for CANDU reactor is technically feasible and will bring economical benefit as much as 50 % of the unit price if they are fabricated in Korea by using partially materials which are available from local market. (author)

  5. Health physics considerations at a neutron therapy facility cyclotron

    International Nuclear Information System (INIS)

    Kleck, J.H.; Krueger, D.J.; Mc Laughlin, J.E.; Smathers, J.B.

    1987-01-01

    The U.C.L.A. Neutron Therapy Facility (NTF) is one of four such facilities in the United States currently involved in NCI sponsored trials of neutron therapy and reflects the present interest in the use of high energy neutron beams for treating certain types of human cancers. The NTF houses a CP-45 negative ion cyclotron which accelerates a 46 MeV proton beam for production of neutrons from a beryllium target. In addition to patient treatment, the NTF is involved in the production of positron emitting radioisotopes for diagnostic use in Positron Emission Tomography (PET). The activation of therapy treatment collimators, positron and neutron target systems, and a high and rapidly varying external radiation environment in a clinical setting have contributed to the need for a comprehensive radiation control program in which patient care is balanced with the maintenance of occupational exposures to ALARA levels

  6. General considerations for neutron capture therapy at a reactor facility

    International Nuclear Information System (INIS)

    Binney, S.E.

    2001-01-01

    In addition to neutron beam intensity and quality, there are also a number of other significant criteria related to a nuclear reactor that contribute to a successful neutron capture therapy (NCT) facility. These criteria are classified into four main categories: Nuclear design factors, facility management and operations factors, facility resources, and non-technical factors. Important factors to consider are given for each of these categories. In addition to an adequate neutron beam intensity and quality, key requirements for a successful neutron capture therapy facility include necessary finances to construct or convert a facility for NCT, a capable medical staff to perform the NCT, and the administrative support for the facility. The absence of any one of these four factors seriously jeopardizes the overall probability of success of the facility. Thus nuclear reactor facility management considering becoming involved in neutron capture therapy, should it be proven clinically successful, should take all these factors into consideration. (author)

  7. METHODS OF ASSESSMENT OF THE RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS IN NEUTRON THERAPY

    Directory of Open Access Journals (Sweden)

    V. A. Lisin

    2017-01-01

    Full Text Available The relative biological effectiveness (RBE of fast neutrons is an important factor influencing the quality of neutron therapy therefore, the assessment of RBE is of great importance. Experimental and clinical studies as well as different mathematical and radiobiological models are used for assessing RBE. Research is conducted for neutron sources differing in the method of producing particles, energy and energy spectrum. Purpose: to find and analyze the dose-dependence of fast neutron RBE in neutron therapy using the U-120 cyclotron and NG-12I generator. Material and methods: The optimal method for assessing the relative biological effectiveness of neutrons for neutron therapy was described. To analyze the dependence of the RBE on neutron dose, the multi-target model of cell survival was applied. Results: The dependence of the RBE of neutrons produced from the U-120 cyclotron and NG-120 generator on the dose level was found for a single irradiation of biological objects. It was shown that the function of neutron dose was consistent with similar dependencies found by other authors in the experimental and clinical studies.

  8. The design and analysis of integral assembly experiments for CTR neutronics

    International Nuclear Information System (INIS)

    Beynon, T.D.; Curtis, R.H.; Lambert, C.

    1978-01-01

    The use of simple-geometry integral assemblies of lithium metal or lithium compounds for the study of the neutronics of various CTR designs is considered and four recent experiments are analysed. The relatively long mean free path of neutrons in these assemblies produces significantly different design problems from those encountered in similar experiments for fission reactor design. By considering sensitivity profiles for various parameters it is suggested that experiments can be designed to be optimised for data adjustments. (author)

  9. Measurements of time dependent energy spectra of neutrons in a small graphite assembly

    International Nuclear Information System (INIS)

    Fujita, Yoshiaki; Sakamoto, Shigeyasu; Aizawa, Otohiko; Takahashi, Akito; Sumita, Kenji.

    1975-01-01

    The time-dependent energy spectra of neutrons have been measured in a small 30x30x30 cm 3 graphite assembly by means of the linac-chopper method, with a view to establishing experimental evidence that there is no asymptotic spectrum in such a small assembly, and in order to study the non-asymptotic behavior of neutrons. The arrangement of a polyethylene pre-moderator adjacent to the assembly made the measurements possible with the improvement obtained thereby of the neutron counting statistics. It was indicated from calculation that the presence of the pre-moderator had little effect - at least above the Bragg cut-off energy - on the evolution in time of the energy spectra of neutrons in the graphite assembly. The experimental results indicated very probable disappearance of asymptotic spectra, and revealed significant enhancement of trapping at Bragg energies with the lapse of time. This is consistent with the results of pulsed neutron experiments in small assemblies conducted by Takahashi et al., and falls in line with de Saussure's approximation. The spectra in the graphite assembly showed significant space dependence, the spectra becoming harder with increasing distance from the pre-moderator. This hardening may be attributed to the relatively faster propagation of higher energy neutrons. (auth.)

  10. Utilization of RP-10 reactor for neutron therapy

    International Nuclear Information System (INIS)

    Paucar, R.; Nieto, M.; Parreno, F.; Vela, M.; Pozo, Z.

    1997-01-01

    In the Nuclear Energy Peruvian Institute, IPEN, a research area has established of Neutron Radiotherapy, know as NCT. This research joins the physics of particles (Neutrons and photons) and Medical Physics, and this one is an applied investigation where in considering the construction of a treatment hall in Huarangal (Peru) Reactor's irradiation facility, it can treat patients with brain tumors. In Neutron Therapy (NCT), it tries to use neutrons to destroy tumor cells where other therapeutic techniques are not effective. This process consist on to incise a neutrons beam of adequate characteristics over the tumor area of the patient. The neutrons used are of thermal energy and therefore irradiations are developed in experimental reactors. For this one, it is used horizontal channels prepared suitably. Before the irradiation, it is injected to the patient a substance which is absorbed by tumoral tissue. The substance components will be B-10, nuclide with an absorption cross section high to thermal neutrons (3837 b). The B-10 irradiate with thermal neutrons produce alpha particles of short reach (10 μm. on soft tissue) and with LET values (lineal energy transference) very high. The result is a cell preferential destruction which have absorbed the substance and it's next neighbors, like the cell size is 10 μm. This process as know as Boron Neutron Capture Therapy (BNCT). This work describes Peruvian RP-10 reactor and recently efforts to assess the design and feasibility of the medical neutron irradiation facility for NCT. (author). 22 refs., 6 tabs

  11. Anesthetic management of Boron Neutron Capture Therapy for glioblastoma

    International Nuclear Information System (INIS)

    Shinomura, T.; Furutani, H.; Osawa, M.; Ono, K.; Fukuda, K.

    2000-01-01

    General anesthesia was given to twenty-seven patients who received Boron Neutron Capture Therapy (BNCT) under craniotomy at Kyoto University Research Reactor from 1991 to 1999. Special considerations are required for anesthesia. (author)

  12. Unfolding of neutron spectra from Godiva type critical assemblies

    International Nuclear Information System (INIS)

    Harvey, J.T.; Meason, J.L.; Wright, H.L.

    1976-01-01

    The results from three experiments conducted at the White Sands Missile Range Fast Burst Reactor Facility are discussed. The experiments were designed to measure the ''free-field'' neutron leakage spectrum and the neutron spectra from mildly perturbed environments. SAND-II was used to calculate the neutron spectrum utilizing several different trial input spectra for each experiment. Comparisons are made between the unfolded neutron spectrum for each trial input on the basis of the following parameters: average neutron energy (above 10 KeV), integral fluence (above 10 KeV), spectral index and the hardness parameter, phi/sub eq//phi

  13. A study on the utilization of hyper-thermal neutrons for neutron capture therapy

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori; Kobayashi, Tooru; Kanda, Keiji

    1993-01-01

    The utilization of hyper-thermal neutrons, which have an energy spectrum of a Maxwellian distribution of a higher temperature than the room temperature of 300 K, was studied in order to improve the thermal neutron flux distribution at the deeper part in a living body for neutron capture therapy. Simulation calculations were carried out using MCNP-V3 in order to confirm the characteristics of hyper-thermal neutrons, i.e., (1) depth dependence of neutron energy spectrum, and (2) depth distribution of the reaction rate in a water phantom for materials with 1/v neutron absorption. It is confirmed that the hyper-thermal neutron irradiation can improve the thermal neutron flux distribution in the deeper and wider area in a living body compared with the thermal neutron irradiation. Practically, by the incidence of the hyper-thermal neutrons with a 3000 K Maxwellian distribution, the thermal neutron flux at 5 cm depth can be given about four times larger than by the incidence of the thermal neutrons of 300 K. (author)

  14. Dosimetry methods in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Gambarini, G.; Artuso, E.; Felisi, M.; Regazzoni, V.; Giove, D. [Universita degli Studi di Milano, Department of Physics, Via Festa del Patrono 7, 20122 Milano (Italy); Agosteo, S.; Barcaglioni, L. [Istituto Nazionale di Fisica Nucleare, Milano (Italy); Campi, F.; Garlati, L. [Politecnico di Milano, Energy Department, Piazza Leonardo Da Vinci 32, 20133 Milano (Italy); De Errico, F. [Universita degli Studi di Pisa, Department of Civil and Industrial Engineering, Lungamo Pacinotti 43, 56126 Pisa (Italy); Borroni, M.; Carrara, M. [Fondazione IRCCS Istituto Nazionale Tumori, Medical Physics Unit, Via Venezian 1, 20133 Milano (Italy); Burian, J.; Klupak, V.; Viererbl, L.; Marek, M. [Research Centre Rez, Department of Neutron Physics, 250-68 Husinec-Rez (Czech Republic)

    2014-08-15

    Dosimetry studies have been carried out at thermal and epithermal columns of Lvr-15 research reactor for investigating the spatial distribution of gamma dose, fast neutron dose and thermal neutron fluence. Two different dosimetry methods, both based on solid state detectors, have been studied and applied and the accuracy and consistency of the results have been inspected. One method is based on Fricke gel dosimeters that are dilute water solutions and have good tissue equivalence for neutrons and also for all the secondary radiations produced by neutron interactions in tissue or water phantoms. Fricke gel dosimeters give the possibility of separating the various dose contributions, i.e. the gamma dose, the fast neutron dose and the dose due to charged particles generated during thermal neutron reactions by isotopes having high cross section, like 10-B. From this last dose, thermal neutron fluence can be obtained by means of the kerma factor. The second method is based on thermoluminescence dosimeters. In particular, the developed method draw advantage from the different heights of the peaks of the glow curve of such phosphors when irradiated with photons or with thermal neutrons. The results show that satisfactory results can be obtained with simple methods, in spite of the complexity of the subject. However, the more suitable dosimeters and principally their utilization and analysis modalities are different for the various neutron beams, mainly depending on the relative intensities of the three components of the neutron field, in particular are different for thermal and epithermal columns. (Author)

  15. Dosimetry methods in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gambarini, G.; Artuso, E.; Felisi, M.; Regazzoni, V.; Giove, D.; Agosteo, S.; Barcaglioni, L.; Campi, F.; Garlati, L.; De Errico, F.; Borroni, M.; Carrara, M.; Burian, J.; Klupak, V.; Viererbl, L.; Marek, M.

    2014-08-01

    Dosimetry studies have been carried out at thermal and epithermal columns of Lvr-15 research reactor for investigating the spatial distribution of gamma dose, fast neutron dose and thermal neutron fluence. Two different dosimetry methods, both based on solid state detectors, have been studied and applied and the accuracy and consistency of the results have been inspected. One method is based on Fricke gel dosimeters that are dilute water solutions and have good tissue equivalence for neutrons and also for all the secondary radiations produced by neutron interactions in tissue or water phantoms. Fricke gel dosimeters give the possibility of separating the various dose contributions, i.e. the gamma dose, the fast neutron dose and the dose due to charged particles generated during thermal neutron reactions by isotopes having high cross section, like 10-B. From this last dose, thermal neutron fluence can be obtained by means of the kerma factor. The second method is based on thermoluminescence dosimeters. In particular, the developed method draw advantage from the different heights of the peaks of the glow curve of such phosphors when irradiated with photons or with thermal neutrons. The results show that satisfactory results can be obtained with simple methods, in spite of the complexity of the subject. However, the more suitable dosimeters and principally their utilization and analysis modalities are different for the various neutron beams, mainly depending on the relative intensities of the three components of the neutron field, in particular are different for thermal and epithermal columns. (Author)

  16. Neutron pulse propagation in natural UO sub(2) subcritical assembly moderated by heavy water

    International Nuclear Information System (INIS)

    Prado Souza, R.M.G. do.

    1976-01-01

    Short neutron bursts are fed to the graphite base of CAPITU, a D sub(2)O - natural uranium subcritical assembly. Due to the dispersive properties of the media the wave -components of the neutron pulses are attenuated and phase shifted along the axial direction. The experimental impulse response is Fourier transformed to yield the system's dispersion law, a relationship connecting the neutron diffusion parameters and the inverse complex relaxation length K (ω). The experimental results for five assemblies studied in CAPITU are compared with the theoretical dispersion law obtained from the two group diffusion theory. (author)

  17. Medical and biological requirements for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gahbauer, R.; Goodman, J.H.; Kanellitsas, C.; Clendenon, N.; Blue, J.

    1986-01-01

    In conventional radiation therapy, tumor doses applied to most solid tumors are limited by the tolerance of normal tissues. The promise of Boron Neutron Capture Therapy lies in its potential to deposit high doses of radiation very specifically to tumor tissue. Theoretically ratios of tumor to normal tissue doses can be achieved significantly higher than conventional radiotherapeutic techniques would allow. Effective dose distributions obtainable are a complex function of the neutron beam characteristics and the macro and micro distributions of boron in tumor and normal tissues. Effective RBE doses are calculated in tumors and normal tissue for thermal, epithermal and 2 keV neutrons

  18. Advances in neutron capture therapy 2006. Proceedings of 12th international congress on neutron capture therapy

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu; Kobayashi, Tooru; Fukuda, Hiroshi

    2006-01-01

    The Twelfth International Congress on Neutron Capture Therapy (ICNCT-12) is being held from October 9th to 13th, 2006 at the Kagawa International Congress Hall in Takamatsu, Kagawa, Japan. The main theme of the congress is From the past to the Future'. Five symposiums were organized to accommodate all the contributions from the international scientific committees of the International Society for Neutron Capture Therapy (ISNCT), and two symposiums were added to balance the number of fields of specialties. The seven symposiums for ICNCT-12 are as follows: 1) Clinical Results of BNCT for Brain Tumors, 2) Dosimetry, 3) Treatment Planning system, 4) Drug Delivery System, 5) Biomedical and General Matters, 6) BNCT Systems using Accelerators, 7) New Applications and Protocols for BNCT. There are a total of 195 presentations in this congress: 3 special lectures, 34 symposium presentations, 10 presentations in two special sessions from the recipients of the Ralph G. Fairchild Award, 70 presentations in the oral parallel sessions and 78 presentations in the poster sessions. A compilation of 169 papers are published in this proceedings. The 165 of the presented papers are indexed individually. (J.P.N.)

  19. Neutron capture therapy beams at the MIT Research Reactor

    International Nuclear Information System (INIS)

    Choi, J.R.; Clement, S.D.; Harling, O.K.; Zamenhof, R.G.

    1990-01-01

    Several neutron beams that could be used for neutron capture therapy at MITR-II are dosimetrically characterized and their suitability for the treatment of glioblastoma multiforme and other types of tumors are described. The types of neutron beams studied are: (1) those filtered by various thicknesses of cadmium, D2O, 6Li, and bismuth; and (2) epithermal beams achieved by filtration with aluminum, sulfur, cadmium, 6Li, and bismuth. Measured dose vs. depth data are presented in polyethylene phantom with references to what can be expected in brain. The results indicate that both types of neutron beams are useful for neutron capture therapy. The first type of neutron beams have good therapeutic advantage depths (approximately 5 cm) and excellent in-phantom ratios of therapeutic dose to background dose. Such beams would be useful for treating tumors located at relatively shallow depths in the brain. On the other hand, the second type of neutron beams have superior therapeutic advantage depths (greater than 6 cm) and good in-phantom therapeutic advantage ratios. Such beams, when used along with bilateral irradiation schemes, would be able to treat tumors at any depth in the brain. Numerical examples of what could be achieved with these beams, using RBEs, fractionated-dose delivery, unilateral, and bilateral irradiation are presented in the paper. Finally, additional plans for further neutron beam development at MITR-II are discussed

  20. Fuel assembly inspection by three-dimensional neutron radiography

    International Nuclear Information System (INIS)

    Lapinski, N.P.; Reimann, K.J.; Berger, H.

    1979-01-01

    Radiographic inspection of complex objects such as fuel subassemblies often presents problems because superimposition of images at different depths in the object complicates interpretation. One method for obtaining and displaying three-dimensional neutron radiographic images in multiple-film laminagraphy; a series of radiographs generated at different angular orientations are superimposed to provide focussed images of any object plane. In the present work multiple-film neutron laminagraphs were generated using direct and indirect exposure techniques, with neutrons in thermal, epithermal, and fast energy ranges

  1. Study on the dose distribution of the mixed field with thermal and epi-thermal neutrons for neutron capture therapy

    International Nuclear Information System (INIS)

    Kobayashi, Tooru; Sakurai, Yoshinori; Kanda, Keiji

    1994-01-01

    Simulation calculations using DOT 3.5 were carried out in order to confirm the characteristics of depth-dependent dose distribution in water phantom dependent on incident neutron energy. The epithermal neutrons mixed to thermal neutron field is effective improving the thermal neutron depth-dose distribution for neutron capture therapy. A feasibility study on the neutron energy spectrum shifter was performed using ANISN-JR for the KUR Heavy Water Facility. The design of the neutron spectrum shifter is feasible, without reducing the performance as a thermal neutron irradiation field. (author)

  2. Slow neutron capture therapy for malignant glioma (boron or lithium neutron capture therapy)

    International Nuclear Information System (INIS)

    Hatanaka, Hiroshi

    1981-01-01

    In recurrent glioblastoma, the mean survival period is approx. 6 months by the routine methods of treatment, but is extended more than 3-fold by neutron capture therapy. This method and a routine method with 60 Co or an accelerator were used for comparison in the clinical treatment of 26 patients with supratentorial malignant glioma. There were no significant differences as for prognostic factors of the group treated by this method and those of the control group; No. of cases 14 and 12, the mean age 46 and 53.5 yr, and the stage (TNM) 3.14 and 2.83, respectively. As of the end of Feb. 1980, this method showed a lifeprolonging effect 3 times that of the control, the mean survival period being 67 weeks for this method and 21 for the control. Although 100% improvement was observed in about one half of the cases by this method, the control group showed improvement of only 80% at maximum. It is also possible to treat any deep portion of the brain with thermal neutrons. As a Boron compound, mercaptoundecahydrododecarborate with a low toxicity has been put into practical use for brain tumors, and as Li, the use of 6 LiCl for lung cancer is under examination. (Chiba, N.)

  3. Physical engineering and medical physics on boron neutron capture therapy

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori

    2011-01-01

    The contents of physical engineering and medical physics that support boron neutron capture therapy (BNCT) can be roughly classified to the four items, (1) neutron irradiation system, (2) development and improvement of dose assessment techniques, (3) development and improvement of dose planning system, and (4) quality assurance and quality control. This paper introduces the BNCT at Kyoto University Research Reactor Institute, with a focus on the basic physics of BNCT, thermal neutron irradiation and epithermal neutron irradiation, heavy water neutron irradiation facilities of KUR, and medical irradiation system of KUR. It also introduces the world's first BNCT clinical cyclotron irradiation system (C-BENS) of Kyoto University Research Reactor Institute, BNCT dose assessment techniques, dose planning system, and quality assurance and quality control. (A.O.)

  4. Neutronic characteristics of linear-assembly breed-and-burn reactors

    International Nuclear Information System (INIS)

    Petroski, Robert; Forget, Benoit; Forsberg, Charles

    2012-01-01

    Highlights: ► Simple models used to characterize general behavior of linear-assembly B and B reactors. ► Diffusion theory model developed to explain axial distributions, height vs. reactivity. ► Neutron excess concept reformulated to include linear-assembly B and B reactors. ► Designed model of B and B reactor started using melt-refined B and B reactor used fuel. ► Computed doubling time of fuel cycle requiring no chemical separations. - Abstract: Linear-assembly breed-and-burn (B and B) reactors are B and B reactors that use axially connected assemblies similar to conventional LWR or fast reactor fuel assemblies. Methods for analyzing linear-assembly B and B reactors and their fuel cycles are developed and applied. General neutronic characteristics of linear-assembly B and B reactors are analyzed, including the effects that burnup, shuffling sequence, and radial and axial size have on equilibrium-cycle k-effective. The mechanisms that give rise to a highly peaked axial burnup distribution are explained, and a method for predicting peak burnup vs. k-effective based on infinite-medium depletion calculations is developed. Next, the neutron excess concept from previous studies of B and B reactors is extended to apply to linear-assembly B and B reactors, which allows the amount of starter fuel needed to establish a given equilibrium cycle to be calculated. Several example applications of the neutron excess formulation are given. First, an example model of a linear-assembly B and B reactor is analyzed to find the neutron excess cost of an equilibrium cycle. Second, simple one-dimensional models are used to predict the neutron excess value obtainable from different starter fuel configurations. Finally, these ideas are applied to design a fuel cycle consisting of linear-assembly B and B reactors and fuel recycling via a melt refining process. The neutron excess concept is used to design an appropriate starter fuel configuration made from melt refined fuel, which

  5. EXPERIMENTAL ANALYSES OF SPALLATION NEUTRONS GENERATED BY 100 MEV PROTONS AT THE KYOTO UNIVERSITY CRITICAL ASSEMBLY

    Directory of Open Access Journals (Sweden)

    CHEOL HO PYEON

    2013-02-01

    Full Text Available Neutron spectrum analyses of spallation neutrons are conducted in the accelerator-driven system (ADS facility at the Kyoto University Critical Assembly (KUCA. High-energy protons (100 MeV obtained from the fixed field alternating gradient accelerator are injected onto a tungsten target, whereby the spallation neutrons are generated. For neutronic characteristics of spallation neutrons, the reaction rates and the continuous energy distribution of spallation neutrons are measured by the foil activation method and by an organic liquid scintillator, respectively. Numerical calculations are executed by MCNPX with JENDL/HE-2007 and ENDF/B-VI libraries to evaluate the reaction rates of activation foils (bismuth and indium set at the target and the continuous energy distribution of spallation neutrons set in front of the target. For the reaction rates by the foil activation method, the C/E values between the experiments and the calculations are found around a relative difference of 10%, except for some reactions. For continuous energy distribution by the organic liquid scintillator, the spallation neutrons are observed up to 45 MeV. From these results, the neutron spectrum information on the spallation neutrons generated at the target are attained successfully in injecting 100 MeV protons onto the tungsten target.

  6. Beam neutron energy optimization for boron neutron capture therapy using monte Carlo method

    International Nuclear Information System (INIS)

    Pazirandeh, A.; Shekarian, E.

    2006-01-01

    In last two decades the optimal neutron energy for the treatment of deep seated tumors in boron neutron capture therapy in view of neutron physics and chemical compounds of boron carrier has been under thorough study. Although neutron absorption cross section of boron is high (3836b), the treatment of deep seated tumors such as glioblastoma multiform requires beam of neutrons of higher energy that can penetrate deeply into the brain and thermalized in the proximity of the tumor. Dosage from recoil proton associated with fast neutrons however poses some constraints on maximum neutron energy that can be used in the treatment. For this reason neutrons in the epithermal energy range of 10eV-10keV are generally to be the most appropriate. The simulation carried out by Monte Carlo methods using MCBNCT and MCNP4C codes along with the cross section library in 290 groups extracted from ENDF/B6 main library. The ptimal neutron energy for deep seated tumors depends on the sue and depth of tumor. Our estimated optimized energy for the tumor of 5cm wide and 1-2cm thick stands at 5cm depth is in the range of 3-5keV

  7. Commissioning of accelerator based boron neutron capture therapy system

    International Nuclear Information System (INIS)

    Nakamura, S.; Wakita, A.; Okamoto, H.; Igaki, H.; Itami, J.; Ito, M.; Abe, Y.; Imahori, Y.

    2017-01-01

    Boron neutron capture therapy (BNCT) is a treatment method using a nuclear reaction of 10 B(n, α) 7 Li. BNCT can be deposited the energy to a tumor since the 10 B which has a higher cross-section to a neutron is high is concentrated on the tumor. It is different from conventional radiation therapies that BNCT expects higher treatment effect to radiation resistant tumors since the generated alpha and lithium particles have higher radiological biological effectiveness. In general, BNCT has been performed in research nuclear reactor. Thus, BNCT is not widely applied in a clinical use. According to recent development of accelerator-based boron neutron capture therapy system, the system has an adequate flux of neutrons. Therefore, National Cancer Canter Hospital, Tokyo, Japan is planning to install accelerator based BNCT system. Protons with 2.5 MeV are irradiated to a lithium target system to generate neutrons. As a result, thermal load of the target is 50 kW since current of the protons is 20.0 mA. Additionally, when the accelerator-based BNCT system is installed in a hospital, the facility size is disadvantage in term of neutron measurements. Therefore, the commissioning of the BNCT system is being performed carefully. In this article, we report about the commissioning. (author)

  8. Research of accelerator-based neutron source for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Li Changkai; Ma Yingjie; Tang Xiaobin; Xie Qin; Geng Changran; Chen Da

    2013-01-01

    Background: 7 Li (p, n) reaction of high neutron yield and low threshold energy has become one of the most important neutron generating reactions for Accelerator-based Boron Neutron Capture Therapy (BNCT). Purpose Focuses on neutron yield and spectrum characteristics of this kind of neutron generating reaction which serves as an accelerator-based neutron source and moderates the high energy neutron beams to meet BNCT requirements. Methods: The yield and energy spectrum of neutrons generated by accelerator-based 7 Li(p, n) reaction with incident proton energy from 1.9 MeV to 3.0 MeV are researched using the Monte Carlo code-MCNPX2.5.0. And the energy and angular distribution of differential neutron yield by 2.5-MeV incident proton are also given in this part. In the following part, the character of epithermal neutron beam generated by 2.5-MeV incident protons is moderated by a new-designed moderator. Results: Energy spectra of neutrons generated by accelerator-based 7 Li(p, n) reaction with incident proton energy from 1.9 MeV to 3.0 MeV are got through the simulation and calculation. The best moderator thickness is got through comparison. Conclusions: Neutron beam produced by accelerator-based 7 Li(p, n) reaction, with the bombarding beam of 10 mA and the energy of 2.5 MeV, can meet the requirement of BNCT well after being moderated. (authors)

  9. Force chains in monodisperse spherical particle assemblies: Three-dimensional measurements using neutrons

    Science.gov (United States)

    Wensrich, C. M.; Kisi, E. H.; Luzin, V.; Garbe, U.; Kirstein, O.; Smith, A. L.; Zhang, J. F.

    2014-10-01

    The full triaxial stress state within individual particles in a monodisperse spherical granular assembly has been measured. This was made possible by neutron imaging and computed tomography combined with neutron diffraction strain measurement techniques and associated stress reconstruction. The assembly in question consists of 549 precision steel ball bearings under an applied axial load of 85 MPa in a cylindrical die. Clear evidence of force chains was observed in terms of both the shape of the probability distribution function for normal stresses and the network formed by highly loaded particles. An extensive analysis of the source and magnitude of uncertainty in these measurements is also presented.

  10. Two level calculation of assembly neutronic data libraries; Schema de calcul de bibliotheques a deux niveaux

    Energy Technology Data Exchange (ETDEWEB)

    Benomar, M

    1998-09-01

    The neutronic modeling of a nuclear reactor core requires 2 steps. The first step that is called transport calculation, is an accurate modeling of each type of assemblies put in a simple configuration. APOLLO2, a French neutronic code is used. This step allows the constitution of assembly data libraries. The second step represents the computing of the whole core by the diffusion theory and by using the data libraries defined in the first step. This work is dedicated to the improvement of the first step by allowing both a 172 group energy meshing and a two-dimension spatial processing. (A.C.) 7 refs.

  11. Physics study of D-D/D-T neutron driven experimental subcritical assembly

    International Nuclear Information System (INIS)

    Sinha, Amar

    2015-01-01

    An experimental program to design and study external source driven subcritical assembly has been initiated at BARC. This program is aimed at understanding neutronic characteristics of accelerator driven system at low power level. In this series, a zero-power, sub-critical assembly driven by a D-D/D-T neutron generator has been developed. This system is modular in design and it is first in the series of subcritical assemblies being designed. The subcritical core consists of natural uranium fuel with high density polyethylene as moderator and beryllium oxide as reflector. The subcritical core is coupled to Purnima Neutron Generator. Preliminary experiments have been carried out for spatial flux measurement and reactivity estimation using pulsed neutron source (PNS) techniques. Further experiments are being planned to measure the reactivity and other kinetic parameters using noise methods. This facility would also be used for carrying out studies on effect of source importance and measurement of source multiplication factor k s and external neutron source efficiency φ* in great details. Some experiments with D-D and D-T neutrons have been presented. (author)

  12. Phantom models for neutron capture therapy

    International Nuclear Information System (INIS)

    Storr, G.J.

    1990-08-01

    The development of a two-dimensional phantom model using the neutron and photon transport code DOT-IV is detailed. The effects of varying basic parameters such as aperture width, neutron source energy and tissue composition have been studied. One important conclusion from the study is that narrow beam apertures will give little or no advantage for tumour dose over tissue dose even in the 'ideal beam' range of 2-7 keV. The model may be used for future filter and beam studies with confidence. 10 refs., 7 tabs., 13 figs

  13. Monte Carlo modeling and analyses of YALINA- booster subcritical assembly Part II: pulsed neutron source

    International Nuclear Information System (INIS)

    Talamo, A.; Gohar, M.Y.A.; Rabiti, C.

    2008-01-01

    One of the most reliable experimental methods for measuring the kinetic parameters of a subcritical assembly is the Sjoestrand method applied to the reaction rate generated from a pulsed neutron source. This study developed a new analytical methodology for characterizing the kinetic parameters of a subcritical assembly using the Sjoestrand method, which allows comparing the analytical and experimental time dependent reaction rates and the reactivity measurements. In this methodology, the reaction rate, detector response, is calculated due to a single neutron pulse using MCNP/MCNPX computer code or any other neutron transport code that explicitly simulates the fission delayed neutrons. The calculation simulates a single neutron pulse over a long time period until the delayed neutron contribution to the reaction is vanished. The obtained reaction rate is superimposed to itself, with respect to the time, to simulate the repeated pulse operation until the asymptotic level of the reaction rate, set by the delayed neutrons, is achieved. The superimposition of the pulse to itself was calculated by a simple C computer program. A parallel version of the C program is used due to the large amount of data being processed, e.g. by the Message Passing Interface (MPI). The new calculation methodology has shown an excellent agreement with the experimental results available from the YALINA-Booster facility of Belarus. The facility has been driven by a Deuterium-Deuterium or Deuterium-Tritium pulsed neutron source and the (n,p) reaction rate has been experimentally measured by a 3 He detector. The MCNP calculation has utilized the weight window and delayed neutron biasing variance reduction techniques since the detector volume is small compared to the assembly volume. Finally, this methodology was used to calculate the IAEA benchmark of the YALINA-Booster experiment

  14. Role of gel dosimeters in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Khajeali, Azim; Farajollahi, Ali Reza; Khodadadi, Roghayeh; Kasesaz, Yaser; Khalili, Assef

    2015-01-01

    Gel dosimeters have acquired a unique status in radiotherapy, especially with the advent of the new techniques in which there is a need for three-dimensional dose measurement with high spatial resolution. One of the techniques in which the use of gel dosimeters has drawn the attention of the researchers is the boron neutron capture therapy. Exploring the history of gel dosimeters, this paper sets out to study their role in the boron neutron capture therapy dosimetric process. - Highlights: • Gel dosimeters have been investigated. • Conventional dosimetric proses of BNCT has been investigated. • Role of gel dosimeters in BNCT has been investigated

  15. Polarized neutron reflectivity from monolayers of self-assembled magnetic nanoparticles.

    Science.gov (United States)

    Mishra, D; Petracic, O; Devishvili, A; Theis-Bröhl, K; Toperverg, B P; Zabel, H

    2015-04-10

    We prepared monolayers of iron oxide nanoparticles via self-assembly on a bare silicon wafer and on a vanadium film sputter deposited onto a plane sapphire substrate. The magnetic configuration of nanoparticles in such a dense assembly was investigated by polarized neutron reflectivity. A theoretical model fit shows that the magnetic moments of nanoparticles form quasi domain-like configurations at remanence. This is attributed to the dipolar coupling amongst the nanoparticles.

  16. Investigation of the neutron detection statistics in fast critical assembly BFS-24-1

    International Nuclear Information System (INIS)

    Avramov, A.M.; Tyutyunnikov, P.L.; Mikulski, A.T.; Rafalska, E.; Chwaszczewski, S.; Jablonski, K.

    1974-01-01

    The results of the neutron detection statistics investigation at the fast critical assembly BFS-24-1 are given. The Ross-α measurements were carried out using: digital flash-start unit and 256 channel time analyzer, 10 channel time analyzer, alphameter device. Parallely the measurements using the variable dead time method and zero probability method were performed. The prompt neutron decay constants, the effectiveness of neutron detector and the intensity of external neutron source are determined using the experimental data. The experimental values of prompt neutron decay constant are compared with the calculated ones. The codes used in the calculation are following: one dimensional, diffusion, 26-group code 26-M and EWA-1, one dimensional, multiregion, nonstationary diffusion 3-group code SPECTR, 26-group, diffusion code in buckling approximation, MIXSPECTR. In all codes the 26 group nuclear constants BNAB-26 and BNAB-70 are used. (author)

  17. A neutron dynamic therapy with a boron tracedrug UTX-51 using a compact neutron generator.

    Science.gov (United States)

    Hori, Hitoshi; Tada, Ryu; Uto, Yoshihiro; Nakata, Eiji; Morii, Takashi; Masuda, Kai

    2014-08-01

    We are developing a neutron dynamic therapy (NDT) with boron tracedrugs for a new mechanical-clearance treatment of pathotoxic misfolded, aggregated, and self-propagating prion-associated disease proteins. We present a compact neutron generator-based NDT using a boron tracedrug UTX-51. Our NDT is based on the weak thermal neutron-bombarded destructive action of UTX-51 on bovine serum albumin (BSA) using the neutron beams produced from a compact inertial electrostatic confinement fusion (IECF) neutron generator. BSA as an NDT molecular target was subjected to thermal neutron irradiation for eight hours using a compact neutron generator. The sodium dodecyl sulfate-polyacrylamide gel electrophoresis pattern showed no protein band when 2 nmoles of BSA were irradiated with more than 100 nmoles of UTX-51, while BSA was not affected when irradiated without UTX-51. For the first time, we have succeeded in the molecular destruction of a prion-disease model protein, BSA, by NDT with a boron tracedrug, UTX-51, using a compact neutron generator. Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

  18. Neutron transport calculations of some fast critical assemblies

    Energy Technology Data Exchange (ETDEWEB)

    Martinez-Val Penalosa, J A

    1976-07-01

    To analyse the influence of the input variables of the transport codes upon the neutronic results (eigenvalues, generation times, . . . ) four Benchmark calculations have been performed. Sensitivity analysis have been applied to express these dependences in a useful way, and also to get an unavoidable experience to carry out calculations achieving the required accuracy and doing them in practical computing times. (Author) 29 refs.

  19. Neutron transport calculations of some fast critical assemblies

    International Nuclear Information System (INIS)

    Martinez-Val Penalosa, J. A.

    1976-01-01

    To analyse the influence of the input variables of the transport codes upon the neutronic results (eigenvalues, generation times, . . . ) four Benchmark calculations have been performed. Sensitivity analysis have been applied to express these dependences in a useful way, and also to get an unavoidable experience to carry out calculations achieving the required accuracy and doing them in practical computing times. (Author) 29 refs

  20. An immersed body method for coupled neutron transport and thermal hydraulic simulations of PWR assemblies

    International Nuclear Information System (INIS)

    Jewer, S.; Buchan, A.G.; Pain, C.C.; Cacuci, D.G.

    2014-01-01

    Highlights: • A new method of coupled radiation transport, heat and momentum exchanges on fluids, and heat transfer simulations. • Simulation of the thermal hydraulics and radiative properties within whole PWR assemblies. • An immersed body method for modelling complex solid domains on practical computational meshes. - Abstract: A recently developed immersed body method is adapted and used to model a typical pressurised water reactor (PWR) fuel assembly. The approach is implemented with the numerical framework of the finite element, transient criticality code, FETCH which is composed of the neutron transport code, EVENT, and the CFD code, FLUIDITY. Within this framework the neutron transport equation, Navier–Stokes equations and a fluid energy conservation equation are solved in a coupled manner on a coincident structured or unstructured mesh. The immersed body method has been used to model the solid fuel pins. The key feature of this method is that the fluid/neutronic domain and the solid domain are represented by overlapping and non-conforming meshes. The main difficulty of this approach, for which a solution is proposed in this work, is the conservative mapping of the energy and momentum exchange between the fluid/neutronic mesh and the solid fuel pin mesh. Three numerical examples are presented which include a validation of the fuel pin submodel against an analytical solution; an uncoupled (no neutron transport solution) PWR fuel assembly model with a specified power distribution which was validated against the COBRA-EN subchannel analysis code; and finally a coupled model of a PWR fuel assembly with reflective neutron boundary conditions. Coupling between the fluid and neutron transport solutions is through the nuclear cross sections dependence on Doppler fuel temperature, coolant density and temperature, which was taken into account by using pre-calculated cross-section lookup tables generated using WIMS9a. The method was found to show good agreement

  1. Microdosimetric investigations at the fast neutron therapy facility at Fermilab

    International Nuclear Information System (INIS)

    Langen, K.M.

    1997-01-01

    Microdosimetry was used to investigate three issues at the neutron therapy facility (NTF) at Fermilab. Firstly, the conversion factor from absorbed dose in A-150 tissue equivalent plastic to absorbed dose in ICRU tissue was determined. For this, the effective neutron kerma factor ratios, i.e., oxygen tissue equivalent plastic and carbon to A-150 tissue equivalent plastic, were measured in the neutron beam. An A-150 tissue equivalent plastic to ICRU tissue absorbed dose conversion factor of 0.92 ± 0.04 was determined. Secondly, variations in the radiobiological effectiveness (RBE) in the beam were mapped by determining variations in two related quantities, e * and R, with field size and depth in tissue. Maximal variation in e * and R of 9% and 15% respectively were determined. Lastly, the feasibility of utilizing the boron neutron capture reaction on boron-10 to selectively enhance the tumor dose in the NTF beam was investigated

  2. The Swedish facility for boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Skoeld, K.; Capala, J. [Studsvik Medical AB (Sweden); Kierkegaard, J.; Haakansson, R. [Studsvik Nuclear AB (Sweden); Gudowska, I. [Karolinska Institute (Sweden)

    2000-10-01

    A BNCT (Boron Neutron Capture Therapy) facility has been constructed at the R2-0 reactor at Studsvik, Sweden. R2-0 is a 1 MW, open core, pool reactor. The reactor core is suspended on a movable tower and can be positioned anywhere in the pool. The BNCT facility includes two adjacent, parallel filter/moderator configurations and the reactor core is positioned in front of any of them as appropriate. One of the resulting neutron beams has been optimized for clinical irradiations with a filter/moderator system that allows easy variation of the neutron spectrum from the thermal to the epithermal energy range and with an extended collimator for convenient patient positioning. The other beam has been designed for radiobiological research and is equipped with a heavy water moderator and a large irradiation cavity with a uniform field of thermal neutrons. (author)

  3. The Swedish facility for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Skoeld, K.; Capala, J.; Kierkegaard, J.; Haakansson, R.; Gudowska, I.

    2000-01-01

    A BNCT (Boron Neutron Capture Therapy) facility has been constructed at the R2-0 reactor at Studsvik, Sweden. R2-0 is a 1 MW, open core, pool reactor. The reactor core is suspended on a movable tower and can be positioned anywhere in the pool. The BNCT facility includes two adjacent, parallel filter/moderator configurations and the reactor core is positioned in front of any of them as appropriate. One of the resulting neutron beams has been optimized for clinical irradiations with a filter/moderator system that allows easy variation of the neutron spectrum from the thermal to the epithermal energy range and with an extended collimator for convenient patient positioning. The other beam has been designed for radiobiological research and is equipped with a heavy water moderator and a large irradiation cavity with a uniform field of thermal neutrons. (author)

  4. Expanding options in radiation oncology: neutron beam therapy

    International Nuclear Information System (INIS)

    Cohen, L.

    1982-01-01

    Twelve years experience with neutron beam therapy in Britain, the USA, Europe and Japan shows that local control is achievable in late-stage epidermoid cancer somewhat more frequently than with conventional radiotherapy. Tumours reputed to be radioresistant (salivary gland, bladder, rectosigmoid, melanoma, bone and soft-tissue sarcomas) have proved to be particularly responsive to neutrons. Pilot studies in brain and pancreatic tumours suggest promising new approaches to management of cancer in these sites. The availability of neutron therapy in the clinical environment opens new prospects for irradiation of 'radioresistant' tumours, permits more conservative cancer surgery, expands the use of elective chemotherapy and provides a wider range of options for cancer patients. (author)

  5. European protocol for neutron dosimetry for external beam therapy

    International Nuclear Information System (INIS)

    Broerse, J.J.; Mijnheer, B.J.; Williams, J.R.

    1981-01-01

    The paper attempts to serve the needs of European centres participating in the High LET Therapy Project Group set up under the sponsorship of The European Organization for Research on Treatment of Cancer, to promote cooperation between physicists involved in fast neutron therapy and establish a common basis for neutron dosimetry. Differences in dosimetry procedures between European and American Groups are indicated if relevant. The subject is dealt with under the following main headings: principles of dosimetry of neutron fields, dosimetric methods, physical parameters, determination of absorbed dose at a reference point, determination of absorbed dose at any point, check of absorbed dose given to a patient, dosimetry intercomparisons between institutes. There is an ample bibliography. (U.K.)

  6. Estimation dose of secondary neutrons in proton therapy

    International Nuclear Information System (INIS)

    Urban, T.

    2014-01-01

    Most of proton therapy centers for cancer treatment are still based on the passive scattering, in some of them there is system of the active scanning installed as well. The aim of this study is to compare secondary neutron doses in and around target volumes in proton therapy for both treatment techniques and for different energies and profile of incident proton beam. The proton induced neutrons have been simulated in the very simple geometry of tissue equivalent phantom (imitate the patient) and scattering and scanning nozzle, respectively. In simulations of the scattering nozzle, different types of scattering filters and brass collimators have been used as well. 3D map of neutron doses in and around the chosen/potential target volume in the phantom/patient have been evaluated and compared in the context of the dose deposited in the target volume. Finally, the simulation results have been compared with published data. (author)

  7. Neutron metrology in the fuel assemblies of a material test reactor

    International Nuclear Information System (INIS)

    Voorbraak, W.P.; Paardekoper, A.; Polle, A.N.; Freudenreich, W.E.

    1993-08-01

    Results are presented of detailed thermal and fast neutron measurements performed in all fuel and control assemblies of the HFR in Petten. The results give information about deviations of a general shape of vertical thermal and fast fluence rate distributions due to material transitions in the reactor core and different control assembly settings. Further it is demonstrated that the ratio of fast and thermal fluence rate at the various monitor positions in the assemblies give useful information for the (relative) local burn-up of the fuel. (orig.)

  8. Self-powered in-core neutron detector assembly with uniform perturbation characteristics

    International Nuclear Information System (INIS)

    1981-01-01

    An in-core neutron detector assembly consisting of a number of longitudinally extending self-powered detectors is described. The uniform mechanical structures and materials are placed symmetrically at each active detector portion thus ensuring that local perturbation factors are uniform. (U.K.)

  9. Measurement of the neutron spectrum of the Big Ten critical assembly by lithium-6 spectrometry

    International Nuclear Information System (INIS)

    De Leeuw-Gierts, G.; De Leeuw, S.; Hansen, G.E.; Helmick, H.H.

    1979-01-01

    The central neutron-flux spectrum of the Los Alamos Scientific Laboratory's critical assembly, Big Ten, was measured with a 6 Li spectrometer and techniques developed at the Centre d'Etude de L'Energie Nucleaire, Mol, as part of an experimental program to establish the characteristics of Big Ten

  10. Effect of absorption discontinuity on neutron spectra of water assemblies poisoned with non-1/V absorbers

    International Nuclear Information System (INIS)

    Gupta, I.J.; Trikha, S.K.

    1977-01-01

    Calculations are presented of the diffusion of thermal neutrons (2.5 x 10 -4 to 7 x 10 -1 eV) across an absorption discontinuity in a water assembly, consisting of pure water on one side and aqueous solutions of three different non-1/V absorbers on the other, which were obtained by solving the Boltzmann transport equation in the diffusion approximation using the multigroup formalism. The gradual appearance and disappearance of the depletion region in the neutron spectra (caused by the resonance absorption peaks at energies 0.096 and 0.179 eV for samarium and cadmium respectively), as one moves from the pure water assembly to the poisoned water assembly and vice versa, have also been studied. The minimum concentrations of Sm and Cd atoms in water for which the depletion region in the spectra just starts building up are found to be 60 x 10 18 Sm atom cm -3 and 125 x 10 18 Cd atom cm -3 respectively. However no such depletion region is observed in gadolinium-poisoned water assembly. At the boundary, the equilibrium neutron distribution gets disturbed and is re-established to the equilibrium distribution of the second medium at some distance from the interface. The diffusion lengths so calculated from the total neutron density curves are in good agreement with the experimental results of Goddard and Johnson (Nucl. Sci. Eng.; 37:127 (1969)) at various concentrations of Gd and Cd atoms in water. (author)

  11. Measurement of the neutron spectrum of the Big Ten critical assembly by lithium-6 spectrometry

    International Nuclear Information System (INIS)

    Leeuw-Gierts, G. de; Leeuw, S. de

    1980-01-01

    The central neutron-flux spectrum of the Los Alamos Scientific Laboratory's critical assembly, Big Ten, was measured with a 6 Li spectrometer and techniques developed at the Centre d'Etude de l'Energie Nucleaire, Mol, as part of an experimental program to establish the characteristics of Big Ten

  12. Proceedings of the first international symposium on neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Brownell, G.L.

    1982-01-01

    This meeting was arranged jointly by MIT and BNL in order to illuminate progress in the synthesis and targeting of boron compounds and to evaluate and document progress in radiobiological and dosimetric aspects of neutron capture therapy. It is hoped that this meeting will facilitate transfer of information between groups working in these fields, and encourage synergistic collaboration

  13. Proceedings of the first international symposium on neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Fairchild, R.G.; Brownell, G.L. (eds.)

    1982-01-01

    This meeting was arranged jointly by MIT and BNL in order to illuminate progress in the synthesis and targeting of boron compounds and to evaluate and document progress in radiobiological and dosimetric aspects of neutron capture therapy. It is hoped that this meeting will facilitate transfer of information between groups working in these fields, and encourage synergistic collaboration.

  14. FERMILAB: operation resumes in meson area; fast neutron therapy

    International Nuclear Information System (INIS)

    Anon.

    1979-01-01

    Improvements and modifications in the Meson Area at Fermilab are described. The target train was rebuilt and energy range of some beams raised to 400 GeV with provisions for Tevatron beams of 1000 GeV in the future. The work of the fast neutron therapy facility is summarised. (W.D.L.).

  15. Clinical considerations for neutron capture therapy of brain tumors

    International Nuclear Information System (INIS)

    Madoc-Jones, H.; Wazer, D.E.; Zamenhof, R.G.; Harling, O.K.; Bernard, J.A. Jr.

    1990-01-01

    The radiotherapeutic management of primary brain tumors and metastatic melanoma in brain has had disappointing clinical results for many years. Although neutron capture therapy was tried in the US in the 1950s and 1960s, the results were not as hoped. However, with the newly developed capability to measure boron concentrations in blood and tissue both quickly and accurately, and with the advent of epithermal neutron beams obviating the need for scalp and skull reflection, it should not be possible to mount such a clinical trial of NCT again and avoid serious complications. As a prerequisite, it will be important to demonstrate the differential uptake of boron compound in brain tumor as compared with normal brain and its blood supply. If this can be done, then a trial of boron neutron capture therapy for brain tumors should be feasible. Because boronated phenylalanine has been demonstrated to be preferentially taken up by melanoma cells through the biosynthetic pathway for melanin, there is special interest in a trial of boron neutron capture therapy for metastatic melanoma in brain. Again, the use of an epithermal beam would make this a practical possibility. However, because any epithermal (or thermal) beam must contain a certain contaminating level of gamma rays, and because even a pure neutron beam cases gamma rays to be generated when it interacts with tissue, they think that it is essential to deliver treatments with an epithermal beam for boron neutron capture therapy in fractions in order to minimize the late-effects of low-LET gamma rays in the normal tissue

  16. Investigation of neutron physical features of WWER-440 assembly containing differently enriched pins and Gd burnable poison

    International Nuclear Information System (INIS)

    Nemes, Imre

    2000-01-01

    In this paper different pin-distributions of WWER-440 fuel assembly are examined. Assemblies contain 3 Gd-doped pins (Hungarian design), 6 Gd-doped pins near the assembly corners (Russian design) and differently profiled U5-enrichment in different pins. The main neutron physical characteristics of this assemblies - as the function of burnup - are calculated using HELIOS code. The calculated parameters of different assembly designs are analyzed from the standpoint of fuel cycle economy and refueling design practice. (Authors)

  17. Boron neutron capture therapy (BNCT). Recent aspect, a change from thermal neutron to epithermal neutron beam and a new protocol

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu

    1999-01-01

    Since 1968, One-hundred seventy three patients with glioblastoma (n=81), anaplastic astrocytoma (n=44), low grade astrocytoma (n=16) or other types of tumor (n=32) were treated by boron-neutron capture therapy (BNCT) using a combination of thermal neutron and BSH in 5 reactors (HTR n=13, JRR-3 n=1, MuITR n=98, KUR n=28, JRR-2 n=33). Out of 101 patients with glioma treated by BNCT under the recent protocol, 33 (10 glioblastoma, 14 anaplastic astrocytoma, 9 low grade astrocytoma) patients lived or have lived longer than 3 years. Nine of these 33 lived or have lived longer than 10 years. According to the retrospective analysis, the important factors related to the clinical results were tumor dose radiation dose and maximum radiation dose in thermal brain cortex. The result was not satisfied as it was expected. Then, we decided to introduce mixed beams which contain thermal neutron and epithermal neutron beams. KUR was reconstructed in 1996 and developed to be available to use mixed beams. Following the shutdown of the JRR-2, JRR-4 was renewed for medical use in 1998. Both reactors have capacity to yield thermal neutron beam, epithermal neutron beam and mixed beams. The development of the neutron source lead us to make a new protocol. (author)

  18. High-power liquid-lithium target prototype for accelerator-based boron neutron capture therapy.

    Science.gov (United States)

    Halfon, S; Paul, M; Arenshtam, A; Berkovits, D; Bisyakoev, M; Eliyahu, I; Feinberg, G; Hazenshprung, N; Kijel, D; Nagler, A; Silverman, I

    2011-12-01

    A prototype of a compact Liquid-Lithium Target (LiLiT), which will possibly constitute an accelerator-based intense neutron source for Boron Neutron Capture Therapy (BNCT) in hospitals, was built. The LiLiT setup is presently being commissioned at Soreq Nuclear Research Center (SNRC). The liquid-lithium target will produce neutrons through the (7)Li(p,n)(7)Be reaction and it will overcome the major problem of removing the thermal power generated using a high-intensity proton beam (>10 kW), necessary for sufficient neutron flux. In off-line circulation tests, the liquid-lithium loop generated a stable lithium jet at high velocity, on a concave supporting wall; the concept will first be tested using a high-power electron beam impinging on the lithium jet. High intensity proton beam irradiation (1.91-2.5 MeV, 2-4 mA) will take place at Soreq Applied Research Accelerator Facility (SARAF) superconducting linear accelerator currently in construction at SNRC. Radiological risks due to the (7)Be produced in the reaction were studied and will be handled through a proper design, including a cold trap and appropriate shielding. A moderator/reflector assembly is planned according to a Monte Carlo simulation, to create a neutron spectrum and intensity maximally effective to the treatment and to reduce prompt gamma radiation dose risks. Copyright © 2011 Elsevier Ltd. All rights reserved.

  19. Research on neutron energy spectrum of the beryllium, iron and polyethylene shells assemblies injected by D-T neutron

    International Nuclear Information System (INIS)

    An, Li; Guo, Haiping; Wang, Xinhua

    2009-04-01

    To test a simulation code, the multi-shell assemblies were established, which were made of beryllium stainless steel and polyethylene from the interior to the outer. The symmetry axes are all in the line of the D + beam. The neutron energy spectra above 1 MeV were obtained in medium by the detector of stilbene crystal of φ18 min x 20 mm. The distance between source and the spherical surface was 30 cm and 50 cm. The measurement channels are in the angle 0 degree and 120 degree relative to D + beam direction. The measurement positions are 0 cm, 9.7 cm, 12.8 cm and 17.3 cm away from the center of the assembly in both directions. The spectrum in different positions of the multi-shell assemblies in medium were compared and analyzed. (authors)

  20. Theoretical analysis of time-dependent neutron spectra in bulk assemblies

    International Nuclear Information System (INIS)

    Akimoto, Tadashi; Ogawa, Yuichi; Togawa, Orihiko.

    1988-01-01

    Time-dependent neutron spectra in an iron assembly and in a graphite assembly are obtained with the one-dimensional S N calculation, in order an attempt to investigate the availability of these spectra to the benchmark test by the LINAC-TOF method for evaluation of nuclear data and numerical methods. The group constants are taken from the JAERI FAST SET Version 1, 2 and the ABBN SET. It was demonstrated by a sensitivity test that the time-dependent neutron spectra are sensitive to changes in the inelastic scattering cross section data in the iron assembly and to changes in the elastic scattering cross section data in the graphite assembly. Moreover, it is shown that the time-dependent spectra in the graphite assembly are sensitive to the group structure. Because some information about the neutron transport phenomena which has not been obtained in the stationary spectra is observed in the time-dependent spectra, the availability of the benchmark test based on the time-dependent spectra is indicated from the theoretical analysis. (author)

  1. Alanine and TLD coupled detectors for fast neutron dose measurements in neutron capture therapy (NCT)

    Energy Technology Data Exchange (ETDEWEB)

    Cecilia, A.; Baccaro, S.; Cemmi, A. [ENEA-FIS-ION, Casaccia RC, Via Anguillarese 301, 00060 Santa Maria di Galeria, Rome (Italy); Colli, V.; Gambarini, G. [Dept. of Physics of the Univ., INFN, Via Celoria 16, 20133 Milan (Italy); Rosi, G. [ENEA-FIS-ION, Casaccia RC, Via Anguillarese 301, 00060 Santa Maria di Galeria, Rome (Italy); Scolari, L. [Dept. of Physics of the Univ., INFN, Via Celoria 16, 20133 Milan (Italy)

    2004-07-01

    A method was investigated to measure gamma and fast neutron doses in phantoms exposed to an epithermal neutron beam designed for neutron capture therapy (NCT). The gamma dose component was measured by TLD-300 [CaF{sub 2}:Tm] and the fast neutron dose, mainly due to elastic scattering with hydrogen nuclei, was measured by alanine dosemeters [CH{sub 3}CH(NH{sub 2})COOH]. The gamma and fast neutron doses deposited in alanine dosemeters are very near to those released in tissue, because of the alanine tissue equivalence. Couples of TLD-300 and alanine dosemeters were irradiated in phantoms positioned in the epithermal column of the Tapiro reactor (ENEA-Casaccia RC). The dosemeter response depends on the linear energy transfer (LET) of radiation, hence the precision and reliability of the fast neutron dose values obtained with the proposed method have been investigated. Results showed that the combination of alanine and TLD detectors is a promising method to separate gamma dose and fast neutron dose in NCT. (authors)

  2. Aspects of OER and RBE relevant to neutron therapy

    International Nuclear Information System (INIS)

    Field, S.B.; Hornsey, S.

    1979-01-01

    This chapter contains information concerning the mechanisms involved in neutron radiotherapy. Early studies on the attempts of using neutrons in radiotherapy are described. The rationale for fast neutron therapy is discussed as well as the relationships between OER and LET. Tissue responses include: repopulation of surviving cells; repair of sublethal damage; and slow repair. These mechanisms are considered separately. The relationships between RBE and dose per fraction for damage to skin, intestine, esophagus, lungs, hemopoietic tissue, and nerve tissue are discussed. Factors governing the effects of fractionation of dose in neutron radiotherapy are presented. Observations on mammalian cells and tissues show a general reduction in RBE with increasing neutron energy. The benefits of using mixed treatments, part with neutrons and the remainder with photons, are discussed. Problems with this approach include uncertainties of how the combination will effect normal tissue, how it effects slow repair, or its potentially lethal damage. Tumor response, as compared with x rays, to single and multiple doses of radiation is described. Clinical results are given

  3. Computer aided design of fast neutron therapy units

    International Nuclear Information System (INIS)

    Gileadi, A.E.; Gomberg, H.J.; Lampe, I.

    1980-01-01

    Conceptual design of a radiation-therapy unit using fusion neutrons is presently being considered by KMS Fusion, Inc. As part of this effort, a powerful and versatile computer code, TBEAM, has been developed which enables the user to determine physical characteristics of the fast neutron beam generated in the facility under consideration, using certain given design parameters of the facility as inputs. TBEAM uses the method of statistical sampling (Monte Carlo) to solve the space, time and energy dependent neutron transport equation relating to the conceptual design described by the user-supplied input parameters. The code traces the individual source neutrons as they propagate throughout the shield-collimator structure of the unit, and it keeps track of each interaction by type, position and energy. In its present version, TBEAM is applicable to homogeneous and laminated shields of spherical geometry, to collimator apertures of conical shape, and to neutrons emitted by point sources or such plate sources as are used in neutron generators of various types. TBEAM-generated results comparing the performance of point or plate sources in otherwise identical shield-collimator configurations are presented in numerical form. (H.K.)

  4. Current status of accelerator-based boron neutron capture therapy

    International Nuclear Information System (INIS)

    Kreiner, A. J.; Bergueiro, J.; Di Paolo, H.; Castell, W.; Vento, V. Thatar; Cartelli, D.; Kesque, J.M.; Valda, A.A.; Ilardo, J.C.; Baldo, M.; Erhardt, J.; Debray, M.E.; Somacal, H.R.; Estrada, L.; Sandin, J.C. Suarez; Igarzabal, M.; Huck, H.; Padulo, J.; Minsky, D.M.

    2011-01-01

    The direct use of proton and heavy ion beams for radiotherapy is a well established cancer treatment modality, which is becoming increasingly widespread due to its clear advantages over conventional photon-based treatments. This strategy is suitable when the tumor is spatially well localized. Also the use of neutrons has a long tradition. Here Boron Neutron Capture Therapy (BNCT) stands out, though on a much smaller scale, being a second-generation promising alternative for tumors which are diffuse and infiltrating. On this sector, so far only nuclear reactors have been used as neutron sources. In this paper we describe the current situation worldwide as far as the use of accelerator-based neutron sources for BNCT is concerned (so-called Accelerator-Based (AB)-BNCT). In particular we discuss the present status of an ongoing project to develop a folded Tandem-ElectroStatic-Quadrupole (TESQ) accelerator at the Atomic Energy Commission of Argentina. The project goal is a machine capable of delivering 30 mA of 2.4 MeV protons to be used in conjunction with a neutron production target based on the 7 Li(p,n) 7 Be reaction. These are the specifications needed to produce sufficiently intense and clean epithermal neutron beams to perform BNCT for deep-seated tumors in less than an hour. (author)

  5. Experience of boron neutron capture therapy in Japan

    International Nuclear Information System (INIS)

    Kanda, K.

    2004-01-01

    Four research reactors are currently licensed for medical application in Japan. As of July 1995, approximately 210 clinical irradiations using these research reactors have been done for brain and skin tumors as shown. The number of chief medical doctors certified by the Government is eleven so far. Among them, eight doctors have already treated tumor patients using the Kyoto University Reactor (KUR, 5MW). Recently in USA clinical trials have been restarted using epithermal neutrons at MIT and BNL. In this paper, the experience of clinical trials of boron neutron capture therapy (BNCT) which have been performed in Japan, mainly physics studies, are reviewed, and current studies are also introduced

  6. Study of the neutronic behavior of a fuel assembly with gadolinium of a reactor HPLWR

    International Nuclear Information System (INIS)

    Barragan M, A.; Martin del Campo M, C.; Francois L, J. L.; Espinosa P, G.

    2012-10-01

    This work presents a neutronic study of a square assembly design of double line of fuel rods, with moderator box to center of the arrangement, for the nuclear reactor cooled with supercritical water, High Performance Light Water Reactor (HPLWR). For the fuel analyses of the reactor HPLWR the neutronic code Helios-2 was used, settling down as the first study on fuel under conditions of supercritical water that has been simulated with this code. The analyzed variables, essentials in the neutronic design of any reactor, were the infinite neutrons multiplication factor (k∞) and the maximum power peaking factor (PPF max ), as well as the reactivity coefficients by the fuel temperature. The k∞ and PPF max values were obtained under conditions in cold (293.6 K) and in hot (to 880.8 K). The tests were realized for a reference fuel assembly design, with 40 fuel rods with enrichments of 4 and 5% of U-235, and considering different concentrations of consumable poison (gadolinium - Gd 2O3 ) in some rods of the same assembly. The obtained results show values k∞ and PPF max minors to the present in the conventional light water reactors. Moreover, the reactivity coefficients by fuel temperature were verified with the purpose of satisfying the safety conditions required in the nuclear reactors. (Author)

  7. Improved apparatus for neutron capture therapy of rat brain tumors

    International Nuclear Information System (INIS)

    Liu, Hungyuan B.; Joel, D.D.; Slatkin, D.N.; Coderre, J.A.

    1994-01-01

    The assembly for irradiating tumors in the rat brain at the thermal neutron beam port of the Brookhaven Medical Research Reactor was redesigned to lower the average whole-body dose from different components of concomitant radiation without changing the thermal neutron fluence at the brain tumor. At present, the tumor-bearing rat is positioned in a rat holder that functions as a whole-body radiation shield. A 2.54 cm-thick collimator with a centered conical aperture, 6 cm diameter tapering to 2 cm diameter, is used to restrict the size of the thermal neutron field. Using the present holder and collimator as a baseline design, Monte Carlo calculations and mixed-field dosimetry were used to assess new designs. The computations indicate that a 0.5 cm-thick plate, made of 6 Li 2 CO 3 dispersed in polyethylene (Li-poly), instead of the existing rat holder, will reduce the whole-body radiation dose. Other computations show that a 10.16 cm-thick (4 inches) Li-poly collimator, having a centered conical aperture of 12 cm diameter tapering to 2 cm diameter, would further reduce the whole-body dose. The proposed irradiation apparatus of tumors in the rat brain, although requiring a 2.3-fold longer irradiation time, would reduce the average whole-body dose to less than half of that from the existing irradiation assembly. 7 refs., 4 figs., 7 tabs

  8. In-phantom dosimetry using the 13C(d,n)14N reaction for BNCT (boron neutron capture therapy)

    International Nuclear Information System (INIS)

    Burlon, Alejandro; Kreiner, Andres J.; White, S.; Blackburn, B.; Gierga, David; Yanch, Jacquelyn C.

    2000-01-01

    The use of the 13 C(d,n) 14 N reaction at E d =1.5 MeV for accelerator-based boron neutron capture therapy is investigated. The 13 C(d,n) 14 N reaction presents the advantages of carbon as a target material and its large cross section. The deuteron beam was produced by a tandem accelerator at MIT's Laboratory for Accelerator Beam Applications. The resulting neutron spectra were evaluated in terms of RBE-dose rates at different depths inside a water-filled brain phantom using a heavy water moderator and lead reflector assembly. All results were simulated using the code MCNP. (author)

  9. Development of inverse-planning system for neutron capture therapy

    International Nuclear Information System (INIS)

    Kumada, Hiroaki; Yamamoto, Kazuyoshi; Maruo, Takeshi

    2006-01-01

    To lead proper irradiation condition effectively, Japan Atomic Energy Agency (JAEA) is developing an inverse-planning system for neutron capture therapy (NCT-IPS) based on the JAEA computational dosimetry system (JCDS) for BNCT. The leading methodology of an optimum condition in the NCT-IPS has been applied spatial channel theory with adjoint flux solution of Botzman transport. By analyzing the results obtained from the adjoint flux calculations according to the theory, optimum incident point of the beam against the patient can be found, and neutron spectrum of the beam which can generate ideal distribution of neutron flux around tumor region can be determined. The conceptual design of the NCT-IPS was investigated, and prototype of NCT-IPS with JCDS is being developed. (author)

  10. Neutron data testing for plutonium isotopes in experiments at fast critical assemblies

    International Nuclear Information System (INIS)

    Bednyakov, S.M.; Dulin, V.A.; Manturov, G.N.; Mozhaev, V.K.; Semenov, M.Yu.; Tsibulya, A.M.

    1996-01-01

    Experimental results on checking neutron data, obtained at the fast critical assemblies, are presented. They constitute sufficiently large collection of data making it possible to test nuclear neutron constants of plutonium isotopes for the new system of group constants BNAB-93. The work contains comparison of the measurement results on average fission cross section ratios and reactivity coefficients ratios for 239,240,241 Pu (to 235 U) with calculational data, obtained on the basis of the new testing system of the BNAB-93 group constants system. 14 refs., 6 figs

  11. Status of nuclear data for use in neutron therapy

    International Nuclear Information System (INIS)

    White, R.M.

    1992-03-01

    Optimization of neutron therapy requires nuclear cross section data for: (1) the selection of source reaction for neutron production, (2) the design of collimators and shields, (3) the calculation of absorbed dose in the irradiation tissues, including heterogeneity corrections, (4) microdosimetry, and (5) studies of the influence of radiation quality on biological effects. Under the auspices of the International Atomic Energy Agency (IAEA), a Coordinated Research Program (CRP) has been underway since 1987 to assess the status of these nuclear data, to coordinate research efforts, to report recent progress, and to recommend acceptance of appropriate data and further research where necessary. In this paper, we outline the results of the CRP's final report to be published and evaluate the status of the most critical nuclear data needs for therapy, i.e., kerma calculations and measurements, from low neutron energies to 70 MeV. Recommended values for (n,p) kerma and the carbon-to-oxygen neutron kerma factor ratios up to 70 MeV are given with estimates of their current uncertainties

  12. Recombination methods for boron neutron capture therapy dosimetry

    International Nuclear Information System (INIS)

    Golnik, N.; Tulik, P.; Zielczynski, M.

    2003-01-01

    The radiation effects of boron neutron capture therapy (BNCT) are associated with four-dose-compartment radiation field - boron dose (from 10 B(n,α) 7 Li) reaction), proton dose from 14 N(n,p) 14 C reaction, neutron dose (mainly fast and epithermal neutrons) and gamma-ray dose (external and from capture reaction 1 H(n,γ) 2 D). Because of this the relation between the absorbed dose and the biological effects is very complex and all the above mentioned absorbed dose components should be determined. From this point of view, the recombination chambers can be very useful instruments for characterization of the BNCT beams. They can be used for determination of gamma and high-LET dose components for the characterization of radiation quality of mixed radiation fields by recombination microdosimetric method (RMM). In present work, a graphite high-pressure recombination chamber filled with nitrogen, 10 BF 3 and tissue equivalent gas was used for studies on application of RMM for BNCT dosimetry. The use of these gases or their mixtures opens a possibility to design a recombination chamber for determination of the dose fractions due to gamma radiation, fast neutrons, neutron capture on nitrogen and high LET particles from (n, 10 B) reaction in simulated tissue with different content of 10 B. (author)

  13. Development of lithium target for accelerator based neutron capture therapy

    International Nuclear Information System (INIS)

    Taskaev, Sergey; Bayanov, Boris; Belov, Victor; Zhoorov, Eugene

    2006-01-01

    Pilot innovative accelerator based neutron source for neutron capture therapy of cancer is now of the threshold of its operation at the BINP, Russia. One of the main elements of the facility is lithium target producing neutrons via threshold 7 Li(p,n) 7 Be reaction at 25 kW proton beam with energies 1.915 MeV or 2.5 MeV. The main problems of lithium target were determined to be: 7 Be radioactive isotope activation keeping lithium layer solid, presence of photons due to proton inelastic scattering on lithium nuclei, and radiation blistering. The results of thermal test of target prototype were presented as previous NCT Congress. It becomes clear that water is preferable for cooling the target, and that lithium target 10 cm in diameter is able to run before melting. In the present report, the conception of optimal target is proposed: thin metal disk 10 cm in diameter easy for detaching, with evaporated thin layer of pure lithium from the side of proton beam exposure, its back being intensively cooled with turbulent water flow to maintain lithium layer solid. Design of the target for the neutron source constructed at BINP is shown. The results of investigation of radiation blistering and lithium layer are presented. Target unit of facility is under construction now, and obtaining neutrons is expected in nearest future. (author)

  14. Irradiation system for neutron capture therapy using the small accelerator

    International Nuclear Information System (INIS)

    Kobayashi, Tooru; Hoshi, Masaharu

    2002-01-01

    Neutron capture therapy (NCT) is to kill tumor cells that previously incorporated the stable isotope which generates heavy charged particles with a short range and a high linear energy transfer (LET) on neutron irradiation. Boron-10 is ordinarily used as such an isotope. The tumor tissue is neutron-irradiated at craniotomy after preceding craniotomy for tumor extraction: therefore two surgeries are required for the present NCT in Japan. The reactions 10 B(n, αγ) 7 Li and 7 Li (p, n) 7 Be are thought preferential for patients and doctors if a convenient small accelerator, not the reactor used at present, is available in the hospital because only one craniotomy is sufficient. Authors' examinations of the system for NCT using the small accelerator involve irradiation conditions, desirable energy spectrum of neutron, characterization of thermal and epi-thermal neutrons, social, practical and technical comparison of the reactor and accelerator, and usefulness of the reaction 7 Li (p, n) 7 Be. The system devoted to the NCT is awaited in future. (K.H.)

  15. SU-E-J-115: Graticule for Verification of Treatment Position in Neutron Therapy.

    Science.gov (United States)

    Halford, R; Snyder, M

    2012-06-01

    Until recently the treatment verification for patients undergoing fast neutron therapy at our facility was accomplished through a combination of neutron beam portal films aligned with a graticule mounted on an orthronormal x-ray tube. To eliminate uncertainty with respect to the relative positions of the x-ray graticule and the therapy beam, we have developed a graticule which is placed in the neutron beam itself. For a graticule to be visible on the portal film, the attenuation of the neutron beam by the graticule landmarks must be significantly greater than that of the material in which the landmarks are mounted. Various materials, thicknesses, and mounting points were tried to gain the largest contrast between the graticule landmarks and the mounting material. The final design involved 2 inch steel pins of 0.125 inch diameter captured between two parallel plates of 0.25 inch thick clear acrylic plastic. The distance between the two acrylic plates was 1.625 inches, held together at the perimeter with acrylic sidewall spacers. This allowed the majority of length of the steel pins to be surrounded by air. The pins were set 1 cm apart and mounted at angles parallel to the divergence of the beam dependent on their position within the array. The entire steel pin and acrylic plate assembly was mounted on an acrylic accessory tray to allow for graticule alignment. Despite the inherent difficulties in attenuating fast neutrons, our simple graticule design produces the required difference of attenuation between the arrays of landmarks and the mounting material. The graticule successfully provides an in-beam frame of reference for patient portal verification. © 2012 American Association of Physicists in Medicine.

  16. Design of a cryogenic deuterium gas target for neutron therapy

    International Nuclear Information System (INIS)

    Kuchnir, F.T.; Waterman, F.M.; Forsthoff, H.; Skaggs, L.S.; Vander Arend, P.C.; Stoy, S.

    1976-01-01

    A cryogenic deuterium gas target operating at 80 0 K and 10 atm pressure has been designed for use with a small cyclotron; the D(d,n) reaction is used to produce a neutron beam suitable for radiation therapy. The target is cooled by circulation of the gas in a closed loop between the target and an external heat exchanger immersed in liquid nitrogen

  17. Accelerator conceptual design and needs of nuclear data for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Sasaki, Makoto; Yamanaka, Toshiyuki; Yokobori, Hitoshi

    1999-01-01

    An optimization study has been made on an accelerator-based facility for the boron neutron capture therapy. The energy of the incident proton and the arrangement of the moderator assemblies are optimized. The beam current and the accelerating voltage are determined so that the accelerator power becomes minimum. The proposed facility is equipped with a 2.5 MeV proton accelerator of 10-25 mA, a lithium target, and a heavy water moderator contained in an aluminum tank. Each of these equipment is feasible, if proper R and D works have been done. Our new design requires the beam power of less than a hundred kW for the accelerator, although that of our previous design was 1 MW. The reduction of the beam power makes the cooling system for the target much simpler. The essential issues for realization of this concept are long-life lithium targets under high heat flux and high current proton accelerators with average currents of more than 10 mA. It is necessary for the reasonable design of a small-sized and low cost facility to get good accuracy nuclear reaction data. Especially, the latest Li/Be(p, n) neutron yield data in a range of threshold energy - few MeV are required for exact evaluation of neutron energy spectrum used therapy. And damage data by low energy proton beam are also important to evaluate integrity of target material. (author)

  18. Calculation of neutron importance function in fissionable assemblies using Monte Carlo method

    International Nuclear Information System (INIS)

    Feghhi, S.A.H.; Shahriari, M.; Afarideh, H.

    2007-01-01

    The purpose of the present work is to develop an efficient solution method for the calculation of neutron importance function in fissionable assemblies for all criticality conditions, based on Monte Carlo calculations. The neutron importance function has an important role in perturbation theory and reactor dynamic calculations. Usually this function can be determined by calculating the adjoint flux while solving the adjoint weighted transport equation based on deterministic methods. However, in complex geometries these calculations are very complicated. In this article, considering the capabilities of MCNP code in solving problems with complex geometries and its closeness to physical concepts, a comprehensive method based on the physical concept of neutron importance has been introduced for calculating the neutron importance function in sub-critical, critical and super-critical conditions. For this propose a computer program has been developed. The results of the method have been benchmarked with ANISN code calculations in 1 and 2 group modes for simple geometries. The correctness of these results has been confirmed for all three criticality conditions. Finally, the efficiency of the method for complex geometries has been shown by the calculation of neutron importance in Miniature Neutron Source Reactor (MNSR) research reactor

  19. A novel design of beam shaping assembly to use D-T neutron generator for BNCT.

    Science.gov (United States)

    Kasesaz, Yaser; Karimi, Marjan

    2016-12-01

    In order to use 14.1MeV neutrons produced by d-T neutron generators, two special and novel Beam Shaping Assemblies (BSA), including multi-layer and hexagonal lattice have been suggested and the effect of them has been investigated by MCNP4C Monte Carlo code. The results show that the proposed BSA can provide the qualified epithermal neutron beam for BNCT. The final epithermal neutron flux is about 6e9 n/cm2.s. The final proposed BSA has some different advantages: 1) it consists of usual and well-known materials (Pb, Al, Fluental and Cd); 2) it has a simple geometry; 3) it does not need any additional gamma filter; 4) it can provide high flux of epithermal neutrons. As this type of neutron source is under development in the world, it seems that they can be used clinically in a hospital considering the proposed BSA. Copyright © 2016 Elsevier Ltd. All rights reserved.

  20. Preliminary investigations of Monte Carlo Simulations of neutron energy and LET spectra for fast neutron therapy facilities

    International Nuclear Information System (INIS)

    Kroc, T.K.

    2009-01-01

    No fast neutron therapy facility has been built with optimized beam quality based on a thorough understanding of the neutron spectrum and its resulting biological effectiveness. A study has been initiated to provide the information necessary for such an optimization. Monte Carlo studies will be used to simulate neutron energy spectra and LET spectra. These studies will be bench-marked with data taken at existing fast neutron therapy facilities. Results will also be compared with radiobiological studies to further support beam quality ptimization. These simulations, anchored by this data, will then be used to determine what parameters might be optimized to take full advantage of the unique LET properties of fast neutron beams. This paper will present preliminary work in generating energy and LET spectra for the Fermilab fast neutron therapy facility.

  1. Tritium breeding experiments in a fusion blanket assembly using a low-intensity neutron generator

    International Nuclear Information System (INIS)

    Dalton, A.W.; Woodley, H.J.; McGregor, B.J.

    1987-01-01

    Experiments have been carried out to determine the accuracy with which tritium production rates (TPRs) can be measured in a fusion blanket assembly of non-spherical geometry by a non-central low intensity D-T neutron source (2x10 10 neutrons per second). The tritium production was determined for samples of lithium carbonate containing high enrichments of 6 Li(96%) and 7 Li(99.9%). The measured data were used to check the accuracy with which the TPRs could be numerically predicted using current nuclear data and calculational methods. The numerical predictions from tritium production from the 7 Li samples agreed within the experimental errors of the measurements, but 6 Li measurements which differ by more than 20 per cent from the predicted values were observed in the lower half of the assembly

  2. Theoretical and Experimental Research in Neutron Spectra and Nuclear Waste Transmutation on Fast Subcritical Assembly with MOX Fuel

    Science.gov (United States)

    Arkhipkin, D. A.; Buttsev, V. S.; Chigrinov, S. E.; Kutuev, R. Kh.; Polanski, A.; Rakhno, I. L.; Sissakian, A.; Zulkarneev, R. Ya.; Zulkarneeva, Yu. R.

    2003-07-01

    The paper deals with theoretical and experimental investigation of transmutation rates for a number of long-lived fission products and minor actinides, as well as with neutron spectra formed in a subcritical assembly driven with the following monodirectional beams: 660-MeV protons and 14-MeV neutrons. In this work, the main objective is the comparison of neutron spectra in the MOX assembly for different external driving sources: a 660-MeV proton accelerator and a 14-MeV neutron generator. The SAD project (JINR, Russia) has being discussed. In the context of this project, a subcritical assembly consisting of a cylindrical lead target surrounded by a cylindrical MOX fuel layer will be constructed. Present conceptual design of the subcritical assembly is based on the core with a nominal unit capacity of 15 kW (thermal). This corresponds to a multiplication coefficient, keff= 0.945, and an accelerator beam power of 0.5 kW. The results of theoretical investigations on the possibility of incinerating long-lived fission products and minor actinides in fast neutron spectrum and formation of neutron spectra with different hardness in subcritical systems based on the MOX subcritical assembly are discussed. Calculated neutron spectra emitted from a lead target irradiated by a 660-MeV protons are also presented.

  3. Characterization of the CALIBAN Critical Assembly Neutron Spectra using Several Adjustment Methods Based on Activation Foils Measurement

    OpenAIRE

    Casoli Pierre; Grégoire Gilles; Rousseau Guillaume; Jacquet Xavier; Authier Nicolas

    2016-01-01

    CALIBAN is a metallic critical assembly managed by the Criticality, Neutron Science and Measurement Department located on the French CEA Center of Valduc. The reactor is extensively used for benchmark experiments dedicated to the evaluation of nuclear data, for electronic hardening or to study the effect of the neutrons on various materials. Therefore CALIBAN irradiation characteristics and especially its central cavity neutron spectrum have to be very accurately evaluated. In order to streng...

  4. Preliminary neutronics calculation of fusion-fission hybrid reactor breeding spent fuel assembly

    International Nuclear Information System (INIS)

    Ma Xubo; Chen Yixue; Gao Bin

    2013-01-01

    The possibility of using the fusion-fission hybrid reactor breeding spent fuel in PWR was preliminarily studied in this paper. According to the fusion-fission hybrid reactor breeding spent fuel characteristics, PWR assembly including fusion-fission hybrid reactor breeding spent fuel was designed. The parameters such as fuel temperature coefficient, moderator temperature coefficient and their variation were investigated. Results show that the neutron properties of uranium-based assembly and hybrid reactor breeding spent fuel assembly are similar. The design of this paper has a smaller uniformity coefficient of power at the same fissile isotope mass percentage. The results will provide technical support for the future fusion-fission hybrid reactor and PWR combined with cycle system. (authors)

  5. Research on neutron capture therapy in the USSR

    International Nuclear Information System (INIS)

    Ryabukhin, Y.

    1988-01-01

    Research on neutron capture therapy in the USSR began in 1964. Towards 1975 prime knowledge in physics, pharmacology and radiobiology had been accumulated. It was realized that inherent to NCT is a variety of modalities as to the type and location of the tumor, the energy and source of neutrons, the nature and transportation of the nuclide-carrying agent (NCA), etc. Thus, it became likely that some modalities would turn out to be clinically feasible. At the end of the 70s, studies of boron derivatives began at the All-Union Oncological Research Center, Moscow. These studies were stimulated by the clinical trials in Japan. Still, neutron capturing nuclides (NCN) other than 10 b are regarded as promising. Research was aimed at clinical trials that could ensure sufficient safety, convenience and conclusiveness. Hence, new requirements emerged, such as the pre-clinical modeling of NCT in big animals and the monitoring of tumor response to each fraction of NCT. Usual requirements are also to be met, that is: tailoring neutron beams with an adequate intensity and energy, choosing NCNs and finding suitable NCAs, physical and radiobiological planning including adoption of tentative RBEs and time-fractionation regimen, selecting tumors as candidates for NCT, and developing techniques for monitoring NCNs in vivo

  6. Boron neutron capture therapy for malignant brain tumor in Japan

    Energy Technology Data Exchange (ETDEWEB)

    Nakagawa, Yoshinobu [National Kagawa Children`s Hospital, Takamatsu, Kagawa (Japan)

    1998-03-01

    Since 1968, we have treated 149 patients and performed boron-neutron capture therapy (BNCT) on 164 occasions using 5 reactors in Japan. There were 64 patients with glioblastoma, 39 patients with anaplastic astrocytoma and 17 patients with low grade astrocytoma (grade 1 or 2). There were 30 patients with other types of tumor. The overall response rate in the glioma patients was 64%. Seven patients (12%) of glioblastoma, 22 patients (56%) of anaplastic astrocytoma and 8 patients (62%) of low grade astrocytoma lived more than 2 years Median survival time of glioblastoma was 640 days. Median survival times of patients with anaplastic astrocytoma was 1811 days, and 1669 days in low grade astrocytoma. Six patients (5 glioblastoma and one anaplastic astrocytoma) died within 90 days after BNCT. Six patients lived more than 10 years. Histological grading, age of the patients, neutron fluence at the target point and target depth or size of the tumor were proved to be important factors. BNCT is an effective treatment for malignant brain tumors. We are now became able to radiate the tumor more correctly with a high enough dose of neutron beam even if we use thermal neutron beam. (author)

  7. Measurement of time-dependent fast neutron energy spectra in a depleted uranium assembly

    International Nuclear Information System (INIS)

    Whittlestone, S.

    1980-10-01

    Time-dependent neutron energy spectra in the range 0.6 to 6.4 MeV have been measured in a depleted uranium assembly. By selecting windows in the time range 0.9 to 82 ns after the beam pulse, it was possible to observe the change of the neutron energy distributions from spectra of predominantly 4 to 6 MeV neutrons to spectra composed almost entirely of fission neutrons. The measured spectra were compared to a Monte Carlo calculation of the experiment using the ENDF/B-IV data file. At times and energies at which the calculation predicted a fission spectrum, the experiment agreed with the calculation, confirming the accuracy of the neutron spectroscopy system. However, the presence of discrepancies at other times and energies suggested that there are significant inconsistencies in the inelastic cross sections in the 1 to 6 MeV range. The time response generated concurrently with the energy spectra was compared to the Monte Carlo calculation. From this comparison, and from examination of time spectra measured by other workers using 235 U and 237 Np fission detectors, it would appear that there are discrepancies in the ENDF/B-IV cross sections below 1 MeV. The predicted decay rates were too low below and too high above 0.8 MeV

  8. Calculation of neutron importance function in fissionable assemblies using Monte Carlo method

    International Nuclear Information System (INIS)

    Feghhi, S. A. H.; Afarideh, H.; Shahriari, M.

    2007-01-01

    The purpose of the present work is to develop an efficient solution method to calculate neutron importance function in fissionable assemblies for all criticality conditions, using Monte Carlo Method. The neutron importance function has a well important role in perturbation theory and reactor dynamic calculations. Usually this function can be determined by calculating adjoint flux through out solving the Adjoint weighted transport equation with deterministic methods. However, in complex geometries these calculations are very difficult. In this article, considering the capabilities of MCNP code in solving problems with complex geometries and its closeness to physical concepts, a comprehensive method based on physical concept of neutron importance has been introduced for calculating neutron importance function in sub-critical, critical and supercritical conditions. For this means a computer program has been developed. The results of the method has been benchmarked with ANISN code calculations in 1 and 2 group modes for simple geometries and their correctness has been approved for all three criticality conditions. Ultimately, the efficiency of the method for complex geometries has been shown by calculation of neutron importance in MNSR research reactor

  9. Computational Dosimetry and Treatment Planning Considerations for Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Nigg, David Waler

    2003-01-01

    Specialized treatment planning software systems are generally required for neutron capture therapy (NCT) research and clinical applications. The standard simplifying approximations that work well for treatment planning computations in the case of many other modalities are usually not appropriate for application to neutron transport. One generally must obtain an explicit three-dimensional numerical solution of the governing transport equation, with energy-dependent neutron scattering completely taken into account. Treatment planning systems that have been successfully introduced for NCT applications over the past 15 years rely on the Monte Carlo stochastic simulation method for the necessary computations, primarily because of the geometric complexity of human anatomy. However, historically, there has also been interest in the application of deterministic methods, and there have been some practical developments in this area. Most recently, interest has turned toward the creation of treatment planning software that is not limited to any specific therapy modality, with NCT as only one of several applications. A key issue with NCT treatment planning has to do with boron quantification, and whether improved information concerning the spatial biodistribution of boron can be effectively used to improve the treatment planning process. Validation and benchmarking of computations for NCT are also of current developmental interest. Various institutions have their own procedures, but standard validation models are not yet in wide use

  10. Experimental Assessment of a New Passive Neutron Multiplication Counter for Partial Defect Verification of LWR Fuel Assemblies

    International Nuclear Information System (INIS)

    LaFleur, A.; Menlove, H.; Park, S.-H.; Lee, S. K.; Oh, J.-M.; Kim, H.-D.

    2015-01-01

    The development of non-destructive assay (NDA) capabilities to improve partial defect verification of spent fuel assemblies is needed to improve the timely detection of the diversion of significant quantities of fissile material. This NDA capability is important to the implementation of integrated safeguards for spent fuel verification by the International Atomic Energy Agency (IAEA) and would improve deterrence of possible diversions by increasing the risk of early detection. A new NDA technique called Passive Neutron Multiplication Counter (PNMC) is currently being developed at Los Alamos National Laboratory (LANL) to improve safeguards measurements of LightWater Reactor (LWR) fuel assemblies. The PNMC uses the ratio of the fast-neutron emission rate to the thermalneutron emission rate to quantify the neutron multiplication of the item. The fast neutrons versus thermal neutrons are measured using fission chambers (FC) that have differential shielding to isolate fast and thermal energies. The fast-neutron emission rate is directly proportional to the neutron multiplication in the spent fuel assembly; whereas, the thermalneutron leakage is suppressed by the fissile material absorption in the assembly. These FCs are already implemented in the basic Self-Interrogation Neutron Resonance Densitometry (SINRD) detector package. Experimental measurements of fresh and spent PWR fuel assemblies were performed at LANL and the Korea Atomic Energy Research Institute (KAERI), respectively, using a hybrid PNMC and SINRD detector. The results from these measurements provides valuable experimental data that directly supports safeguards research and development (R&D) efforts on the viability of passive neutron NDA techniques and detector designs for partial defect verification of spent fuel assemblies. (author)

  11. Neutron capture therapy of ocular melanoma: dosimetry and microdosimetry approaches

    International Nuclear Information System (INIS)

    Pignol, J.P.; Methlin, G.; Abbe, J.C.; Lefebvre, O.; Sahel, J.

    1994-01-01

    Neutron capture therapy (NCT) aims at destroying cancerous cells with the α and 7 Li particles produced by the neutron capture reaction on 10 B. This note reports on the study of the boron distribution in tissues on an animal model (nude mice) xenografted with a human ocular melanoma after an i.p.injection of 2g/kg of 10 B-BPA and in cells cultured in the presence of 530 μmol/l of 10 B-BPA. A concentration of 64 ppm of 10 B in the active part of the tumour with a ratio of concentrations versus the skin of 3.7 are observed. Investigations on cells reveal the presence of boron in the cytoplasm. The biological, dosimetric and microdosimetric consequences of these findings are discussed. (authors). 15 refs., 2 tabs., 2 figs

  12. Neutron therapy planning: Principles and practice in Edinburgh

    International Nuclear Information System (INIS)

    Duncan, W.; Williams, J.R.; Redpath, A.T.; Arnott, S.J.

    1981-01-01

    The principles of treatment planning using beams of fast neutron irradiation are the same as that involved in X-ray therapy. The optimum treatment technique to be employed and the standard of dose distribution depend on the penetration of the beam, the sophistication of the treatment head and certain clinical constraints. These inter-related factors are briefly discussed. The Edinburgh Cyclotron produces d(15)+Be neutrons and compared to megavoltage X-rays it is necessary to use a greater number of fields, respect greater restraints on planning and, when wedge filters are used, accept relatively higher doses in 'hot spots'. With careful and detailed planning satisfactory dose distributions can be achieved. The procedures followed in clinical planning, field selection and dose computation are described. (orig.)

  13. Desain Beam Shaping Assembly (BSA berbasis D-D Neutron Generator 2,45 MeV untuk Uji Fasilitas BNCT

    Directory of Open Access Journals (Sweden)

    Desman P. Gulo

    2015-12-01

    Full Text Available Boron Neutron Capture Therapy (BNCT is one of the cancer treatments that are being developed in nowadays. In order to support BNCT treatment for cancer that exists in underneath skin like breast cancer, the facility needs a generator that is able to produce epithermal neutron. One of the generator that is able to produce neutron is D-D neutron generator with 2.45 MeV energy. Based on the calculation of this paper, we found that the total production of neutron per second (neutron yield from Neutron Generator (NG by PSTA-BATAN Yogyakarta is 2.55×1011 n/s. The energy and flux that we found is in the range of quick neutron. Thus, it needs to be moderated to the level of epithermal neutron which is located in the interval energy of 1 eV to 10 KeV with 109 n/cm2s flux. This number is the recommendation standard from IAEA. Beam Shaping Assembly (BSA is needed in order to moderate the quick neutron to the level of epithermal neutron. One part of BSA that has the responsibility in moderating the quick neutron to epithermal neutron is the moderator. The substance of moderator used in this paper is MgF2 and A1F3. The thickness of moderator has been set in in such a way by using MCNPX software in order to fulfill the standard of IAEA. As the result of optimizing BSA moderator, the data obtain epithermal flux with the total number of 4.64×108 n/cm2/s for both of moderators with the thickness of moderator up to 15 cm. At the end of this research, the number of epithermal flux does not follow the standard of IAEA. This is because the flux neutron that is being produced by NG is relatively small. In conclusion, the NG from PSTA-BATAN Yogyakarta is not ready to be used for the BNCT treatment facility for the underneath skin cancer like breast cancer.

  14. Characteristics of neutron irradiation facility and dose estimation method for neutron capture therapy at Kyoto University research reactor institute

    International Nuclear Information System (INIS)

    Kobayashi, T.; Sakurai, Y.; Kanda, K.

    2001-01-01

    The neutron irradiation characteristics of the Heavy Water Neutron Irradiation Facility (HWNIF) at the Kyoto University Research Reactor Institute (KIJRRI) for boron neutron capture therapy (BNCT), is described. The present method of dose measurement and its evaluation at the KURRI, is explained. Especially, the special feature and noticeable matters were expounded for the BNCT with craniotomy, which has been applied at present only in Japan. (author)

  15. Carborane derivative development for boron neutron capture therapy. Final report

    International Nuclear Information System (INIS)

    Barnum, Beverly A.; Yan Hao; Moore, Roger; Hawthorne, M. Frederick; Baum, Kurt

    1999-01-01

    Boron Neutron Capture Therapy [BNCT] is a binary method of cancer therapy based on the capture of neutrons by a boron-10 atom [ 10 B]. Cytotoxic 7 Li nuclei and α-particles are emitted, with a range in tissue of 9 and 5 microm, respectively, about one cell diameter. The major obstacle to clinically viable BNCT is the selective localization of 5-30 ppm 10 B in tumor cells required for effective therapy. A promising approach to BNCT is based on hydrophilic boron-rich oligomeric phosphate diesters, or ''trailers'' that have been shown to concentrate selectively in tumor tissue. Examples of these compounds were prepared previously at high cost using an automated DNA synthesizer. Direct synthesis methods are needed for the production of gram-scale quantities for further biological evaluation. The work accomplished as a result of the collaboration between Fluorochem, Inc. and UCLA demonstrates that short oligomers containing at least five carborane units with four phosphodiester linkages can be prepared in substantial quantities. This work was accomplished by the application of standard phosphoramidite coupling chemistry

  16. Results of two randomised clinical trials of neutron therapy in rectal adenocarcinoma

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Jack, W.J.L.; Orr, J.A.; Kerr, G.R.; Williams, J.R.

    1987-01-01

    Two clinical trials of neutron therapy were instituted to compare fast neutron therapy with megavoltage therapy in inoperable adenocarcinoma of the rectum and in postoperative recurrent adenocarcinoma of the rectum and to evaluate local tumour control, radiation morbidity and survival rates. In both rectal trials, complete local regression and persistent local control of tumour were similar in each treatment group. Survival was poor and so there is little long-term experience of tumour control and morbidity. The possibility that the relatively poor penetration of the neutron beam had an adverse effect on the results of neutron therapy should be considered. (Auth.)

  17. Spin-Assisted Layer-by-Layer Assembly: Variation of Stratification as Studied with Neutron Reflectivity

    International Nuclear Information System (INIS)

    Kharlampieva, Eugenia; Kozlovskaya, Veronika; Chan, Jennifer; Ankner, John Francis; Tsukruk, Vladimir V.

    2009-01-01

    We apply neutron reflectivity to probe the internal structure of spin-assisted layer-by-layer (LbL) films composed of electrostatically assembled polyelectrolytes. We find that the level of stratification and the degree of layer intermixing can be controlled by varying the type and concentration of salt during LbL assembly. We observe well-defined layer structure in spin-assisted LbL films when deposited from salt-free solutions. These films feature 2-nm-thick bilayers, which are ∼3-fold thicker than those in dipped LbL films assembled under similar conditions. Addition of a 10mM phosphate buffer promotes progressive layer inter-diffusion with increasing distance from the substrate. However, adding 0.1M NaCl to the phosphate buffer solution restores the layer stratification. We also find that spin-assisted LbL films obtained from buffer solutions are more highly stratified as compared to the highly intermixed layers seen in dipped LbL films assembled from buffer. Our results yield new insight into the mechanism of spin-assisted LbL assembly that should prove useful for biotechnological applications.

  18. Study on high speed lithium jet for neutron source of boron neutron capture therapy (BNCT)

    International Nuclear Information System (INIS)

    Takahashi, Minoru; Kobayashi, Tooru; Zhang, Mingguang; Mak, Michael; Stefanica, Jiri; Dostal, Vaclav; Zhao Wei

    2012-01-01

    The feasibility study of a liquid lithium type proton beam target was performed for the neutron source of the boron neutron capture therapy (BNCT). As the candidates of the liquid lithium target, a thin sheet jet and a thin film flow on a concave wall were chosen, and a lithium flow experiment was conducted to investigate the hydrodynamic stability of the targets. The surfaces of the jets and film flows with a thickness of 0.5 mm and a width of 50 mm were observed by means of photography. It has been found that a stable sheet jet and a stable film flow on a concave wall can be formed up to certain velocities by using a straight nozzle and a curved nozzle with the concave wall, respectively. (author)

  19. Novel amino-carboxy-dihydroboranes for neutron capture therapy

    International Nuclear Information System (INIS)

    Boehmel, T.

    1985-01-01

    The thesis discusses the following topics: I. Synthesis of boron compounds for the neutron capture therapy which are to meet the following requirements: 1. Low toxicity; 2. High boron content; 3. High enrichment and long retention time in the neoplastic tissue and simultaneous low concentration in blood and normal tissue; 4. Independent cytostatic effects; 5. Functional groups which allow a connection with polymers. II. Presentation of compounds with increased 10 B content. III. Examination of the distribution of boric substances in living organisms by means of a quantitative analysis of the boron content. (orig./PW) [de

  20. Dose modification factors in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Allen, B.J. (Australian Nuclear Science and Technology Organization (ANSTO), Menai (Australia))

    1993-01-01

    The effective treatment depth and therapeutic ratio in boron neutron capture therapy (BNCT) depend on a number of macroscopic dose factors such as boron concentrations in the tumor, normal tissue and blood. However, the role of various microscopic dose modification factors can be of critical importance in the evaluation of normal tissue tolerance levels. An understanding of these factors is valuable in designing BNCT experiments and the selection of appropriate boron compounds. These factors are defined in this paper and applied to the case of brain tumors with particular attention to capillary endothelial cells and oligodendrocytes. (orig.).

  1. Ultrastructural changes in tumor cells following boron neutron capture therapy

    International Nuclear Information System (INIS)

    Barkla, D.H.; Brown, J.K.; Meriaty, H.; Allen, B.J.

    1992-01-01

    In a previous study the authors reported on morphological changes in two human melanoma cell lines treated with 10 B-phenylalanine(BPA) and Boron Neutron Capture Therapy(BNCT). The present study describes morphological changes in melanoma and glioma cell lines treated with boron-tetraphenyl porphyrin(BTPP) and BNCT. Porphyrin compounds are selectively taken up by tumor cells and have been used clinically in phototherapy treatment of cancer patients. Boronated porphyrins show good potential as therapeutic agents in BNCT treatment of human cancer patients

  2. Boron neutron capture therapy: Brain Tumor Treatment Evaluation Program

    International Nuclear Information System (INIS)

    Griebenow, M.L.; Dorn, R.V. III; Gavin, P.R.; Spickard, J.H.

    1988-01-01

    The United States (US) Department of Energy (DOE) recently initiated a focused, multidisciplined program to evaluate Boron Neutron Capture Therapy (BNCT) for the treatment of brain tumors. The program, centered at the DOE/endash/Idaho National Engineering Laboratory (INEL), will develop the analytical, diagnostic and treatment tools, and the database required for BNCT technical assessment. The integrated technology will be evaluated in a spontaneously-occurring canine brain-tumor model. Successful animal studies are expected to lead to human clinical trials within four to five years. 2 refs., 3 figs

  3. Overview of neutronic fuel assembly design and in-core fuel management

    International Nuclear Information System (INIS)

    Porsch, D.; Charlier, A.; Meier, G.; Mougniot, J.C.; Tsuda, K.

    2000-01-01

    The civil and military utilization of nuclear power results in stockpiles of spent fuel and separated plutonium. Recycling of the recovered plutonium in Light Water Reactors (LWR) is currently practiced in Belgium, France, Germany, and Switzerland, in Japan it is in preparation. Modern MOX fuel, with its optimized irradiation and reprocessing behavior, was introduced in 1981. Since then, about 1700 MOX fuel assemblies of different mechanical and neutronic design were irradiated in commercial LWRs and reached fuel assembly averaged exposures of up to 51.000 MWd/t HM. MOX fuel assemblies reloaded in PWR have an average fissile plutonium content of up to 4.8 w/o. For BWR, the average fissile plutonium content in actual reloads is 3.0 w/o. Targets for the MOX fuel assembly design are the compatibility to uranium fuel assemblies with respect to their mechanical fuel rod and fuel assembly design, they should have no impact on the flexibility of the reactor operation, and its reload should be economically feasible. In either cycle independent safety analyses or individually for each designed core it has to be demonstrated that recycling cores meet the same safety criteria as uranium cores. The safety criteria are determined for normal operation and for operational as well as design basis transients. Experience with realized MOX core loadings confirms the reliability of the applied modern design codes. Studies for reloads of advanced MOX assemblies in LWRs demonstrate the feasibility of a future development of the thermal plutonium recycling. New concepts for the utilization of plutonium are under consideration and reveal an attractive potential for further developments on the plutonium exploitation sector. (author)

  4. Design of hyper-thermal neutron irradiation fields for neutron capture therapy in KUR-heavy water neutron irradiation facility. Mounting of hyper-thermal neutron converter in therapeutic collimator

    International Nuclear Information System (INIS)

    Sakurai, Y.; Kobayashi, T.

    2001-01-01

    Neutron capture therapy (NCP) using thermal neutron needs to improve of depth dose distribution in a living body. Epi-thermal neutron following moderation of fast neutron is usually used for improving of the depth dose distribution. The moderation method of fast neutron, however, gets mixed some of high energy neutron which give some of serious effects to a living body, and involves the difficulty for collimation of thermal neutron to the diseased part. Hyper-thermal neutrons, which are in an energy range of 0.1-3 eV at high temperature side of thermal neutron, are under consideration for application to the NCP. The hyper-thermal neutrons can be produced by up-scattering of thermal neutron in a high temperature material. Fast neutron components in collimator for the NCP reduce on application of the up-scattering method. Graphite at high temperature (>1000k) is used as a hyper-thermal neutron converter. The hyper-thermal neutron converter is planted to mount on therapeutic collimator which is located at the nearest side of patient for the NCP. Total neutron flux, ratio of hyper-thermal neutron to total neutron, and ratio of gamma-ray dose to neutron flux are calculated as a function of thickness of the graphite converter using monte carlo code MCNP-V4B. (M. Suetake)

  5. Simulation of the spherical experimental assemblies for the mixed neutron-gamma reference fields implementation

    International Nuclear Information System (INIS)

    Kluson, J.; Jansky, B.

    2009-01-01

    Reference mixed neutron-gamma fields are used for test and calibration of dosimetric and spectrometric systems, intercomparison measurements, and benchmark tests and represent experimental base for reactor studies. Set of the spherical experimental assemblies for the mixed neutron-gamma reference fields implementation was build in the NRI Rez. Extended sets of measurements and simulation calculations were done to describe the reference mixed field dosimetry and spectral characteristics with best achievable precision. The Monte Carlo technique was used for different experimental setups models description, comparison and verification and field characteristics simulation. Effects (hardly distinguishable experimentally) were also studied ( contributions from individual parts of experimental setup, field individual components and next effects as shadow shield cones transparency, etc.). Some results and main conclusions of these studies and calculations are presented and discussed. (authors)

  6. Simulation of the spherical experimental assemblies for the mixed neutron-gamma reference fields implementation

    International Nuclear Information System (INIS)

    Kluson, J.; Jansky, B.

    2008-01-01

    Reference mixed neutron-gamma fields are used for test and calibration of dosimetric and spectrometric systems, intercomparison measurements, and benchmark tests and represent experimental base for reactor studies. Set of the spherical experimental assemblies for the mixed neutron-gamma reference fields implementation was build in the NRI Rez. Extended sets of measurements and simulation calculations were done to describe the reference mixed field dosimetry and spectral characteristics with best achievable precision. The Monte Carlo technique was used for different experimental setups models description, comparison and verification and field characteristics simulation. Effects (hardly distinguishable experimentally) were also studied ( contributions from individual parts of experimental setup, field individual components and next effects as shadow shield cones transparency, etc.). Some results and main conclusions of these studies and calculations are presented and discussed. (authors)

  7. Gadolinium neutron capture therapy for brain tumors. Biological aspects

    International Nuclear Information System (INIS)

    Takagaki, Masao; Oda, Yoshifumi; Matsumoto, Masato; Kikuchi, Haruhiko; Kobayashi, Tooru; Kanda, Keiji; Ujeno, Yowri.

    1994-01-01

    This study investigated the tumoricidal effect of gadolinium neutron capture therapy (Gd-NCT) in in vitro and in vivo systems using Gd-DTPA. In in vitro study, a certain amount of Gd-DTPA, yielding 5000 ppm Gd-n, was added to human glioma cells, T98G, upon which thermal neutrons were exposed. After irradiation, the cells were incubated and the colonies were counted 10 days later. In in vivo study, Fisher-344 rats with experimentally induced gliosarcoma cells (9L) were exposed to thermal neutrons at a fluence rate of 3E+9/s for 1 h immediately after iv injection of Gd-DTPA. Two weeks after irradiation, brain samples were histologically examined. Tumor clearance of Gd-DTPA was also determined. In vitro analysis showed that a 1% survival level was obtained at 3.75E+12 (n/cm 2 ) for the Gd (+) medium and 2.50E+13 (n/cm 2 ) for the Gd (-) medium. In in vivo analysis, the concentration of Gd in 9L-rat brain tumor after iv injection of 0.2 mg/kg Gd-DTPA was found to be less than 100 ppm, but Gd-NCT on 9L-rat brain tumor administered with a ten-fold dose showed a substantial killing effect on tumor without serious injury to the normal brain structure. The killing effect of Gd-NCT was confirmed in in vitro and in vivo systems. (N.K.)

  8. Supplementary neutron flux calculations for the ORNL pool critical assembly pressure vessel facility

    Energy Technology Data Exchange (ETDEWEB)

    Maerker, R.E.; Maudlin, P.J.

    1981-02-01

    A three-dimensional Monte Carlo calculation was performed to estimate the neutron flux in the 8/7 configuration of the ORNL Pool Critical Assembly Pressure Vessel Facility. The calculational tool was the multigroup transport code MORSE operated in the adjoint mode. The MORSE flux results compared well with those using a previously adopted procedure for constructing a three-dimensional flux from one- and two-dimensional discrete ordinates calculations using the DOT-IV code. This study concluded that use of these discrete ordinates constructions in previous calculations is sufficiently accurate and does not account for the existing discrepancies between calculation and experiment.

  9. Supplementary neutron flux calculations for the ORNL pool critical assembly pressure vessel facility

    International Nuclear Information System (INIS)

    Maerker, R.E.; Maudlin, P.J.

    1981-02-01

    A three-dimensional Monte Carlo calculation was performed to estimate the neutron flux in the 8/7 configuration of the ORNL Pool Critical Assembly Pressure Vessel Facility. The calculational tool was the multigroup transport code MORSE operated in the adjoint mode. The MORSE flux results compared well with those using a previously adopted procedure for constructing a three-dimensional flux from one- and two-dimensional discrete ordinates calculations using the DOT-IV code. This study concluded that use of these discrete ordinates constructions in previous calculations is sufficiently accurate and does not account for the existing discrepancies between calculation and experiment

  10. Neutron transport study based on assembly modular ray tracing MOC method

    International Nuclear Information System (INIS)

    Tian Chao; Zheng Youqi; Li Yunzhao; Li Shuo; Chai Xiaoming

    2015-01-01

    It is difficulty for the MOC method based on Cell Modular Ray Tracing to deal with the irregular geometry such as the water gap between the PWR lattices. Hence, the neutron transport code NECP-Medlar based on Assembly Modular Ray Tracing is developed. CMFD method is used to accelerate the transport calculation. The numerical results of the 2D C5G7 benchmark and typical PWR lattice prove that NECP-Medlar has an excellent performance in terms of accuracy and efficiency. Besides, NECP-Medlar can describe clearly the flux distribution of the lattice with water gap. (authors)

  11. A conceptual design of neutron tumor therapy reactor facility with a YAYOI based fast neutron source reactor

    International Nuclear Information System (INIS)

    Wakabayashi, Hiroaki; An, Shigehiro.

    1983-01-01

    Fast neutron is known as one of useful radiations for radiation therapy of tumors. Boron neutron capture therapy (BNCT) of tumors which makes use of 10 B(n, α) 7 Li reaction of 10 B compounds selectively attached to tumor cells with thermal and intermediate neutrons is another way of neutron based radiation therapy which is, above all, attractive enough to kill tumor cells selectively sparing normal tissue. In Japan, BNCT has already been applied and leaned to be effective. After more than a decade operational experiences and the specific experiments designed for therapeutical purposes, in this paper, a conceptual design of a special neutron therapy reactor facility based on YAYOI - fast neutron source reactor of Nuclear Engineering Research Laboratory, Faculty of Engineering, the University of Tokyo - modified to provide an upward beam of fast and intermediate neutrons is presented. Emphasis is placed on the in-house nature of facility and on the coordinating capability of biological and physical researches as well as maintenances of the facility. (author)

  12. The radiation biology of Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Coderre, J.A.

    2003-01-01

    Boron Neutron Capture Therapy (BNCT) produces a complex mixture of high and low-LET radiations in tissue. Using data on the biological effectiveness of these various dose components, derived primarily in small animals irradiated with thermal neutrons, it has been possible to express clinical BNCT doses in photon-equivalent units. The accuracy of these calculated doses in normal tissue and tumor will be reviewed. Clinical trials are underway at a number of centers. There are differences in the neutron beams at these centers, and differences in the details of the clinical protocols. Ideally, data from all centers using similar boron compounds and treatment protocols should be compared and combined, if appropriate, in a multi-institutional study in order to strengthen statistical analysis. An international dosimetry exchange is underway that will allow the physical doses from the various treatment centers to be quantitatively compared. As a first step towards the comparison of the clinical data, the normal brain tolerance data from the patients treated in the initial Brookhaven National Laboratory and the Harvard/MIT BNCT clinical trials have been compared. The data provide a good estimate of the normal brain tolerance for a somnolence syndrome endpoint, and provide guidance for setting normal brain tolerance limits in ongoing and future clinical trials. Escalation of the dose in BNCT can be accomplished by increasing the amount of the boron compound administered, increasing the duration of the neutron exposure, or both. The dose escalations that have been carried out to date at the various treatment centers will be compared and contrasted. Possible future clinical trials using BNCT in combination with other modalities will be discussed

  13. A standardized method for beam design in neutron capture therapy

    International Nuclear Information System (INIS)

    Storr, G.J.: Harrington, B.V.

    1993-01-01

    A desirable end point for a given beam design for Neutron Capture Therapy (NCT) should be quantitative description of tumour control probability and normal tissue damage. Achieving this goal will ultimately rely on data from NCT human clinical trials. Traditional descriptions of beam designs have used a variety of assessment methods to quantify proposed or installed beam designs. These methods include measurement and calculation of open-quotes free fieldclose quotes parameters, such as neutron and gamma flux intensities and energy spectra, and figures-of-merit in tissue equivalent phantoms. The authors propose here a standardized method for beam design in NCT. This method would allow all proposed and existing NCT beam facilities to be compared equally. The traditional approach to determining a quantitative description of tumour control probability and normal tissue damage in NCT research may be described by the following path: Beam design → dosimetry → macroscopic effects → microscopic effects. Methods exist that allow neutron and gamma fluxes and energy dependence to be calculated and measured to good accuracy. By using this information and intermediate dosimetric quantities such as kerma factors for neutrons and gammas, macroscopic effect (absorbed dose) in geometries of tissue or tissue-equivalent materials can be calculated. After this stage, for NCT the data begins to become more sparse and in some areas ambiguous. Uncertainties in the Relative Biological Effectiveness (RBE) of some NCT dose components means that beam designs based on assumptions considered valid a few years ago may have to be reassessed. A standard method is therefore useful for comparing different NCT facilities

  14. Boron containing compounds and their preparation and use in neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Gabel, D.

    1992-09-01

    The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

  15. Thiourea derivatives, methods of their preparation and their use in neutron capture therapy of malignant melanoma

    Energy Technology Data Exchange (ETDEWEB)

    Gabel, D.

    1991-06-04

    The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

  16. Boron neutron capture therapy for malignant melanoma: An experimental approach

    Energy Technology Data Exchange (ETDEWEB)

    Larsson, B.S.; Larsson, B.; Roberto, A. (Uppsala Univ. (Sweden))

    1989-07-01

    Previous studies have shown that some thioamides, e.g., thiouracil, are incorporated as false precursors into melanin during its synthesis. If boronated analogs of the thioamides share this property, the melanin of melanotic melanomas offers a possibility for specific tumoural uptake and retention of boron as a basis for neutron capture therapy. We report on the synthesis of boronated 1H-1,2,4-triazole-3-thiol (B-TZT), boronated 5-carboxy-2-thiouracil (B-CTU), and boronated 5-diethylaminomethyl-2-thiouracil (B-DEAMTU) and the localization of these substances in melanotic melanomas transplanted to mice. The distribution in the mice was studied by boron neutron capture radiography. B-TZT and B-CTU showed the highest tumour:normal tissue concentration ratios, with tumour:liver ratios of about 4 and tumour:muscle ratios of about 14; B-DEAMTU showed corresponding ratios of 1.4 and 5, respectively. The absolute concentration of boron in the tumours, however, was more than three times higher in the mice injected with B-TZT, compared with B-CTU. The results suggest that B-TZT may be the most promising compound of the three tested with regard to possible therapy of melanotic melanomas.

  17. Measurements of fast neutron spectra in iron, uranium and sodium-iron assemblies

    International Nuclear Information System (INIS)

    Kappler, F.; Pieroni, N.; Rusch, D.; Schmidt, A.; Wattecamps, E.; Werle, H.

    1979-01-01

    Spectrum measurements were performed at the fast subcritical facility SUAK to test nuclear data and computer codes used in fast reactor calculations. In order to obtain a specific and quantitative interpretation of discrepancies between measured and calculated spectrum, homogeneous assemblies consisting of single materials were investigated. The leakage spectrum of iron and uranium cylinders was measured by time-of-flight and proportional counters. Time-dependent leakage spectra were measured by a NE 213 liquid scintillator. It was demonstrated that the investigation of time-dependent spectra is a sensitive test of inelastic scattering cross section data. The effect of an interface on fast neutron spectra was also investigated by measuring space dependent spectra across a sodium-iron interface. The measured spectra of these assemblies are suitable for testing the adequacy of computational approximations and cross section data. (author)

  18. Studies on the optimal collimation of fast neutrons for neutron therapy

    International Nuclear Information System (INIS)

    Pfister, G.

    1973-08-01

    Optimal dimensions and materials of collimators for the neutron therapy installations under construction in Hamburg and Heidelberg were investigated by computer simulation of clinical irradiations. The neutron transport from the source through collimator and phantom was calculated by numerical solution of the Boltzmann equation by the Ssub(N) method with first collision correction. It was shown that the collimater quantity can be the same for both installations if the same materials are used. With homogeneous distribution of the materials in the collimator, tungsten was found to be most suitable, but almost the same results were achieved with nickel. Alloys of various elements did not improve W/Fe and Fe/(CH 2 )sub(n) distribution significantly improved the collimator quantity. The radiation scattering component is reduced by filters, by smaller beam cross sections, and by longer collimators. The γ quanta which are due to nuclear excitation and by the isotopes produced in the collimator are not dangerous to the patient. Long-term activation of the collimator material should, however, be allowed for in order to ensure radiation protection of the operating personnel. A hardening of the neutron energy spectra on the sides of the useful radiation beam could be determined. (orig./AK) [de

  19. Monte Carlo codes use in neutron therapy; Application de codes Monte Carlo en neutrontherapie

    Energy Technology Data Exchange (ETDEWEB)

    Paquis, P.; Mokhtari, F.; Karamanoukian, D. [Hopital Pasteur, 06 - Nice (France); Pignol, J.P. [Hopital du Hasenrain, 68 - Mulhouse (France); Cuendet, P. [CEA Centre d' Etudes de Saclay, 91 - Gif-sur-Yvette (France). Direction des Reacteurs Nucleaires; Fares, G.; Hachem, A. [Faculte des Sciences, 06 - Nice (France); Iborra, N. [Centre Antoine-Lacassagne, 06 - Nice (France)

    1998-04-01

    Monte Carlo calculation codes allow to study accurately all the parameters relevant to radiation effects, like the dose deposition or the type of microscopic interactions, through one by one particle transport simulation. These features are very useful for neutron irradiations, from device development up to dosimetry. This paper illustrates some applications of these codes in Neutron Capture Therapy and Neutron Capture Enhancement of fast neutrons irradiations. (authors)

  20. Beam shaping assembly of a D-T neutron source for BNCT and its dosimetry simulation in deeply-seated tumor

    Science.gov (United States)

    Faghihi, F.; Khalili, S.

    2013-08-01

    This article involves two aims for BNCT. First case includes a beam shaping assembly estimation for a D-T neutron source to find epi-thermal neutrons which are the goal in the BNCT. Second issue is the percent depth dose calculation in the adult Snyder head phantom. Monte-Carlo simulations and verification of a suggested beam shaping assembly (including internal neutron multiplier, moderator, filter, external neutron multiplier, collimator, and reflector dimensions) for thermalizing a D-T neutron source as well as increasing neutron flux are carried out and our results are given herein. Finally, we have simulated its corresponding doses for treatment planning of a deeply-seated tumor.

  1. Possibility of construction in Bulgaria of a fast neutron therapy center on the base of the U-250 isochronous cyclotron

    International Nuclear Information System (INIS)

    Angelov, V.A.; Enchevich, I.B.

    1985-01-01

    Development of oncological disease treatment by fast neutrons in the world practice is reviewed. Main radiobiological results, which point to peculiarities of neutron therapy in comparison with standard X-ray therapy are considered. Main requirements for devices to be met, used in fast neutron therapy, are enumerated. On the basis of it, the possibility of construction in Bulgaria a fast neutron therapy center using the U-250 multipurpose cyclotron has been made. The conclusion is made that the main parameters of a proton beam in combination with an isocentrical head as a fast neutron source will create the conditions for realization of high-efficiency neutron therapy

  2. MODELING THE RADIATION SHIELDING OF BORON NEUTRON CAPTURE THERAPY BASED ON 2.4 MEV D-D NEUTRON GENERATOR FACILITY

    Directory of Open Access Journals (Sweden)

    Muhammad Mu’Alim

    2018-01-01

    PEMODELAN PERISAI RADIASI PADA FASILITAS BORON NEUTRON CAPTURE THERAPY BERBASIS GENERATOR NEUTRON D-D 2,4 MeV. Telah dimodelkan perisai radiasi pada fasilitas Boron Neutron Capture Therapy (BNCT berbasis reaksi D-D pada Neutron Generator 2,4 MeV dengan Beam Shaping Assembly (BSA yang telah didesain sebelumnya. Pemodelan ini dilakukan untuk memperoleh suatu desain perisai radiasi untuk fasilitas BNCT berbasis generator neutron 2,4 MeV. Pemodelan dilakukan dengan cara memvariasikan bahan dan ketebalan perisasi radiasi. Bahan yang dipilih adalah beton barit, parafin, polietilen terborasi dan timbal. Perhitungan dilakukan menggunakan program MCNPX dengan tally F4 untuk menentukan laju dosis yang keluar dari perisai radiasi. Desain periasi radiasi dinyatakan optimal jika radiasi yang dihasilkan diluar perisai radiasi tidak melebihi Nilai Batas Dosis (NBD yang telah ditentukan oleh BAPETEN. Hasilnya, diperoleh suatu desain perisai radiasi menggunakan lapisan utama beton barit setebal 100 cm yang mengelilingi ruangan 100 cm x 100 cm x 166,4 cm dan polietilen terborasi 40 cm yang mengelilingi bahan beton barit. Kemudian ditambahkan beton barit 10 cm dan polietilen terborasi 10 cm untuk mengurangi radiasi primer yang lurus dari BSA setelah keluar dari lapisan utama. Laju dosis terbesar adalah 4,58 μSv·jam-1 pada sel 227 dan laju dosis rata-rata yang dihasilkan adalah sebesar 0,65 µSv·jam-1. Nilai laju dosis tersebut masih dibawah ambang batas NBD yang diperbolehkan oleh BAPETEN untuk pekerja radiasi. Kata kunci: Perisai radiasi, tally, laju dosis radiasi, BSA, BNCT

  3. ESR-dosimetry in thermal and epithermal neutron fields for application in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Schmitz, Tobias

    2016-01-22

    Dosimetry is essential for every form of radiotherapy. In Boron Neutron Capture Therapy (BNCT) mixed neutron and gamma fields have to be considered. Dose is deposited in different neutron interactions with elements in the penetrated tissue and by gamma particles, which are always part of a neutron field. The therapeutic dose in BNCT is deposited by densely ionising particles, originating from the fragmentation of the isotope boron-10 after capture of a thermal neutron. Despite being investigated for decades, dosimetry in neutron beams or fields for BNCT remains complex, due to the variety in type and energy of the secondary particles. Today usually ionisation chambers combined with metal foils are used. The applied techniques require extensive effort and are time consuming, while the resulting uncertainties remain high. Consequently, the investigation of more effective techniques or alternative dosimeters is an important field of research. In this work the possibilities of ESR-dosimeters in those fields have been investigated. Certain materials, such as alanine, generate stable radicals upon irradiation. Using Electron Spin Resonance (ESR) spectrometry the amount of radicals, which is proportional to absorbed dose, can be quantified. Different ESR detector materials have been irradiated in the thermal neutron field of the research reactor TRIGA research reactor in Mainz, Germany, with five setups, generating different secondary particle spectra. Further irradiations have been conducted in two epithermal neutron beams. The detector response, however, strongly depends on the dose depositing particle type and energy. It is hence necessary to accompany measurements by computational modelling and simulation. In this work the Monte Carlo code FLUKA was used to calculate absorbed doses and dose components. The relative effectiveness (RE), linking absorbed dose and detector response, has been calculated using amorphous track models. For the simulation, detailed models of

  4. Dose Determination using alanine detectors in a Mixed Neutron and Gamma Field for Boron Neutron Capture Therapy of Liver Malignancies

    DEFF Research Database (Denmark)

    Schmitz, T.; Blaickner, M.; Ziegner, M.

    2011-01-01

    Introduction Boron Neutron Capture Therapy for liver malignancies is being investigated at the University of Mainz. One important aim is the set-up of a reliable dosimetry system. Alanine dosimeters have previously been applied for dosimetry of mixed radiation fields in antiproton therapy, and ma...

  5. Self-assembled iron oxide nanoparticle multilayer: x-ray and polarized neutron reflectivity

    International Nuclear Information System (INIS)

    Mishra, D; Benitez, M J; Petracic, O; Badini Confalonieri, G A; Szary, P; Brüssing, F; Devishvili, A; Toperverg, B P; Zabel, H; Theis-Bröhl, K; Vorobiev, A; Konovalov, O; Paulus, M; Sternemann, C

    2012-01-01

    We have investigated the structure and magnetism of self-assembled, 20 nm diameter iron oxide nanoparticles covered by an oleic acid shell for scrutinizing their structural and magnetic correlations. The nanoparticles were spin-coated on an Si substrate as a single monolayer and as a stack of 5 ML forming a multilayer. X-ray scattering (reflectivity and grazing incidence small-angle scattering) confirms high in-plane hexagonal correlation and a good layering property of the nanoparticles. Using polarized neutron reflectivity we have also determined the long range magnetic correlations parallel and perpendicular to the layers in addition to the structural ones. In a field of 5 kOe we determine a magnetization value of about 80% of the saturation value. At remanence the global magnetization is close to zero. However, polarized neutron reflectivity reveals the existence of regions in which magnetic moments of nanoparticles are well aligned, while losing order over longer distances. These findings confirm that in the nanoparticle assembly the magnetic dipole–dipole interaction is rather strong, dominating the collective magnetic properties at room temperature. (paper)

  6. Self-assembled iron oxide nanoparticle multilayer: x-ray and polarized neutron reflectivity.

    Science.gov (United States)

    Mishra, D; Benitez, M J; Petracic, O; Badini Confalonieri, G A; Szary, P; Brüssing, F; Theis-Bröhl, K; Devishvili, A; Vorobiev, A; Konovalov, O; Paulus, M; Sternemann, C; Toperverg, B P; Zabel, H

    2012-02-10

    We have investigated the structure and magnetism of self-assembled, 20 nm diameter iron oxide nanoparticles covered by an oleic acid shell for scrutinizing their structural and magnetic correlations. The nanoparticles were spin-coated on an Si substrate as a single monolayer and as a stack of 5 ML forming a multilayer. X-ray scattering (reflectivity and grazing incidence small-angle scattering) confirms high in-plane hexagonal correlation and a good layering property of the nanoparticles. Using polarized neutron reflectivity we have also determined the long range magnetic correlations parallel and perpendicular to the layers in addition to the structural ones. In a field of 5 kOe we determine a magnetization value of about 80% of the saturation value. At remanence the global magnetization is close to zero. However, polarized neutron reflectivity reveals the existence of regions in which magnetic moments of nanoparticles are well aligned, while losing order over longer distances. These findings confirm that in the nanoparticle assembly the magnetic dipole-dipole interaction is rather strong, dominating the collective magnetic properties at room temperature.

  7. Small angle neutron and x-ray scattering studies of self-assembled nano structured materials

    International Nuclear Information System (INIS)

    Choi, Sung Min

    2009-01-01

    Full text: Small angle neutron and x-ray scattering are very powerful techniques to investigate nano structured materials. In this presentation, examples of nano structured materials investigated by neutron and x-ray scattering will be presented. Part I: The unique anisotropic physical properties of columnar discotic liquid crystals (DLCs) have attracted considerable interest for their potential applications as electronic devices. For many practical applications, however, it is crucial to obtain uniaxially oriented and highly ordered columnar superstructures of DLC molecules covering macroscopic area. Here, we present a simple and straight-forward approach to fabricate uniaxially oriented and highly ordered columnar superstructures of cobalt octa(n-decylthio) porphyrazine (CoS 1 0), a discotic supra-molecule, in bulk and on substrates [1] over a macroscopic length scale, utilizing an applied magnetic field and the interaction of CoS 1 0 with an OTS-functionalized substrate. The details of the oriented and ordered columnar nano-structures are investigated by SANS and GISAXS. Part II: Self-assembly of one-dimensional (1D) nanoparticles with metallic or semiconducting properties into highly ordered superstructures using various interactions has been of great interest as a route towards materials with new functionalities. Here, we report a new phase diagram of negatively charged 1D nanoparticle (cROD) and cationic liposome (CL) complexes in water which exhibit three different highly ordered phases [2]. Small angle neutron and x-ray scattering measurements show that the cROD-CL complexes exhibit three different highly ordered phases, intercalated lamellar, doubly intercalated lamellar and centered rectangular phases, depending on particle curvature and electrostatic interactions. The new phase diagram can be used to understand and design new highly ordered self-assemblies of 1D nanoparticles in soft matter which provide new functionalities. (author)

  8. Radiation Transport Simulation for Boron Neutron Capture Therapy (BNCT)

    Energy Technology Data Exchange (ETDEWEB)

    Ziegner, M.; Blaickner, M. [AIT Austrian Institute of Technology GmbH, Health and Environment Department, Molecular Medicine, Muthgasse 11, 1190 Wien (Austria); Ziegner, M.; Khan, R.; Boeck, H. [Vienna University of Technology, Institute of Atomic and Subatomic Physics, Stadionallee 2, 1020 Wien (Austria); Bortolussi, S.; Altieri, S. [Department of Nuclear and Theoretical Physics, University of Pavia, National Institute of Nuclear Physics (INFN) Pavia Section, Pavia (Italy); Schmitz, T.; Hampel, G. [Nuclear Chemistry, University of Mainz, Fritz Strassmann Weg 2, 55099 Mainz (Germany)

    2011-07-01

    This work is part of a larger project initiated by the University of Mainz and aiming to use the university's TRIGA reactor to develop a treatment for liver metastases based on Boron Neutron Capture Therapy (BNCT). Diffuse distribution of cancerous cells within the organ makes complete resection difficult and the vicinity to radiosensitive organs impedes external irradiation. Therefore the method of 'autotransplantation', first established at the University of Pavia, is used. The liver is taken out of the body, irradiated in the thermal column of the reactor, therewith purged of metastases and then reimplanted. A highly precise dosimetry system is to be developed by means of measurements at the University of Mainz and computational calculations at the AIT. The stochastic MCNP-5 Monte Carlo-Code, developed by Los Alamos Laboratories, is applied. To verify the calculations of the flux and the absorbed dose in matter a number of measurements are performed irradiating different phantoms and liver sections in a 20cm x 20cm beam tube, which was created by removing graphite blocks from the thermal column of the reactor. The detector material consists of L- {alpha} -alanine pellets which are thought to be the most suitable because of their good tissue equivalence, small size and their wide response range. Another experiment focuses on the determination of the relative biological effectiveness (RBE-factor) of the neutron and photon dose for liver cells. Therefore cell culture plates with the cell medium enriched with {sup 157}Gd and {sup 10}B at different concentrations are irradiated. With regard to the alanine pellets MCNP-5 calculations give stable results. Nevertheless the absorbed dose is underestimated compared to the measurements, a phenomenon already observed in previous works. The cell culture calculations showed the enormous impact of the added isotopes with high thermal neutron cross sections, especially {sup 157}Gd, on the absorbed dose

  9. Development of a Tandem-ElectroStatic-Quadrupole accelerator facility for Boron Neutron Capture Therapy (BNCT)

    International Nuclear Information System (INIS)

    Kreiner, A.J.; Thatar Vento, V.; Levinas, P.; Bergueiro, J.; Burlon, A.A.; Di Paolo, H.; Kesque, J.M.; Valda, A.A.; Debray, M.E.; Somacal, H.R.; Minsky, D.M.; Estrada, L.; Hazarabedian, A.; Johann, F.; Suarez Sandin, J.C.; Castell, W.; Davidson, J.; Davidson, M.; Repetto, M.; Obligado, M.; Nery, J.P.; Huck, H.; Igarzabal, M.; Fernandez Salares, A.

    2008-01-01

    There is a generalized perception that the availability of suitable particle accelerators installed in hospitals, as neutron sources, may be crucial for the advancement of Boron Neutron Capture Therapy (BNCT). An ongoing project to develop a Tandem-ElectroStatic-Quadrupole (TESQ) accelerator facility for Accelerator-Based (AB)-BNCT is described here. The project goal is a machine capable of delivering 30 mA of 2.4-2.5 MeV protons to be used in conjunction with a neutron production target based on the 7 Li(p,n) 7 Be reaction slightly beyond its resonance at 2.25 MeV. A folded tandem, with 1.20-1.25 MV terminal voltage, combined with an ESQ chain is being designed and constructed. This machine is conceptually shown to be capable of accelerating a 30 mA proton beam to 2.5 MeV. These are the specifications needed to produce sufficiently intense and clean epithermal neutron beams, based on the 7 Li(p,n) 7 Be reaction, to perform BNCT treatment for deep-seated tumors in less than an hour. This electrostatic machine is one of the technologically simplest and cheapest solutions for optimized AB-BNCT. At present there is no BNCT facility in the world with the characteristics presented in this work. For the accelerator, results on its design, construction and beam transport calculations are discussed. Taking into account the peculiarities of the expected irradiation field, the project also considers a specific study of the treatment room. This study aims at the design of the treatment room emphasizing aspects related to patient, personnel and public radiation protection; dose monitoring; patient positioning and room construction. The design considers both thermal (for the treatment of shallow tumors) and epithermal (for deep-seated tumors) neutron beams entering the room through a port connected to the accelerator via a moderation and neutron beam shaping assembly. Preliminary results of dose calculations for the treatment room design, using the MCNP program, are presented

  10. Study of neutron noise from reflected, metal assemblies with criticality safety applications in mind

    International Nuclear Information System (INIS)

    Barnett, C.S.

    1985-01-01

    The author studied the statistics of detected neutrons that leaked from four subcritical reflected, enriched-uranium assemblies, to explore the feasibility of developing a criticality warning system based on neutron noise analysis. The calculated multiplication factors of the assemblies are 0.59, 0.74, 0.82, and 0.92. The author studied three possible discriminators, i.e., three signatures that might be used to discriminate among assemblies of various multiplications. They are (1) variance-to-mean ratio of the counts in a time bin (V/M), (2) covariance-to-mean ratio of the counts in a common time bin from two different detectors (C/M), (3) covariance-to-mean ratio of the counts from a single detector in two adjacent time bins of equal length, which the author calls the serial-covariance-to-mean ratio (SC/M). The performances of the three discriminators were not greatly different, but a hierarchy did emerge: SC/M greater than or equal to V/M greater than or equal to C/M. An example of some results: in the neighborhood of k = 0.6 the Δk required for satisfactory discrimination varies from about 3% to 7% as detector solid angle varies from 19% to 5%. In the neighborhood of k = 0.8 the corresponding Δks are 1% and 2%. The noise analysis techniques studied performed well enough in deeply subcritical situations to deserve testing in an applications environment. They have a good chance of detecting changes in reactivity that are potentially dangerous. One can expect sharpest results when doing comparison, i.e., when comparing two records, one taken in the past under circumstances known to be normal and one taken now to search for change

  11. Study of neutron noise from reflected, metal assemblies with criticality safety applications in mind

    International Nuclear Information System (INIS)

    Barnett, C.S.

    1985-01-01

    The author studied the statistics of detected neutrons that leaked from four subcritical reflected, enriched-uranium assemblies, to explore the feasibility of developing a criticality warning system based on neutron noise analysis. The calculated multiplication factors of the assemblies are 0.59, 0.74, 0.82, and 0.92. The author studied three possible discriminators, i.e., three signatures that might be used to discriminate among assemblies of various multiplications. They are: (1) variance-to-mean ratio of the counts in a time bin (V/M); (2) covariance-to-mean ratio of the counts in a common time bin from two different detectors (C/M); and (3) covariance-to-mean ratio of the counts from a single detector in two adjacent time bins of equal length, which the author calls the serial-covariance-to-mean ratio (SC/M). The performances of the three discriminators were not greatly different, but a hierarchy did emerge: SC/M greater than or equal to V/M greater than or equal to C/M. An example of some results: in the neighborhood of k = 0.6 the Δk required for satisfactory discrimination varies from about 3% to 7% as detector solid angle varies from 19% to 5%. In the neighborhood of k = 0.8 the corresponding Δks are 1% and 2%. The noise analysis techniques studied performed well enough in deeply subcritical situations to deserve testing in an applications environment. They have a good chance of detecting changes in reactivity that are potentially dangerous. One can expect sharpest results when doing comparisons, i.e., when comparing two records, one taken in the past under circumstances known to be normal and one taken now to search for change

  12. Measurement of multiple α-modes at the Delphi subcritical assembly by neutron noise techniques

    International Nuclear Information System (INIS)

    Szieberth, Máté; Klujber, Gergely; Kloosterman, Jan Leen; Haas, Dick de

    2015-01-01

    Highlights: • Neutron noise measurements were performed at the Delphi subcritical assembly. • Bias in the fitted prompt decay constant was observed due to higher modes. • Spatial dependence of the higher mode was surveyed. • Effect of two different source distributions was investigated. • An estimation of the prompt decay constant is given for the Delphi. - Abstract: The paper presents the results and evaluations of a comprehensive set of neutron noise measurements on the Delphi subcritical assembly of the Delft University of Technology. The measurements investigated the effect of different source distributions (inherent spontaneous fission and 252 Cf) and the position of the detectors applied (both radially and vertically). The evaluation of the measured data has been performed by the variance-to-mean (VTM, Feynman-α), the autocorrelation (ACF, Rossi-α) and the cross-correlation (CCF) methods. The values obtained for the prompt decay constant show a strong bias, which depends both on the detector position and on the source distribution. This is due to the presence of higher modes in the system. It has been observed that the α value fitted is higher when the detector is close to the boundary of the core or to the 252 Cf point-source. The higher alpha-modes have also been observed by fitting functions describing two alpha-modes. The successful set of measurements also provides a good basis for further theoretical investigations including the Monte Carlo simulation of the noise measurements and the calculation of the alpha-modes in the Delphi subcritical assembly

  13. Optimization study for an epithermal neutron beam for boron neutron capture therapy at the University of Virginia Research Reactor

    International Nuclear Information System (INIS)

    Burns, T.D. Jr.

    1995-05-01

    The non-surgical brain cancer treatment modality, Boron Neutron Capture Therapy (BNCT), requires the use of an epithermal neutron beam. This purpose of this thesis was to design an epithermal neutron beam at the University of Virginia Research Reactor (UVAR) suitable for BNCT applications. A suitable epithermal neutron beam for BNCT must have minimal fast neutron and gamma radiation contamination, and yet retain an appreciable intensity. The low power of the UVAR core makes reaching a balance between beam quality and intensity a very challenging design endeavor. The MCNP monte carlo neutron transport code was used to develop an equivalent core radiation source, and to perform the subsequent neutron transport calculations necessary for beam model analysis and development. The code accuracy was validated by benchmarking output against experimental criticality measurements. An epithermal beam was designed for the UVAR, with performance characteristics comparable to beams at facilities with cores of higher power. The epithermal neutron intensity of this beam is 2.2 x 10 8 n/cm 2 · s. The fast neutron and gamma radiation KERMA factors are 10 x 10 -11 cGy·cm 2 /n epi and 20 x 10 -11 cGy·cm 2 /n epi , respectively, and the current-to-flux ratio is 0.85. This thesis has shown that the UVAR has the capability to provide BNCT treatments, however the performance characteristics of the final beam of this study were limited by the low core power

  14. Boron neutron capture therapy in cancer: past, present and future

    Energy Technology Data Exchange (ETDEWEB)

    Pisarev, Mario A.; Dagrosa, Maria Alejandra; Juvenal, Guilermo J. [National Atomic Energy Commission, Buenos Aires (Argentina). Div. of Nuclear Biochemistry; University of Buenos Aires (Argentina). School of Medicine. Dept. of Human Biochemistry

    2007-07-15

    Undifferentiated thyroid cancer (UTC) is a very aggressive tumor with no effective treatment, since it lacks iodine uptake and does not respond to radio or chemotherapy. The prognosis of these patients is bad, due to the rapid growth of the tumor and the early development of metastasis. Boron neutron capture therapy (BNCT) is based on the selective uptake of certain boron non-radioactive compounds by a tumor, and the subsequent irradiation of the area with an appropriate neutron beam. {sup 10}B is then activated to {sup 11}B, which will immediately decay releasing alpha particles and {sup 7}Li, of high linear energy transfer (LET) and limited reach. Clinical trials are being performed in patients with glioblastoma multiform and melanoma. We have explored its possible application to UTC. Our results demonstrated that a cell line of human UTC has a selective uptake of borophenylalanine (BPA) both in vitro and after transplantation to nude mice. Treatment of mice by BNCT led to a complete control of growth and cure of 100% of the animals. Moreover dogs with spontaneous UTC also have a selective uptake of BPA. At the present we are studying the biodistribution of BPA in patients with UTC before its application in humans. (author)

  15. Boron-containing thioureas for neutron capture therapy

    International Nuclear Information System (INIS)

    Ketz, H.

    1993-01-01

    Melanin is produced in large amounts in malignant melanotic melanomas. Because thiourea compounds are covalently incorporated into melanin during its biosynthesis, the preparation of boronated thiourea-derivatives is of particular interest for the BNCT (Boron Neutron Capture Therapy). Accumulation of boron in tumors by means of boronated thiourea-derivatives may therefore provide levels of 10 B which are useful for BNCT. In BNCT the tumor containing the boron compound is irradiated with epithermal neutrons to generate He- and Li-nuclei from the 10 B which can then destroy the tumor cells. Because of the short ranges of these particles (approximately one cell diameter) the damage will be almost exclusively confined to the tumor leaving normal tissue unharmed. High accumulation of 2-mercapto-1-methylimidazole (methimazole) in melanotic melanomas has been described in the literature. Boronated derivatives of methimazole were therefore synthesized. Boron was in the form of a boronic acid, a nido-carbonate and a mercaptoundeca hydro-closo-dodecaborate (BSH). The synthesis of the boron cluster derivatives of methimazole (nido-carborate- and BSH-derivatives) with 9 resp. 12 boron atoms in the molecule were expected to achieve higher concentrations of boron in the tumor than in the case of the boronic acid compound with its single boron atom. (orig.) [de

  16. Possible application of boron neutron capture therapy to canine osteosarcoma

    International Nuclear Information System (INIS)

    Takeuchi, Akira

    1985-01-01

    Possibility for successful treatment of canine osteosarcoma by boron neutron capture therapy (BNCT) was demonstrated based upon an uptake study of the boron compound and an experimental treatment by BNCT. In the up take study following intravenous administration of Na 2 B 12 H 11 SH, satisfactorily higher boron concentration with some variation between tumors is likely to be obtained 12 hours after the administration, together with significantly lower boron levels in blood and bone. Based upon these results, osteosarcoma of a mongrel dog was successfully treated by BNCT. The tumor received approximately 3800 rads with single neutron irradiation (approximately 1.4 x 10 13 n./cm 2 ) about 12 hours after intravenous infusion of Na 2 B 12 H 11 SH of 96 % enriched 10 B in the ratio of 50 mg 10 B/kg. Clinical and radiographical improvements were remarkable and no neoplastic cell was found in any part of the original neoplastic lesion and its surrounding tissue at the time of autopsy after 30 days. (author)

  17. Boron neutron capture therapy for children with malignant brain tumor

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu; Komatsu, Hisao; Kageji, Teruyoshi; Tsuji, Fumio; Matsumoto, Keizo; Kitamura, Katsuji; Hatanaka, Hiroshi; Minobe, Takashi.

    1993-01-01

    Among the 131 cases with brain tumors treated by boron-neutron capture therapy (BNCT), seventeen were children. Eight supratentorial tumors included five astrocytomas(grade 2-4), two primitive neuroectodermal tumors (PNET) and one rhabdomyosarcoma. Seven pontine tumors included one astrocytoma, one PNET and 5 unverified gliomas. Two cerebellar tumors (PNET and astrocytoma) were also treated. All pontine tumors showed remarkable decrease in size after BNCT. However, most of them showed regrowth of the tumors because the neutrons were insufficient due to the depth. Four cases with cerebral tumor died of remote cell dissemination, although they all responded to BNCT. One of them survived 7 years after repeated BNCTs. An 11 years old girl with a large astrocytoma in the right frontal lobe has lived more than 11 years and is now a draftswoman at a civil engineering company after graduating from a technical college. An 8 years old girl with an astrocytoma in the left occipital lobe has no recurrence of the tumor for 2 years and attends on elementary school without mental and physical problems. Two children (one year old girl and four years old boy) with cerebellar tumors have shown showed an excellent growth after BNCT and had no neurological deficits. Mental and physical development in patients treated by BNCT is usually better than that in patients treated by conventional radiotherapy. (author)

  18. New approaches to novel boronated porphyrins for neutron capture therapy

    International Nuclear Information System (INIS)

    Kahl, S.B.

    1986-01-01

    The use of boon compounds in the treatment of human cancer is based on the unique ability of nonradioactive 10 B nuclei to absorb thermal neutrons. The prompt nuclear reactions, which occur in neutron absorption, deliver a dose of nearly 2.8 MeV only in the vicinity of boron-containing cells, since the nuclear garments produced (alpha particles and recoil lithium atoms) travel only 10 to 15 μm. The practical, clinical use of this technique to date has been limited by the authors inability to target boron-containing compounds specifically to tumor cells in amounts sufficient for therapy and in a chemical form that has an acceptable level of toxicity. Porphyrins are one important and large class of compounds that are known to accumulate in practically all tumor systems yet examined. Such site-specific accumulation is not known to be based on any currently identifiable selective transport mechanism and yet is observed for both natural and synthetic porphyrins. Tetraphenylporphine sulfonate (TPPS) has been shown by Fairchild et al. to be an ideal model compound for assessing porphyrin uptake, and suitably boronated tetraphenyl porphine might be expected to behave similarly. This report describes the synthesis, properties, and preliminary biodistribution of such compounds

  19. A comparison of the COG and MCNP codes in computational neutron capture therapy modeling, Part I: boron neutron capture therapy models.

    Science.gov (United States)

    Culbertson, C N; Wangerin, K; Ghandourah, E; Jevremovic, T

    2005-08-01

    The goal of this study was to evaluate the COG Monte Carlo radiation transport code, developed and tested by Lawrence Livermore National Laboratory, for neutron capture therapy related modeling. A boron neutron capture therapy model was analyzed comparing COG calculational results to results from the widely used MCNP4B (Monte Carlo N-Particle) transport code. The approach for computing neutron fluence rate and each dose component relevant in boron neutron capture therapy is described, and calculated values are shown in detail. The differences between the COG and MCNP predictions are qualified and quantified. The differences are generally small and suggest that the COG code can be applied for BNCT research related problems.

  20. Measurement of the energy spectrum of the neutrons inside the neutron flux trap assembled in the center of the reactor core IPEN/MB-01

    Energy Technology Data Exchange (ETDEWEB)

    Bitelli, Ulysses d' Utra; Mura, Luiz Ernesto Credidio; Santos, Diogo Feliciano dos; Jerez, Rogerio; Mura, Luis Felipe Liamos, E-mail: ubitelli@ipen.br, E-mail: credidiomura@gmail.com [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil)

    2013-07-01

    This paper presents the neutron energy spectrum in the central position of a neutron flux trap assembled in the core center of the research nuclear reactor IPEN/MB-01 obtained by an unfolding method. To this end, have been used several different types of activation foils (Au, Sc, Ti, Ni, and plates) which have been irradiated in the central position of the reactor core (setting number 203) at a reactor power level of 64.57 ±2.91 watts . The activation foils were counted by solid-state detector HPGe (gamma spectrometry). The experimental data of nuclear reaction rates (saturated activity per target nucleus) and a neutron spectrum estimated by a reactor physics computer code are the main input data to get the most suitable neutron spectrum in the irradiation position obtained through SANDBP code: a neutron spectra unfolding code that use an iterative adjustment method. The adjustment resulted in 3.85 ± 0.14 10{sup 9} n cm{sup -2} s{sup -1} for the integral neutron flux, 2.41 ± 0.01 10{sup 9} n cm{sup -2} s{sup -1} for the thermal neutron flux, 1.09 ± 0.02 10{sup 9} n cm{sup -2} s{sup -1} for intermediate neutron flux and 3.41± 0.02 10{sup 8} n cm{sup -2} s{sup -1} for the fast neutrons flux. These results can be used to verify and validate the nuclear reactor codes and its associated nuclear data libraries, besides show how much is effective the use of a neutron flux trap in the nuclear reactor core to increase the thermal neutron flux without increase the operation reactor power level. The thermal neutral flux increased 4.04 ± 0.21 times compared with the standard configuration of the reactor core. (author)

  1. Potential use of superconducting magnets for neutron therapy

    Energy Technology Data Exchange (ETDEWEB)

    Duthil, R; Kircher, F; Lottin, J C; Palanque, S [CEA/Saclay, 91 - Gif-sur-Yvette (France); Aucouturier, J; Fache, P [DT, CGR MeV, 78 Buc (France)

    1984-01-01

    The results of a feasibility study on the use of superconducting magnets for neutron therapy devices will be reported. Two possibilities can be foreseen: - SC magnets used in the isocentric primary beam transport line. The advantage is to increase the energy of the particles which can be transported (up to 70 MeV for protons), compared to existing systems, with a lower weight. This solution could be used very quickly. - A SC isocentric cyclotron, working at on average field of 4.7 T for accelerating deuterons up to 30 MeV. The feasibility of such a machine is fairly established but technical developments are needed, mainly in view of the rotation and of the miniaturisation of the cyclotron.

  2. Boron compounds in neutron capture therapy of tumors

    International Nuclear Information System (INIS)

    Strouf, O.; Gregor, V.

    1986-01-01

    In the selective incorporation of a sufficient amount of a compound containing boron isotope 10 B in the tumor tissue for neutron capture therapy, high efficiency is achieved in tumor destruction while sparing the surrounding tissues. In the treatment of brain tumors, 4-carboxy phenylboric acid and the disodium salt of mercaptoundecahydrododecaborate were successfully tested. The use of the compounds minimizes radiation damage to the blood stream of the brain. In case of melanomas the L-DOPA-borate complex, boronophenylalanine and chlorpromazine preparations containing 10 B are used. In the treatment of cancer of the reproductive organs, boron derivatives of estradiol and testosterone have been proven. The immunobiological procedure, i.e., the use of antibodies with bound boron compounds, is being intensively studied. (M.D.)

  3. Neutron therapy for malignant tumours of the salivary glands

    International Nuclear Information System (INIS)

    Duncan, W.; Orr, J.A.; Arnott, S.J.; Jack, W.J.L.

    1987-01-01

    A group of 28 patients with malignant tumours of the salivary glands have been treated by d(15)+Be neutron irradiation. Nineteen patients had inoperable cancers. Three had gross recurrent cancer and three had measurable residual cancer after surgery. Three patients were treated post-operatively for microscopic residual disease. Seven different histological types of tumour were included. Six out of 8 patients with adenoid cystic carcinomas have lasting local tumour control. 54% of the gross tumours were locally controlled. All three of those classified as microscopic residual disease have no evidence of local recurrence. 11/14 cancers given 16.0 Gy or more in 20 fractions in 4 weeks were controlled compared with only 1/8 given a lower dose. 12/19 cancers less than 10.0 cm maximum diameter were controlled. The radiation-related morbidity was similar to that observed after photon therapy. (Auth.)

  4. Physico-technical progress in neutron-capture therapy method

    International Nuclear Information System (INIS)

    Kanda, Keiji; Furubayashi, Toru; Aoki, Kazuhiko

    1985-01-01

    This paper describes mainly development studies on the determination method of in vivo 10 B for the purpose of employment for neutron capture therapy for malignant melanoma and other tumors. To darify the efficacy of the neutron capture therapy, it is necessary to determine 10 B concentration in the diseased part. This study aimed at in vivo 10 B concention determination in living sample to the level of ppm order with 10 % of analytical error within 1 hour, and these determination conditions were satified by prompt γ-ray (478 keV) determination of 10 B (n, αγ) 7 Li reaction. This method required no sample pretreatment. Further, data normalization by γ-ray of H(n, γ)D reaction permitted no disturbance by sample shape or size. Lower limit of detection of the proposed method was estimated in terms of measuring time and statistical error by the equations of 10 B concentration and error analysis derived by the authors. As for the effect of prompt γ-rays of 23 Na(n, γ) 24 Na and 6 Li(n, γ) 7 Li reactions, it was clarified that the former showed no disturbance but some correction was necessary in case of less than 0.1 g of smaple size owing to the latter reaction. In vivo sample determination showed the proposed method was practical. In this paper some results of phantom experiment for in vivo non-destructive 10 B measurement and related simulation calculation, and examination of effect of (γ, n) reaction in heavy water of biomedical irradiation equipment on radiation quality were also described. (Takagi, S.)

  5. Adjuvant neutron therapy in complex treatment of patients with locally advanced breast cancer

    Science.gov (United States)

    Lisin, V. A.; Velikaya, V. V.; Startseva, Zh. A.; Popova, N. O.; Goldberg, V. E.

    2017-09-01

    The study included 128 patients with stage T2-4N0-3M0 locally advanced breast cancer. All patients were divided into two groups. Group I (study group) consisted of 68 patients, who received neutron therapy, and group II (control group) comprised 60 patients, who received electron beam therapy. Neutron therapy was well tolerated by the patients and 1-2 grade radiation skin reactions were the most common. Neutron therapy was shown to be effective in multimodality treatment of the patients with locally advanced breast cancer. The 8-year recurrence-free survival rate in the patients with locally advanced breast cancer was 94.5 ± 4.1% after neutron therapy and 81.4 ± 5.9% after electron beam therapy (p = 0.05).

  6. IMPROVED COMPUTATIONAL CHARACTERIZATION OF THE THERMAL NEUTRON SOURCE FOR NEUTRON CAPTURE THERAPY RESEARCH AT THE UNIVERSITY OF MISSOURI

    Energy Technology Data Exchange (ETDEWEB)

    Stuart R. Slattery; David W. Nigg; John D. Brockman; M. Frederick Hawthorne

    2010-05-01

    Parameter studies, design calculations and initial neutronic performance measurements have been completed for a new thermal neutron beamline to be used for neutron capture therapy cell and small-animal radiobiology studies at the University of Missouri Research Reactor. The beamline features the use of single-crystal silicon and bismuth sections for neutron filtering and for reduction of incident gamma radiation. The computational models used for the final beam design and performance evaluation are based on coupled discrete-ordinates and Monte Carlo techniques that permit detailed modeling of the neutron transmission properties of the filtering crystals with very few approximations. This is essential for detailed dosimetric studies required for the anticipated research program.

  7. Design and fabrication of 4π Clover Detector Array Assembly for gamma-spectroscopy studies using thermal neutrons

    International Nuclear Information System (INIS)

    Kumar, Manish; Kamble, S.R.; Chaudhari, A.T.; Sabharwal, T.P.; Pathak, Kavindra; Prasad, N.K.; Kinage, L.A.; Biswas, D.C.; Bhagwat, P.V.

    2017-01-01

    Nuclear spectroscopy has been studied earlier from the measurement of prompt gamma rays produced in reactions with thermal neutrons from CIRUS reactor. For studying the prompt γ-spectroscopy using thermal neutrons from Dhruva Reactor, BARC, the development of a dedicated beam line (R-3001) is in progress. In this beam line a detector assembly consisting of Clover Ge detectors will be used. This experimental setup will be utilized to investigate nuclear structure using prompt (n,γ) reactions and also to study the spectroscopy of neutron-rich fission-fragment nuclei

  8. A feasibility study of a deuterium-deuterium neutron generator-based boron neutron capture therapy system for treatment of brain tumors.

    Science.gov (United States)

    Hsieh, Mindy; Liu, Yingzi; Mostafaei, Farshad; Poulson, Jean M; Nie, Linda H

    2017-02-01

    Boron neutron capture therapy (BNCT) is a binary treatment modality that uses high LET particles to achieve tumor cell killing. Deuterium-deuterium (DD) compact neutron generators have advantages over nuclear reactors and large accelerators as the BNCT neutron source, such as their compact size, low cost, and relatively easy installation. The purpose of this study is to design a beam shaping assembly (BSA) for a DD neutron generator and assess the potential of a DD-based BNCT system using Monte Carlo (MC) simulations. The MC model consisted of a head phantom, a DD neutron source, and a BSA. The head phantom had tally cylinders along the centerline for computing neutron and photon fluences and calculating the dose as a function of depth. The head phantom was placed at 4 cm from the BSA. The neutron source was modeled to resemble the source of our current DD neutron generator. A BSA was designed to moderate and shape the 2.45-MeV DD neutrons to the epithermal (0.5 eV to 10 keV) range. The BSA had multiple components, including moderator, reflector, collimator, and filter. Various materials and configurations were tested for each component. Each BSA layout was assessed in terms of the in-air and in-phantom parameters. The maximum brain dose was limited to 12.5 Gray-Equivalent (Gy-Eq) and the skin dose to 18 Gy-Eq. The optimized BSA configuration included 30 cm of lead for reflector, 45 cm of LiF, and 10 cm of MgF 2 for moderator, 10 cm of lead for collimator, and 0.1 mm of cadmium for thermal neutron filter. Epithermal flux at the beam aperture was 1.0 × 10 5  n epi /cm 2 -s; thermal-to-epithermal neutron ratio was 0.05; fast neutron dose per epithermal was 5.5 × 10 -13  Gy-cm 2 /φ epi , and photon dose per epithermal was 2.4 × 10 -13  Gy-cm 2 /φ epi . The AD, AR, and the advantage depth dose rate were 12.1 cm, 3.7, and 3.2 × 10 -3  cGy-Eq/min, respectively. The maximum skin dose was 0.56 Gy-Eq. The DD neutron yield that is needed to

  9. Design of neutron beams at the Argonne Continuous Wave Linac (ACWL) for boron neutron capture therapy and neutron radiography

    International Nuclear Information System (INIS)

    Zhou, X.L.; McMichael, G.E.

    1994-01-01

    Neutron beams are designed for capture therapy based on p-Li and p-Sc reactions using the Argonne Continuous Wave Linac (ACWL). The p-Li beam will provide a 2.5 x 10 9 n/cm 2 s epithermal flux with 7 x 10 5 γ/cm 2 s contamination. On a human brain phantom, this beam allows an advantage depth (AD) of 10 cm, an advantage depth dose rate (ADDR) of 78 cGy/min and an advantage ratio (AR) of 3.2. The p-Sc beam offers 5.9 x 10 7 n/cm 2 s and a dose performance of AD = 8 cm and AR = 3.5, suggesting the potential of near-threshold (p,n) reactions such as the p-Li reaction at E p = 1.92 MeV. A thermal radiography beam could also be obtained from ACWL

  10. New compounds for neutron capture therapy (NCT) and their significance

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Bond, V.P.

    1982-01-01

    Clearly the most effective tumor therapy would be obtained by the selective targeting of cytotoxic agents to tumor cells. Although many biomolecules are known to be taken up in tumors, the targeting of cytotoxic agents to tumors is limited by the fact that other essential cell pools compete with equal or even greater effectiveness. The approach of delivering stable non-toxic isotopes to tumor, with activation by means of an external radiation beam, is advantageous for two reasons: (1) it obviates problems associated with high uptake of isotopes in normal tissues, as these cell pools can be excluded from the radiation field, and (2) the general tumor area can be included in the activating beam field; thus, the possibility exists that all microscopic tumor extensions can be irradiated. As long as range of reaction products is short, dose will be restricted to the tumor, with a resultant high therapeutic ratio. This method can be accomplished with either photon activation therapy (PAT) or Neutron Capture Therapy (NCT), the latter will be emphasized here. The range of the high LET, low OER particles from the 10 B(n,α) 7 Li reaction is approx. 10 μm, or one cell diameter; hence this reaction is optimal for cell killing. A number of biomolecules have been investigated as possible vehicles for transport of boron to tumors, including phenothiazines, thiouracils, porphyrins, nucleosides, and amino acids. Biodistributions of these compounds show selective concentration in tumor adequate for therapy. The biological halflives are in the order of days, allowing the possibility of fractionated or protracted irradiations. The radiobiological and physical implication of these parameters on NCT are discussed. The possibility of using an approximately-monoenergetic, scandium-filtered beam of about 2 keV, to reduce the dose from background radiations by about 85%, is also discussed

  11. Investigation on the neutron beam characteristics for boron neutron capture therapy with 3D and 2D transport calculations

    International Nuclear Information System (INIS)

    Kodeli, I.; Diop, C.M.; Nimal, J.C.

    1994-01-01

    In the framework of future Boron Neutron Capture Therapy (BNCT) experiments, where cells and animals irradiations are planned at the research reactor of Strasbourg University, the feasibility to obtain a suitable epithermal neutron beam is investigated. The neutron fluence and spectra calculations in the reactor are performed using the 3D Monte Carlo code TRIPOLI-3 and the 2D SN code TWODANT. The preliminary analysis of Al 2 O 3 and Al-Al 2 O 3 filters configurations are carried out in an attempt to optimize the flux characteristics in the beam tube facility. 7 figs., 7 refs

  12. Neutron dose equivalent next to the target shield of a neutron therapy facility using an LET counter

    International Nuclear Information System (INIS)

    Stinchcomb, T.G.; Kuchnir, F.T.

    1981-01-01

    The use of a spherical tissue-equivalent proportional counter for measurements of the lineal energy (y) and derivations of the linear energy transfer (LET) for fast neutrons has the advantage of giving distributions of dose and dose equivalent as functions of either LET or y. A measurement next to the target shielding of the neutron therapy facility at the University of Chicago Hospitals and Clinics (UCHC) is described, and the data processing is outlined. The distributions are presented and compared to those from measurements in the neutron beam. The average quality factors are presented

  13. A test-type hyper-thermal neutron generator for neutron capture therapy - estimation of neutron energy spectrum by simulation calculations and TOF experiments

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori; Kobayashi, Tooru; Kobayashi, Katsuhei

    1999-01-01

    In order to clarify the irradiation characteristics of hyper-thermal neutrons and the feasibility of a hyper-thermal neutron irradiation field for neutron capture therapy, a 'test-type' hyper-thermal neutron generator was designed and made. Graphite of 6 cm thickness and 21 cm diameter was selected as the high temperature scatterer. The scatterer is heated up to 1200 deg. C maximum using molybdenum heaters. The radiation heat is shielded by reflectors of molybdenum and stainless steel. The temperature is measured using three R-type thermo-couples and controlled by a program controller. The total thickness of the generator is designed to be as thin as possible, 20 cm in maximum, in the standing point of the neutron beam intensity. The thermal stability, controllability and safety of the generator at high temperature employment were confirmed by the heating tests. As one of the experiments for the characteristics estimation, the neutron energy spectrum dependent on the scatterer temperature was measured by the TOF (time of flight) method using the LINAC neutron generator. The estimations by simulation calculations were also performed. From the experiment and calculation results, it was confirmed that the neutron temperature shifted higher as the scatterer temperature was higher. The prospect of the feasibility of the 'hyper-thermal neutron irradiation field for NCT' was opened from the estimation results of the generator characteristics by the simulation calculations and experiments

  14. Evaluation of neutron streaming in fast breeder reactor fuel assembly by double heterogeneous modelling

    International Nuclear Information System (INIS)

    Unesaki, Hironobu; Takeda, Toshikazu

    1988-01-01

    Neutron streaming in a fast breeder reactor fuel assembly caused by the double heterogeneity structure is estimated by double heterogeneous modelling. The conventional pin cell model, a two-region subassembly model and the exact pin cluster model are used to take into account the streaming effect caused by the pin cell structure and the surrounding wrapper tube structure. The heterogeneity of wrapper tube and its surrounding sodium is explicitly considered. The streaming effect is evaluated based on Benoist's diffusion coefficient. The total streaming effect caused by the double heterogeneity structure of a fuel subassembly is found to be -0.2 % dk/kk' for k eff , which is almost twice that obtained from the conventional pin cell model of -0.1 % dk/kk'. (author)

  15. Elucidation of density profile of self-assembled sitosterol + oryzanol tubules with small-angle neutron scattering

    NARCIS (Netherlands)

    Bot, A.; Gilbert, E.P.; Bouwman, W.G.; Sawalha, H.I.M.; Adel, den R.; Garamus, V.M.; Venema, P.; Linden, van der E.; Flöter, E.

    2012-01-01

    Small-angle neutron scattering (SANS) experiments have been performed on self-assembled tubules of sitosterol and oryzanol in triglyceride oils to investigate details of their structure. Alternative organic phases (deuterated and non-deuterated decane, limonene, castor oil and eugenol) were used to

  16. The multi leaf collimator for fast neutron therapy at louvain-la-Neuve

    International Nuclear Information System (INIS)

    Denis, J.M.; Richard, F.; Vynckier, S.; Wambersie, A.; Meulders, J.P.; Lannoye, E.; Longree, Y.; Ryckewaert, G.

    1996-01-01

    The multi-leaf collimator of the fast neutron therapy facility at Louvain-la-Neuve is described, as well as some of the physics experiments performed in order to evaluate the attenuation of neutron beams in different materials and thus optimize the composition of collimator leaves. The multi-leaf collimator consists of two sets of 22 leaves each, which can be moved independently. They are made of iron and their thickness is 95 cm. Seven borated polyethylene disks are located in the distal part of the leaves in order to absorb more efficiently the low-energy component of the neutron spectrum. The width of the leaves is 1 cm at their distal part. The leaves can more 11 cm outwards and 6 cm inwards from their reference position, and field size up to 25.7 x 24.8 cm as well as irregular field shapes, can be obtained. The inner part of the leaves and their two sides are always focused on the target. The complete multi-leaf collimator can rotate around the beam axis, from -90 deg to + 90 deg from the reference position. The width of the penumbra (80 - 20 % isodoses) is 0.64 cm and 1.17 cm at the depth of the maximum buildup and at 10 cm in depth respectively, for a 10 x 10 cm field size. The collimator is adequate for the energy of the p(65)+Be neutron beam of Louvain-la-Neuve and has been adapted to the fixed vertical beam. It has been designed following the original plans of Scanditronix, adjusted and fully assembled at the workshop of the Centre de Recherches du Cyclotron (CRC). Systematic measurements were performed in order to optimize the design and the composition of the leaves. In particular the attenuations of the actual beam and of monoenergetic neutron beams were measured in different materials such as iron and polyethylene. Above (upstream) the multi-leaf collimator, a fixed pre-collimator (iron thickness 50 cm; section 1 x 1 m) defines a conical aperture aligned on the largest opening of the leaves. It contains the two transmission chambers and a 2 cm thick

  17. MCNP speed advances for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Goorley, J.T.; McKinney, G.; Adams, K.; Estes, G.

    1998-04-01

    The Boron Neutron Capture Therapy (BNCT) treatment planning process of the Beth Israel Deaconess Medical Center-M.I.T team relies on MCNP to determine dose rates in the subject's head for various beam orientations. In this time consuming computational process, four or five potential beams are investigated. Of these, one or two final beams are selected and thoroughly evaluated. Recent advances greatly decreased the time needed to do these MCNP calculations. Two modifications to the new MCNP4B source code, lattice tally and tracking enhancements, reduced the wall-clock run times of a typical one million source neutrons run to one hour twenty five minutes on a 200 MHz Pentium Pro computer running Linux and using the GNU FORTRAN compiler. Previously these jobs used a special version of MCNP4AB created by Everett Redmond, which completed in two hours two minutes. In addition to this 30% speedup, the MCNP4B version was adapted for use with Parallel Virtual Machine (PVM) on personal computers running the Linux operating system. MCNP, using PVM, can be run on multiple computers simultaneously, offering a factor of speedup roughly the same as the number of computers used. With two 200 MHz Pentium Pro machines, the run time was reduced to forty five minutes, a 1.9 factor of improvement over the single Linux computer. While the time of a single run was greatly reduced, the advantages associated with PVM derive from using computational power not already used. Four possible beams, currently requiring four separate runs, could be run faster when each is individually run on a single machine under Windows NT, rather than using Linux and PVM to run one after another with each multiprocessed across four computers. It would be advantageous, however, to use PVM to distribute the final two beam orientations over four computers

  18. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?

    Science.gov (United States)

    De Stasio, Gelsomina; Rajesh, Deepika; Casalbore, Patrizia; Daniels, Matthew J; Erhardt, Robert J; Frazer, Bradley H; Wiese, Lisa M; Richter, Katherine L; Sonderegger, Brandon R; Gilbert, Benjamin; Schaub, Sebastien; Cannara, Rachel J; Crawford, John F; Gilles, Mary K; Tyliszczak, Tolek; Fowler, John F; Larocca, Luigi M; Howard, Steven P; Mercanti, Delio; Mehta, Minesh P; Pallini, Roberto

    2005-06-01

    Gadolinium neutron capture therapy (GdNCT) is a potential treatment for malignant tumors based on two steps: (1) injection of a tumor-specific (157)Gd compound; (2) tumor irradiation with thermal neutrons. The GdNC reaction can induce cell death provided that Gd is proximate to DNA. Here, we studied the nuclear uptake of Gd by glioblastoma (GBM) tumor cells after treatment with two Gd compounds commonly used for magnetic resonance imaging, to evaluate their potential as GdNCT agents. Using synchrotron X-ray spectromicroscopy, we analyzed the Gd distribution at the subcellular level in: (1) human cultured GBM cells exposed to Gd-DTPA or Gd-DOTA for 0-72 hours; (2) intracerebrally implanted C6 glioma tumors in rats injected with one or two doses of Gd-DOTA, and (3) tumor samples from GBM patients injected with Gd-DTPA. In cell cultures, Gd-DTPA and Gd-DOTA were found in 84% and 56% of the cell nuclei, respectively. In rat tumors, Gd penetrated the nuclei of 47% and 85% of the tumor cells, after single and double injection of Gd-DOTA, respectively. In contrast, in human GBM tumors 6.1% of the cell nuclei contained Gd-DTPA. Efficacy of Gd-DTPA and Gd-DOTA as GdNCT agents is predicted to be low, due to the insufficient number of tumor cell nuclei incorporating Gd. Although multiple administration schedules in vivo might induce Gd penetration into more tumor cell nuclei, a search for new Gd compounds with higher nuclear affinity is warranted before planning GdNCT in animal models or clinical trials.

  19. Demonstration of a high-intensity neutron source based on a liquid-lithium target for Accelerator based Boron Neutron Capture Therapy.

    Science.gov (United States)

    Halfon, S; Arenshtam, A; Kijel, D; Paul, M; Weissman, L; Berkovits, D; Eliyahu, I; Feinberg, G; Kreisel, A; Mardor, I; Shimel, G; Shor, A; Silverman, I; Tessler, M

    2015-12-01

    A free surface liquid-lithium jet target is operating routinely at Soreq Applied Research Accelerator Facility (SARAF), bombarded with a ~1.91 MeV, ~1.2 mA continuous-wave narrow proton beam. The experiments demonstrate the liquid lithium target (LiLiT) capability to constitute an intense source of epithermal neutrons, for Accelerator based Boron Neutron Capture Therapy (BNCT). The target dissipates extremely high ion beam power densities (>3 kW/cm(2), >0.5 MW/cm(3)) for long periods of time, while maintaining stable conditions and localized residual activity. LiLiT generates ~3×10(10) n/s, which is more than one order of magnitude larger than conventional (7)Li(p,n)-based near threshold neutron sources. A shield and moderator assembly for BNCT, with LiLiT irradiated with protons at 1.91 MeV, was designed based on Monte Carlo (MCNP) simulations of BNCT-doses produced in a phantom. According to these simulations it was found that a ~15 mA near threshold proton current will apply the therapeutic doses in ~1h treatment duration. According to our present results, such high current beams can be dissipated in a liquid-lithium target, hence the target design is readily applicable for accelerator-based BNCT. Copyright © 2015 Elsevier Ltd. All rights reserved.

  20. A hospital-based proton linac for neutron therapy and radioisotope production

    International Nuclear Information System (INIS)

    Lennox, A.J.

    1988-10-01

    Fermilab's Alvarez proton linac has been used routinely for neutron therapy since 1976. The Neutron Therapy Facility (NTF) operates in a mode parasitic to the laboratory's high energy physics program, which uses the linac as an injector for a synchrotron. Parasitic operation is possible because the linac delivers /approximately/1.2 /times/ 10 13 protons per pulse at a 15 Hz rate, while the high energy physics program requires beam at a rate not greater than 0.5 Hz. Protons not needed for physics experiments strike a beryllium target to produce neutrons for neutron therapy. Encouraging clinical results from NTF have led to a study of the issues involved in providing hospitals with a neutron beam of the type available at Fermilab. This paper describes the issues addressed by that study. 12 refs., 1 fig., 1 tab

  1. Predicting fissile content of spent nuclear fuel assemblies with the Passive Neutron Albedo Reactivity technique and Monte Carlo code emulation

    International Nuclear Information System (INIS)

    Conlin, Jeremy Lloyd; Tobin, Stephen J.

    2011-01-01

    There is a great need in the safeguards community to be able to nondestructively quantify the mass of plutonium of a spent nuclear fuel assembly. As part of the Next Generation of Safeguards Initiative, we are investigating several techniques, or detector systems, which, when integrated, will be capable of quantifying the plutonium mass of a spent fuel assembly without dismantling the assembly. This paper reports on the simulation of one of these techniques, the Passive Neutron Albedo Reactivity with Fission Chambers (PNAR-FC) system. The response of this system over a wide range of spent fuel assemblies with different burnup, initial enrichment, and cooling time characteristics is shown. A Monte Carlo method of using these modeled results to estimate the fissile content of a spent fuel assembly has been developed. A few numerical simulations of using this method are shown. Finally, additional developments still needed and being worked on are discussed. (author)

  2. Analysis of experimental measurements of PWR fresh and spent fuel assemblies using Self-Interrogation Neutron Resonance Densitometry

    Energy Technology Data Exchange (ETDEWEB)

    LaFleur, Adrienne M., E-mail: alafleur@lanl.gov; Menlove, Howard O., E-mail: hmenlove@lanl.gov

    2015-05-01

    Self-Interrogation Neutron Resonance Densitometry (SINRD) is a new NDA technique that was developed at Los Alamos National Laboratory (LANL) to improve existing nuclear safeguards measurements for LWR fuel assemblies. The SINRD detector consists of four fission chambers (FCs) wrapped with different absorber filters to isolate different parts of the neutron energy spectrum and one ion chamber (IC) to measure the gross gamma rate. As a result, two different techniques can be utilized using the same SINRD detector unit and hardware. These techniques are the Passive Neutron Multiplication Counter (PNMC) method and the SINRD method. The focus of the work described in this paper is the analysis of experimental measurements of fresh and spent PWR fuel assemblies that were performed at LANL and the Korea Atomic Energy Research Institute (KAERI), respectively, using the SINRD detector. The purpose of these experiments was to assess the following capabilities of the SINRD detector: 1) reproducibility of measurements to quantify systematic errors, 2) sensitivity to water gap between detector and fuel assembly, 3) sensitivity and penetrability to the removal of fuel rods from the assembly, and 4) use of PNMC/SINRD ratios to quantify neutron multiplication and/or fissile content. The results from these simulations and measurements provide valuable experimental data that directly supports safeguards research and development (R&D) efforts on the viability of passive neutron NDA techniques and detector designs for partial defect verification of spent fuel assemblies. - Highlights: • Experimental measurements of PWR fresh and spent FAs were performed with SINRD. • Good agreement of MCNPX and measured results confirmed accuracy of SINRD model. • For fresh fuel, SINRD and PNMC ratios were not sensitive to water gaps of ≤5-mm. • Practical use of SINRD would be in Fork detector to reduce systematic uncertainties.

  3. Determination of average fission fraction produced by 14 MeV neutrons in assemblies with large volume of depleted uranium

    International Nuclear Information System (INIS)

    Wang Dalun; Li Benci; Wang Xiuchun; Li Yijun; Zhang Shaohua; He Yongwu

    1991-07-01

    The average fission fraction of 238 U caused by 14 MeV neutrons in assemblies with large volume depleted uranium has been determined. The measured value of p f 238U (R ∞ depleted ) 14 was 0.897 ± 0.036. Measurements were also completed for neutron flux distribution and average fission fraction of 235 U isotope in depleted uranium sphere. Values of p f 238U (R depleted ) have been obtained by using a series of uranium spheres. For a sphere with Φ 600 the p f 23 '8 U (R 300 depleted ) is 0.823 ± 0.041, the density of depleted uranium assembly is 18.8g/cm 3 and total weight of assembly is about 2.8t

  4. OPTIMIZATION OF THE EPITHERMAL NEUTRON BEAM FOR BORON NEUTRON CAPTURE THERAPY AT THE BROOKHAVEN MEDICAL RESEARCH REACTOR.

    Energy Technology Data Exchange (ETDEWEB)

    HU,J.P.; RORER,D.C.; RECINIELLO,R.N.; HOLDEN,N.E.

    2002-08-18

    Clinical trials of Boron Neutron Capture Therapy for patients with malignant brain tumor had been carried out for half a decade, using an epithermal neutron beam at the Brookhaven's Medical Reactor. The decision to permanently close this reactor in 2000 cut short the efforts to implement a new conceptual design to optimize this beam in preparation for use with possible new protocols. Details of the conceptual design to produce a higher intensity, more forward-directed neutron beam with less contamination from gamma rays, fast and thermal neutrons are presented here for their potential applicability to other reactor facilities. Monte Carlo calculations were used to predict the flux and absorbed dose produced by the proposed design. The results were benchmarked by the dose rate and flux measurements taken at the facility then in use.

  5. Monte Carlo based dosimetry and treatment planning for neutron capture therapy of brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.; Brenner, J.F.; Wazer, D.E.; Madoc-Jones, H.; Clement, S.D.; Harling, O.K.; Yanch, J.C.

    1990-01-01

    Monte Carlo based dosimetry and computer-aided treatment planning for neutron capture therapy have been developed to provide the necessary link between physical dosimetric measurements performed on the MITR-II epithermal-neutron beams and the need of the radiation oncologist to synthesize large amounts of dosimetric data into a clinically meaningful treatment plan for each individual patient. Monte Carlo simulation has been employed to characterize the spatial dose distributions within a skull/brain model irradiated by an epithermal-neutron beam designed for neutron capture therapy applications. The geometry and elemental composition employed for the mathematical skull/brain model and the neutron and photon fluence-to-dose conversion formalism are presented. A treatment planning program, NCTPLAN, developed specifically for neutron capture therapy, is described. Examples are presented illustrating both one and two-dimensional dose distributions obtainable within the brain with an experimental epithermal-neutron beam, together with beam quality and treatment plan efficacy criteria which have been formulated for neutron capture therapy. The incorporation of three-dimensional computed tomographic image data into the treatment planning procedure is illustrated

  6. Average fast neutron flux in three energy ranges in the Quinta assembly irradiated by two types of beams

    Directory of Open Access Journals (Sweden)

    Strugalska-Gola Elzbieta

    2017-01-01

    Full Text Available This work was performed within the international project “Energy plus Transmutation of Radioactive Wastes” (E&T - RAW for investigations of energy production and transmutation of radioactive waste of the nuclear power industry. 89Y (Yttrium 89 samples were located in the Quinta assembly in order to measure an average high neutron flux density in three different energy ranges using deuteron and proton beams from Dubna accelerators. Our analysis showed that the neutron density flux for the neutron energy range 20.8 - 32.7 MeV is higher than for the neutron energy range 11.5 - 20.8 MeV both for protons with an energy of 0.66 GeV and deuterons with an energy of 2 GeV, while for deuteron beams of 4 and 6 GeV we did not observe this.

  7. An accelerator-based Boron Neutron Capture Therapy (BNCT) facility based on the 7Li(p,n)7Be

    Science.gov (United States)

    Musacchio González, Elizabeth; Martín Hernández, Guido

    2017-09-01

    BNCT (Boron Neutron Capture Therapy) is a therapeutic modality used to irradiate tumors cells previously loaded with the stable isotope 10B, with thermal or epithermal neutrons. This technique is capable of delivering a high dose to the tumor cells while the healthy surrounding tissue receive a much lower dose depending on the 10B biodistribution. In this study, therapeutic gain and tumor dose per target power, as parameters to evaluate the treatment quality, were calculated. The common neutron-producing reaction 7Li(p,n)7Be for accelerator-based BNCT, having a reaction threshold of 1880.4 keV, was considered as the primary source of neutrons. Energies near the reaction threshold for deep-seated brain tumors were employed. These calculations were performed with the Monte Carlo N-Particle (MCNP) code. A simple but effective beam shaping assembly (BSA) was calculated producing a high therapeutic gain compared to previously proposed facilities with the same nuclear reaction.

  8. Monte Carlo modeling and analyses of YALINA-booster subcritical assembly part 1: analytical models and main neutronics parameters

    International Nuclear Information System (INIS)

    Talamo, A.; Gohar, M. Y. A.; Nuclear Engineering Division

    2008-01-01

    This study was carried out to model and analyze the YALINA-Booster facility, of the Joint Institute for Power and Nuclear Research of Belarus, with the long term objective of advancing the utilization of accelerator driven systems for the incineration of nuclear waste. The YALINA-Booster facility is a subcritical assembly, driven by an external neutron source, which has been constructed to study the neutron physics and to develop and refine methodologies to control the operation of accelerator driven systems. The external neutron source consists of Californium-252 spontaneous fission neutrons, 2.45 MeV neutrons from Deuterium-Deuterium reactions, or 14.1 MeV neutrons from Deuterium-Tritium reactions. In the latter two cases a deuteron beam is used to generate the neutrons. This study is a part of the collaborative activity between Argonne National Laboratory (ANL) of USA and the Joint Institute for Power and Nuclear Research of Belarus. In addition, the International Atomic Energy Agency (IAEA) has a coordinated research project benchmarking and comparing the results of different numerical codes with the experimental data available from the YALINA-Booster facility and ANL has a leading role coordinating the IAEA activity. The YALINA-Booster facility has been modeled according to the benchmark specifications defined for the IAEA activity without any geometrical homogenization using the Monte Carlo codes MONK and MCNP/MCNPX/MCB. The MONK model perfectly matches the MCNP one. The computational analyses have been extended through the MCB code, which is an extension of the MCNP code with burnup capability because of its additional feature for analyzing source driven multiplying assemblies. The main neutronics parameters of the YALINA-Booster facility were calculated using these computer codes with different nuclear data libraries based on ENDF/B-VI-0, -6, JEF-2.2, and JEF-3.1

  9. Monte Carlo modeling and analyses of YALINA-booster subcritical assembly part 1: analytical models and main neutronics parameters.

    Energy Technology Data Exchange (ETDEWEB)

    Talamo, A.; Gohar, M. Y. A.; Nuclear Engineering Division

    2008-09-11

    This study was carried out to model and analyze the YALINA-Booster facility, of the Joint Institute for Power and Nuclear Research of Belarus, with the long term objective of advancing the utilization of accelerator driven systems for the incineration of nuclear waste. The YALINA-Booster facility is a subcritical assembly, driven by an external neutron source, which has been constructed to study the neutron physics and to develop and refine methodologies to control the operation of accelerator driven systems. The external neutron source consists of Californium-252 spontaneous fission neutrons, 2.45 MeV neutrons from Deuterium-Deuterium reactions, or 14.1 MeV neutrons from Deuterium-Tritium reactions. In the latter two cases a deuteron beam is used to generate the neutrons. This study is a part of the collaborative activity between Argonne National Laboratory (ANL) of USA and the Joint Institute for Power and Nuclear Research of Belarus. In addition, the International Atomic Energy Agency (IAEA) has a coordinated research project benchmarking and comparing the results of different numerical codes with the experimental data available from the YALINA-Booster facility and ANL has a leading role coordinating the IAEA activity. The YALINA-Booster facility has been modeled according to the benchmark specifications defined for the IAEA activity without any geometrical homogenization using the Monte Carlo codes MONK and MCNP/MCNPX/MCB. The MONK model perfectly matches the MCNP one. The computational analyses have been extended through the MCB code, which is an extension of the MCNP code with burnup capability because of its additional feature for analyzing source driven multiplying assemblies. The main neutronics parameters of the YALINA-Booster facility were calculated using these computer codes with different nuclear data libraries based on ENDF/B-VI-0, -6, JEF-2.2, and JEF-3.1.

  10. Boron neutron capture therapy for recurrent head and neck malignancies

    International Nuclear Information System (INIS)

    Kato, Itsuro; Ono, Koji; Sakurai, Yoshinori

    2006-01-01

    To avoid severe impairment of oro-facial structures and functions, it is necessary to explore new treatments for recurrent head and neck malignancies (HNM). Boron neutron capture therapy (BNCT) is tumor-cell targeted radiotherapy that has significant superiority over conventional radiotherapies in principle. So far for 4 years and 3 months, we have treated with 37 times of BNCT for 21 patients (14 squamous cell carcinomas (SCC), 4 salivary gland carcinomas and 3 sarcomas) with a recurrent and far advanced HNM since 2001. Results are (1) 10 B concentration of tumor/normal tissue ratio (T/N ratio) of FBPA-PET studies were SCC: 1.8-5.7, sarcoma: 2.5-4.0, parotid tumor: 2.5-3.7. (2) Therapeutic effects were CR: 6cases, PR: 11cases, PD: 3cases NE (not evaluated): 1case. Response rate was 81%. (3) Improvement of QOL such as a relief of severe pain, bleeding, and exudates at the local lesion, improvement of PS, disappearance of ulceration, covered with normal skin and preserved oral and maxillofacial functions and tissues. (4) Survival periods after BNCT were 1-51 months (mean: 9.8 months). 4-year survival rate was 39% by Kaplan-Meier analysis. (5) A few adverse-effects such as transient mucositis, alopecia were recognized. These results indicate that BNCT represents a new and promising treatment approach for advanced HNM. (author)

  11. Clinical results of boron neutron capture therapy (BNCT) for glioblastoma

    International Nuclear Information System (INIS)

    Kageji, T.; Mizobuchi, Y.; Nagahiro, S.; Nakagawa, Y.; Kumada, H.

    2011-01-01

    The purpose of this study was to evaluate the clinical outcome of BSH-based intra-operative BNCT (IO-BNCT) and BSH and BPA-based non-operative BNCT (NO-BNCT). We have treated 23 glioblastoma patients with BNCT without any additional chemotherapy since 1998. The median survival time (MST) of BNCT was 19.5 months, and 2-year, 3-year and 5-year survival rates were 26.1%, 17.4% and 5.8%, respectively. This clinical result of BNCT in patients with GBM is superior to that of single treatment of conventional radiotherapy compared with historical data of conventional treatment. - Highlights: ► In this study, we evaluate the clinical outcome of boron neutron capture therapy (BNCT) for malignant brain tumors. ► We have treated 23 glioblastoma (GBM) patients with BNCT without any additional chemotherapy. ► Clinical results of BNCT in patients with GBM are superior to that of single treatment of conventional radiotherapy compared with historical data of conventional treatment.

  12. Commercial Clinical Application of Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    1999-01-01

    CRADA No. 95-CR-09 among the LITCO--now Bechtel BWXT Idaho, LLC; a private company, Neutron Therapies Limited Liability Company, NTL formerly Ionix Corporation; and Washington State University was established in 1996 to further the development of BNCT. NTL has established a laboratory for the synthesis, under US FDA approved current Good Manufacturing Practices (cGMP) guidelines, of key boron intermediates and final boron agents for BNCT. The company has focused initially on the development of the compound GB-10 (Na 2 B 10 H 10 ) as the first boron agent of interest. An Investigational New Drug (IND) application for GB-10 has been filed and approved by the FDA for a Phase I human biodistribution trial in patients with non-small cell lung cancer and glioblastoma multiforme at UW under the direction of Professor Keith Stelzer, Principal Investigator (PI). These trials are funded by NTL under a contract with the UW, Department of Radiation Oncology, and the initial phases are nearing completion. Initial results show that boron-10 concentrations on the order of 100 micrograms per gram (100 ppm) can be achieved and maintained in blood with no indication of toxicity

  13. Neutronic evaluation of annular fuel rods to assemblies 13 x 13, 14 x 14 and 15 x 15

    Energy Technology Data Exchange (ETDEWEB)

    Silva, Raphael H.M.; Ramos, Mario C.; Velasquez, Carlos E.; Silva, Clarysson A.M. da; Pereira, Cláubia; Costa, Antonella L., E-mail: rapha.galo@hotmail.com, E-mail: marc5663@gmail.com, E-mail: carlosvelcab@hotmail.com, E-mail: clarysson@nuclear.ufmg.br, E-mail: claubia@nuclear.ufmg.br, E-mail: antonella@nuclear.ufmg.br [Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG (Brazil). Departamento de Engenharia Nuclear

    2017-07-01

    Research and development in nuclear reactor field has been proposed a new concept of fuel rod such as annular shape. The design of the annular fuel rods allows the coolant flow through the inner and outer side of it. Such project was proposed as an alternative to the traditional fuel rods used in LWR reactors. This new geometry allows an increase in power density in the reactor core with greater heat transfer from the fuel to the coolant which reduces the temperature in central region of the rod, in which a better configuration and dimension of fuel elements are aimed due to improvement of cooling in possible replacement of PWR traditional rods for annular rods. The aim of this work is to evaluate the neutronic parameters of fuel element with annular fuel rods where three configurations were studied: 13 x 13, 14 x 14 and 15 x 15. The goal is compare the neutronic between the advanced and the standard fuel assembly 16 x 16. In these studies, the external dimension and the moderator to fuel volume ratio (V{sub M}/V{sub F}) of standard 16 x 16 is the same in all annular fuels assemblies. The MCNPX 2.6.0 (Monte Carlo N-Particle eXtended – version 2.6.0) code was used in all simulations. After all procedures, the annular fuel assemblies 13 have obtained greater neutronics parameters and were selected to more neutronics simulations. (author)

  14. Neutronic evaluation of annular fuel rods to assemblies 13 x 13, 14 x 14 and 15 x 15

    International Nuclear Information System (INIS)

    Silva, Raphael H.M.; Ramos, Mario C.; Velasquez, Carlos E.; Silva, Clarysson A.M. da; Pereira, Cláubia; Costa, Antonella L.

    2017-01-01

    Research and development in nuclear reactor field has been proposed a new concept of fuel rod such as annular shape. The design of the annular fuel rods allows the coolant flow through the inner and outer side of it. Such project was proposed as an alternative to the traditional fuel rods used in LWR reactors. This new geometry allows an increase in power density in the reactor core with greater heat transfer from the fuel to the coolant which reduces the temperature in central region of the rod, in which a better configuration and dimension of fuel elements are aimed due to improvement of cooling in possible replacement of PWR traditional rods for annular rods. The aim of this work is to evaluate the neutronic parameters of fuel element with annular fuel rods where three configurations were studied: 13 x 13, 14 x 14 and 15 x 15. The goal is compare the neutronic between the advanced and the standard fuel assembly 16 x 16. In these studies, the external dimension and the moderator to fuel volume ratio (V M /V F ) of standard 16 x 16 is the same in all annular fuels assemblies. The MCNPX 2.6.0 (Monte Carlo N-Particle eXtended – version 2.6.0) code was used in all simulations. After all procedures, the annular fuel assemblies 13 have obtained greater neutronics parameters and were selected to more neutronics simulations. (author)

  15. Boron neutron capture therapy of intracerebral rat gliosarcomas

    International Nuclear Information System (INIS)

    Joel, D.D.; Fairchild, R.G.; Laissue, J.A.; Saraf, S.K.; Kalef-Ezra, J.A.; Slatkin, D.N.

    1990-01-01

    The efficacy of boron neutron capture therapy (BNCT) for the treatment of intracerebrally implanted rat gliosarcomas was tested. Preferential accumulation of 10B in tumors was achieved by continuous infusion of the sulfhydryl borane dimer, Na4(10)B24H22S2, at a rate of 45-50 micrograms of 10B per g of body weight per day from day 11 to day 14 after tumor initiation (day 0). This infusion schedule resulted in average blood 10B concentrations of 35 micrograms/ml in a group of 12 gliosarcoma-bearing rats and 45 micrograms/ml in a group of 10 similar gliosarcoma-bearing rats treated by BNCT. Estimated tumor 10B levels in these two groups were 26 and 34 micrograms/g, respectively. On day 14, boron-treated and non-boron-treated rats were exposed to 5.0 or 7.5 MW.min of radiation from the Brookhaven Medical Research Reactor that yielded thermal neutron fluences of approximately 2.0 x 10(12) or approximately 3.0 x 10(12) n/cm2, respectively, in the tumors. Untreated rats had a median postinitiation survival time of 21 days. Reactor radiation alone increased median postinitiation survival time to 26 (5.0 MW.min) or 28 (7.5 MW.min) days. The 12 rats that received 5 MW.min of BNCT had a median postinitiation survival time of 60 days. Two of these animals survived greater than 15 months. In the 7.5 MW.min group, the median survival time is not calculable since 6 of the 10 animals remain alive greater than 10 months after BNCT. The estimated radiation doses to tumors in the two BNCT groups were 14.2 and 25.6 Gy equivalents, respectively. Similar gliosarcoma-bearing rats treated with 15.0 or 22.5 Gy of 250-kilovolt peak x-rays had median survival times of only 26 or 31 days, respectively, after tumor initiation

  16. Designing an Epithermal Neutron Beam for Boron Neutron Capture Therapy for the Fusion Reactions 2H(d,n)3He and 3H(d,n)4He1

    International Nuclear Information System (INIS)

    Verbeke, J.M.; Costes, S.V.; Bleuel, D.; Vujic, J.; Leung, K.N.

    1998-01-01

    A beam shaping assembly has been designed to moderate high energy neutrons from the fusion reactions 2 H(d,N) 3 He and 3 H(d,n) 4 He for use fin boron neutron capture therapy. The low neutron yield of the 2 H(d,n) 3 He reaction led to unacceptably long treatment times. However, a 160 mA deuteron beam of energy 400 keV led to a treatment time of 120 minutes with the reaction 3 H(d,n) 4 He. Equivalent doses of 9.6 Gy-Eq and 21.9 Gy-Eq to the skin and to a 8 cm deep tumor respectively have been computed

  17. Rapid method of calculating the fluence and spectrum of neutrons from a critical assembly and the resulting dose

    International Nuclear Information System (INIS)

    Bessis, J.

    1977-01-01

    The proposed calculation method is unsophisticated but rapid. The first part (computer code CRITIC), which is based on the Fermi age equation, evaluates the number of neutrons per fission emitted from a moderated critical assembly and their energy spectrum. The second part (computer code NARCISSE), which uses the current albedo for concrete, evaluates the product of neutron reflection on the walls and calculates the fluence resulting at any point in the room and its energy distribution by 21 groups. The results obtained are shown to compare satisfactorily with those obtained through the use of a Monte Carlo program

  18. A parameter study to determine the optimal source neutron energy in boron neutron capture therapy of brain tumours

    Energy Technology Data Exchange (ETDEWEB)

    Nievaart, V A [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands); Moss, R L [Joint Research Centre of the European Commission, Postbus 2, 1755ZG Petten (Netherlands); Kloosterman, J L [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands); Hagen, T H J J van der [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands); Dam, H van [Reactor Physics Department, Delft University of Technology, Mekelweg 15, 2629JB Delft (Netherlands)

    2004-09-21

    The values of the parameters used in boron neutron capture therapy (BNCT) to calculate a given dose to human tissue vary with patients due to different physical, biological and/or medical circumstances. Parameters include the tissue dimensions, the {sup 10}B concentration and the relative biological effectiveness (RBE) factors for the different dose components associated with BNCT. Because there is still no worldwide agreement on RBE values, more often than not, average values for these parameters are used. It turns out that the RBE-problem can be circumvented by taking into account all imaginable parameter values. Approaching this quest from another angle: the outcome will also provide the parameters (and values) which influence the optimal source neutron energy. For brain tumours it turns out that the {sup 10}B concentration, the RBE factors for {sup 10}B as well as fast neutrons, together with the dose limit set for healthy tissue, affect the optimal BNCT source neutron energy. By using source neutrons of a few keV together with neutrons of a few eV, it ensures that, under all imaginable circumstances, a maximum of alpha (and lithium) particles can be delivered in the tumour.

  19. ANALYSIS OF THE EFFICIENCY OF A THERAPEUTIC PROGRAM USING 10.2-MEV FAST NEUTRONS. OPTIMIZATION AND PROSPECTS OF THE DEVELOPMENT OF A PROCEDURE FOR COMBINED PHOTON-NEUTRON THERAPY. THE EXPERIENCE OF THE URAL CENTER FOR NEUTRON THERAPY

    Directory of Open Access Journals (Sweden)

    E. Yu. Kandakova

    2013-01-01

    Full Text Available The Ural Center for Neutron Therapy performs combined photon-neutron therapy for cancer patients, by applying an ELLIT-80 gamma unit and a NG-12I neutron generator. After modernization of the NG-12I generator, there was a need for redetermination of the relative biological efficiency (RBE to optimize radiotherapy for the patients. An exotest was used to experimentally estimate RBE according to the survival criteria for stem hematopoietic cells in CBA mice after modernization of the equipment generated by the NG-12I unit with respect to the gamma radiation generated by the ELLIT-80 unit. The investigation established that the RBE factor of NG-12I unit-induced radiation determined as the ratio of equally effective doses (our study used D0 was 1.53 for an acute radiation regimen. During fractional radiation, the RBE factor of neutron radiation was 3.05. That is to say, the total neutron radiation dose replacing 20 % gamma radiation (13 Gy in the used photon-neutron therapy regimen is 4.26 Gy. The experimental findings have led us to conclude that the previously described neuron therapy regimen may be optimized, by increasing the contribution of neutrons to the total course of radiotherapy in a definite category of patients with radioresistant tumors of the head and neck.

  20. Boron neutron capture therapy (BNCT) for glioblastoma multiforme using the epithermal neutron beam at the Brookhaven Medical Research Reactor

    International Nuclear Information System (INIS)

    Capala, J.; Diaz, A.Z.; Chadha, M.

    1997-01-01

    The abstract describes evaluation of boron neutron capture therapy (BNCT) for two groups of glioblastoma multiforme patients. From September 1994 to February 1996 15 patients have been treated. In September 1997 another 34 patients were examined. Authors determined a safe starting dose for BNCT using epithermal neutrons and BPA-F. They have also evaluated adverse effects of BNCT at this starting dose. Therapeutic effectiveness of this starting dose has been evaluated. No significant side effects from BPA-F infusion or BNCT treatment were observed in normal brains

  1. Boron neutron capture therapy (BNCT) for glioblastoma multiforme using the epithermal neutron beam at the Brookhaven Medical Research Reactor

    Energy Technology Data Exchange (ETDEWEB)

    Capala, J. [Brookhaven National Lab., Upton, NY (United States); Diaz, A.Z.; Chadha, M. [Univ. Hospital, State Univ. of New York, NY (United States)] [and others

    1997-12-31

    The abstract describes evaluation of boron neutron capture therapy (BNCT) for two groups of glioblastoma multiforme patients. From September 1994 to February 1996 15 patients have been treated. In September 1997 another 34 patients were examined. Authors determined a safe starting dose for BNCT using epithermal neutrons and BPA-F. They have also evaluated adverse effects of BNCT at this starting dose. Therapeutic effectiveness of this starting dose has been evaluated. No significant side effects from BPA-F infusion or BNCT treatment were observed in normal brains.

  2. Primary study for boron neutron capture therapy uses the RSG-GAS beam tube facility

    International Nuclear Information System (INIS)

    Suroso

    2000-01-01

    The minimum epithermal neutron flux as one of the prerequisite of Boron Neutron Capture Therapy (BNCT) is 1.0 x 10 9 n/(cm 2 s) RSG-GAS have 6 beam tube facilities for neutron source, which is one of the beam tube S-2 has a possibility to utilization for BNCT facility. The totally flux neutron measurement in the front of S-2 beam tube is 1.8 x 10 7 n/(cm 2 s). The neutron flux measurement was less than for BNCT minimum prerequisite. Concerning to the flux neutron production in the reactor, which is reach to 2.5 x 10 14 n/(cm 2 s), there for the S-2 beam tube could be used beside collimator modification

  3. Neutron reflector design with Californium 252 neutron for Boron neutron chapter therapy facility using MCNP5 simulation method

    International Nuclear Information System (INIS)

    Muhammad Fakhrurreza; Kusminanto; Y Sardjono

    2014-01-01

    In this research has made a reflector design to provide beams of Neutron for BNCT with Californium-252 radioactive source. This collimator is useful to obtain optimum epithermal neutron flux with the smallest impurity radiation (thermal neutron, fast neutron, and gamma). The design process is done using Monte Carlo N-Particle simulation version 5 (MCNP5) code to calculate the neutron flux tally form. The chosen reflector design is the reflectors which use material such as BeO ceramic with 13 cm thick. Moderator use sulfur material with the slope angle of the cone is 30°. From the calculation result, it is obtained that Reflector with 1 gram Californium-252 source can produce a neutron output thermal which has thermal neutron specification 2.23189 x 10 9 n/s.cm 2 , epithermal neutron 3.51548 x 10 9 n/s.cm 2 , and fast neutron 4.82241 x 10 9 n/s.cm 2 From the result, it needs additional collimator because the BNCT requirement. (author)

  4. Long-term prognosis of maxillary sinus malignant tumor patients treated by fast neutron radiation therapy

    Energy Technology Data Exchange (ETDEWEB)

    Kishi, Hirohisa; Numata, Tsutomu; Yuza, Jun; Suzuki, Haruhiko; Konno, Akiyoshi [Chiba Univ. (Japan). School of Medicine; Miyamoto, Tadaaki

    1995-03-01

    From 1976 through 1990, 19 patients with maxillary sinus malignant tumor were treated with combination therapy consisting of maxillectomy and radiation of fast neutron. Fast neutron radiotherapy was performed at National Institute of Radiological Sciences. Eight patients had adenoid cystic carcinomas, three patients squamous cell carcinomas, one patient a carcinoma in pleomorphic adenoma, four patients fibrosarcomas, one patient osteosarcoma, one patient chondrosarcoma and one patient rhabdomyosarcoma. Fast neutron therapy after/before surgery was effective in fresh cases with T2-3N0M0 adenoid cystic carcinomas and sarcomas (except for fibrosarcoma). Nine patients were alive more than three years after treatment. And serious complications of fast neutron radiation therapy appeared in six of these nine patients. Visual impairment of opposite side occurred in four patients. Bone necrosis occured in one patient and brain dysfunction in one patient. (author).

  5. Long-term prognosis of maxillary sinus malignant tumor patients treated by fast neutron radiation therapy

    International Nuclear Information System (INIS)

    Kishi, Hirohisa; Numata, Tsutomu; Yuza, Jun; Suzuki, Haruhiko; Konno, Akiyoshi; Miyamoto, Tadaaki.

    1995-01-01

    From 1976 through 1990, 19 patients with maxillary sinus malignant tumor were treated with combination therapy consisting of maxillectomy and radiation of fast neutron. Fast neutron radiotherapy was performed at National Institute of Radiological Sciences. Eight patients had adenoid cystic carcinomas, three patients squamous cell carcinomas, one patient a carcinoma in pleomorphic adenoma, four patients fibrosarcomas, one patient osteosarcoma, one patient chondrosarcoma and one patient rhabdomyosarcoma. Fast neutron therapy after/before surgery was effective in fresh cases with T2-3N0M0 adenoid cystic carcinomas and sarcomas (except for fibrosarcoma). Nine patients were alive more than three years after treatment. And serious complications of fast neutron radiation therapy appeared in six of these nine patients. Visual impairment of opposite side occurred in four patients. Bone necrosis occured in one patient and brain dysfunction in one patient. (author)

  6. Development of fast neutron therapy worldwide. Radiobiological, clinical and technical aspects

    International Nuclear Information System (INIS)

    Wambersie, A.; Richard, F.; Breteau, N.

    1994-01-01

    Radiobiological data indicate that fast neutrons could bring a benefit in the treatment of some tumour types, and suggest mechanisms through which this benefit could be achieved. However, radiobiology also clearly indicates that there is a need for patient selection as well as for a high-physical selectivity. The main difficulty when interpreting the results of neutron therapy are the poor technical conditions in which the first treatments were applied. This explains why the value and the place of neutron therapy are not universally recognized, although more than 15000 patients have been treated so far worldwide. There are, however, clinical indications of fast neutrons bringing a benefit for the following tumour sites: salivary glands, paranasal sinuses, soft tissue sarcomas, prostatic adenocarcinomas, palliative treatment of melanoma and rectum. These tumours represent about 10-15% of all patients currently referred to the radiation therapy departments. (orig.)

  7. Neutrons in active proton therapy. Parameterization of dose and dose equivalent

    Energy Technology Data Exchange (ETDEWEB)

    Schneider, Uwe; Haelg, Roger A. [Univ. of Zurich (Switzerland). Dept. of Physics; Radiotherapy Hirslanden AG, Aarau (Switzerland); Lomax, Tony [Paul Scherrer Institute, Villigen (Switzerland). Center for Proton Therapy

    2017-08-01

    One of the essential elements of an epidemiological study to decide if proton therapy may be associated with increased or decreased subsequent malignancies compared to photon therapy is an ability to estimate all doses to non-target tissues, including neutron dose. This work therefore aims to predict for patients using proton pencil beam scanning the spatially localized neutron doses and dose equivalents. The proton pencil beam of Gantry 1 at the Paul Scherrer Institute (PSI) was Monte Carlo simulated using GEANT. Based on the simulated neutron dose and neutron spectra an analytical mechanistic dose model was developed. The pencil beam algorithm used for treatment planning at PSI has been extended using the developed model in order to calculate the neutron component of the delivered dose distribution for each treated patient. The neutron dose was estimated for two patient example cases. The analytical neutron dose model represents the three-dimensional Monte Carlo simulated dose distribution up to 85 cm from the proton pencil beam with a satisfying precision. The root mean square error between Monte Carlo simulation and model is largest for 138 MeV protons and is 19% and 20% for dose and dose equivalent, respectively. The model was successfully integrated into the PSI treatment planning system. In average the neutron dose is increased by 10% or 65% when using 160 MeV or 177 MeV instead of 138 MeV. For the neutron dose equivalent the increase is 8% and 57%. The presented neutron dose calculations allow for estimates of dose that can be used in subsequent epidemiological studies or, should the need arise, to estimate the neutron dose at any point where a subsequent secondary tumour may occur. It was found that the neutron dose to the patient is heavily increased with proton energy.

  8. Fertile assembly for a fast neutron nuclear reactor cooled by liquid sodium, with regulation of the cooling rate

    International Nuclear Information System (INIS)

    Pradal, L.; Berte, M.; Chiarelli, C.

    1985-01-01

    The assembly has a casing in which are arranged the fertile elements, the liquid sodium flowing through the casing along these elements. It includes several apertured diaphragms transverse to the rods to regulate the liquid sodium flow rate. At least one diaphragm, in its central part around its aperture, of a material soluble in liquid sodium, such as copper. The invention applies, more particularly, to fast neutron nuclear reactor having a heterogeneous core. The coolant flow can increase with time to match the increased power generated by the fertile assembly along its life [fr

  9. Feasibility of boron neutron capture therapy for malignant spinal tumors

    International Nuclear Information System (INIS)

    Nakai, Kei; Kumada, Hiroaki; Yamamoto, Tetsuya; Tsurubuchi, Takao; Zaboronok, Alexander; Matsumura, Akira

    2009-01-01

    Treatment of malignant spinal cord tumors is currently ineffective. The characteristics of the spine are its seriality, small volume, and vulnerability: severe QOL impairment can be brought about by small neuronal damage. The present study aimed to investigate the feasibility of BNCT as a tumor-selective charged particle therapy for spinal cord tumors from the viewpoint of protecting the normal spine. A previous report suggested the tolerance dose of the spinal cord was 13.8 Gy-Eq for radiation myelopathy; a dose as high as 11 Gy-Eq demonstrated no spinal cord damage in an experimental animal model. We calculated the tumor dose and the normal spinal cord dose on a virtual model of a spinal cord tumor patient with a JAEA computational dosimetry system (JCDS) treatment planning system. The present study made use of boronophenylalanine (BPA). In these calculations, conditions were set as follows: tumor/normal (T/N) ratio of 3.5, blood boron concentration of 12 ppm, tumor boron concentration of 42 ppm, and relative biological effectiveness (RBE) values for tumor and normal spinal cord of 3.8 and 1.35, respectively. We examined how to optimize neutron irradiation by changing the beam direction and number. In our theoretical example, simple opposed two-field irradiation achieved 28.0 Gy-Eq as a minimum tumor dose and 7.3 Gy-Eq as a maximum normal spinal dose. The BNCT for the spinal cord tumor was therefore feasible when a sufficient T/N ratio could be achieved. The use of F-BPA PET imaging for spinal tumor patients is supported by this study.

  10. A large animal model for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Gavin, P.R.; Kraft, S.L.; DeHaan, C.E.; Moore, M.P.; Griebenow, M.L.

    1992-01-01

    An epithermal neutron beam is needed to treat relatively deep seated tumors. The scattering characteristics of neutrons in this energy range dictate that in vivo experiments be conducted in a large animal to prevent unacceptable total body irradiation. The canine species has proven an excellent model to evaluate the various problems of boron neutron capture utilizing an epithermal neutron beam. This paper discusses three major components of the authors study: (1) the pharmacokinetics of borocaptate sodium (NA 2 B 12 H 11 SH or BSH) in dogs with spontaneously occurring brain tumors, (2) the radiation tolerance of normal tissues in the dog using an epithermal beam alone and in combination with borocaptate sodium, and (3) initial treatment of dogs with spontaneously occurring brain tumors utilizing borocaptate sodium and an epithermal neutron beam

  11. Dosimetric properties of the fast neutron therapy beams at TAMVEC

    International Nuclear Information System (INIS)

    Almond, P.R.; Smith, A.R.; Smathers, J.R.; Otte, V.A.

    1975-01-01

    In October 1972, M.D. Anderson Hospital and Tumor Institute of the University of Texas System Cancer Center initiated a clinical trial of fast neutron radiotherapy using the cyclotron at Texas A and M University. Initially, the study used neutrons produced by bombarding beryllium with 16 MeV deuterons, but since March, 1973, neutrons from 50 MeV deuterons have been used. The dosimetric properties of the 30 MeV beams have also been measured for comparison with the neutron beams from D-T generators. The three beams are compared in terms of dose rate, skin sparing, depth dose and field flatness. Isodose curves for treatment planning were generated using the decrement line method and compared to curves measured by a computer controlled isodose plotter. This system was also used to measure the isodose curves for wedge fields. Dosimetry checks on various patients were made using silicon diodes as in vivo fast neutron dosimeters

  12. A new fast neutron collar for safeguards inspection measurements of fresh low enriched uranium fuel assemblies containing burnable poison rods

    Energy Technology Data Exchange (ETDEWEB)

    Evans, Louise G., E-mail: evanslg@ornl.gov [Los Alamos National Laboratory, Los Alamos, NM 87545 (United States); Swinhoe, Martyn T.; Menlove, Howard O. [Los Alamos National Laboratory, Los Alamos, NM 87545 (United States); Schwalbach, Peter; Baere, Paul De [European Commission, Euratom Safeguards Office (Luxembourg); Browne, Michael C. [Los Alamos National Laboratory, Los Alamos, NM 87545 (United States)

    2013-11-21

    Safeguards inspection measurements must be performed in a timely manner in order to detect the diversion of significant quantities of nuclear material. A shorter measurement time can increase the number of items that a nuclear safeguards inspector can reliably measure during a period of access to a nuclear facility. In turn, this improves the reliability of the acquired statistical sample, which is used to inform decisions regarding compliance. Safeguards inspection measurements should also maintain independence from facility operator declarations. Existing neutron collars employ thermal neutron interrogation for safeguards inspection measurements of fresh fuel assemblies. A new fast neutron collar has been developed for safeguards inspection measurements of fresh low-enriched uranium (LEU) fuel assemblies containing gadolinia (Gd{sub 2}O{sub 3}) burnable poison rods. The Euratom Fast Collar (EFC) was designed with high neutron detection efficiency to make a fast (Cd) mode measurement viable whilst meeting the high counting precision and short assay time requirements of the Euratom safeguards inspectorate. A fast mode measurement reduces the instrument sensitivity to burnable poison rod content and therefore reduces the applied poison correction, consequently reducing the dependence on the operator declaration of the poison content within an assembly. The EFC non-destructive assay (NDA) of typical modern European pressurized water reactor (PWR) fresh fuel assembly designs have been simulated using Monte Carlo N-particle extended transport code (MCNPX) simulations. Simulations predict that the EFC can achieve 2% relative statistical uncertainty on the doubles neutron counting rate for a fast mode measurement in an assay time of 600 s (10 min) with the available {sup 241}AmLi (α,n) interrogation source strength of 5.7×10{sup 4} s{sup −1}. Furthermore, the calibration range of the new collar has been extended to verify {sup 235}U content in variable PWR fuel

  13. A new fast neutron collar for safeguards inspection measurements of fresh low enriched uranium fuel assemblies containing burnable poison rods

    International Nuclear Information System (INIS)

    Evans, Louise G.; Swinhoe, Martyn T.; Menlove, Howard O.; Schwalbach, Peter; Baere, Paul De; Browne, Michael C.

    2013-01-01

    Safeguards inspection measurements must be performed in a timely manner in order to detect the diversion of significant quantities of nuclear material. A shorter measurement time can increase the number of items that a nuclear safeguards inspector can reliably measure during a period of access to a nuclear facility. In turn, this improves the reliability of the acquired statistical sample, which is used to inform decisions regarding compliance. Safeguards inspection measurements should also maintain independence from facility operator declarations. Existing neutron collars employ thermal neutron interrogation for safeguards inspection measurements of fresh fuel assemblies. A new fast neutron collar has been developed for safeguards inspection measurements of fresh low-enriched uranium (LEU) fuel assemblies containing gadolinia (Gd 2 O 3 ) burnable poison rods. The Euratom Fast Collar (EFC) was designed with high neutron detection efficiency to make a fast (Cd) mode measurement viable whilst meeting the high counting precision and short assay time requirements of the Euratom safeguards inspectorate. A fast mode measurement reduces the instrument sensitivity to burnable poison rod content and therefore reduces the applied poison correction, consequently reducing the dependence on the operator declaration of the poison content within an assembly. The EFC non-destructive assay (NDA) of typical modern European pressurized water reactor (PWR) fresh fuel assembly designs have been simulated using Monte Carlo N-particle extended transport code (MCNPX) simulations. Simulations predict that the EFC can achieve 2% relative statistical uncertainty on the doubles neutron counting rate for a fast mode measurement in an assay time of 600 s (10 min) with the available 241 AmLi (α,n) interrogation source strength of 5.7×10 4 s −1 . Furthermore, the calibration range of the new collar has been extended to verify 235 U content in variable PWR fuel designs in the presence of up to

  14. Neutronics feasibility of using Gd2O3 particles in VVER-1000 fuel assembly

    International Nuclear Information System (INIS)

    Hoang Van Khanh; Hoang Thanh Phi Hung; Tran Hoai Nam

    2016-01-01

    Neutronics feasibility of using Gd 2 O 3 particles for controlling excess reactivity of VVER-1000 fuel assembly has been investigated. The motivation is that the use of Gd 2 O 3 particles would increase the thermal conductivity of the UO 2 +Gd 2 O 3 fuel pellet which is one of the desirable characteristics for designing future high burnup fuel. The calculation results show that the Gd 2 O 3 particles with the diameter of 60 µm could control the reactivity similarly to that of homogeneous mixture with the same amount of Gd 2 O 3 . The power densities at the fuel pin with Gd 2 O 3 particles increase by about 10-11%, leading to the decrease of the power peak and a slightly flatter power distribution. The power peak appears at the periphery pins at the beginning of burnup process which is decreased by 0.9 % when using Gd 2 O 3 particles. Further work and improvement are being planned to optimize the high power peaking at the beginning of burnup. (author)

  15. Investigation of dose distribution in mixed neutron-gamma field of boron neutron capture therapy using N isopropylacrylamide gel

    Energy Technology Data Exchange (ETDEWEB)

    Bavarmegin, Elham; Sadremomtaz, Alireza [Nuclear Science and Technology Research Institute (NSTRI), Tehran (Iran, Islamic Republic of); Khalafi, Hossein; Kasesaz, Yaser [Dept. of Physics, University of Guilan, Rasht (Iran, Islamic Republic of); Khajeali, Azim [Medical Education Research Center, Tabriz (Iran, Islamic Republic of)

    2017-02-15

    Gel dosimeters have unique advantages in comparison with other dosimeters. Until now, these gels have been used in different radiotherapy techniques as a reliable dosimetric tool. Because dose distribution measurement is an important factor for appropriate treatment planning in different radiotherapy techniques, in this study, we evaluated the ability of the N-isopropylacrylamide (NIPAM) polymer gel to record the dose distribution resulting from the mixed neutron-gamma field of boron neutron capture therapy (BNCT). In this regard, a head phantom containing NIPAM gel was irradiated using the Tehran Research Reactor BNCT beam line, and then by a magnetic resonance scanner. Eventually, the R2 maps were obtained in different slices of the phantom by analyzing T2-weighted images. The results show that NIPAM gel has a suitable potential for recording three-dimensional dose distribution in mixed neutron-gamma field dosimetry.

  16. Review of clinical results of fast neutron therapy in the USA

    International Nuclear Information System (INIS)

    Peters, L.J.; Maor, M.H.; Laramore, G.E.; Griffin, T.W.; Hendrickson, F.R.

    1986-01-01

    Fast neutron radiotherapy in the United States is entering a new era in which dedicated hospital-based generators with isocentric beam capability are replacing treatment facilities based on fixed beams extracted from physics accelerators. All available clinical data, however, come from the older facilities. The majority of randomized trials conducted in the U.S. have used neutrons in a mixed schedule with photons, in which the aim was to deliver two-fifths of the total dose with neutrons; the neutron dose per fraction was set as the estimated equivalent of 2 Gy photons in terms of late normal tissue injury. Overall treatment time was held constant compared with the control photon therapy regimens (usually 6-8 weeks). Random studies of this type showed no evidence of a therapeutic gain in the treatment of advanced primary carcinomas of the head and neck, lung, uterine cervix, or pancreas. Based on a reassessment of all the available clinical and radiobiological data, and taking advantage of the greater technical flexibility offered by hospital-based facilities, the strategy of fast neutron therapy for future trials has been changed. In these trials neutrons are being used in a 12 fraction, 4 week regimen to treat gross disease, with elective therapy given wherever possible using low LET irradiation. Concomitantly, research is proceeding to define predictors of tumor response to high LET radiations in order to better select patients for fast neutron radiotherapy

  17. Boron neutron capture therapy of malignant brain tumors at the Brookhaven Medical Research Reactor

    Energy Technology Data Exchange (ETDEWEB)

    Joel, D.D.; Coderre, J.A.; Chanana, A.D. [Brookhaven National Lab., Upton, NY (United States). Medical Dept.

    1996-12-31

    Boron neutron capture therapy (BNCT) is a bimodal form of radiation therapy for cancer. The first component of this treatment is the preferential localization of the stable isotope {sup 10}B in tumor cells by targeting with boronated compounds. The tumor and surrounding tissue is then irradiated with a neutron beam resulting in thermal neutron/{sup 10}B reactions ({sup 10}B(n,{alpha}){sup 7}Li) resulting in the production of localized high LET radiation from alpha and {sup 7}Li particles. These products of the neutron capture reaction are very damaging to cells, but of short range so that the majority of the ionizing energy released is microscopically confined to the vicinity of the boron-containing compound. In principal it should be possible with BNCT to selectively destroy small nests or even single cancer cells located within normal tissue. It follows that the major improvements in this form of radiation therapy are going to come largely from the development of boron compounds with greater tumor selectivity, although there will certainly be advances made in neutron beam quality as well as the possible development of alternative sources of neutron beams, particularly accelerator-based epithermal neutron beams.

  18. Boron neutron capture therapy of malignant brain tumors at the Brookhaven Medical Research Reactor

    International Nuclear Information System (INIS)

    Joel, D.D.; Coderre, J.A.; Chanana, A.D.

    1996-01-01

    Boron neutron capture therapy (BNCT) is a bimodal form of radiation therapy for cancer. The first component of this treatment is the preferential localization of the stable isotope 10 B in tumor cells by targeting with boronated compounds. The tumor and surrounding tissue is then irradiated with a neutron beam resulting in thermal neutron/ 10 B reactions ( 10 B(n,α) 7 Li) resulting in the production of localized high LET radiation from alpha and 7 Li particles. These products of the neutron capture reaction are very damaging to cells, but of short range so that the majority of the ionizing energy released is microscopically confined to the vicinity of the boron-containing compound. In principal it should be possible with BNCT to selectively destroy small nests or even single cancer cells located within normal tissue. It follows that the major improvements in this form of radiation therapy are going to come largely from the development of boron compounds with greater tumor selectivity, although there will certainly be advances made in neutron beam quality as well as the possible development of alternative sources of neutron beams, particularly accelerator-based epithermal neutron beams

  19. A setup for active neutron analysis of the fissile material content in fuel assemblies of nuclear reactors

    Energy Technology Data Exchange (ETDEWEB)

    Bushuev, A. V.; Kozhin, A. F., E-mail: alexfkozhin@yandex.ru; Aleeva, T. B.; Zubarev, V. N.; Petrova, E. V.; Smirnov, V. E. [National Research Nuclear University MEPhI (Russian Federation)

    2016-12-15

    An active neutron method for measuring the residual mass of {sup 235}U in spent fuel assemblies (FAs) of the IRT MEPhI research reactor is presented. The special measuring stand design and uniform irradiation of the fuel with neutrons along the entire length of the active part of the FA provide high accuracy of determination of the residual {sup 235}U content. AmLi neutron sources yield a higher effect/background ratio than other types of sources and do not induce the fission of {sup 238}U. The proposed method of transfer of the isotope source in accordance with a given algorithm may be used in experiments where the studied object needs to be irradiated with a uniform fluence.

  20. Monte Carlo based dosimetry and treatment planning for neutron capture therapy of brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.; Clement, S.D.; Harling, O.K.; Brenner, J.F.; Wazer, D.E.; Madoc-Jones, H.; Yanch, J.C.

    1990-01-01

    Monte Carlo based dosimetry and computer-aided treatment planning for neutron capture therapy have been developed to provide the necessary link between physical dosimetric measurements performed on the MITR-II epithermal-neutron beams and the need of the radiation oncologist to synthesize large amounts of dosimetric data into a clinically meaningful treatment plan for each individual patient. Monte Carlo simulation has been employed to characterize the spatial dose distributions within a skull/brain model irradiated by an epithermal-neutron beam designed for neutron capture therapy applications. The geometry and elemental composition employed for the mathematical skull/brain model and the neutron and photon fluence-to-dose conversion formalism are presented. A treatment planning program, NCTPLAN, developed specifically for neutron capture therapy, is described. Examples are presented illustrating both one and two-dimensional dose distributions obtainable within the brain with an experimental epithermal-neutron beam, together with beam quality and treatment plan efficacy criteria which have been formulated for neutron capture therapy. The incorporation of three-dimensional computed tomographic image data into the treatment planning procedure is illustrated. The experimental epithermal-neutron beam has a maximum usable circular diameter of 20 cm, and with 30 ppm of B-10 in tumor and 3 ppm of B-10 in blood, it produces a beam-axis advantage depth of 7.4 cm, a beam-axis advantage ratio of 1.83, a global advantage ratio of 1.70, and an advantage depth RBE-dose rate to tumor of 20.6 RBE-cGy/min (cJ/kg-min). These characteristics make this beam well suited for clinical applications, enabling an RBE-dose of 2,000 RBE-cGy/min (cJ/kg-min) to be delivered to tumor at brain midline in six fractions with a treatment time of approximately 16 minutes per fraction

  1. In-plant test and evaluation of the neutron collar for verification of PWR fuel assemblies at Resende, Brazil

    International Nuclear Information System (INIS)

    Menlove, H.O.; Marzo, M.A.S.; de Almeida, S.G.; de Almeida, M.C.; Moitta, L.P.M.; Conti, L.F.; de Paiva, J.R.T.

    1985-11-01

    The neutron-coincidence collar has been evaluated for the measurement of pressurized-water reactor (PWR) fuel assemblies at the Fabrica de Elementos Combustiveis plant in Resende, Brazil. This evaluation was part of the cooperative-bilateral-safeguards technical-exchange program between the United States and Brazil. The neutron collar measures the 235 U content per unit length of full fuel assemblies using neutron interrogation and coincidence counting. The 238 U content is measured in the passive mode without the AmLi neutron-interrogation source. The extended evaluation took place over a period of 6 months with both scanning and single-zone measurements. The results of the tests gave a coincidence-response standard deviation of 0.7% (sigma = 1.49% for mass) for the active case and 2.5% for the passive case in 1000-s measurement times. The length measurement in the scanning mode was accurate to 0.77%. The accuracies of different calibration methods were evaluated and compared

  2. Use of the Power Burst Facility for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Crocker, J.G.; Griebenow, M.L.; Leatham, J.

    1990-01-01

    A program is under development at the Idaho National Engineering Laboratory (INEL) that involves using the Power Burst Facility (PBF) for research into boron neutron capture therapy (BNCT). BNCT utilizes the ionizing energy from boron-neutron capture to stop reproduction of or destroy cells in cancerous tissue in a two-step process. The first step is to selectively concentrate a boron isotope within the tumor cell, that when activated by neutron capture emits highly ionizing, short range particles. The second step involves activation of the isotope only in the vicinity of the tumor with a narrow neutron beam. The ( 10 B[n, 4 He] 7 Li) reaction with thermal neutrons produces fission products with track lengths approximately equal to a cell diameter. The INEL program includes the modification of the PBF by the addition of a filter and treatment area. The filter will down-scatter high energy neutrons into the epithermal range and remove thermal neutrons and excessively damaging gamma components. The intense source of epithermal neutrons from PBF is considered necessary to achieve optimum therapy for deep-seated tumors with minimum damage to surface tissue. THe neutron filter conceptualized for PBF utilizes aluminum and heavy water to down-scatter neutrons into the proper energy range. Bismuth will be used for gamma shielding and cadmium will remove the thermal neutron contaminant from the beam. The INEL program leads to human clinical trials at PBF which are intended to prove that brain tumors can be successfully treated through noninvasive techniques. Further research into BNCT at PBF for other cancer types is also anticipated

  3. Fast neutron therapy at the end of 1988 - a survey of the clinical data

    International Nuclear Information System (INIS)

    Wambersie, A.

    1990-01-01

    The clinical results reported from the different neutron therapy centres, in USA, Europe and Asia, are reviewed. Fast neutrons were proven to be superior to photons for locally extended inoperable salivary gland tumours. The reported overall local control rates are 67% and 24% respectively. Paranasal sinuses and some tumours of the head and neck area, especially extended tumours with large fixed lymph nodes, are also indications for neutrons. By contrast, the results obtained for brain tumours were, in general, disappointing. Neutrons were shown to bring a benefit in the treatment of well differentiated slowly growing soft tissue sarcomas. The reported overall local control rates are 53% and 38% after neutron and photon irradiation respectively. Better results were also reported for bone- and chondrosarcomas. The reported local control rates are 54% for osteosarcomas and 49% for chondrosarcomas after neutron irradiation; the corresponding values are 21% and 33% respectively after photon irradiation. For locally extended prostatic adenocarcinoma, the superiority of mixed schedule (neutrons+photons) was demonstrated by a RTOG randomized trial (local control rates 77% for mixed schedule compared to 31% for photons). Neutrons were also shown to be useful for palliative treatment of melanomas. Further studies are needed in order to evaluate the benefit of fast neutrons for other localisations such as cervix, bladder, rectum. It can be concluded that fast neutrons are superior to photons for at least 10% of the radiotherapy patients. It is likely that the new high-energy hospital-based cyclotron will further extend the indications of neutron therapy. However, patient selection remains one of the main problems and there is a need for development of individual predictive tests. (orig.)

  4. Experiment and analysis of neutron spectra in a concrete assembly bombarded by 14 MeV neutrons

    International Nuclear Information System (INIS)

    Oishi, Koji; Tomioka, Kazuyuki; Ikeda, Yujiro; Nakamura, Tomoo.

    1988-01-01

    Neutron spectrum in concrete bombarded by 14 MeV neutrons was measured using a miniature NE213 spectrometer and multi-foil activation method. A good agreement between those two experimental methods was obtained within experimental errors. The measured spectrum was compared with calculated ones using two-dimensional transport code DOT3.5 with 125 group structure cross section libraries based on ENDF/B-IV, JENDL-2, and JENDL-3T (the testing version of JENDL-3.) In the D-T neutron peak region, measured and calculated neutron spectra agreed well with each other for those libraries. However, disagreements of about -10 % to +50 % and -30 % to +40 % were obtained in the MeV region and still lower neutron energy range, respectively. As a result, it was concluded that those discrepancies were caused by the overestimation of secondary neutrons emitted by inelastic scattering from O, Si, and/or Ca which were the main components of concrete. (author)

  5. Optimization of combined delayed neutron and differential die-away prompt neutron signal detection for characterization of spent nuclear fuel assemblies

    International Nuclear Information System (INIS)

    Blanc, Pauline; Tobin, Stephen J.; Croft, Stephen; Menlove, Howard O.; Swinhoe, M.; Lee, T.

    2010-01-01

    The Next Generation Safeguards Initiative (NGSI) of the U.S. Department of Energy (DOE) has funded multiple laboratories and universities to develop a means to accurately quantify the Plutonium (Pu) mass in spent nuclear fuel assemblies and ways to also detect potential diversion of fuel pins. Delayed Neutron (DN) counting provides a signature somewhat more sensitive to 235 U than Pu while Differential Die-Away (DDA) is complementary in that it has greater sensitivity to Pu. The two methods can, with care, be combined into a single instrument which also provides passive neutron information. Individually the techniques cannot robustly quantify the Pu content but coupled together the information content in the signatures enables Pu quantification separate to the total fissile content. The challenge of merging DN and DDA, prompt neutron (PN) signal, capabilities in the same design is the focus of this paper. Other possibilities also suggest themselves, such as a direct measurement of the reactivity (multiplication) by either the boost in signal obtained during the active interrogation itself or by the extension of the die-away profile. In an early study, conceptual designs have been modeled using a neutron detector comprising fission chambers or 3He proportional counters and a ∼14 MeV neutron Deuterium-Tritium (DT) generator as the interrogation source. Modeling was performed using the radiation transport code Monte Carlo N-Particles eXtended (MCNPX). Building on this foundation, the present paper quantifies the capability of a new design using an array of 3 He detectors together with fission chambers to optimize both DN and PN detections and active characterization, respectively. This new design was created in order to minimize fission in 238 U (a nuisance DN emitter), to use a realistic neutron generator, to reduce the cost and to achieve near spatial interrogation and detection of the DN and PN, important for detection of diversion, all within the constraints of

  6. Power Burst Reactor Facility as an epithermal neutron source for brain cancer therapy

    International Nuclear Information System (INIS)

    Wheeler, F.J.

    1986-01-01

    The Power Burst Facility (PBF) reactor is considered for modification to provide an intense, clean source of intermediate-energy (epithermal) neutrons desirable for clinical studies of neutron capture therapy (NCT) for malignant tumors. The modifications include partial replacement of the reflector, installation of a neutron-moderating, shifting region, additional shielding, and penetration of the present concrete shield with a collimating (and optionally) filtering region. The studies have indicated that the reactor, after these modifications, will be safely operable at full power (28 MW) within the acceptable limits of the plant protection systems. The neutron beam exiting from the collimator port is predicted to be of sufficient intensity (approx.10 10 neutrons/cm 2 -s) to provide therapeutic doses in very short irradiation times. The beam would be relatively free of undesirable fast neutrons, thermal neutrons and gamma rays. The calculated neutron energy spectrum and associated gamma rays in the beam were provided as input in simulation studies that used a computer model of a patient with a brain tumor to determine predicted dose rates to the tumor and healthy tissue. The results of this conceptual study indicate an intense, clean beam of epithermal neutrons for NCT clinical trials is attainable in the PBF facility with properly engineered design modifications. 9 refs., 11 figs., 3 tabs

  7. Study on uranium-water multiplicative means of the (RESUCO-Subcritical experimental reactor of uranium with oxygen) subcritical assembly by pulsed neutron technique

    International Nuclear Information System (INIS)

    Jesus Barbosa, S. de.

    1987-01-01

    The effective multiplication factor and the nuclear parameters associated with the variation of (RESUCO- Subcritical Experimental Reactor of Uranium with Oxygen) Subcritical Assembly Configuration, using pulsed neutron technique are analysed. BF3 detectors were used to detect the variation of thermal neutrons in the system, positioned parallelly to fuel elements, and a proton recoil detector was used for monitoring the neutron generation. (M.C.K.) [pt

  8. Possible alternation of the blood-brain barrier by boron-neutron capture therapy

    International Nuclear Information System (INIS)

    Hatanaka, H.; Moritani, M.; Camillo, M.

    1991-01-01

    In the course of re-assessment of boron-neutron capture therapy (BNCT) for malignant brain tumors, fractionation of neutron irradiation has been proposed. The authors have used BNCT with a single fraction technique during the past 21 years and now decided to study some effects of fractionation. Twenty-two healthy mouse brains were irradiated with thermal neutrons after boron-10 injection (mercaptoundecahydrododecaborate). A second dose of boron-10 was administered and its uptake in the boron-neutron-capture-irradiated brains was determined. A tendency towards increased boron uptake in the moderately BNCT-treated brains was noticed, which may result in increased brain damage if fractionated neutron irradiation is used. (orig.)

  9. Assessment of doses due to secondary neutrons received by patient treated by proton therapy

    International Nuclear Information System (INIS)

    Sayah, R.; Martinetti, F.; Donadille, L.; Clairand, I.; Delacroix, S.; De Oliveira, A.; Herault, J.

    2010-01-01

    Proton therapy is a specific technique of radiotherapy which aims at destroying cancerous cells by irradiating them with a proton beam. Nuclear reactions in the device and in the patient himself induce secondary radiations involving mainly neutrons which contribute to an additional dose for the patient. The author reports a study aimed at the assessment of these doses due to secondary neutrons in the case of ophthalmological and intra-cranial treatments. He presents a Monte Carlo simulation of the room and of the apparatus, reports the experimental validation of the model (dose deposited by protons in a water phantom, ambient dose equivalent due to neutrons in the treatment room, absorbed dose due to secondary particles in an anthropomorphic phantom), and the assessment with a mathematical phantom of doses dues to secondary neutrons received by organs during an ophthalmological treatment. He finally evokes current works of calculation of doses due to secondary neutrons in the case of intra-cranial treatments

  10. SU-E-T-75: Commissioning Optically Stimulated Luminescence Dosimeters for Fast Neutron Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Young, L [UniversityWashington, Seattle, WA (United States); Yang, F; Sandison, G [University of Washington, Seattle, WA (United States); Woodworth, D [University of California, Santa Barbara, Santa Barbara, CA (United States); McCormick, Z [University of Nevada - Reno, Reno, Nevada (United States)

    2014-06-01

    Purpose: Fast neutrons therapy used at the University of Washington is clinically proven to be more effective than photon therapy in treating salivary gland and other cancers. A nanodot optically stimulated luminescence (OSL) system was chosen to be commissioned for patient in vivo dosimetry for neutron therapy. The OSL-based radiation detectors are not susceptible to radiation damage caused by neutrons compared to diodes or MOSFET systems. Methods: An In-Light microStar OSL system was commissioned for in vivo use by radiating Landauer nanodots with neutrons generated from 50.0 MeV protons accelerated onto a beryllium target. The OSLs were calibrated the depth of maximum dose in solid water localized to 150 cm SAD isocenter in a 10.3 cm square field. Linearity was tested over a typical clinical dose fractionation range i.e. 0 to 150 neutron-cGy. Correction factors for transient signal fading, trap depletion, gantry angle, field size, and wedge factor dependencies were also evaluated. The OSLs were photo-bleached between radiations using a tungsten-halogen lamp. Results: Landauer sensitivity factors published for each nanodot are valid for measuring photon and electron doses but do not apply for neutron irradiation. Individually calculated nanodot calibration factors exhibited a 2–5% improvement over calibration factors computed by the microStar InLight software. Transient fading effects had a significant impact on neutron dose reading accuracy compared to photon and electron in vivo dosimetry. Greater accuracy can be achieved by calibrating and reading each dosimeter within 1–2 hours after irradiation. No additional OSL correction factors were needed for field size, gantry angle, or wedge factors in solid water phantom measurements. Conclusion: OSL detectors are a useful for neutron beam in vivo dosimetry verification. Dosimetric accuracy comparable to conventional diode systems can be achieved. Accounting for transient fading effects during the neutron beam

  11. Commissioning optically stimulated luminescence in vivo dosimeters for fast neutron therapy

    Energy Technology Data Exchange (ETDEWEB)

    Young, Lori A., E-mail: layoung@uw.edu; Sandison, George [Department of Radiation Oncology, University of Washington, Seattle, Washington 98115 (United States); Yang, Fei [Sylvester comprehensive Cancer Center, University of Miami, Miami, Florida 33124 (United States); Woodworth, Davis [Department of Physics, University of Reno, Reno, Nevada 89557 (United States); McCormick, Zephyr [Department of Physics, University of California, Santa Barbara, California 93106 (United States)

    2016-01-15

    Purpose: Clinical in vivo dosimeters intended for use with photon and electron therapies have not been utilized for fast neutron therapy because they are highly susceptible to neutron damage. The objective of this work was to determine if a commercial optically stimulated luminescence (OSL) in vivo dosimetry system could be adapted for use in fast neutron therapy. Methods: A 50.5 MeV fast neutron beam generated by a clinical neutron therapy cyclotron was used to irradiate carbon doped aluminum oxide (Al{sub 2}O{sub 3}:C) optically simulated luminescence dosimeters (OSLDs) in a solid water phantom under standard calibration conditions, 150 cm SAD, 1.7 cm depth, and 10.3 × 10.0 cm field size. OSLD fading and electron trap depletion studies were performed with the OSLDs irradiated with 20 and 50 cGy and monitored over a 24-h period to determine the optimal time for reading the dosimeters during calibration. Four OSLDs per group were calibrated over a clinical dose range of 0–150 cGy. Results: OSLD measurement uncertainties were lowered to within ±2%–3% of the expected dose by minimizing the effect of transient fading that occurs with neutron irradiation and maintaining individual calibration factors for each dosimeter. Dose dependent luminescence fading extended beyond the manufacturer’s recommended 10 min period for irradiation with photon or electron beams. To minimize OSL variances caused by inconsistent fading among dosimeters, the observed optimal time for reading the OSLDs postirradiation was between 30 and 90 min. No field size, wedge factor, or gantry angle dependencies were observed in the OSLDs irradiated by the studied fast neutron beam. Conclusions: Measurements demonstrated that uncertainties less than ±3% were attainable in OSLDs irradiated with fast neutrons under clinical conditions. Accuracy and precision comparable to clinical OSL measurements observed with photons can be achieved by maintaining individual OSLD calibration factors and

  12. Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT).

    Science.gov (United States)

    Seki, Ryoichi; Wakisaka, Yushi; Morimoto, Nami; Takashina, Masaaki; Koizumi, Masahiko; Toki, Hiroshi; Fukuda, Mitsuhiro

    2017-12-01

    The physics of epi-thermal neutrons in the human body is discussed in the effort to clarify the nature of the unique radiologic properties of boron neutron capture therapy (BNCT). This discussion leads to the computational method of Monte Carlo simulation in BNCT. The method is discussed through two examples based on model phantoms. The physics is kept at an introductory level in the discussion in this tutorial review.

  13. SU-E-T-566: Neutron Dose Cloud Map for Compact ProteusONE Proton Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Syh, J; Patel, B; Syh, J; Rosen, L; Wu, H [Willis-Knighton Medical Center, Shreveport, LA (United States)

    2015-06-15

    Purpose: To establish the base line of neutron cloud during patient treatment in our new compact Proteus One proton pencil beam scanning (PBS) system with various beam delivery gantry angles, with or without range shifter (RS) at different body sites. Pencil beam scanning is an emerging treatment technique, for the concerns of neutron exposure, this study is to evaluate the neutron dose equivalent per given delivered dose under various treatment conditions at our proton therapy center. Methods: A wide energy neutron dose equivalent detector (SWENDI-II, Thermo Scientific, MA) was used for neutron dose measurements. It was conducted in the proton therapy vault during beam was on. The measurement location was specifically marked in order to obtain the equivalent dose of neutron activities (H). The distances of 100, 150 and 200 cm at various locations are from the patient isocenter. The neutron dose was measured of proton energy layers, # of spots, maximal energy range, modulation width, field radius, gantry angle, snout position and delivered dose in CGE. The neutron dose cloud is reproducible and is useful for the future reference. Results: When distance increased the neutron equivalent dose (H) reading did not decrease rapidly with changes of proton energy range, modulation width or spot layers. For cranial cases, the average mSv/CGE was about 0.02 versus 0.032 for pelvis cases. RS will induce higher H to be 0.10 mSv/CGE in average. Conclusion: From this study, neutron per dose ratio (mSv/CGE) slightly depends upon various treatment parameters for pencil beams. For similar treatment conditions, our measurement demonstrates this value for pencil beam scanning beam has lowest than uniform scanning or passive scattering beam with a factor of 5. This factor will be monitored continuously for other upcoming treatment parameters in our facility.

  14. Epithermal neutron beam adoption for lung and pancreatic cancer treatment by boron neutron capture therapy

    International Nuclear Information System (INIS)

    Matsumoto, Tetsuo; Fukushima, Yuji

    2001-01-01

    The depth-dose distributions were evaluated for possible treatment of both lung and pancreatic cancers using an epithermal neutron beam. The Monte Carlo Neutron Photon (MCNP) calculations showed that physical dose in tumors were 6 and 7 Gy/h, respectively, for lung and pancreas, attaining an epithermal neutron flux of 5 x 10 8 ncm -2 s -1 . The boron concentrations were assumed at 100 ppm and 30 ppm, respectively, for lung and pancreas tumors and normal tissues contains 1/10 tumor concentrations. The dose ratios of tumor to normal tissue were 2.5 and 2.4, respectively, for lung and pancreas. The dose evaluation suggests that BNCT using an epithermal neutron beam could be applied for both lung and pancreatic cancer treatment. (author)

  15. The neutron therapy facility at the University of Pennsylvania-Fox Chase Cancer Center

    International Nuclear Information System (INIS)

    Bloch, P.; Chu, J.; Larsen, R.

    1983-01-01

    The fusion of deuterium and tritium nuclei results in the formation of a helium-4 nucleus and a 14 MEV neutron. This reaction readily takes place when deuterium and tritium ions are accelerated to potentials between 150-200 kV. These energy ions can be obtained in a moderate size accelerator. A DT neutron facility has been installed in the radiation therapy department of the University of Pennsylvania Hospital-Fox Chase Cancer Center. The system is being commissioned in a hospital setting to test the efficacy of fast neutron radiotherapy

  16. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax

    OpenAIRE

    Wang, Peng; Zhen, Haining; Jiang, Xinbiao; Zhang, Wei; Cheng, Xin; Guo, Geng; Mao, Xinggang; Zhang, Xiang

    2010-01-01

    Abstract Background Boron neutron capture therapy (BNCT) is an alternative treatment modality for patients with glioma. The aim of this study was to determine whether induction of apoptosis contributes to the main therapeutic efficacy of BNCT and to compare the relative biological effect (RBE) of BNCT, γ-ray and reactor neutron irradiation. Methods The neutron beam was obtained from the Xi'an Pulsed Reactor (XAPR) and γ-rays were obtained from [60Co] γ source of the Fourth Military Medical Un...

  17. Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells

    Energy Technology Data Exchange (ETDEWEB)

    Faiao-Flores, F. [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)] [Faculty of Medicine, University of Sao Paulo, 455 Doutor Arnaldo Avenue, Sao Paulo (Brazil); Coelho, P.R.P. [Institute for Nuclear and Energy Research, 2242 Lineu Prestes Avenue, Sao Paulo (Brazil); Arruda-Neto, J. [Physics Institute, University of Sao Paulo, 187 Matao Street, Sao Paulo (Brazil)] [FESP, Sao Paulo Engineering School, 5520 Nove de Julho Avenue, Sao Paulo (Brazil); Maria, Durvanei A., E-mail: durvaneiaugusto@yahoo.br [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)

    2011-12-15

    The melanoma is a highly lethal skin tumor, with a high incidence. Boron Neutron Capture Therapy (BNCT) is a radiotherapy which combines Boron with thermal neutrons, constituting a binary system. B16F10 melanoma and L929 fibroblasts were treated with Boronophenylalanine and irradiated with thermal neutron flux. The electric potential of mitochondrial membrane, cyclin D1 and caspase-3 markers were analyzed. BNCT induced a cell death increase and cyclin D1 amount decreased only in B16F10 melanoma. Besides, there was not caspase-3 phosphorylation.

  18. Neutron shielding verification measurements and simulations for a 235-MeV proton therapy center

    International Nuclear Information System (INIS)

    Newhauser, W.D.; Titt, U.; Dexheimer, D.; Yan, X.; Nill, S.

    2002-01-01

    The neutron shielding at the Massachusetts General Hospital's 235-MeV proton therapy facility was investigated with measurements, analytical calculations, and realistic three-dimensional Monte Carlo simulations. In 37 of 40 cases studied, the analytical calculations predicted higher neutron dose equivalent rates outside the shielding than the measured, typically by more than a factor of 10, and in some cases more than 100. Monte Carlo predictions of dose equivalent at three locations are, on average, 1.1 times the measured values. Except at one location, all of the analytical model predictions and Monte Carlo simulations overestimate neutron dose equivalent

  19. Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial

    Energy Technology Data Exchange (ETDEWEB)

    Maor, Moshe H; Errington, R Douglas; Caplan, Richard J; Griffin, Thomas W; Laramore, George E; Parker, Robert G; Burnison, Michele; Stetz, Joann; Zink, Sandra; Davis, Lawrence W; Peters, Lester J

    1995-06-15

    Purpose: To compare the efficacy of fast-neutron radiotherapy with that of conventionally fractionated photon therapy in the management of patients with locally advanced squamous cell carcinoma of the head and neck. Methods and Materials: Patients with Stage III or IV disease were randomized to receive either 20.4 Gy/12 fractions/4 weeks of neutrons or 70 Gy/35 fractions/7 weeks of photons (control). Between April 1986 and March 1991, 178 patients were entered, 169 of whom were eligible for analysis. The treatment arms were balanced for age, stage, and performance status, but not for primary site of origin. Results: Complete response occurred in 70 and 52% with neutrons and photons, respectively (p = 0.006). Local regional failure at 3 years for all patients was 63% for neutrons and 68% for photons. Actuarial overall survival curves were virtually identical in both study arms, falling to 27% at 3 years. Acute toxicity was similar in the two arms, but late grade 3-5 toxicity was 40% with neutrons compared to 18% with photons (p = 0.008). Conclusion: Although the initial response rate was higher with neutrons, permanent local control and survival were not improved, and the incidence of late normal tissue toxicity was increased. As a result, fast-neutron therapy for advanced squamous cell carcinoma of the head and neck can only be recommended for patients in whom the logistic benefit of treatment in 12 sessions over 4 weeks outweighs the increased risk of late toxicity.

  20. Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial

    International Nuclear Information System (INIS)

    Maor, Moshe H.; Errington, R. Douglas; Caplan, Richard J.; Griffin, Thomas W.; Laramore, George E.; Parker, Robert G.; Burnison, Michele; Stetz, Joann; Zink, Sandra; Davis, Lawrence W.; Peters, Lester J.

    1995-01-01

    Purpose: To compare the efficacy of fast-neutron radiotherapy with that of conventionally fractionated photon therapy in the management of patients with locally advanced squamous cell carcinoma of the head and neck. Methods and Materials: Patients with Stage III or IV disease were randomized to receive either 20.4 Gy/12 fractions/4 weeks of neutrons or 70 Gy/35 fractions/7 weeks of photons (control). Between April 1986 and March 1991, 178 patients were entered, 169 of whom were eligible for analysis. The treatment arms were balanced for age, stage, and performance status, but not for primary site of origin. Results: Complete response occurred in 70 and 52% with neutrons and photons, respectively (p = 0.006). Local regional failure at 3 years for all patients was 63% for neutrons and 68% for photons. Actuarial overall survival curves were virtually identical in both study arms, falling to 27% at 3 years. Acute toxicity was similar in the two arms, but late grade 3-5 toxicity was 40% with neutrons compared to 18% with photons (p = 0.008). Conclusion: Although the initial response rate was higher with neutrons, permanent local control and survival were not improved, and the incidence of late normal tissue toxicity was increased. As a result, fast-neutron therapy for advanced squamous cell carcinoma of the head and neck can only be recommended for patients in whom the logistic benefit of treatment in 12 sessions over 4 weeks outweighs the increased risk of late toxicity

  1. Feasibility of the utilization of BNCT in the fast neutron therapy beam at Fermilab

    International Nuclear Information System (INIS)

    Langen, Katja; Lennox, Arlene J.; Kroc, Thomas K.; DeLuca, Paul M. Jr.

    2000-01-01

    The Neutron Therapy Facility at Fermilab has treated cancer patients since 1976. Since then more than 2,300 patients have been treated and a wealth of clinical information accumulated. The therapeutic neutron beam at Fermilab is produced by bombarding a beryllium target with 66 MeV protons. The resulting continuous neutron spectrum ranges from thermal to 66 MeV in neutron energy. It is clear that this spectrum is not well suited for the treatment of tumors with boron neutron capture therapy (BNCT) only However, since this spectrum contains thermal and epithermal components the authors are investigating whether BNCT can be used in this beam to boost the tumor dose. There are clinical scenarios in which a selective tumor dose boost of 10 - 15% could be clinically significant. For these cases the principal treatment would still be fast neutron therapy but a tumor boost could be used either to deliver a higher dose to the tumor tissue or to reduce the dose to the normal healthy tissue while maintaining the absorbed dose level in the tumor tissue

  2. Antitumor potential induction and free radicals production in melanoma cells by Boron Neutron Capture Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Faiao-Flores, F. [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)] [Faculty of Medicine, University of Sao Paulo, 455 Doutor Arnaldo Avenue, Sao Paulo (Brazil); Coelho, P.R.P.; Muniz, R.O.R.; Souza, G.S. [Institute for Nuclear and Energy Research, 2242 Lineu Prestes Avenue, Sao Paulo (Brazil); Arruda-Neto, J. [Physics Institute, University of Sao Paulo, 187 Matao Street, Sao Paulo (Brazil)] [FESP, Sao Paulo Engineering School, 5520 Nove de Julho Avenue, Sao Paulo (Brazil); Maria, Durvanei A., E-mail: durvaneiaugusto@yahoo.com.br [Biochemical and Biophysical Laboratory, Butantan Institute, 1500 Vital Brasil Avenue, Sao Paulo (Brazil)

    2011-12-15

    Antiproliferative and oxidative damage effects occurring in Boron Neutron Capture Therapy (BNCT) in normal fibroblasts and melanoma cell lines were analyzed. Melanoma cells and normal fibroblasts were treated with different concentrations of Boronophenylalanine and irradiated with thermal neutron flux. The cellular viability and the oxidative stress were determined. BNCT induced free radicals production and proliferative potential inhibition in melanoma cells. Therefore, this therapeutic technique could be considered efficient to inhibit growth of melanoma with minimal effects on normal tissues. - Highlights: Black-Right-Pointing-Pointer Boron Neutron Capture Therapy (BNCT) induces melanoma cell death. Black-Right-Pointing-Pointer BNCT stimulates free radicals production and proliferative inhibition in melanoma cells. Black-Right-Pointing-Pointer It produces tumor membrane degeneration and destruction with apoptotic bodies formation. Black-Right-Pointing-Pointer This therapy damages tumor cells selectively, with minimum effects on normal adjacent tissue.

  3. Monte Carlo simulation of secondary neutron dose for scanning proton therapy using FLUKA.

    Directory of Open Access Journals (Sweden)

    Chaeyeong Lee

    Full Text Available Proton therapy is a rapidly progressing field for cancer treatment. Globally, many proton therapy facilities are being commissioned or under construction. Secondary neutrons are an important issue during the commissioning process of a proton therapy facility. The purpose of this study is to model and validate scanning nozzles of proton therapy at Samsung Medical Center (SMC by Monte Carlo simulation for beam commissioning. After the commissioning, a secondary neutron ambient dose from proton scanning nozzle (Gantry 1 was simulated and measured. This simulation was performed to evaluate beam properties such as percent depth dose curve, Bragg peak, and distal fall-off, so that they could be verified with measured data. Using the validated beam nozzle, the secondary neutron ambient dose was simulated and then compared with the measured ambient dose from Gantry 1. We calculated secondary neutron dose at several different points. We demonstrated the validity modeling a proton scanning nozzle system to evaluate various parameters using FLUKA. The measured secondary neutron ambient dose showed a similar tendency with the simulation result. This work will increase the knowledge necessary for the development of radiation safety technology in medical particle accelerators.

  4. An accelerator-based epithermal photoneutron source for boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Mitchell, Hannah E. [Georgia Inst. of Technology, Atlanta, GA (United States)

    1996-04-01

    Boron neutron capture therapy is an experimental binary cancer radiotherapy modality in which a boronated pharmaceutical that preferentially accumulates in malignant tissue is first administered, followed by exposing the tissue in the treatment volume to a thermal neutron field. Current usable beams are reactor-based but a viable alternative is the production of an epithermal neutron beam from an accelerator. Current literature cites various proposed accelerator-based designs, most of which are based on proton beams with beryllium or lithium targets. This dissertation examines the efficacy of a novel approach to BNCT treatments that incorporates an electron linear accelerator in the production of a photoneutron source. This source may help to resolve some of the present concerns associated with accelerator sources, including that of target cooling. The photoneutron production process is discussed as a possible alternate source of neutrons for eventual BNCT treatments for cancer. A conceptual design to produce epithermal photoneutrons by high photons (due to bremsstrahlung) impinging on deuterium targets is presented along with computational and experimental neutron production data. A clinically acceptable filtered epithermal neutron flux on the order of 107 neutrons per second per milliampere of electron current is shown to be obtainable. Additionally, the neutron beam is modified and characterized for BNCT applications by employing two unique moderating materials (an Al/AlF3 composite and a stacked Al/Teflon design) at various incident electron energies.

  5. An accelerator-based epithermal photoneutron source for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Mitchell, H.E.

    1996-04-01

    Boron neutron capture therapy is an experimental binary cancer radiotherapy modality in which a boronated pharmaceutical that preferentially accumulates in malignant tissue is first administered, followed by exposing the tissue in the treatment volume to a thermal neutron field. Current usable beams are reactor-based but a viable alternative is the production of an epithermal neutron beam from an accelerator. Current literature cites various proposed accelerator-based designs, most of which are based on proton beams with beryllium or lithium targets. This dissertation examines the efficacy of a novel approach to BNCT treatments that incorporates an electron linear accelerator in the production of a photoneutron source. This source may help to resolve some of the present concerns associated with accelerator sources, including that of target cooling. The photoneutron production process is discussed as a possible alternate source of neutrons for eventual BNCT treatments for cancer. A conceptual design to produce epithermal photoneutrons by high photons (due to bremsstrahlung) impinging on deuterium targets is presented along with computational and experimental neutron production data. A clinically acceptable filtered epithermal neutron flux on the order of 10 7 neutrons per second per milliampere of electron current is shown to be obtainable. Additionally, the neutron beam is modified and characterized for BNCT applications by employing two unique moderating materials (an Al/AlF 3 composite and a stacked Al/Teflon design) at various incident electron energies

  6. Nominal effective radiation doses delivered during clinical trials of boron neutron capture therapy

    International Nuclear Information System (INIS)

    Capala, J.; Diaz, A.Z.; Chanana, A.D.

    1997-01-01

    Boron neutron capture therapy (BNCT) is a binary system that, in theory, should selectively deliver lethal, high linear energy transfer (LET) radiation to tumor cells dispersed within normal tissues. It is based on the nuclear reaction 10-B(n, α)7-Li, which occurs when the stable nucleus of boron-10 captures a thermal neutron. Due to the relatively high cross-section of the 10-B nucleus for thermal neutron capture and short ranges of the products of this reaction, tumor cells in the volume exposed to thermal neutrons and containing sufficiently high concentration of 10-B would receive a much higher radiation dose than the normal cells contained within the exposed volume. Nevertheless, radiation dose deposited in normal tissue by gamma and fast neutron contamination of the neutron beam, as well as neutron capture in nitrogen, 14-N(n,p)14-C, hydrogen, 1-H(n,γ)2-H, and in boron present in blood and normal cells, limits the dose that can be delivered to tumor cells. It is, therefore, imperative for the success of the BNCT the dosed delivered to normal tissues be accurately determined in order to optimize the irradiation geometry and to limit the volume of normal tissue exposed to thermal neutrons. These are the major objectives of BNCT treatment planning

  7. Production of fast neutron beams for therapy: The application of and need for nuclear data

    International Nuclear Information System (INIS)

    Chaudhri, M.A.

    1987-01-01

    A brief review of the historical development of the production of therapy neutron beams is presented, with special reference to the author's contribution, using the available nuclear data. Different nuclear reactions and target systems have been critically examined regarding their suitability for cyclotrons of different sizes. A few current problems in this field, especially relating to the nonavailability of appropriate nuclear data, where the nuclear physics and nuclear data communities can greatly contribute, are highlighted. Specific recommendations are made as to what sort of nuclear data need to be acquired/compiled that would be most useful in the neutron therapy programme. (author). 28 refs

  8. Reactor-moderated intermediate-energy neutron beams for neutron-capture therapy

    International Nuclear Information System (INIS)

    Less, T.J.

    1987-01-01

    One approach to producing an intermediate energy beam is moderating fission neutrons escaping from a reactor core. The objective of this research is to evaluate materials that might produce an intermediate beam for NCT via moderation of fission neutrons. A second objective is to use the more promising moderator material in a preliminary design of an NCT facility at a research reactor. The evaluations showed that several materials or combinations of materials could produce a moderator source for an intermediate beam for NCT. The best neutron spectrum for use in NCT is produced by Al 2 O 3 , but mixtures of Al metal and D 2 O are also attractive. Using the best moderator materials, results were applied to the design of an NCT moderator at the Georgia Institute of Technology Research Reactor's bio-medical facility. The amount of photon shielding and thermal neutron absorber were optimized with respect to the desired photon dose rate and intermediate neutron flux at the patient position

  9. [A clinical trial of neutron capture therapy for brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.

    1989-01-01

    This report describes accomplishments by this laboratory concerning development of high-resolution alpha-autoradiography design of an optimized epithermal neutron beam dosimetry and treatment planning Using Monte Carlo techniques development of a prompt-gamma 10 B analysis facility

  10. [A clinical trial of neutron capture therapy for brain tumors

    International Nuclear Information System (INIS)

    Zamenhof, R.G.

    1990-01-01

    This document briefly describes recent advances in the author's laboratory. Topics described include neutron beam design, high- resolution autoradiography, boronated phenylalanine (BPA) distribution and survival studies in glioma bearing mice, computer- aided treatment planning, prompt gamma boron 10 analysis facility at MITI-II, non-rodent BPA toxicity studies, and preparations for clinical studies

  11. Multi-resolution and multi-scale simulation of the thermal hydraulics in fast neutron reactor assemblies

    International Nuclear Information System (INIS)

    Angeli, P.-E.

    2011-01-01

    The present work is devoted to a multi-scale numerical simulation of an assembly of fast neutron reactor. In spite of the rapid growth of the computer power, the fine complete CFD of a such system remains out of reach in a context of research and development. After the determination of the thermalhydraulic behaviour of the assembly at the macroscopic scale, we propose to carry out a local reconstruction of the fine scale information. The complete approach will require a much lower CPU time than the CFD of the entire structure. The macro-scale description is obtained using either the volume averaging formalism in porous media, or an alternative modeling historically developed for the study of fast neutron reactor assemblies. It provides some information used as constraint of a down-scaling problem, through a penalization technique of the local conservation equations. This problem lean on the periodic nature of the structure by integrating periodic boundary conditions for the required microscale fields or their spatial deviation. After validating the methodologies on some model applications, we undertake to perform them on 'industrial' configurations which demonstrate the viability of this multi-scale approach. (author) [fr

  12. The Clatterbridge high-energy neutron therapy facility: specification and performance

    International Nuclear Information System (INIS)

    Bonnett, D.E.; Blake, S.W.; Shaw, J.E.; Bewley, D.K.

    1988-01-01

    A high energy neutron therapy facility has been installed at the Douglas Cyclotron Centre, Clatterbridge Hospital Merseyside, to extend M.R.C. clinical trials of fast neutrons. The neutron beam is produced by bombarding a beryllium target with 62 MeV protons. The target is isocentrically mounted with potential for 360 0 rotation, with a fully variable collimator, giving a range of rectilinear field sizes from 5 cm x 5 cm to 30 cm x 30 cm. Basic neutron beam data including output, field flatness, penumbra and depth-dose data have been measured. For a 10 cm x 10 cm field, 50% depth dose occurs at 16.2 cm in water and output is 1.63 cGy μ A -1 min -1 at maximum dose depth. Effectiveness of the target shielding and neutron-induced radioactivity in the treatment head were also measured. It is concluded that the equipment meets design specifications and fully satisfies criticisms of earlier neutron therapy equipment. A full radiation survey showed that radiation levels present no significant staff hazard. (UK)

  13. Boron-Containing Compounds for Liposome-Mediated Tumor Localization and Application to Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Hawthorne, M. Frederick

    2005-01-01

    Medical application of boron neutron capture therapy (BNCT) has been significantly hindered by the slow development of boron drug-targeting methodologies for the selective delivery of high boron concentration sto malignant cells. We have successfully sought to fill this need by creating liposomes suitable as in vivo boron delivery vehicles for BNCT. Delivery of therapeutic quantities of boron to tumors in murine models has been achieved with small unilamellar boron-rich liposomes. Subsequently, attempts have been made to improve delivery efficiency of liposomes encapsulating boron-containing water-soluble species into their hollow core by incorporating lipophilic boron compounds as addenda to the liposome bilayer, incorporating boron compounds as structural components of the bilayer (which however, poses the risk of sacrificing some stability), and combinations thereof. Regardless of the method, approximately 90% of the total liposome mass remains therapeutically inactive and comprised of the vehicle's construction materials, while less than 5% is boron for neutron targeting. Following this laboratory's intensive study, the observed tumor specificity of certain liposomes has been attributed to their diminutive size of these liposomes (30-150 nm), which enables these small vesicles to pass through the porous, immature vasculature of rapidly growing tumor tissue. We surmised that any amphiphilic nanoparticle of suitable size could possess some tumor selectivity. Consequently, the discovery of a very boron-rich nanoparticle delivery agent with biodistribution performance similar to unilamellar liposomes became one of our goals. Closomers, a new class of polyhedral borane derivatives, attracted us as an alternative BNCT drug-delivery system. We specifically envisioned dodeca (nido-carboranyl)-substituted closomers as possibly having a great potential role in BNCT drug delivery. They could function as extraordinarily boron-rich BNCT drugs since they are amphiphilic

  14. Monte Carlo calculations on efficiency of boron neutron capture therapy for brain cancer

    International Nuclear Information System (INIS)

    Awadalla, Galaleldin Mohamed Suliman

    2015-11-01

    The search for ways to treat cancer has led to many different treatments, including surgery, chemotherapy, and radiation therapy. Among these treatments, boron neutron capture therapy (BNCT) has shown promising results. BNCT is a radiotherapy treatment modality that has been proposed to treat brain cancer. In this technique, cancerous cells are being injected with 1 0B and irradiated by thermal neutrons to increase the probability of 1 0B (n, a)7 L i reaction to occur. This reaction can potentially deliver a high radiation dose sufficient to kill cancer cells by concentrating boron in them. The short rang of 1 0B (n, a) 7 L i reaction limits the damage to only cancerous cells without affecting healthy tissues. The effectiveness and safety of radiotherapy are dependent on the radiation dose delivered to the tumor and healthy tissues. In this thesis, after reviewing the basics and working principles of boron neutron capture therapy (BNCT), monte Carlo simulations were carried out to model a thermal neutron source suitable for BNCT and to examine the performance of proposed model when used to irradiate a sample of boron containing both 1 0B and 1 1B isotopes. MCNP5 code was used to examine the modeled neutron source through different shielding materials. The results were presented, analyzed and discussed at the end of the work. (author)

  15. Benchmark experiment on vanadium assembly with D-T neutrons. In-situ measurement

    Energy Technology Data Exchange (ETDEWEB)

    Maekawa, Fujio; Kasugai, Yoshimi; Konno, Chikara; Wada, Masayuki; Oyama, Yukio; Ikeda, Yujiro [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment; Murata, Isao; Kokooo; Takahashi, Akito

    1998-03-01

    Fusion neutronics benchmark experimental data on vanadium were obtained for neutrons in almost entire energies as well as secondary gamma-rays. Benchmark calculations for the experiment were performed to investigate validity of recent nuclear data files, i.e., JENDL Fusion File, FENDL/E-1.0 and EFF-3. (author)

  16. Phantom experiment of depth-dose distributions for gadolinium neutron capture therapy

    International Nuclear Information System (INIS)

    Matsumoto, T.; Kato, K.; Sakuma, Y.; Tsuruno, A.; Matsubayashi, M.

    1993-01-01

    Depth-dose distributions in a tumor simulated phantom were measured for thermal neutron flux, capture gamma-ray and internal conversion electron dose rates for gadolinium neutron capture therapy. The results show that (i) a significant dose enhancement can be achieved in the tumor by capture gamma-rays and internal conversion electrons but the dose is mainly due to capture gamma-rays from the Gd(n, γ) reactions, therefore, is not selective at the cellular level, (ii) the dose distribution was a function of strongly interrelated parameters such as gadolinium concentrations, tumor site and neutron beam size (collimator aperture size), and (iii) the Gd-NCT by thermal neutrons appears to be a potential for treatment of superficial tumor. (author)

  17. Design study of a medical reactor for Boron Neutron Capture Therapy

    International Nuclear Information System (INIS)

    Sasaki, M.; Hirota, J.; Tamao, S.; Kanda, K.; Mishima, Y.

    1992-01-01

    A new design study of a medical reactor for Boron Neutron Capture Therapy (BNCT) has been carried out. The reactor is to be used exclusively for the treatment of malignant melanoma and other cancers as well as for the further biomedical research. Main specifications of the reactor are as follows; thermal power of 2 MW, water cooling by natural convection, semitight core of triangular lattice, UO 2 fuel rod of 9.5 mm diameter and no refueling in the reactor-life. Three horizontal and one vertical neutron beam hole are to be provided to deliver thermal and epithermal neutrons. N-γ coupling Sn transport calculations indicate that the patient treatment period will be about 30 minutes with minimal fast neutron and gamma contaminants. (author)

  18. Progress in study of a medical reactor for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Sasaki, Makoto; Hirota, Jitsuya; Tamao, Shigeo; Kanda, Keiji; Mishima, Yutaka.

    1993-01-01

    A design study of a medical reactor for Boron Neutron Capture Therapy has made progress. Main specifications of the reactor are as follows; thermal power of 2 MW, water cooling by natural convection, semitight core of hexagonal lattice, UO 2 fuel rod of 9.5 mm diameter and no refueling in the reactor-life. Three horizontal and one vertical neutron beam holes are to be provided for simultaneous treatments by thermal and epithermal neutrons and for further biomedical research. The design objectives for the beam holes are to deliver the therapeutic doses in a modest time (30 to 60 min) with minimal fast neutron and gamma contaminants. The n-γ coupling Sn transport calculations have been carried out using n-21 and γ-9 group cross sections on 2-dim. practical models. The calculated results indicate that the design objectives will be achievable even if the thermal power of the reactor is reduced to 1 MW. (author)

  19. Nuclear data for fast neutron and proton therapy

    International Nuclear Information System (INIS)

    Chadwick, M.B.; Jones, D.T.L.; Barschall, H.H.

    2001-01-01

    ICRU Report 63 entitled 'Nuclear Data for Neutron and Proton Radiotherapy and for Radiation Protection' has recently been published. The present paper presents an overview of this report, along with examples of some of the results obtained for evaluated nuclear cross sections and kerma coefficients. These cross sections are evaluated using a combination of measured data and the GNASH nuclear model code for elements of importance for biological, dosimetric, beam modification and shielding purposes. In the case of hydrogen both R-matrix and phase-shift scattering theories are used. Neutron cross sections and kerma coefficients were evaluated up to 100 MeV and proton cross sections up to 250 MeV. (author)

  20. A colorimetric determination of boron in biological sample for boron neutron capture therapy (BNCT)

    International Nuclear Information System (INIS)

    Camillo, M.A.P.; Tomac Junior, U.

    1990-01-01

    The boron neutron capture therapy (BNCT) has shown better prognosis in the treatment of glyemas and gluoblastomas grade III and IV than other therapies. During the treatment the levels of Na 2 10 B 12 H 11 SH must be known in several compartiments of the organism and with this purpose the method of colorimetric determination of boron using curcumine was established. This method is simple, reprodutible and adequate sensitivity for this control. (author) [pt

  1. A colorimetric determination of boron in biological sample for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Camilo, M.A.P.; Tomac Junior, U.

    1989-01-01

    The boron neutron capture therapy (BNCT) has shown better prognosis in the treatment of gliomas and glioblastomas grade III and IV than other therapies. During the treatment of levels of Na 2 10 B 12 H 11 S H must be known in several compartments of the organism and with this purpose the method of colorimetric determination of boron using curcumin was established. This method is simples, reproducible and has adequate sensitivity for this control. (author). 7 refs, 3 figs, 1 tab

  2. Viability of neutron brachytherapy technique using Cf252 for tumors of salivary glands therapy

    International Nuclear Information System (INIS)

    Andrade, Lidia M.; Campos, Tarcisio P.R.

    2000-01-01

    Gland salivary tumors, although uncommon, present significant characteristics such as distant metastasis, recurrence and average survive of five year for treated patients. Those tumors presents low response to a conventional radiotherapy, photon and electron therapy; thus, this modality is associated with surgery. Fast neutron therapy has been presented better results in controlling the local tumor in comparison with conventional radiotherapy. Brachytherapy with Cf-252 presents an alternative treatment for tumors. Those radiotherapy technique are discussed and analyzed. (author)

  3. Dysphagia after fast neutron therapy to the head and neck

    International Nuclear Information System (INIS)

    Alexander, M.S.M.; Edelman, G.M.; Man, Kate; Randall, C.J.

    1989-01-01

    Nine patients presenting with dysphagia following successful treatment for head and neck cancer with neutron radiotherapy are reviewed. Combined clinical and videofluoroscopic investigation is used to analyse their deficits and provide indications for management. All patients show impairment of both the oral and pharyngeal phases of the swallow, with the exception of one subject who shows signs of focal neurological damage. It is suggested that fibrosis is the underlying cause of dysphagia in the remainder. (author)

  4. The Prompt Fission Neutron Spectrum: From Experiment to the Evaluated Data and its Impact on Critical Assemblies

    Energy Technology Data Exchange (ETDEWEB)

    Rising, Michael Evan [Los Alamos National Laboratory

    2015-06-10

    After a brief introduction concerning nuclear data, prompt fission neutron spectrum (PFNS) evaluations and the limited PFNS covariance data in the ENDF/B-VII library, and the important fact that cross section uncertainties ~ PFNS uncertainties, the author presents background information on the PFNS (experimental data, theoretical models, data evaluation, uncertainty quantification) and discusses the impact on certain well-known critical assemblies with regard to integral quantities, sensitivity analysis, and uncertainty propagation. He sketches recent and ongoing research and concludes with some final thoughts.

  5. Further development of thermal neutron capture therapy for metastatic and deeply-invasive human malignant melanoma

    International Nuclear Information System (INIS)

    Mishima, Yutaka

    1995-03-01

    This issue is the collection of the papers presented thermal neutron capture therapy for metastatic and deeply-invasive human malignant melanoma. Separate abstracts were prepared for 2 of the papers in this report. The remaining 32 papers were considered outside the subject scope of INIS. (J.P.N.)

  6. Proceedings of workshop on 'boron science and boron neutron capture therapy'

    Energy Technology Data Exchange (ETDEWEB)

    Kitaoka, Y. [ed.

    1998-12-01

    This volume contains the abstracts and programs of the 8th (1996), 9th (1997) and 10th (1998) of the workshop on 'the Boron Science and Boron Neutron Capture Therapy' and the recent progress reports especially subscribed. The 11 of the presented papers are indexed individually. (J.P.N.)

  7. Evaluation of conditions of radiation protection of medical personnel in intracavitary neutron therapy of cervical cancer

    International Nuclear Information System (INIS)

    Kostromina, K.N.; Korenkov, I.P.; Bocharov, A.L.; Gladkikh, N.N.

    1991-01-01

    Combined radiation therapy was provided to cervical cancer patients. Working conditions of personnel were examined, the rate of exposure doses and flows of neutrons at working places were measured, dose exposures of the personnel were evaluated. It has been concluded that occupational conditions for the medical personnel are considered to be relatively safe

  8. Contemporary state of neutron capture therapy in the Czech Republic - (Part 2)

    Czech Academy of Sciences Publication Activity Database

    Dbalý, V.; Tovaryš, F.; Honová, H.; Petruželka, L.; Prokeš, K.; Burian, J.; Marek, M.; Honzátko, Jaroslav; Tomandl, Ivo; Kříž, O.; Janků, I.; Mareš, Vladislav

    2003-01-01

    Roč. 66, č. 1 (2003), s. 60-63 ISSN 1210-7859 Institutional research plan: CEZ:AV0Z5011922; CEZ:AV0Z1048901 Keywords : boron neutron therapy * radiotherapy Subject RIV: FH - Neurology Impact factor: 0.047, year: 2003

  9. The Boron Neutron Capture Therapy (BNCT) Project at the TRIGA Reactor in Mainz, Germany

    DEFF Research Database (Denmark)

    Hampel, G.; Grunewald, C.; Schütz, C.

    2011-01-01

    The thermal column of the TRIGA reactor in Mainz is being used very effectively for medical and biological applications. The BNCT (boron neutron capture therapy) project at the University of Mainz is focussed on the treatment of liver tumours, similar to the work performed at Pavia (Italy) a few ...

  10. Gastrocutaneous fistula as a late complication of fast neutron therapy for carcinoma of the stomach

    International Nuclear Information System (INIS)

    Griffith, C.D.M.; Arnott, S.J.

    1984-01-01

    A brief report is presented of a case of gastrocutaneous fistula in a 36-year-old housewife, who had been treated a year previously for carcinoma of the stomach with fast neutron therapy at a dose of 1500 cGy delivered in 20 daily treatments. The maximum tissue dose delivered to the skin surface was 1780 cGy. (U.K.)

  11. Beam shaping assembly of a D–T neutron source for BNCT and its dosimetry simulation in deeply-seated tumor

    International Nuclear Information System (INIS)

    Faghihi, F.; Khalili, S.

    2013-01-01

    This article involves two aims for BNCT. First case includes a beam shaping assembly estimation for a D–T neutron source to find epi-thermal neutrons which are the goal in the BNCT. Second issue is the percent depth dose calculation in the adult Snyder head phantom. Monte-Carlo simulations and verification of a suggested beam shaping assembly (including internal neutron multiplier, moderator, filter, external neutron multiplier, collimator, and reflector dimensions) for thermalizing a D–T neutron source as well as increasing neutron flux are carried out and our results are given herein. Finally, we have simulated its corresponding doses for treatment planning of a deeply-seated tumor. - Highlights: ► An assembly for the D–T neutron source including many regions is given herein. ► Dosimetry simulations in the Snyder head phantom for a deeply-seated tumor are carried out. ► Brief literatures conclusions on the recent BNCT studies are presented herein

  12. Transport theory calculation for a heterogeneous multi-assembly problem by characteristics method with direct neutron path linking technique

    International Nuclear Information System (INIS)

    Kosaka, Shinya; Saji, Etsuro

    2000-01-01

    A characteristics transport theory code, CHAPLET, has been developed for the purpose of making it practical to perform a whole LWR core calculation with the same level of calculational model and accuracy as that of an ordinary single assembly calculation. The characteristics routine employs the CACTUS algorithm for drawing ray tracing lines, which assists the two key features of the flux solution in the CHAPLET code. One is the direct neutron path linking (DNPL) technique which strictly connects angular fluxes at each assembly interface in the flux solution separated between assemblies. Another is to reduce the required memory storage by sharing the data related to ray tracing among assemblies with the same configuration. For faster computation, the coarse mesh rebalance (CMR) method and the Aitken method were incorporated in the code and the combined use of both methods showed the most promising acceleration performance among the trials. In addition, the parallelization of the flux solution was attempted, resulting in a significant reduction in the wall-clock time of the calculation. By all these efforts, coupled with the results of many verification studies, a whole LWR core heterogeneous transport theory calculation finally became practical. CHAPLET is thought to be a useful tool which can produce the reference solutions for analyses of an LWR (author)

  13. Assembly Discontinuity Factors for the Neutron Diffusion Equation discretized with the Finite Volume Method. Application to BWR

    International Nuclear Information System (INIS)

    Bernal, A.; Roman, J.E.; Miró, R.; Verdú, G.

    2016-01-01

    Highlights: • A method is proposed to solve the eigenvalue problem of the Neutron Diffusion Equation in BWR. • The Neutron Diffusion Equation is discretized with the Finite Volume Method. • The currents are calculated by using a polynomial expansion of the neutron flux. • The current continuity and boundary conditions are defined implicitly to reduce the size of the matrices. • Different structured and unstructured meshes were used to discretize the BWR. - Abstract: The neutron flux spatial distribution in Boiling Water Reactors (BWRs) can be calculated by means of the Neutron Diffusion Equation (NDE), which is a space- and time-dependent differential equation. In steady state conditions, the time derivative terms are zero and this equation is rewritten as an eigenvalue problem. In addition, the spatial partial derivatives terms are transformed into algebraic terms by discretizing the geometry and using numerical methods. As regards the geometrical discretization, BWRs are complex systems containing different components of different geometries and materials, but they are usually modelled as parallelepiped nodes each one containing only one homogenized material to simplify the solution of the NDE. There are several techniques to correct the homogenization in the node, but the most commonly used in BWRs is that based on Assembly Discontinuity Factors (ADFs). As regards numerical methods, the Finite Volume Method (FVM) is feasible and suitable to be applied to the NDE. In this paper, a FVM based on a polynomial expansion method has been used to obtain the matrices of the eigenvalue problem, assuring the accomplishment of the ADFs for a BWR. This eigenvalue problem has been solved by means of the SLEPc library.

  14. Simulation of silicon microdosimetry spectra in fast neutron therapy using the GEANT4 Monte Carlo toolkit

    International Nuclear Information System (INIS)

    Cornelius, I.M.; Rosenfeld, A.B.

    2003-01-01

    Microdosimetry is used to predict the biological effects of the densely ionizing radiation environments of hadron therapy and space. The creation of a solid state microdosimeter to replace the conventional Tissue Equivalent Proportional Counter (TEPC) is a topic of ongoing research. The Centre for Medical Radiation Physics has been investigating a technique using microscopic arrays of reverse biased PN junctions. A prototype silicon-on-insulator (SOI) microdosimeter was developed and preliminary measurements have been conducted at several hadron therapy facilities. Several factors impede the application of silicon microdosimeters to hadron therapy. One of the major limitations is that of tissue equivalence, ideally the silicon microdosimeter should provide a microdosimetry distribution identical to that of a microscopic volume of tissue. For microdosimetry in neutron fields, such as Fast Neutron Therapy, it is important that products resulting from neutron interactions in the non tissue equivalent sensitive volume do not contribute significantly to the spectrum. Experimental measurements have been conducted at the Gershenson Radiation Oncology Center, Harper Hospital, Detroit by Bradley et al. The aim was to provide a comparison with measurements performed with a TEPC under identical experimental conditions. Monte Carlo based calculations of these measurements were made using the GEANT4 Monte Carlo toolkit. Agreement between experimental and theoretical results was observed. The model illustrated the importance of neutron interactions in the non tissue equivalent sensitive volume and showed this effect to decrease with sensitive volume size as expected. Simulations were also performed for 1 micron cubic silicon sensitive volumes embedded in tissue equivalent material to predict the best case scenario for silicon microdosimetry in Fast Neutron Therapy

  15. Calculations of neutron source at the KYIV research reactor for the boron neutron capture therapy aims

    International Nuclear Information System (INIS)

    Gritzay, O.; Kalchenko, O.; Klimova, N.; Razbudey, V.; Sanzhur, A.

    2006-01-01

    Calculation results of an epithermal neutron source which can be created at the Kyiv Research Reactor (KRR) by means of placing of specially selected moderators, filters, collimators, and shielding into the 10-th horizontal experimental tube (so-called thermal column) are presented. The general Monte-Carlo radiation transport code MCNP4C [1], the Oak Ridge isotope generation code ORIGEN2 [2] and the NJOY99 [3] nuclear data processing system have been used for these calculations

  16. Coupled neutronics/thermal-hydraulics analysis of a high-performance light-water reactor fuel assembly

    International Nuclear Information System (INIS)

    Waata, C.L.

    2006-07-01

    The use of water at supercritical pressure as coolant and moderator introduces a challenge in the design of a High-Performance Light-Water Reactor (HPLWR) fuel assembly. At supercritical pressure condition (P=25 MPa), the thermal-hydraulics behaviour of water differs strongly from that at sub-critical pressure due to a rapid variation of the thermal-physical properties across the pseudo-critical line. Due of the strong link between the water (moderation) and the neutron spectrum and subsequently the power distribution, a coupling of neutronics and thermal-hydraulics has become a necessity for reactor concepts operating at supercritical pressure condition. The effect of neutron moderation on the local parameters of thermal-hydraulics and vice-verse in a fuel assembly has to be considered for an accurate design analysis. In this study, the Monte Carlo N-Particle code (MCNP) and the sub-channel code STAFAS (Sub-channel Thermal-hydraulics Analysis of a Fuel Assembly under Supercritical conditions) have been coupled for the design analysis of a fuel assembly with supercritical water as coolant and moderator. Both codes are well known for complex geometry modelling. The MCNP code is used for neutronics analyses and for the prediction of power profiles of individual fuel rods. The sub-channel code STAFAS for the thermal-hydraulics analyses takes into account the coolant properties beyond the critical point as well as separate moderator channels. The coupling procedure is realized automatically. MCNP calculates the power distribution in each fuel rod, which is then transferred into STAFAS to obtain the corresponding thermal-hydraulic conditions in each sub-channel. The new thermal-hydraulic conditions are used to generate a new input deck for the next MCNP calculation. This procedure is repeated until a converged state is achieved. The coupled code system was tested on a proposed fuel assembly design of a HPLWR. An under-relaxation was introduced to achieve convergence

  17. A comparison of the COG and MCNP codes in computational neutron capture therapy modeling, Part II: gadolinium neutron capture therapy models and therapeutic effects.

    Science.gov (United States)

    Wangerin, K; Culbertson, C N; Jevremovic, T

    2005-08-01

    The goal of this study was to evaluate the COG Monte Carlo radiation transport code, developed and tested by Lawrence Livermore National Laboratory, for gadolinium neutron capture therapy (GdNCT) related modeling. The validity of COG NCT model has been established for this model, and here the calculation was extended to analyze the effect of various gadolinium concentrations on dose distribution and cell-kill effect of the GdNCT modality and to determine the optimum therapeutic conditions for treating brain cancers. The computational results were compared with the widely used MCNP code. The differences between the COG and MCNP predictions were generally small and suggest that the COG code can be applied to similar research problems in NCT. Results for this study also showed that a concentration of 100 ppm gadolinium in the tumor was most beneficial when using an epithermal neutron beam.

  18. Local control of murine melanoma xenografts in nude mice by neutron capture therapy

    International Nuclear Information System (INIS)

    Allen, B.J.; Corderoy-Buck, S.; Moore, D.E.; Mishima, Y.; Ichihashi, M.

    1992-01-01

    In recent years considerable progress has been made in the development and implementation of neutron capture therapy (NCT) for the treatment of cancer. In particular, the boron analogue of the melanin precursor phenylalanine, i.e., DL-p-boronophenylalanine (BPA), has been used to demonstrate the regression and cure of Harding-Passey (HP) melanoma in syngeneic mice. However, 18 to 25% cures were obtained for neutron irradiations without boron, suggesting that the neutron dose alone plays an important role. Neutron capture therapy of B-16 melanoma xenografts in nude mice showed substantial tumor regression over 35 days, but the survival rate of NCT treated mice after 7 weeks was only 40-60%. In this paper the authors demonstrate the equivalence of the nude mouse model with a syngeneic model, using the same Harding-Passey murine melanoma line, and delineate the conditions required for maximum differential response between neutron irradiation with and without BPA administration, with complete local control as the end point

  19. Perspectives of boron-neutron capture therapy of malignant brain tumors

    Science.gov (United States)

    Kanygin, V. V.; Kichigin, A. I.; Krivoshapkin, A. L.; Taskaev, S. Yu.

    2017-09-01

    Boron neutron capture therapy (BNCT) is characterized by a selective effect directly on the cells of malignant tumors. The carried out research showed the perspective of the given kind of therapy concerning malignant tumors of the brain. However, the introduction of BNCT into clinical practice is hampered by the lack of a single protocol for the treatment of patients and the difficulty in using nuclear reactors to produce a neutron beam. This problem can be solved by using a compact accelerator as a source of neutrons, with the possibility of installation in a medical institution. Such a neutron accelerator for BNCT was developed at Budker Institute of Nuclear Physics, Novosibirsk. A neutron beam was obtained on this accelerator, which fully complies with the requirements of BNCT, as confirmed by studies on cell cultures and experiments with laboratory animals. The conducted experiments showed the relative safety of the method with the absence of negative effects on cell cultures and living organisms, and also confirmed the effectiveness of BNCT for malignant brain tumors.

  20. Clinical experience of therapy with cyclotron neutrons at the University of Washington

    International Nuclear Information System (INIS)

    Parker, R.G.; Gerdes, A.J.; Berry, H.C.; Soronen, M.D.

    1975-01-01

    Proper clinical evaluation of fast neutron teletherapy of human cancers will be difficult and time-consuming and will require extension over many years. Fast neutron teletherapy may not have significant advantage over modern conventional supervoltage/megavoltage radiation therapy. A negative answer will be acceptable only if based on sound evidence. If fast neutron teletherapy has an advantage over modern conventional radiation therapy, the advantage may be small and tumor- and site-specific. Detection of a small advantage will require study of a large number of patients and this will be possible only in carefully planned cooperative clinical trials. The study of a large number of patients over a long period will require installation of dedicated neutron generators in research-oriented medical centers. Cooperative clinical trials must be preceded by careful definition of target tumors, normal tissue tolerances, reasonable doses and advantageous patterns of application. Any improvement in local tumor control attributed to fast neutron teletherapy might be dissipated by a concurrent increase in treatment-related sequelae. Much related physics and radiobiology remains to be done and must be supported concurrent with the clinical programs

  1. Neutron production with a pyroelectric double-crystal assembly without nano-tip

    International Nuclear Information System (INIS)

    Tornow, W.; Corse, W.; Crimi, S.; Fox, J.

    2010-01-01

    Two cylindrical LiTaO 3 crystals facing each other's deuterated circular face were exposed to deuterium gas at an ambient pressure of a few mTorr. With a distance of about 4 cm between the z + and z - cut crystal faces, neutrons were produced via the 2 H(d,n) 3 He fusion reaction upon the heating and cooling of the crystals. The 2.5 MeV neutrons were detected with organic liquid scintillation detectors equipped with neutron-gamma pulse-shape discrimination electronics to reject pulses generated by the intense X-ray flux. During the cooling phase of naked crystals, deuterium ion-beam (D 2 + ) energies of up to 400 keV were obtained as deduced from the associated electron bremsstrahlung end-point energy. The highest electron-beam energy observed during the heating phase was 360 keV. With a layer of deuterated polyethylene evaporated on the front face of the crystals, the maximal energies were about 10% lower. In contrast to earlier studies, an electric-field enhancing nano-tip was not employed. Neutron yields up to 500 per thermal cycle were observed, resulting in a total neutron production yield of about 1.6x10 4 neutrons per thermal cycle. Our approach has the potential of being substantially improved by reducing the frequency of the discharges we are currently experiencing with our geometry, which was not designed for the unprecedented high potentials produced in the presentwork.

  2. Distribution of exogenous porphyrins in vivo; implications for neutron capture therapy

    International Nuclear Information System (INIS)

    Fairchild, R.G.; Gabel, D.; Hillman, M.; Watts, K.

    1982-01-01

    Endogenous porphyrins (HpD) are already in clinical use for phototherapy, in which red light is used to stimulate a cytotoxic response in tumors. The evident success, at least with superficial cancers, gives biological evidence of selective concentrations of porphyrins in tumors adequate for therapy. The authors have investigated, in addition, the biodistribution of a synthetic porphyrin (tetraphenylporphinesulfonate, or TPPS) in seven different animal tumor models. Their data, as well as those of others, indicate abundant accumulations of TPPS in tumor. If boronated analogs behave in the same way, boron concentrations would be up to 10 times that needed for therapy. Utilization of such porphyrin analogs in the neutron capture therapy (NCT) procedure is similar in concept to phototherapy currently being used clinically, with the distinct advantage of deeper tissue penetration produced by the activating neutrons

  3. Cf-252 neutron brachytherapy: an advance for bulky localized cancer therapy

    International Nuclear Information System (INIS)

    Maruyama, Y.

    1984-01-01

    The physical and radiobiogical basis as well as the rationale for neutron brachytherapy, using Cf-252, in human cancer therapy is reviewed. Cf-252 brachytherapy represents an economical and effective form of neutron radiotherapy that is readily and safely applied clinically. It can be used anywhere in the world without unusual personnel, equipment or facilities, or prohibitive expenses or maintenance costs. Used on bulky head and neck, thoracic, abdominal, pelvic, brain and appendage cancers, it overcomes hypoxic radioresistance and produces remarkable rates of tumor clearance. It is easily combined with photon radiotherapy and in proper schedules and doses, it can control advanced but still localized regional cancers to produce tumor cure. It will clear the local manifestations of recurrent or metastatic tumors or advanced stages of primary tumors and therefore in conjunction with other adjuvant therapies offers much more effective tumor control and palliation than present conventional therapy. (Auth.)

  4. Medical aspects of boron-slow neutron capture therapy

    International Nuclear Information System (INIS)

    Sweet, W.H.

    1986-01-01

    Earlier radiations of patients with cerebral tumors disclosed the need: (1) to find a carrier of the boron compound which would leave the blood and concentrate in the tumor, (2) to use a more penetrating neutron beam, and (3) to develop a much faster method for assaying boron in blood and tissue. To some extent number1 has been accomplished in the form of Na 2 B 12 H 11 SH, number2 has yet to be achieved, and number3 has been solved by the measurement of the 478-keV gamma ray when the 10 B atom disintegrates following its capture of a slow neutron. The hitherto unreported data in this paper describe through the courtesy of Professor Hiroshi Hatanaka his studies on the pharmacokinetics and quality control of Na 2 B 12 H 11 SH based on 96 boron infusions in 86 patients. Simultaneous blood and tumor data are plotted here for 30 patients with glioblastomas (Grade III-IV gliomas), illustrating remarkable variability. Detailed autopsy findings on 18 patients with BNCT showed radiation injury in only 1. Clinical results in 12 of the most favorably situated glioblastomas reveal that 5 are still alive with a 5-year survival rate of 58% and the excellent Karnofsky performance rating of 87%. For the first time evidence is presented that slow-growing astrocytomas may benefit from BNCT. 10 references, 8 figures, 5 tables

  5. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma

    International Nuclear Information System (INIS)

    Kageji, Teruyoshi; Nagahiro, Shinji; Kitamura, Katsushi; Nakagawa, Yoshinobu; Hatanaka, Hiroshi; Haritz, Dietrich; Grochulla, Frank; Haselsberger, Klaus; Gabel, Detlef

    2001-01-01

    Purpose: A cooperative study in Europe and Japan was conducted to determine the pharmacokinetics and boron uptake of sodium borocaptate (BSH: Na 2 B 12 H 11 SH), which has been introduced clinically as a boron carrier for boron neutron capture therapy in patients with glioblastoma. Methods and Materials: Data from 56 patients with glioblastoma who received BSH intravenous infusion were retrospectively reviewed. The pharmacokinetics were evaluated in 50 patients, and boron uptake was investigated in 47 patients. Patients received BSH doses between 12 and 100 mg/kg of body weight. For the evaluation, the infused boron dose was scaled linearly to 100 mg/kg BSH. Results: In BSH pharmacokinetics, the average value for total body clearance, distribution volume of steady state, and mean residence time was 3.6±1.5 L/h, 223.3±160.7 L, and 68.0±52.5 h, respectively. The average values of the boron concentration in tumor adjusted to 100 mg/kg BSH, the boron concentration in blood adjusted to 100 mg/kg BSH, and the tumor/blood boron concentration ratio were 37.1±35.8 ppm, 35.2±41.8 ppm, and 1.53±1.43, respectively. A good correlation was found between the logarithmic value of T adj and the interval from BSH infusion to tumor tissue sampling. About 12-19 h after infusion, the actual values for T adj and tumor/blood boron concentration ratio were 46.2±36.0 ppm and 1.70±1.06, respectively. The dose ratio between tumor and healthy tissue peaked in the same interval. Conclusion: For boron neutron capture therapy using BSH administered by intravenous infusion, this work confirms that neutron irradiation is optimal around 12-19 h after the infusion is started

  6. Boron Neutron Capture Therapy activity of diffused tumors at TRIGA Mark II in Pavia

    Energy Technology Data Exchange (ETDEWEB)

    Bortolussi, S.; Stella, S.; De Bari, A.; Altieri, S. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy)]|[National Institute of Nuclear Physics (INFN), Pavia (Italy); Bruschi, P.; Bakeine, J.G. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy); Clerici, A.; Ferrari, C.; Zonta, C.; Zonta, A. [Department of Surgery, University of Pavia, Pavia (Italy); Nano, R. [Department of Animal Biology, University of Pavia, Pavia (Italy)

    2008-10-29

    The Boron neutron Capture Therapy research in Pavia has a long tradition: it begun more than 20 years ago at the TRIGA Mark II reactor of the University. A technique for the treatment of the hepatic metastases was developed, consisting in explanting the liver treated with {sup 10}B, irradiating it in the thermal column of the reactor, and re-implanting the organ in the patient. In the last years, the possibility of applying BNCT to the lung tumours using epithermal collimated neutron beams and without explanting the organ, is being explored. The principal obtained results of the BNCT research will be presented, with particular emphasis on the following aspects: a) the project of a new thermal column configuration to make the thermal neutron flux more uniform inside the explanted liver, b) the Monte Carlo study by means of the MCNP code of the thermal neutron flux distribution inside a patient's thorax irradiated with epithermal neutrons, and c) the measurement of the boron concentration in tissues by (n,{alpha}) spectroscopy and neutron autoradiography. (authors)

  7. Development of the JAERI computational dosimetry system (JCDS) for boron neutron capture therapy. Cooperative research

    CERN Document Server

    Kumada, H; Matsumura, A; Nakagawa, Y; Nose, T; Torii, Y; Uchiyama, J; Yamamoto, K; Yamamoto, T

    2003-01-01

    The Neutron Beam Facility at JRR-4 enables us to carry out boron neutron capture therapy with epithermal neutron beam. In order to make treatment plans for performing the epithermal neutron beam BNCT, it is necessary to estimate radiation doses in a patient's head in advance. The JAERI Computational Dosimetry System (JCDS), which can estimate distributions of radiation doses in a patient's head by simulating in order to support the treatment planning for epithermal neutron beam BNCT, was developed. JCDS is a software that creates a 3-dimentional head model of a patient by using CT and MRI images, and that generates a input data file automatically for calculation of neutron flux and gamma-ray dose distributions in the brain with the Monte Carlo code MCNP, and that displays these dose distributions on the head model for dosimetry by using the MCNP calculation results. JCDS has any advantages as follows; By using CT data and MRI data which are medical images, a detail three-dimensional model of patient's head is...

  8. Boron Neutron Capture Therapy activity of diffused tumors at TRIGA Mark II in Pavia

    International Nuclear Information System (INIS)

    Bortolussi, S.; Stella, S.; De Bari, A.; Altieri, S.; Bruschi, P.; Bakeine, J.G.; Clerici, A.; Ferrari, C.; Zonta, C.; Zonta, A.; Nano, R.

    2008-01-01

    The Boron neutron Capture Therapy research in Pavia has a long tradition: it begun more than 20 years ago at the TRIGA Mark II reactor of the University. A technique for the treatment of the hepatic metastases was developed, consisting in explanting the liver treated with 10 B, irradiating it in the thermal column of the reactor, and re-implanting the organ in the patient. In the last years, the possibility of applying BNCT to the lung tumours using epithermal collimated neutron beams and without explanting the organ, is being explored. The principal obtained results of the BNCT research will be presented, with particular emphasis on the following aspects: a) the project of a new thermal column configuration to make the thermal neutron flux more uniform inside the explanted liver, b) the Monte Carlo study by means of the MCNP code of the thermal neutron flux distribution inside a patient's thorax irradiated with epithermal neutrons, and c) the measurement of the boron concentration in tissues by (n,α) spectroscopy and neutron autoradiography. (authors)

  9. Comparison of the radiobiological effects of Boron neutron capture therapy (BNCT) and conventional Gamma Radiation

    International Nuclear Information System (INIS)

    Dagrosa, Maria A.; Carpano, Marina; Perona, Marina; Thomasz, Lisa; Juvenal, Guillermo J.; Pisarev, Mario; Pozzi, Emiliano; Thorp, Silvia

    2009-01-01

    BNCT is an experimental radiotherapeutic modality that uses the capacity of the isotope 10 B to capture thermal neutrons leading to the production of 4 He and 7 Li, particles with high linear energy transfer (LET). The aim was to evaluate and compare in vitro the mechanisms of response to the radiation arising of BNCT and conventional gamma therapy. We measured the survival cell fraction as a function of the total physical dose and analyzed the expression of p27/Kip1 and p53 by Western blotting in cells of colon cancer (ARO81-1). Exponentially growing cells were distributed into the following groups: 1) BPA (10 ppm 10 B) + neutrons; 2) BOPP (10 ppm 10 B) + neutrons; 3) neutrons alone; 4) gamma-rays. A control group without irradiation for each treatment was added. The cells were irradiated in the thermal neutron beam of the RA-3 (flux= 7.5 10 9 n/cm 2 sec) or with 60 Co (1Gy/min) during different times in order to obtain total physical dose between 1-5 Gy (±10 %). A decrease in the survival fraction as a function of the physical dose was observed for all the treatments. We also observed that neutrons and neutrons + BOPP did not differ significantly and that BPA was the more effective compound. Protein extracts of irradiated cells (3Gy) were isolated to 24 h and 48 h post radiation exposure. The irradiation with neutrons in presence of 10 BPA or 10 BOPP produced an increase of p53 at 24 h maintain until 48 h. On the contrary, in the groups irradiated with neutrons alone or gamma the peak was observed at 48 hr. The level of expression of p27/Kip1 showed a reduction of this protein in all the groups irradiated with neutrons (neutrons alone or neutrons plus boron compound), being more marked at 24 h. These preliminary results suggest different radiobiological response for high and low let radiation. Future studies will permit establish the role of cell cycle in the tumor radio sensibility to BNCT. (author)

  10. SBNCT plan: A 3-dimensional treatment planning system for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Reinstein, L.E.; Ramsay, E.B.; Gajewski, J.; Ramamoorthy, S.; Meek, A.G.

    1993-01-01

    The need for accurate and comprehensive 3-dimensional treatment planning for boron neutron capture therapy (BNCT) has been debated for the past several years. Although many argue against the need for elaborate and expensive treatment planning programs which mimic conventional radiotherapy planning systems, it is clear that in order to realize significant gains over conventional fractionated radiation therapy, patients must be treated to the edge of normal tissue tolerance. Just how close to this edge is dictated by the uncertainties in dosimetry. Hence the focus of BNCT planning is the determination of dose distribution throughout normal tissue volumes. Although precise geometric manipulation of the epithermal neutron beam is not achievable, the following variables play an important role in BNCT optimization: patient orientation, dose fractionation, number of fields, megawatt-minutes per fraction, use of surface bolus, and use of collimation. Other variables which are not as easily adjustable and would not, therefore, be part of treatment planning optimization, include external patient contour, internal patient heterogeneities, boron compound distributions, and RBE's. The boron neutron capture therapy planning system developed at SUNY Stony Brook (SBNCT-Plan) was designed as an interactive graphic tool to assist the radiation oncologist in generating the optimum plan for a neutron capture treatment

  11. Characterization of the CALIBAN Critical Assembly Neutron Spectra using Several Adjustment Methods Based on Activation Foils Measurement

    Science.gov (United States)

    Casoli, Pierre; Grégoire, Gilles; Rousseau, Guillaume; Jacquet, Xavier; Authier, Nicolas

    2016-02-01

    CALIBAN is a metallic critical assembly managed by the Criticality, Neutron Science and Measurement Department located on the French CEA Center of Valduc. The reactor is extensively used for benchmark experiments dedicated to the evaluation of nuclear data, for electronic hardening or to study the effect of the neutrons on various materials. Therefore CALIBAN irradiation characteristics and especially its central cavity neutron spectrum have to be very accurately evaluated. In order to strengthen our knowledge of this spectrum, several adjustment methods based on activation foils measurements are being studied for a few years in the laboratory. Firstly two codes included in the UMG package have been tested and compared: MAXED and GRAVEL. More recently, the CALIBAN cavity spectrum has been studied using CALMAR, a new adjustment tool currently under development at the CEA Center of Cadarache. The article will discuss and compare the results and the quality of spectrum rebuilding obtained with the UMG codes and with the CALMAR software, from a set of activation measurements carried out in the CALIBAN irradiation cavity.

  12. Characterization of the CALIBAN Critical Assembly Neutron Spectra using Several Adjustment Methods Based on Activation Foils Measurement

    Directory of Open Access Journals (Sweden)

    Casoli Pierre

    2016-01-01

    Full Text Available CALIBAN is a metallic critical assembly managed by the Criticality, Neutron Science and Measurement Department located on the French CEA Center of Valduc. The reactor is extensively used for benchmark experiments dedicated to the evaluation of nuclear data, for electronic hardening or to study the effect of the neutrons on various materials. Therefore CALIBAN irradiation characteristics and especially its central cavity neutron spectrum have to be very accurately evaluated. In order to strengthen our knowledge of this spectrum, several adjustment methods based on activation foils measurements are being studied for a few years in the laboratory. Firstly two codes included in the UMG package have been tested and compared: MAXED and GRAVEL. More recently, the CALIBAN cavity spectrum has been studied using CALMAR, a new adjustment tool currently under development at the CEA Center of Cadarache. The article will discuss and compare the results and the quality of spectrum rebuilding obtained with the UMG codes and with the CALMAR software, from a set of activation measurements carried out in the CALIBAN irradiation cavity.

  13. ENDF/B-VII.1 Neutron Cross Section Data Testing with Critical Assembly Benchmarks and Reactor Experiments

    Energy Technology Data Exchange (ETDEWEB)

    Kahler, A.C.; Herman, M.; Kahler,A.C.; MacFarlane,R.E.; Mosteller,R.D.; Kiedrowski,B.C.; Frankle,S.C.; Chadwick,M.B.; McKnight,R.D.; Lell,R.M.; Palmiotti,G.; Hiruta,H.; Herman,M.; Arcilla,R.; Mughabghab,S.F.; Sublet,J.C.; Trkov,A.; Trumbull,T.H.; Dunn,M.

    2011-12-01

    The ENDF/B-VII.1 library is the latest revision to the United States Evaluated Nuclear Data File (ENDF). The ENDF library is currently in its seventh generation, with ENDF/B-VII.0 being released in 2006. This revision expands upon that library, including the addition of new evaluated files (was 393 neutron files previously, now 423 including replacement of elemental vanadium and zinc evaluations with isotopic evaluations) and extension or updating of many existing neutron data files. Complete details are provided in the companion paper [M. B. Chadwick et al., 'ENDF/B-VII.1 Nuclear Data for Science and Technology: Cross Sections, Covariances, Fission Product Yields and Decay Data,' Nuclear Data Sheets, 112, 2887 (2011)]. This paper focuses on how accurately application libraries may be expected to perform in criticality calculations with these data. Continuous energy cross section libraries, suitable for use with the MCNP Monte Carlo transport code, have been generated and applied to a suite of nearly one thousand critical benchmark assemblies defined in the International Criticality Safety Benchmark Evaluation Project's International Handbook of Evaluated Criticality Safety Benchmark Experiments. This suite covers uranium and plutonium fuel systems in a variety of forms such as metallic, oxide or solution, and under a variety of spectral conditions, including unmoderated (i.e., bare), metal reflected and water or other light element reflected. Assembly eigenvalues that were accurately predicted with ENDF/B-VII.0 cross sections such as unmoderated and uranium reflected {sup 235}U and {sup 239}Pu assemblies, HEU solution systems and LEU oxide lattice systems that mimic commercial PWR configurations continue to be accurately calculated with ENDF/B-VII.1 cross sections, and deficiencies in predicted eigenvalues for assemblies containing selected materials, including titanium, manganese, cadmium and tungsten are greatly reduced. Improvements are also

  14. ENDF/B-VII.1 Neutron Cross Section Data Testing with Critical Assembly Benchmarks and Reactor Experiments

    Energy Technology Data Exchange (ETDEWEB)

    Kahler, A. [Los Alamos National Laboratory (LANL); Macfarlane, R E [Los Alamos National Laboratory (LANL); Mosteller, R D [Los Alamos National Laboratory (LANL); Kiedrowski, B C [Los Alamos National Laboratory (LANL); Frankle, S C [Los Alamos National Laboratory (LANL); Chadwick, M. B. [Los Alamos National Laboratory (LANL); Mcknight, R D [Argonne National Laboratory (ANL); Lell, R M [Argonne National Laboratory (ANL); Palmiotti, G [Idaho National Laboratory (INL); Hiruta, h [Idaho National Laboratory (INL); Herman, Micheal W [Brookhaven National Laboratory (BNL); Arcilla, r [Brookhaven National Laboratory (BNL); Mughabghab, S F [Brookhaven National Laboratory (BNL); Sublet, J C [Culham Science Center, Abington, UK; Trkov, A. [Jozef Stefan Institute, Slovenia; Trumbull, T H [Knolls Atomic Power Laboratory; Dunn, Michael E [ORNL

    2011-01-01

    The ENDF/B-VII.1 library is the latest revision to the United States' Evaluated Nuclear Data File (ENDF). The ENDF library is currently in its seventh generation, with ENDF/B-VII.0 being released in 2006. This revision expands upon that library, including the addition of new evaluated files (was 393 neutron files previously, now 423 including replacement of elemental vanadium and zinc evaluations with isotopic evaluations) and extension or updating of many existing neutron data files. Complete details are provided in the companion paper [1]. This paper focuses on how accurately application libraries may be expected to perform in criticality calculations with these data. Continuous energy cross section libraries, suitable for use with the MCNP Monte Carlo transport code, have been generated and applied to a suite of nearly one thousand critical benchmark assemblies defined in the International Criticality Safety Benchmark Evaluation Project's International Handbook of Evaluated Criticality Safety Benchmark Experiments. This suite covers uranium and plutonium fuel systems in a variety of forms such as metallic, oxide or solution, and under a variety of spectral conditions, including unmoderated (i.e., bare), metal reflected and water or other light element reflected. Assembly eigenvalues that were accurately predicted with ENDF/B-VII.0 cross sections such as unrnoderated and uranium reflected (235)U and (239)Pu assemblies, HEU solution systems and LEU oxide lattice systems that mimic commercial PWR configurations continue to be accurately calculated with ENDF/B-VII.1 cross sections, and deficiencies in predicted eigenvalues for assemblies containing selected materials, including titanium, manganese, cadmium and tungsten are greatly reduced. Improvements are also confirmed for selected actinide reaction rates such as (236)U; (238,242)Pu and (241,243)Am capture in fast systems. Other deficiencies, such as the overprediction of Pu solution system critical

  15. A new target concept for proton accelerator driven boron neutron capture therapy applications

    International Nuclear Information System (INIS)

    Powell, J.R.; Ludewig, H.; Todosow, M.; Reich, M.

    1998-01-01

    A new target concept termed Discs Incorporating Sector Configured Orbiting Sources (DISCOS), is proposed for spallation applications, including BNCT (Boron Neutron Capture Therapy). In the BNCT application a proton beam impacts a sequence of ultra thin lithium DISCOS targets to generate neutrons by the 7 Li(p,n) 7 Be reaction. The proton beam loses only a few keV of its ∼MeV energy as it passes through a given target, and is re-accelerated to its initial energy, by a DC electric field between the targets

  16. Biological Tests for Boron Neutron Capture Therapy Research at the TRIGA Mark II Reactor in Pavia

    Energy Technology Data Exchange (ETDEWEB)

    Protti, N.; Ballarini, F.; Bortolussi, S.; De Bari, A.; Stella, S.; Altieri, S. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy); Nuclear Physics National Institute (INFN), Pavia (Italy); Bruschi, P. [Department of Nuclear and Theoretical Physics, University of Pavia, Pavia (Italy); Bakeine, J.G.; Cansolino, L.; Clerici, A.M. [Laboratory of Experimental Surgery, Department of Surgery, University of Pavia, Pavia (Italy)

    2011-07-01

    The thermal column of the TRIGA Mark II reactor of the Pavia University is used as an irradiation facility to perform biological tests and irradiations of living systems for Boron Neutron Capture Therapy (BNCT) research. The suitability of the facility has been ensured by studying the neutron flux and the photon background in the irradiation chamber inside the thermal column. This characterization has been realized both by flux and dose measurements as well as by Monte Carlo simulations. The routine irradiations concern in vitro cells cultures and different tumor animal models to test the efficacy of the BNCT treatment. Some results about these experiments will be described. (author)

  17. Modeling and Simulation Monte Carlo by the MCNP code for determining neutron parameters of the nuclear reactor-subcritical assembly in CNSTN

    International Nuclear Information System (INIS)

    Romdhani, Ibtissem

    2014-01-01

    As part of developing its nuclear infrastructure base, the National Science and Technology Center Nuclear (CNSTN) examines the technical feasibility of setting up a new installation of subcritical assembly. Our study focuses on determining the neutron parameters of a nuclear zero power reactor based on Monte Carlo simulation MCNP. The objective of the simulation is to model the installation, determine the effective multiplication factor, and spatial distribution of neutron flux.

  18. Validation of dose planning calculations for boron neutron capture therapy using cylindrical and anthropomorphic phantoms

    Energy Technology Data Exchange (ETDEWEB)

    Koivunoro, Hanna; Seppaelae, Tiina; Uusi-Simola, Jouni; Merimaa, Katja; Savolainen, Sauli [Department of Physics, POB 64, FI-00014 University of Helsinki (Finland); Kotiluoto, Petri; Seren, Tom; Auterinen, Iiro [VTT Technical Research Centre of Finland, Espoo, POB 1000, FI-02044 VTT (Finland); Kortesniemi, Mika, E-mail: hanna.koivunoro@helsinki.f [HUS Helsinki Medical Imaging Center, University of Helsinki, POB 340, FI-00029 HUS (Finland)

    2010-06-21

    In this paper, the accuracy of dose planning calculations for boron neutron capture therapy (BNCT) of brain and head and neck cancer was studied at the FiR 1 epithermal neutron beam. A cylindrical water phantom and an anthropomorphic head phantom were applied with two beam aperture-to-surface distances (ASD). The calculations using the simulation environment for radiation application (SERA) treatment planning system were compared to neutron activation measurements with Au and Mn foils, photon dose measurements with an ionization chamber and the reference simulations with the MCNP5 code. Photon dose calculations using SERA differ from the ionization chamber measurements by 2-13% (disagreement increased along the depth in the phantom), but are in agreement with the MCNP5 calculations within 2%. The {sup 55}Mn(n,{gamma}) and {sup 197}Au(n,{gamma}) reaction rates calculated using SERA agree within 10% and 8%, respectively, with the measurements and within 5% with the MCNP5 calculations at depths >0.5 cm from the phantom surface. The {sup 55}Mn(n,{gamma}) reaction rate represents the nitrogen and boron depth dose within 1%. Discrepancy in the SERA fast neutron dose calculation (of up to 37%) is corrected if the biased fast neutron dose calculation option is not applied. Reduced voxel cell size ({<=}0.5 cm) improves the SERA calculation accuracy on the phantom surface. Despite the slight overestimation of the epithermal neutrons and underestimation of the thermal neutrons in the beam model, neutron calculation accuracy with the SERA system is sufficient for reliable BNCT treatment planning with the two studied treatment distances. The discrepancy between measured and calculated photon dose remains unsatisfactorily high for depths >6 cm from the phantom surface. Increasing discrepancy along the phantom depth is expected to be caused by the inaccurately determined effective point of the ionization chamber.

  19. Design study of a medical proton linac for neutron therapy

    International Nuclear Information System (INIS)

    Machida, S.; Raparia, D.

    1988-01-01

    This paper describes a design study which establishes the physical parameters of the low energy beam transport, radiofrequency quadrupole, and linac, using computer programs available at Fermilab. Beam dynamics studies verify that the desired beam parameters can be achieved. The machine described here meets the aforementioned requirements and can be built using existing technology. Also discussed are other technically feasible options which could be attractive to clinicians, though they would complicate the design of the machine and increase construction costs. One of these options would allow the machine to deliver 2.3 MeV protons to produce epithermal neutrons for treating brain tumors. A second option would provide 15 MeV protons for isotope production. 21 refs., 33 figs

  20. Nuclear Physics meets Medicine and Biology: Boron Neutron Capture Therapy

    CERN Document Server

    F. Ballarini, F; S. Bortolussi, S; P. Bruschi, P; A.M. Clerici, A M; A. De Bari, A; P. Dionigi, P; C. Ferrari, C; M.A. Gadan, M A; N. Protti, N; S. Stella, S; C. Zonta, C; A. Zonta, A; S. Altieri, S

    2010-01-01

    BNCT is a tumour treatment based on thermal-neutron irradiation of tissues enriched with 10B, which according to the 10B(n, )7Li reaction produces particles with high Linear Energy Transfer and short range. Since this treatment can deliver a therapeutic tumour dose sparing normal tissues, BNCT represents an alternative for diffuse tumours and metastases, which show poor response to surgery and photontherapy. In 2001 and 2003, in Pavia BNCT was applied to an isolated liver, which was infused with boron, explanted, irradiated and re-implanted. A new project was then initiated for lung tumours, developing a protocol for Boron concentration measurements and performing organ-dose Monte Carlo calculations; in parallel, radiobiology studies are ongoing to characterize the BNCT effects down to cellular level. After a brief introduction, herein we will present the main activities ongoing in Pavia including the radiobiological ones, which are under investigation not only experimentally but also theoretically, basing on...

  1. Control system specification for a cyclotron and neutron therapy facility

    International Nuclear Information System (INIS)

    Jacky, J.; Risler, R.; Kalet, I.; Wootton, P.; Barke, A.; Brossard, S.; Jackson, R.

    1991-01-01

    It is usually considered an essential element of good practice in engineering to produce a specification for a system before building it. However, it has been found to be quite difficult to produce useful specifications of large software systems. The authors have nearly completed a comprehensive specification for the computer control system of a cyclotron and treatment facility that provides particle beams for cancer treatments with fast neutrons, production of medical isotopes, and physics experiments. They describe the control system as thoroughly as is practical using standard technical English, supplemented by tables, diagrams, and some algebraic equations. This specification comprises over 300 single-spaced pages. A more precise and compact specification might be achieved by making greater use of formal mathematical notations instead of English. They have begun work on a formal specification of the system, using the Z and Petri net notations

  2. Burnable absorber-integrated Guide Thimble (BigT) - 1. Design concepts and neutronic characterization on the fuel assembly benchmarks

    International Nuclear Information System (INIS)

    Yahya, Mohd-Syukri; Yu, Hwanyeal; Kim, Yonghee

    2016-01-01

    This paper presents the conceptual designs of a new burnable absorber (BA) for the pressurized water reactor (PWR), which is named 'Burnable absorber-integrated Guide Thimble' (BigT). The BigT integrates BA materials into standard guide thimble in a PWR fuel assembly. Neutronic sensitivities and practical design considerations of the BigT concept are points of highlight in the first half of the paper. Specifically, the BigT concepts are characterized in view of its BA material and spatial self-shielding variations. In addition, the BigT replaceability requirement, bottom-end design specifications and thermal-hydraulic considerations are also deliberated. Meanwhile, much of the second half of the paper is devoted to demonstrate practical viability of the BigT absorbers via comparative evaluations against the conventional BA technologies in representative 17x17 and 16x16 fuel assembly lattices. For the 17x17 lattice evaluations, all three BigT variants are benchmarked against Westinghouse's existing BA technologies, while in the 16x16 assembly analyses, the BigT designs are compared against traditional integral gadolinia-urania rod design. All analyses clearly show that the BigT absorbers perform as well as the commercial BA technologies in terms of reactivity and power peaking management. In addition, it has been shown that sufficiently high control rod worth can be obtained with the BigT absorbers in place. All neutronic simulations were completed using the Monte Carlo Serpent code with ENDF/B-VII.0 library. (author)

  3. Gadolinium as an element for neutron capture therapy

    International Nuclear Information System (INIS)

    Brugger, R.M.; Liu, H.B.; Laster, B.H.; Gordon, C.R.; Greenberg, D.D.; Warkentien, L.S.

    1992-01-01

    At BNL, preparations are being made to test in vitro compounds containing Gd and compare their response to the response of GD-DTPA to determine if one or several compounds can be located that enter the cells and enhance the Auger effect. Two similar rotators with positions for cell vials that have been constructed for these tests. The first rotator is made of only paraffin which simulates healthy tissue and provides control curves. The second rotator has 135 ppM of Gd-157 in the paraffin to simulate a Gd loaded tumor. Cells are irradiated in vials in the paraffin rotator and in the Gd-paraffin rotator at the epithermal beam of the Brookhaven Medical Research Reactor (BMRR). This produces an irradiation similar to what a patient would receive In an actual treatment. A combination of irradiations are made with both rotators; with no Gd compound or IdUrd In the cell media, with only Gd compound in the cell media and with both Gd compound and IdUrd in the cell media. The first set shows the effects of gamma rays from the H(n,gamma) reaction and the prompt gamma rays from capture of neutrons by Gd. The second set shows if there is any effect of Gd being in the cell media or inside the cells, i.e., an Auger effect. The third set shows the effect of enhancement by the IdUrd produced by the gamma rays from neutrons captured by either H or Gd. The fourth set combines all of the reactions and enhancements. Preliminary calculations and physical measurements of the doses that the cells will receive In these rotators have been made

  4. CYCLONE. Neutron therapy facility at Louvain-la-Neuve

    International Nuclear Information System (INIS)

    Meulders, J.P.; Saedeleer, G. de; Winant, M.; Wambersie, A.

    1979-01-01

    The neutrontherapy program at Louvain-la-Neuve is carried out with the cyclotron CYCLONE of the Catholic University. This isochronous variable energy cyclotron, produced by CSF (Corbeville, France), accelerates different types of charged particles; in particular, deuterons can be accelerated at energies ranging from 13 to 50 MeV. Neutrons used for therapeutic applications are produced by bombarding a thick (10 mm) water cooled, Beryllium target with 50 MeV deuterons. A beam current of about 5 μA is used for patient treatments, which produces dose rates of about 0,5 Gy/min at a target-skin-distance (TSD) of 157 cm. The treatment room, and related medical facilities, are located one level below the main level of the cyclotron. This permits the use of a vertical therapeutic neutron beam by bending the deuteron beam at 90 0 . This vertical beam appears to be more adequate for positioning the majority of the patients. The collimation system consists of a fixed shielding and of a series of interchangeable inserts. The inserts are cylindrical in shape; their height is 80 cm and their external diameter 40 cm. The proximal part (50 cm) is a mixture of iron (equivalent thickness 22 cm) and epoxy, and the distal part (30 cm) is a mixture (50%) of borax and epoxy. The emphasis is made on the radioprotection conditions. A series of measurements made in the treatment room and in the entry maze have shown that their special configuration provides a satisfactory protection of the staff. (author)

  5. A study on measurement of neutrons generated in radiation therapy – Measurement of neurons in CR-39 detection method

    International Nuclear Information System (INIS)

    Park, Cheol-Soo; Cho, Jae-Hwan; Lee, Hae-Kag; Lee, Sun-Yeob; Jang, Hyon-Chol; Dong, Kyung-Rae; Chung, Woon-Kwan; Jin, Lee; Moon, Deog-Hwan; Lee, Kwang-Sung; Yang, Nam-Oh; Cho, Moo-Seong

    2013-01-01

    Highlights: ► To measure the neutrons generated in a linear accelerator. ► Both fast neutrons and thermal neutrons produced an increase in the dose of neutrons generated with increasing irradiation dose. ► The generation of neutrons increased when a wedge filter was used. ► When the SRS cone that required a high dose was used, more neutrons were detected. -- Abstract: The CR-39 [diethylene glycol bis-(allylcarbonate)] neuron detection method was used to measure the dose of neutrons generated in X-ray (photon) therapy conducted in a linear accelerator, and to use high-energy photons as part of the clinical applications to examine the problems associated with the dose for patients caused by the generation of neutrons from high-energy photons used for cancer therapy. According to the experimental results, 0.35 mSv, 0.65 mSv 1.82 mSv of fast neutrons on average were generated from 1 Gy, 2 Gy and 5 Gy of photon irradiation, respectively, whereas 0.26 mSv, 0.56 mSv and 1.23 mSv of thermal neutrons were generated. Both fast neutrons and thermal neutrons produced an increase in the dose of neutrons generated with increasing irradiation dose. With in regard to the dose generated within and around the irradiation area of the photon rays, it was confirmed that more neutrons were generated within the irradiation area. A wedge filer was used to measure the generation of neutrons. According to the measurement results, the generation of neutrons increased when a wedge filter was used. When the SRS cone that required a high dose was used, more neutrons were detected than those in the previous experiment. When fast neutrons were used, 2.85 mSv neutrons on average were generated from 5 Gy of photon irradiation. When thermal neutrons were used, 1.37 mSv neutrons on average were generated from 5 Gy of photon irradiation. Overall, approximately 1.6 times and 1.12 times more fast and thermal neutrons, respectively, were generated than in the case of a general treatment with 5 Gy

  6. Fast neutron therapy for squamous cell carcinoma in the head and neck region: results of a randomized trial

    International Nuclear Information System (INIS)

    Duncan, W.; Orr, J.A.; Arnott, S.J.; Jack, W.J.; Kerr, G.R.; Williams, J.R.

    1987-01-01

    A randomized trial of fast neuron therapy compared with 4MV photons for patients with head and neck cancer is reported. One hundred and sixty-eight patients were recruited between 1977 and 1984. The minimum follow-up is 2 years. Three patients were withdrawn before treatment began. Eighty-five were allocated to neutron therapy and 80 to receive photon therapy. All patients had squamous cell cancers in one of four primary sites: oral cavity, oropharynx, larynx, and hypopharynx. Local tumor control was similar in both groups: 44.7% after neutrons and 45.0% after photons. Salvage surgery was performed on 18 patients in each treatment group for residual or recurrent cancer. Acute radiation reactions of the mucous membranes were significantly more severe after photons. The number of patients with serious late reactions was greater after neutron therapy but the difference was not statistically significant. There were six deaths related to late morbidity after neutron therapy but none after photon therapy. Survival was better after photon therapy but the difference compared with the neutron group failed to reach statistical significance. When intercurrent deaths are excluded, the difference is less marked. Photon therapy was clearly better in terms of disease-free survival giving a 2-year local disease-free rate of 41.3% (s.e. 5.5%) compared with 29.4% (s.e. 4.9%) after neutrons

  7. Analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer

    International Nuclear Information System (INIS)

    Duncan, W.; Williams, J.R.; Kerr, G.R.; Arnott, S.J.; Quilty, P.M.; Rodger, A.; MacDougall, R.H.; Jack, W.J.

    1986-01-01

    This report is an analysis of the morbidity in the bladder and bowel observed in a randomized trial of d(15)+Be neutrons versus megavoltage photons in the treatment of bladder cancer. Acute reactions in the bladder and bowel were significantly worse after photon therapy. Of the patients treated with photons 45.7% had severe reactions in the bladder compared with 10.6% after neutron therapy (p less than 0.001). Severe acute bowel reactions were observed in 8.5% of the patients after photon therapy compared with 3.8% after neutron therapy (p less than 0.05). Late reactions were significantly worse after neutrons. Severe late reactions in the bladder were seen in 58.5% of patients after neutron therapy and in 40.5% after photon therapy (p less than 0.05). In the bowel they were observed in 53.3% of patients after neutron therapy compared with 8% after photon therapy (p less than 0.0001). The disparity in the degree of early and late complications makes assessment of RBE values difficult. It is estimated that for bladder morbidity the RBE value, for photon dose fractions of 2.75 Gy, is less than 3.3 for early reactions and equal to 3.4 for late effects. The respective RBE values for early and late effects in the bowel are less than 3.4 and 3.8

  8. Integral test of International Reactor Dosimetry and Fusion File with Li{sub 2}O assembly and DT neutron source at JAEA/FNS

    Energy Technology Data Exchange (ETDEWEB)

    Sato, Satoshi, E-mail: sato.satoshi92@jaea.go.jp [Japan Atomic Energy Agency, Tokai-mura, Naka-gun, Ibaraki-ken (Japan); Kwon, Saerom; Ohta, Masayuki [Japan Atomic Energy Agency, Tokai-mura, Naka-gun, Ibaraki-ken (Japan); Ochiai, Kentaro [Japan Atomic Energy Agency, Rokkasho-mura, Kamikita-gun, Aomori-ken (Japan); Konno, Chikara [Japan Atomic Energy Agency, Tokai-mura, Naka-gun, Ibaraki-ken (Japan)

    2016-11-01

    In order to validate a new library of dosimetry cross section data, International Reactor Dosimetry and Fusion File release 1.0 (IRDFF 1.0), not only for DT neutrons but also for neutrons with energy of less than 14 MeV, we perform an integral test with a Li{sub 2}O rectangular assembly of 60.7 cm in thickness and a DT neutron source at JAEA/FNS. We place a lot of activation foils at depths of 10.1 cm and 30.4 cm for measurements of dosimetry reaction rates in small space along the central axis in the assembly, measure decay gamma-rays from the activation foils with high-purity Ge detectors after the DT neutron irradiation by the foil activation technique, and deduce a variety of dosimetry reaction rates. We calculate the reaction rates by using a Monte Carlo code MCNP5-1.40 and the nuclear data library ENDF/B-VII.1 with the IRDFF-v.1.05 as the response functions for the dosimetry reactions. The calculation results generally show good agreements with the measured ones, and it can be confirmed that most of the data in IRDFF-v.1.05 are valid for the neutron field in the Li{sub 2}O assembly with the DT neutrons.

  9. Report of a randomized trial of d(15)+Be neutrons compared with megavoltage X ray therapy of bladder cancer

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.; Jack, W.J.; MacDougall, R.H.; Quilty, P.M.; Rodger, A.; Kerr, G.R.; Williams, J.R.

    1985-01-01

    The results of a randomized trial of d(15)+Be neutrons compared with 4 or 6 MV photons for the treatment of transitional cell carcinoma of the bladder. Between December 1978 and December 1981, 113 patients were accrued, 53 allocated to be treated by neutrons and 60 by photons. Complete local tumor regression was observed in 64% of patients treated by neutrons and 62% treated by photons. Recurrent cancer was subsequently confirmed in 31% of patients, similar in both treatment groups. There was no significant difference in the control rates by T stage between the two treatment groups. Late morbidity was significantly worse in patients treated by neutrons. Following neutron therapy, 78% of patients had serious late morbidity in at least one tissue compared with 38% in the group treated by photons. Survival was significantly better in the photon treated group 45.3% (+/- 11%) at 5 years compared with 12% (+/- 6%) after neutron therapy

  10. Novel technologies and theoretical models in radiation therapy of cancer patients using 6.3 MeV fast neutrons produced by U-120 cyclotron

    Energy Technology Data Exchange (ETDEWEB)

    Musabaeva, L. I., E-mail: musabaevaLI@oncology.tomsk.ru; Lisin, V. A., E-mail: Lisin@oncology.tomsk.ru [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation); Startseva, Zh. A., E-mail: zhanna.alex@rambler.ru; Gribova, O. V., E-mail: gribova79@mail.ru; Velikaya, V. V., E-mail: viktoria.v.v@inbox.ru [Tomsk Cancer Research Institute, Kooperativny Street 5, Tomsk, 634050 (Russian Federation); National Research Tomsk Polytechnic University, Lenin Avenue 30, Tomsk, 634050 (Russian Federation)

    2016-08-02

    The analysis of clinical use of neutron therapy with 6 MeV fast neutrons compared to conventional radiation therapy was carried out. The experience of using neutron and mixed neutron and photon therapy in patients with different radio-resistant malignant tumors shows the necessity of further studies and development of the novel approaches to densely-ionizing radiation. The results of dosimetry and radiobiological studies have been the basis for planning clinical programs for neutron therapy. Clinical trials over the past 30 years have shown that neutron therapy successfully destroys radio-resistant cancers, including salivary gland tumors, adenoidcystic carcinoma, inoperable sarcomas, locally advanced head and neck tumors, and locally advanced prostate cancer. Radiation therapy with 6.3 MeV fast neutrons used alone and in combination with photon therapy resulted in improved long-term treatment outcomes in patients with radio-resistant malignant tumors.

  11. Stepwise evolution of fuel assembly design toward a sustainable fuel cycle with hard neutron spectrum light water reactors

    International Nuclear Information System (INIS)

    Uchikawa, Sadao; Okubo, Tsutomu; Nakano, Yoshihiro

    2011-01-01

    An advanced LWR with hard neutron spectrum, FLWR, aims at efficient and flexible utilization of nuclear resources by evolving its fuel assembly design keeping the same core configuration. A proposed evolution process of the design toward a sustainable fuel cycle is composed of three stages, the first one based on the LWR fuel cycle infrastructures, the second one for transitioning from the LWR fuel cycle to the FR fuel cycle, and the third one based on the FR fuel cycle infrastructures. For the first stage, a fuel assembly design concept named FLWR/MIX has been developed in which enriched UO 2 fuel rods are arranged in the peripheral region of the assembly, surrounding the MOX fuel rods in the central region. The FLWR/MIX design realizes a breeder type operation under the framework of the LWR-MOX technologies and there experience. A modified FLWR/MIX design with low Pu inventory for the second stage has a potential of high Puf conversion ratio of 1.1 and can contribute to smooth and speedy transition from the LWR fuel cycle to the FR fuel cycle. For the third stage, the FLWR/MIX design is extended into a design with natural UO 2 fuel rods to realize multiple Pu recycling keeping a Puf conversion ratio of around 1.0. (author)

  12. Time-of-flight techniques applied to neutron spectra measurements in fast subcritical assemblies

    International Nuclear Information System (INIS)

    Rotival, Michel

    1975-04-01

    Time-of-flight measurements on Uranium-Graphite assemblies were performed using the BCMN linear accelerator. Methods to provide scalar spectra averaged over a core cell from these experimental results are described [fr

  13. Neutron production with a pyroelectric double-crystal assembly without nano-tip

    Energy Technology Data Exchange (ETDEWEB)

    Tornow, W., E-mail: tornow@tunl.duke.ed [Department of Physics, Duke University and Triangle Universities Nuclear Laboratory, Durham, NC 27708-0308 (United States); Corse, W. [Department of Physics, Duke University and Triangle Universities Nuclear Laboratory, Durham, NC 27708-0308 (United States); Crimi, S. [Harriet L. Wilkes Honors College, Florida Atlantic University, Jupiter, FL 33458 (United States); Fox, J. [Department of Physics, Duke University and Triangle Universities Nuclear Laboratory, Durham, NC 27708-0308 (United States)

    2010-12-21

    Two cylindrical LiTaO{sub 3} crystals facing each other's deuterated circular face were exposed to deuterium gas at an ambient pressure of a few mTorr. With a distance of about 4 cm between the z{sup +} and z{sup -} cut crystal faces, neutrons were produced via the {sup 2}H(d,n){sup 3}He fusion reaction upon the heating and cooling of the crystals. The 2.5 MeV neutrons were detected with organic liquid scintillation detectors equipped with neutron-gamma pulse-shape discrimination electronics to reject pulses generated by the intense X-ray flux. During the cooling phase of naked crystals, deuterium ion-beam (D{sub 2}{sup +}) energies of up to 400 keV were obtained as deduced from the associated electron bremsstrahlung end-point energy. The highest electron-beam energy observed during the heating phase was 360 keV. With a layer of deuterated polyethylene evaporated on the front face of the crystals, the maximal energies were about 10% lower. In contrast to earlier studies, an electric-field enhancing nano-tip was not employed. Neutron yields up to 500 per thermal cycle were observed, resulting in a total neutron production yield of about 1.6x10{sup 4} neutrons per thermal cycle. Our approach has the potential of being substantially improved by reducing the frequency of the discharges we are currently experiencing with our geometry, which was not designed for the unprecedented high potentials produced in the presentwork.

  14. Monte Carlo treatment planning and high-resolution alpha-track autoradiography for neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Zamenhof, R.G.; Lin, K.; Ziegelmiller, D.; Clement, S.; Lui, C.; Harling, O.K.

    Monte Carlo simulations of thermal neutron flux distributions in a mathematical head model have been compared to experimental measurements in a corresponding anthropomorphic gelatin-based head phantom irradiated by a thermal neutron beam as presently available at the MITR-II Research Reactor. Excellent agreement between Monte Carlo and experimental measurements has encouraged us to employ the Monte Carlo simulation technique to approach treatment planning problems in neutron capture therapy. We have also implemented a high-resolution alpha-track autoradiography technique originally developed in our laboratory at MIT. Initial autoradiograms produced by this technique meet our expectations in terms of the high resolution available and the ability to etch tracks without concommitant destruction of stained tissue. Our preliminary results with computer-aided track distribution analysis indicate that this approach is very promising in being able to quantify boron distributions in tissue at the subcellular level with a minimum amount of operator effort necessary.

  15. Neutron, Proton, and Photonuclear Cross Sections for Radiation Therapy and Radiation Protection

    International Nuclear Information System (INIS)

    Chadwick, M.B.

    1998-01-01

    The authors review recent work at Los Alamos to evaluate neutron, proton, and photonuclear cross section up to 150 MeV (to 250 MeV for protons), based on experimental data and nuclear model calculations. These data are represented in the ENDF format and can be used in computer codes to simulate radiation transport. They permit calculations of absorbed dose in the body from therapy beams, and through use of kerma coefficients allow absorbed dose to be estimated for a given neutron energy distribution. For radiation protection, these data can be used to determine shielding requirements in accelerator environments, and to calculate neutron, proton, gamma-ray, and radionuclide production. Illustrative comparisons of the evaluated cross section and kerma coefficient data with measurements are given

  16. Boron neutron capture therapy for malignant brain tumor and future potential

    International Nuclear Information System (INIS)

    Nakagawa, Yoshinobu; Hatanaka, Hiroshi.

    1994-01-01

    This paper presents therapeutic experience with boron neutron capture therapy (BNCT) for malignant brain tumors. Nine patients who survived for 10 years or more as of 1986 are given in a table. A review of the 9 patients concluded that physical dose of 15 Gy is required. In addition, the following factors are defined to be the most important: (1) to determine tumor size and depth as accurately as possible, (2) to measure neutron doses in the deepest site of the tumor during irradiation, (3) to measure the content of boron within the tumor, and to deliver neutron beams as deeply as possible. Finally, the importance of knowing RBE of alpha particles for tumor cells of the human brain is emphasized. (N.K.)

  17. Design status of an intense 14 MeV neutron source for cancer therapy

    CERN Document Server

    Yao, Z E; Cheng, S W; Jia, W B

    2002-01-01

    Design and development of an intense 14 MeV neutron source for cancer therapy is in progress at the Institute of Nuclear Research of Lanzhou University. The neutrons from the T(d,n) sup 4 He reaction are produced by bombarding a rotating titanium tritide target with a 40 mA deuteron beam at 600 keV. The designed neutron yield is 8x10 sup 1 sup 2 n/s and the maximum dose rate at a 100 cm source-to-skin distance is 25 cGy/min. The HV terminal, accelerating column and HV power supply are enclosed inside a stainless steel pressure vessel containing 6 atm SF sub 6 gas to provide the electrical insulation.

  18. Radiation protection metrology at a high-energy neutron therapy facility

    International Nuclear Information System (INIS)

    Bonnett, D.E.; Sherwin, A.G.; More, B.R.

    1991-01-01

    A radiation protection survey has been carried out at a high-energy neutron therapy facility using a combination of different detectors and counters. Included in the survey were measurements with a tissue equivalent proportional counter (TEPC), a rem meter, a large volume ionisation chamber (LVI) and a Geiger counter. Dose equivalent rates, normalised to a proton beam current of 25 μA, of between 1 μSv.h -1 and 0.7 Sv.h -1 were recorded depending on the location. In general the results confirm the tendency of the rem meter to over-read in fields consisting mainly of low energy neutrons and illustrate the advantages of the diagnostic and gamma discriminating properties of the TEPC. The LVI-Geiger system was found to be the least favourable combination of dosemeters, substantially under-reading and being unable to estimate the neutron dose rate at levels below about 32 μGy.h -1 . (author)

  19. Conception of a New Recoil Proton Telescope for Real-Time Neutron Spectrometry in Proton-Therapy

    Science.gov (United States)

    Combe, Rodolphe; Arbor, Nicolas; el Bitar, Ziad; Higueret, Stéphane; Husson, Daniel

    2018-01-01

    Neutrons are the main type of secondary particles emitted in proton-therapy. Because of the risk of secondary cancer and other late occurring effects, the neutron dose should be included in the out-of-field dose calculations. A neutron spectrometer has to be used to take into account the energy dependence of the neutron radiological weighting factor. Due to its high dependence on various parameters of the irradiation (beam, accelerator, patient), the neutron spectrum should be measured independently for each treatment. The current reference method for the measurement of the neutron energy, the Bonner Sphere System, consists of several homogeneous polyethylene spheres with increasing diameters equipped with a proportional counter. It provides a highresolution reconstruction of the neutron spectrum but requires a time-consuming work of signal deconvolution. New neutron spectrometers are being developed, but the main experimental limitation remains the high neutron flux in proton therapy treatment rooms. A new model of a real-time neutron spectrometer, based on a Recoil Proton Telescope technology, has been developed at the IPHC. It enables a real-time high-rate reconstruction of the neutron spectrum from the measurement of the recoil proton trajectory and energy. A new fast-readout microelectronic integrated sensor, called FastPixN, has been developed for this specific purpose. A first prototype, able to detect neutrons between 5 and 20 MeV, has already been validated for metrology with the AMANDE facility at Cadarache. The geometry of the new Recoil Proton Telescope has been optimized via extensive Geant4 Monte Carlo simulations. Uncertainty sources have been carefully studied in order to improve simultaneously efficiency and energy resolution, and solutions have been found to suppress the various expected backgrounds. We are currently upgrading the prototype for secondary neutron detection in proton therapy applications.

  20. A theoretical model for the production of Ac-225 for cancer therapy by neutron capture transmutation of Ra-226.

    Science.gov (United States)

    Melville, G; Melville, P

    2013-02-01

    Radium needles that were once implanted into tumours as a cancer treatment are now obsolete and constitute a radioactive waste problem, as their half-life is 1600 years. We are investigating the reduction of radium by transmutation by bombarding Ra-226 with high-energy neutrons from a neutron source to produce Ra-225 and hence Ac-225, which can be used as a generator to produce Bi-213 for use in 'Targeted Alpha Therapy' for cancer. This paper examines the possibility of producing Ac-225 by neutron capture using a theoretical model in which neutron energy is convoluted with the corresponding neutron cross sections of Ra-226. The total integrated yield can then be obtained. This study shows that an intense beam of high-energy neutrons could initiate neutron capture on Ra-226 to produce Ra-225 and hence practical amounts of Ac-225 and a useful reduction of Ra-226. Copyright © 2012 Elsevier Ltd. All rights reserved.

  1. Neutron transport assembly calculation with non-zero net current boundary condition

    International Nuclear Information System (INIS)

    Jo, Chang Keun

    1993-02-01

    Fuel assembly calculation for the homogenized group constants is one of the most important parts in the reactor core analysis. The homogenized group constants of one a quarter assembly are usually generated for the nodal calculation of the reactor core. In the current nodal calculation, one or a quarter of the fuel assembly corresponds to a unit node. The homogenized group constant calculation for a fuel assembly proceeds through cell spectrum calculations, group condensation and cell homogenization calculations, two dimensional fuel assembly calculation, and then depletion calculations of fuel rods. To obtain the assembly wise homogenized group constants, the two dimensional transport calculation is usually performed. Most codes for the assembly wise homogenized group constants employ a zero net current boundary condition. CASMO-3 is such a code that is in wide use. The zero net current boundary condition is plausible and valid in an infinite reactor composed of the same kind of assemblies. However, the reactor is finite and the core is constructed by different kinds of assemblies. Hence, the assumption of the zero net current boundary condition is not valid in the actual reactor. The objective of this study is to develop a homogenization methodology that can treat any actual boundary condition, i.e. non-zero net current boundary condition. In order to treat the non-zero net current boundary condition, we modify CASMO-3. For the two-dimensional treatment in CASMO-3, a multigroup integral transport routine based on the method of transmission probability is used. The code performs assembly calculation with zero net current boundary condition. CASMO-3 is modified to consider the inhomogeneous source at the assembly boundary surface due to the non-zero net current. The modified version of CASMO-3 is called CASMO-3M. CASMO-3M is applied to several benchmark problems. In order to obtain the inhomogeneous source, the global calculation is performed. The local calculation

  2. Silicon diode measurements for monoenergetic neutrons and critical assemblies (H.P.R.R. and VIPER)

    International Nuclear Information System (INIS)

    Delafield, H.J.; Reading, A.H.

    1981-04-01

    The response of the silicon diode (AEI FNDD1) has been measured for monoenergetic neutrons of mean energies 0.56, 2.00 and 3.68 MeV. Using conversion factors from neutron fluence to kerma (ICRU, 1977) it is shown that the theoretical kerma response in muscle tissue is substantially uniform (+- 20%) over the neutron energy range from 250 keV to 17 MeV. Diode measurements were made at the Health Physics Research Reactor at the Oak Ridge National Laboratory, Tennessee, U.S.A., during the 1979 international intercomparison of nuclear accident dosimetry systems. Measurements of kerma in free air and of the surface absorbed dose on the front surface of a phantom were made with the reactor bare, shielded by 20 cm concrete and by 5 cm steel. Further tests were made at the VIPER reactor at AWRE. These diode measurements, covering a range of neutron spectra, were in good agreement (+- 20%) with measurements made by the threshold detector system. (author)

  3. Monte Carlo assessment of boron neutron capture therapy for the treatment of breast cancer

    Directory of Open Access Journals (Sweden)

    Mundy Daniel W.

    2005-01-01

    Full Text Available For a large number of women who are diagnosed with breast cancer every year the avail able treatment options are effective, though physically and mentally taxing. This work is a starting point of a study of the efficacy of boron neutron capture therapy as an alternative treatment for HER-2+ breast tumors. Using HER-2-specific monoclonal anti bodies coupled with a boron-rich oligomeric phosphate diester, it may be possible to deliver sufficient amounts of 10B to a tumor of the breast to al low for selective cell destruction via irradiation by thermal neutrons. A comprehensive computational model (MCNP for thermal neutron irradiation of the breast is described, as well as the results of calculations made using this model, in order to determine the optimum boron concentration within the tumor for an effective boron neutron capture therapy treatment, as compared with traditional X-ray radiotherapy. The results indicate that a boron concentration of 50-60 mg per gram of tumor tissue is optimal when considering treatment times, dose distributions and skin sparing. How ever these results are based upon best-guess assumptions that must be experimentally verified.

  4. Monte Carlo calculations of lung dose in ORNL phantom for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Krstic, D.; Markovic, V.M.; Jovanovic, Z.; Milenkovic, B.; Nikezic, D.; Atanackovic, J.

    2014-01-01

    Monte Carlo simulations were performed to evaluate dose for possible treatment of cancers by boron neutron capture therapy (BNCT). The computational model of male Oak Ridge National Laboratory (ORNL) phantom was used to simulate tumours in the lung. Calculations have been performed by means of the MCNP5/X code. In this simulation, two opposite neutron beams were considered, in order to obtain uniform neutron flux distribution inside the lung. The obtained results indicate that the lung cancer could be treated by BNCT under the assumptions of calculations. The difference in evaluated dose in cancer and normal lung tissue suggests that BNCT could be applied for the treatment of cancers. The difference in exposure of cancer and healthy tissue can be observed, so the healthy tissue can be spared from damage. An absorbed dose ratio of metastatic tissue-to-the healthy tissue was ∼5. Absorbed dose to all other organs was low when compared with the lung dose. Absorbed dose depth distribution shows that BNC therapy can be very useful in the treatments for tumour. The ratio of the tumour absorbed dose and irradiated healthy tissue absorbed dose was also ∼5. It was seen that an elliptical neutron field was better irradiation choice. (authors)

  5. Comparison of Out-Of-Field Neutron Equivalent Doses in Scanning Carbon and Proton Therapies for Cranial Fields

    DEFF Research Database (Denmark)

    Athar, B.; Henker, K.; Jäkel, O.

    2010-01-01

    Purpose: The purpose of this analysis is to compare the secondary neutron lateral doses from scanning carbon and proton beam therapies. Method and Materials: We simulated secondary neutron doses for out-of-field organs in an 11-year old male patient. Scanned carbon and proton beams were simulated...

  6. A new method to measure the U-235 content in fresh LWR fuel assemblies via fast-neutron passive self-interrogation

    Science.gov (United States)

    Menlove, Howard; Belian, Anthony; Geist, William; Rael, Carlos

    2018-01-01

    The purpose of this paper is to provide a solution to a decades old safeguards problem in the verification of the fissile concentration in fresh light water reactor (LWR) fuel assemblies. The problem is that the burnable poison (e.g. Gd2O3) addition to the fuel rods decreases the active neutron assay for the fuel assemblies. This paper presents a new innovative method for the verification of the 235U linear mass density in fresh LEU fuel assemblies that is insensitive to the burnable poison content. The technique makes use of the 238U atoms in the fuel rods to self-interrogate the 235U mass. The innovation for the new approach is that the 238U spontaneous fission (SF) neutrons from the rods induces fission reactions (IF) in the 235U that are time correlated with the SF source neutrons. Thus, the coincidence gate counting rate benefits from both the nu-bar of the 238U SF (2.07) and the 235U IF (2.44) for a fraction of the IF reactions. Whereas, the 238U SF background has no time-correlation boost. The higher the detection efficiency, the higher the correlated boost because background neutron counts from the SF are being converted to signal doubles. This time-correlation in the IF signal increases signal/background ratio that provides a good precision for the net signal from the 235U mass. The hard neutron energy spectrum makes the technique insensitive to the burnable poison loading where a Cd or Gd liner on the detector walls is used to prevent thermal-neutron reflection back into the fuel assembly from the detector. We have named the system the fast-neutron passive collar (FNPC).

  7. Estimate of neutron secondary doses received by patients in proton therapy: cases of ophthalmologic treatments

    International Nuclear Information System (INIS)

    Martinetti, F.

    2009-12-01

    This research thesis aims at assessing doses due to secondary neutrons and received by the organs of a patient which are located outside of the treatment field. The study focused on ophthalmological treatments performed at the Orsay proton therapy centre. A 75 eV beam line model has first been developed with the MCNPX Monte Carlo code. Several experimental validations of this model have been performed: proton dose distribution in a water phantom, ambient equivalent dose due to secondary neutrons and neutron spectra in the treatment room, and doses deposited by secondary neutrons in an anthropomorphous phantom. Simulations and measurements are in correct agreement. Then, a numeric assessment of secondary doses received by the patient's organs has been performed by using a MIRD-type mathematical phantom. These doses have been computed for several organs: the non-treated eye, the brain, the thyroid, and other parts of the body situated either in the front part of the body (the one directly exposed to neutrons generated in the treatment line) or deeper and further from the treatment field

  8. Proton linac for hospital-based fast neutron therapy and radioisotope production

    International Nuclear Information System (INIS)

    Lennox, A.J.; Hendrickson, F.R.; Swenson, D.A.; Winje, R.A.; Young, D.E.

    1989-09-01

    Recent developments in linac technology have led to the design of a hospital-based proton linac for fast neutron therapy. The 180 microamp average current allows beam to be diverted for radioisotope production during treatments while maintaining an acceptable dose rate. During dedicated operation, dose rates greater than 280 neutron rads per minute are achievable at depth, DMAX = 1.6 cm with source to axis distance, SAD = 190 cm. Maximum machine energy is 70 MeV and several intermediate energies are available for optimizing production of isotopes for Positron Emission Tomography and other medical applications. The linac can be used to produce a horizontal or a gantry can be added to the downstream end of the linac for conventional patient positioning. The 70 MeV protons can also be used for proton therapy for ocular melanomas. 17 refs., 1 fig., 1 tab

  9. Analytical dosimetry for spontaneous tumor dogs receiving boron neutron capture therapy

    International Nuclear Information System (INIS)

    Wheeler, F.J.; Atkinson, C.A.; Gavin, P.R.

    1992-01-01

    The dog irradiation project of the Power Burst Facility/Boron Neutron Capture Therapy (PBF/BNCT) Program is administered by Washington State University (WSU) with analytical and physical dosimetry provided by the Idaho National Engineering Laboratory (INEL). One subtask of this project includes BNCT safety studies for dogs with spontaneously-occurring brain tumors. The boron compound (Na 2 B 12 H 11 SH or BSH) was administered and single irradiations performed using the epithermal-neutron beam at the Brookhaven Medical Research Reactor (BMRR). The main goal of the study was not to provide therapy, but to determine tumorcidal effect while administering a subtolerance dose to healthy tissue. Irradiation times were based on delivery of 19 Gy peak physical dose to the blood

  10. Boron neutron capture therapy for advanced and/or recurrent cancers in the oral cavity

    International Nuclear Information System (INIS)

    Ariyoshi, Yasunori; Shimahara, Masashi; Kimura, Yoshihiro; Miyatake, Shin-ichi; Kuroiwa, Toshihiko; Nagata, Kenji; Sakurai, Yoshinori; Maruhashi, Akira; Ono, Koji

    2006-01-01

    This preliminary study of 5 patients with advanced and/or recurrent cancer in the oral cavity was performed to evaluate the effectiveness of Boron Neutron Capture Therapy (BNCT). The patients received therapy with the 10 B-carrier p-boronophenylalanine (BPA) with or without borocaptate sodium (BSH) and irradiation thereafter with epithermal neutrons. All underwent 18 F-BPA PET studies before receiving BNCT to determine the accumulation ratios of BPA in tumor and normal tissues. The tumor mass was decreased in size and at minimum a transient partial response was achieved in all cases, though rapid tumor re-growth was observed in 2. Although tentative clinical responses and improvements in quality of life were recognized, obliteration of the tumor was not obtained in any of the cases. Additional studies are required to determine the utility and indication of BNCT for oral cancer. (author)

  11. Epithermal neutron beam design for neutron capture therapy at the Power Burst Facility and the Brookhaven Medical Research Reactor

    International Nuclear Information System (INIS)

    Wheeler, F.J.; Parsons, D.K.; Rushton, B.L.; Nigg, D.W.

    1990-01-01

    Nuclear design studies have been performed for two reactor-based epithermal neutron beams for cancer treatment by neutron capture therapy (NCT). An intermediate-intensity epithermal beam has been designed and implemented at the Brookhaven Medical Research Reactor (BMRR). Measurements show that the BMRR design predictions for the principal characteristics of this beam are accurate. A canine program for research into the biological effects of NCT is now under way at BMRR. The design for a high-intensity epithermal beam with minimal contamination from undesirable radiation components has been finalized for the Power Burst Facility (PBF) at the Idaho National Engineering Laboratory. This design will be implemented when it is determined that human NCT trials are advisable. The PBF beam will exhibit approximately an order of magnitude improvement in absolute epithermal flux intensity over that available in the BMRR, and its angular distribution and spectral characteristics will be more advantageous for NCT. The combined effects of beam intensity, angular distribution, spectrum, and contaminant level allow the desired tumor radiation dose to be delivered in much shorter times than are possible with the currently available BMRR beam, with a significant reduction (factor of 3 to 5) in collateral dose due to beam contaminants

  12. Stability of high-speed lithium sheet jets for the neutron source in Boron Neutron Capture Therapy (BNCT)

    International Nuclear Information System (INIS)

    Nakagawa, Masamichi; Takahashi, Minoru; Aritomi, Masanori; Kobayashi, Toru

    2014-01-01

    The stability of high-speed liquid lithium sheet jets was analytically studied for the neutron source in Boron Neutron Capture Therapy (BNCT), which makes cancers and tumors curable with cell-level selections and hence high QOL. The object of our research is to realize the thin and high-speed plane sheet jets of liquid lithium in a high-vacuum as an accelerator target. Linear analysis approach is made to the stability on thin plane sheet jets of liquid lithium in a high-vacuum, and then our analytical results were compared with the previous experimental ones. We proved that the waves of surface tension on thin lithium sheet jets in a high-vacuum are of supercritical flows and neutral stable under about 17.4 m/s in flow velocity and that the fast non-dispersive anti-symmetric waves are more significant than the very slow dispersive symmetric waves. We also formulated the equation of shrinking angle in isosceles-triangularly or isosceles-trapezoidal shrinking sheet jets corresponding to the Mach angle of supersonic gas flows. This formula states universally the physical meaning of Weber number of sheet jets on the wave of surface tension in supercritical flows. We obtained satisfactory prospects (making choice of larger flow velocity U and larger thickness of sheet a) to materialize a liquid target of accelerator in BNCT. (author)

  13. Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model

    Energy Technology Data Exchange (ETDEWEB)

    A. Monti Hughes; ECC Pozzi; S. Thorp; M. A. Garabalino; R. O. Farias; S. J. Gonzalez; E. M. Heber; M. E. Itoiz; R. F. Aromando; A. J. Molinari; M. Miller; D. W. Nigg; P. Curotto; V. A. Trivillin; A. E. Schwint

    2013-11-01

    Field-cancerized tissue can give rise to second primary tumours, causing therapeutic failure. Boron neutron capture therapy (BNCT) is based on biological targeting and would serve to treat undetectable foci of malignant transformation. The aim of this study was to optimize BNCT for the integral treatment for oral cancer, with particular emphasis on the inhibitory effect on tumour development originating in precancerous conditions, and radiotoxicity of different BNCT protocols in a hamster cheek pouch oral precancer model.

  14. Long-survivors of glioblatoma treated with boron neutron capture therapy (BNCT)

    International Nuclear Information System (INIS)

    Kageji, T.; Mizobuchi, Y.; Nagahiro, S.; Nakagawa, Y.; Kumada, H.

    2011-01-01

    The purpose of this study was to compare the radiation dose between long-survivors and non-long-survivors in patients with glioblatoma (GBM) treated with boron neutron capture therapy (BNCT). Among 23 GBM patients treated with BNCT, there were five patients who survived more than three years after diagnosis. The physical and weighted dose of the minimum gross tumor volume (GTV) of long-survivors was much higher than that of non-long survivors with significant statistical differences.

  15. Initiation of a phase-I trial of neutron capture therapy at the MIT research reactor

    International Nuclear Information System (INIS)

    Harling, O.K.; Bernard, J.A.; Yam, Chun-Shan

    1995-01-01

    The Massachusetts Institute of Technology (MIT), the New England Medical Center (NEMC), and Boston University Medical Center (BUMC) initiated a phase-1 trial of boron neutron capture therapy (BNCT) on September 6, 1994, at the 5-MW(thermal) MIT research reactor (MITR). A novel form of experimental cancer therapy, BNCT is being developed for certain types of highly malignant brain tumors such as glioblastoma and melanoma. The results of the phase-1 trials on patients with tumors in the legs or feet are described

  16. CFD - neutronic coupled calculation of a quarter of a simplified PWR fuel assembly including spacer pressure drop and turbulence enhancement

    Energy Technology Data Exchange (ETDEWEB)

    Pena, C.; Pellacani, F.; Macian Juan, R., E-mail: carlos.pena@ntech.mw.tum.de, E-mail: pellacani@ntech.mw.tum.de, E-mail: macian@ntech.mw.tum.de [Technische Universitaet Muenchen, Garching (Germany). Ntech Lehrstuhl fuer Nukleartechnik; Chiva, S., E-mail: schiva@emc.uji.es [Universitat Jaume I, Castellon de la Plana (Spain). Dept. de Ingenieria Mecanica y Construccion; Barrachina, T.; Miro, R., E-mail: rmiro@iqn.upv.es, E-mail: tbarrachina@iqn.upv.es [Universitat Politecnica de Valencia (ISIRYM/UPV) (Spain). Institute for Industrial, Radiophysical and Environmental Safety

    2011-07-01

    A computational code system based on coupling the 3D neutron diffusion code PARCS v2.7 and the Ansys CFX 13.0 Computational Fluid Dynamics (CFD) code has been developed as a tool for nuclear reactor systems simulations. This paper presents the coupling methodology between the CFD and the neutronic code. The methodology to simulate a 3D-neutronic problem coupled with 1D thermal hydraulics is already a mature technology, being part of the regular calculations performed to analyze different kinds of Reactivity Insertion Accidents (RIA) and asymmetric transients in Nuclear Power Plants, with state-of-the-art coupled codes like TRAC-B/NEM, RELAP5/PARCS, TRACE/PARCS, RELAP3D, RETRAN3D, etc. This work represents one of the first attempts to couple the multiphysics of a nuclear reactor core with a 3D spatial resolution in a computer code. This will open new possibilities regarding the analysis of fuel elements, contributing to a better understanding and design of the heat transfer process and specific fluid dynamics phenomena such as cross flow among fuel elements. The transient simulation of control rod insertion, boron dilution and cold water injection will be made possible with a degree of accuracy not achievable with current methodologies based on the use of system and/or subchannel codes. The transport of neutrons depends on several parameters, like fuel temperature, moderator temperature and density, boron concentration and fuel rod insertion. These data are calculated by the CFD code with high local resolution and used as input to the neutronic code to calculate a 3D nodal power distribution that will be returned and remapped to the CFD code control volumes (cells). Since two different nodalizations are used to discretized the same system, an averaging and interpolating procedure is needed to realize an effective data exchange. These procedures have been developed by means of the Ansys CFX 'User Fortran' interface; a library with several subroutines has

  17. CFD - neutronic coupled calculation of a quarter of a simplified PWR fuel assembly including spacer pressure drop and turbulence enhancement

    International Nuclear Information System (INIS)

    Pena, C.; Pellacani, F.; Macian Juan, R.; Chiva, S.; Barrachina, T.; Miro, R.

    2011-01-01

    A computational code system based on coupling the 3D neutron diffusion code PARCS v2.7 and the Ansys CFX 13.0 Computational Fluid Dynamics (CFD) code has been developed as a tool for nuclear reactor systems simulations. This paper presents the coupling methodology between the CFD and the neutronic code. The methodology to simulate a 3D-neutronic problem coupled with 1D thermal hydraulics is already a mature technology, being part of the regular calculations performed to analyze different kinds of Reactivity Insertion Accidents (RIA) and asymmetric transients in Nuclear Power Plants, with state-of-the-art coupled codes like TRAC-B/NEM, RELAP5/PARCS, TRACE/PARCS, RELAP3D, RETRAN3D, etc. This work represents one of the first attempts to couple the multiphysics of a nuclear reactor core with a 3D spatial resolution in a computer code. This will open new possibilities regarding the analysis of fuel elements, contributing to a better understanding and design of the heat transfer process and specific fluid dynamics phenomena such as cross flow among fuel elements. The transient simulation of control rod insertion, boron dilution and cold water injection will be made possible with a degree of accuracy not achievable with current methodologies based on the use of system and/or subchannel codes. The transport of neutrons depends on several parameters, like fuel temperature, moderator temperature and density, boron concentration and fuel rod insertion. These data are calculated by the CFD code with high local resolution and used as input to the neutronic code to calculate a 3D nodal power distribution that will be returned and remapped to the CFD code control volumes (cells). Since two different nodalizations are used to discretized the same system, an averaging and interpolating procedure is needed to realize an effective data exchange. These procedures have been developed by means of the Ansys CFX 'User Fortran' interface; a library with several subroutines has been

  18. Present status of fast neutron therapy survey of the clinical data and of the clinical research programmes

    International Nuclear Information System (INIS)

    Wambersie, A.; Richard, F.

    1989-01-01

    The clinical results reported from the different neutron therapy centres, in USA, Europe and Asia, are reviewed. Fast neutrons were proven to be superior to photons for locally extended inoperable salivary gland tumours. The reported overall local control rates are 67% and 24% respectively. Paranasal sinuses and some tumours of the head and neck area, especially extended tumours with large fixed lymph nodes, are also indications for neutrons. By contrast, the results obtained for brain tumours were, in general, disappointing. Neutrons were shown to bring a benefit in the treatment of well differentiated slowly growing soft tissue sarcomas. The reported overall local control rates were 53% and 38% after neutron and photon irradiation respectively. Better results, after neutron irradiation, were also reported for bone- and chondrosarcomas. The reported local control rates are 54% for osteosarcomas and 49% for chondrosarcomas after neutron irradiation; the corresponding values are 21% and 33% respectively after photon irradiation. For locally extended prostatic adenocarcinoma, the superiority of mixed schedule (neutrons + photons) was demonstrated by a RTOG randomized trial (local control rates 77% for mixed schedule compared to 31% for photons). Neutrons were also shown to be useful for palliative treatment of melanomas. Further studies are needed in order to definitively evaluate the benefit of fast neutrons for other localisations such as uterine cervix, bladder, and rectum. It can be concluded that fast neutrons are superior to photons for at least 10% to 20% of the radiotherapy patients. As far as the technical point of view is concerned, it is recognized that the first patient series were treated in ''suboptimal'' conditions. However, recently, important improvements were made. In particular, several high-energy hospital-based cyclotrons are now fully dedicated to neutron therapy. It is likely that these improved technical conditions will further extend the

  19. Measurement of gamma and neutron radiations inside spent fuel assemblies with passive detectors

    Czech Academy of Sciences Publication Activity Database

    Viererbl, L.; Lahodová, Z.; Voljanskij, A.; Klupák, V.; Koleška, M.; Cabalka, M.; Turek, Karel

    2011-01-01

    Roč. 652, č. 1 (2011), s. 90-93 ISSN 0168-9002 Institutional research plan: CEZ:AV0Z10480505 Keywords : fuel assembly * spent fuel * track detector Subject RIV: JF - Nuclear Energetics Impact factor: 1.207, year: 2011

  20. Neutron Activation Foil and Thermoluminescent Dosimeter Responses to a Lead Reflected Pulse of the CEA Valduc SILENE Critical Assembly

    International Nuclear Information System (INIS)

    Miller, Thomas Martin; Celik, Cihangir; Isbell, Kimberly McMahan; Lee, Yi-kang; Gagnier, Emmanuel; Authier, Nicolas; Piot, Jerome; Jacquet, Xavier; Rousseau, Guillaume; Reynolds, Kevin H.

    2016-01-01

    This benchmark experiment was conducted as a joint venture between the US Department of Energy (DOE) and the French Commissariat à l'Energie Atomique (CEA). Staff at the Oak Ridge National Laboratory (ORNL) in the US and the Centre de Valduc in France planned this experiment. The experiment was conducted on October 13, 2010 in the SILENE critical assembly facility at Valduc. Several other organizations contributed to this experiment and the subsequent evaluation, including CEA Saclay, Lawrence Livermore National Laboratory (LLNL), the Y-12 National Security Complex (NSC), Babcock International Group in the United Kingdom, and Los Alamos National Laboratory (LANL). The goal of this experiment was to measure neutron activation and thermoluminescent dosimeter (TLD) doses from a source similar to a fissile solution critical excursion. The resulting benchmark can be used for validation of computer codes and nuclear data libraries as required when performing analysis of criticality accident alarm systems (CAASs). A secondary goal of this experiment was to qualitatively test performance of two CAAS detectors similar to those currently and formerly in use in some US DOE facilities. The detectors tested were the CIDAS MkX and the Rocky Flats NCD-91. The CIDAS detects gammas with a Geiger-Muller tube, and the Rocky Flats detects neutrons via charged particles produced in a thin 6 LiF disc, depositing energy in a Si solid-state detector. These detectors were being evaluated to determine whether they would alarm, so they were not expected to generate benchmark quality data.

  1. Neutron Activation Foil and Thermoluminescent Dosimeter Responses to a Polyethylene Reflected Pulse of the CEA Valduc SILENE Critical Assembly

    Energy Technology Data Exchange (ETDEWEB)

    Miller, Thomas Martin [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Celik, Cihangir [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); McMahan, Kimberly L. [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Lee, Yi-kang [French Atomic Energy Commission (CEA), Saclay (France); Gagnier, Emmanuel [French Atomic Energy Commission (CEA), Centre de Saclay, Gif sur Yvette; Authier, Nicolas [French Atomic Energy Commission (CEA), Salives (France). Valduc Centre for Nuclear Studies; Piot, Jerome [French Atomic Energy Commission (CEA), Salives (France). Valduc Centre for Nuclear Studies; Jacquet, Xavier [French Atomic Energy Commission (CEA), Salives (France). Valduc Centre for Nuclear Studies; Rousseau, Guillaume [French Atomic Energy Commission (CEA), Salives (France). Valduc Centre for Nuclear Studies; Reynolds, Kevin H. [Y-12 National Security Complex, Oak Ridge, TN (United States)

    2016-09-01

    This benchmark experiment was conducted as a joint venture between the US Department of Energy (DOE) and the French Commissariat à l'Energie Atomique (CEA). Staff at the Oak Ridge National Laboratory (ORNL) in the US and the Centre de Valduc in France planned this experiment. The experiment was conducted on October 19, 2010 in the SILENE critical assembly facility at Valduc. Several other organizations contributed to this experiment and the subsequent evaluation, including CEA Saclay, Lawrence Livermore National Laboratory (LLNL), the Y-12 National Security Complex (NSC), Babcock International Group in the United Kingdom, and Los Alamos National Laboratory (LANL). The goal of this experiment was to measure neutron activation and thermoluminescent dosimeter (TLD) doses from a source similar to a fissile solution critical excursion. The resulting benchmark can be used for validation of computer codes and nuclear data libraries as required when performing analysis of criticality accident alarm systems (CAASs). A secondary goal of this experiment was to qualitatively test performance of two CAAS detectors similar to those currently and formerly in use in some US DOE facilities. The detectors tested were the CIDAS MkX and the Rocky Flats NCD-91. The CIDAS detects gammas with a Geiger-Muller tube and the Rocky Flats detects neutrons via charged particles produced in a thin 6LiF disc depositing energy in a Si solid state detector. These detectors were being evaluated to determine whether they would alarm, so they were not expected to generate benchmark quality data.

  2. Neutron Activation Foil and Thermoluminescent Dosimeter Responses to a Polyethylene Reflected Pulse of the CEA Valduc SILENE Critical Assembly

    International Nuclear Information System (INIS)

    Miller, Thomas Martin; Celik, Cihangir; McMahan, Kimberly L.; Lee, Yi-kang; Gagnier, Emmanuel; Authier, Nicolas

    2016-01-01

    This benchmark experiment was conducted as a joint venture between the US Department of Energy (DOE) and the French Commissariat à l'Energie Atomique (CEA). Staff at the Oak Ridge National Laboratory (ORNL) in the US and the Centre de Valduc in France planned this experiment. The experiment was conducted on October 19, 2010 in the SILENE critical assembly facility at Valduc. Several other organizations contributed to this experiment and the subsequent evaluation, including CEA Saclay, Lawrence Livermore National Laboratory (LLNL), the Y-12 National Security Complex (NSC), Babcock International Group in the United Kingdom, and Los Alamos National Laboratory (LANL). The goal of this experiment was to measure neutron activation and thermoluminescent dosimeter (TLD) doses from a source similar to a fissile solution critical excursion. The resulting benchmark can be used for validation of computer codes and nuclear data libraries as required when performing analysis of criticality accident alarm systems (CAASs). A secondary goal of this experiment was to qualitatively test performance of two CAAS detectors similar to those currently and formerly in use in some US DOE facilities. The detectors tested were the CIDAS MkX and the Rocky Flats NCD-91. The CIDAS detects gammas with a Geiger-Muller tube and the Rocky Flats detects neutrons via charged particles produced in a thin "6LiF disc depositing energy in a Si solid state detector. These detectors were being evaluated to determine whether they would alarm, so they were not expected to generate benchmark quality data.

  3. Fine 3D neutronic characterization of a gas-cooled fast reactor based on plate-type sub-assemblies

    International Nuclear Information System (INIS)

    Bosq, J. C.; Peneliau, Y.; Rimpault, G.; Vanier, M.

    2006-01-01

    CEA neutronic studies have allowed the definition of a first 2400 MWth reference gas-cooled fast reactor core using plate-type sub-assemblies, for which the main neutronic characteristics were calculated by the so-called ERANOS 'design calculation scheme' relying on several method approximations. The last stage has consisted in a new refine characterization, using the reference calculation scheme, in order to confirm the impact of the approximations of the design route. A first core lay-out taking into account control rods was proposed and the reactivity penalty due to the control rod introduction in this hexagonal core lay-out was quantified. A new adjusted core was defined with an increase of the plutonium content. This leads to a significant decrease of the breeding gain which needs to be recovered in future design evolutions in order to achieve the self breeding goal. Finally, the safety criteria associated to the control rods were calculated with a first estimation of the uncertainties. All these criteria are respected, even if the safety analysis of GFR concepts and the determination of these uncertainties should be further studied and improved. (authors)

  4. Response of the oral mucosa to porphyrin mediated boron neutron capture therapy

    International Nuclear Information System (INIS)

    Morris, G.M.

    2003-01-01

    Pre-clinical studies are now in progress to develop boron neutron capture therapy (BNCT) modalities for the treatment of head and neck carcinomas. BNCT is a bimodal therapy which involves the administration of a boron-10 enriched compound, that accumulates preferentially in tumours, prior to irradiation with low energy neutrons. These neutrons are captured by boron-10 atoms to produce a highly localised radiation exposure. More recently, it has been demonstrated that various boronated porphyrins can target a variety of tumours. Of the porphyrins evaluated to date, copper tetracarboranylphenyl porphyrin (CuTCPH) is a strong candidate for potential clinical evaluation. It has extremely high specificity for a variety of tumour models. Therapeutic efficacy of CuTCPH mediated BNCT has been demonstrated in pre-clinical studies using the murine EMT-6 carcinoma model. In the present investigation the response of the oral mucosa to CuTCPH mediated boron neutron capture (BNC) irradiation was assessed using a standard rat model (ventral tongue). Single exposure irradiation was carried out on the thermal neutron beam at the Brookhaven Medical Research Reactor, at 3 days after the final injection of the boronated porphyrin. The impact of CuTCPH mediated BNC irradiation on oral mucosa at therapeutically effective exposure times, assessed using the ventral tongue model, was minimal. This was primarily due to the fact that blood boron levels (from CuTCPH) were very low at the time of irradiation. Analysis of the dose-effect data for CuTCPH gave a compound biological effectiveness (CBE) factor of 2.5. It can be concluded that, although, the CBE factor (calculated using blood boron concentrations) was relatively high, CuTCPH mediated BNC irradiation should not cause significant damage at clinically relevant radiation doses. This is because blood boron levels would be very low at the time of irradiation

  5. Monte Carlo evaluation of a photon pencil kernel algorithm applied to fast neutron therapy treatment planning

    Science.gov (United States)

    Söderberg, Jonas; Alm Carlsson, Gudrun; Ahnesjö, Anders

    2003-10-01

    When dedicated software is lacking, treatment planning for fast neutron therapy is sometimes performed using dose calculation algorithms designed for photon beam therapy. In this work Monte Carlo derived neutron pencil kernels in water were parametrized using the photon dose algorithm implemented in the Nucletron TMS (treatment management system) treatment planning system. A rectangular fast-neutron fluence spectrum with energies 0-40 MeV (resembling a polyethylene filtered p(41)+ Be spectrum) was used. Central axis depth doses and lateral dose distributions were calculated and compared with the corresponding dose distributions from Monte Carlo calculations for homogeneous water and heterogeneous slab phantoms. All absorbed doses were normalized to the reference dose at 10 cm depth for a field of radius 5.6 cm in a 30 × 40 × 20 cm3 water test phantom. Agreement to within 7% was found in both the lateral and the depth dose distributions. The deviations could be explained as due to differences in size between the test phantom and that used in deriving the pencil kernel (radius 200 cm, thickness 50 cm). In the heterogeneous phantom, the TMS, with a directly applied neutron pencil kernel, and Monte Carlo calculated absorbed doses agree approximately for muscle but show large deviations for media such as adipose or bone. For the latter media, agreement was substantially improved by correcting the absorbed doses calculated in TMS with the neutron kerma factor ratio and the stopping power ratio between tissue and water. The multipurpose Monte Carlo code FLUKA was used both in calculating the pencil kernel and in direct calculations of absorbed dose in the phantom.

  6. SU-F-J-196: A Prototype System for Portal Imaging for Intensity Modulated Neutron Therapy

    Energy Technology Data Exchange (ETDEWEB)

    St James, S; Argento, D; DeWitt, D; Miyaoka, R; Stewart, R [University of Washington, Seattle, WA (United States); Moffitt, G [University of Utah, Salt Lake City, UT (United States)

    2016-06-15

    Purpose: Fast neutron therapy is offered at the University of Washington Medical Center for treatment of selected cancers. The hardware and control systems of the UW Clinical Neutron Therapy System are undergoing upgrades to enable delivery of IMNT. To clinically implement IMNT, dose verification tools need to be developed. We propose a portal imaging system that relies on the creation of positron emitting isotopes ({sup 11}C and {sup 15}O) through (n, 2n) reactions with a PMMA plate placed below the patient. After field delivery, the plate is retrieved from the vault and imaged using a reader that detects the annihilation photons. The pattern of activity produced in the plate provides information to reconstruct the neutron fluence map that can be compared to fluence maps from Monte Carlo (MCNP) simulations to verify treatment delivery. We have previously performed Monte Carlo simulations of the portal imaging system (GATE simulations) and the beam line (MCNP simulations). In this work, initial measurements using a prototype system are presented. Methods: Custom electronics were developed for BGO detectors read out with photomultiplier tubes (previous generation PET detectors from a CTI ECAT 953 scanner). Two detectors were placed in coincidence, with a detector separation of 2 cm. Custom software was developed to create the crystal look up tables and perform a limited angle planar reconstruction with a stochastic normalization. To test the initial capabilities of the system, PMMA squares were irradiated with neutrons at a depth of 1.5 cm and read out using the prototype system. Doses ranging from 10–200 cGy were delivered. Results: Using the prototype system, dose differences in the therapeutic range could be determined. Conclusion: The prototype portal imaging system is capable of detecting neutron doses as low as 10–50 cGy and shows great promise as a patient QA tool for IMNT.

  7. Final Report: 8th International Symposium on Neutron Capture Therapy (NCT) for Cancer, May 15, 1998 - May 15, 1999

    International Nuclear Information System (INIS)

    Hawthorne, M.F.

    1999-01-01

    The 8th International Symposium on Neutron Capture Therapy for Cancer (8th ISNCTC) was held in La Jolla, CA on Sept. 13-18, 1998. This biennial meeting of the International Society for Neutron Capture Therapy (ISNCT) was hosted by Society President M.F. Hawthorne (UCLA Dept. of Chemistry and Biochemistry). The Symposium brought together scientists (300 registrants from 21 countries) from diverse fields to report the latest developments in NCT. Topics of the 275 papers presented (30 plenary lectures, 81 oral presentations, and 164 posters) included the physics of neutron sources, chemistry of tumor-targeting agents, dosimetry, radiobiological studies, and clinical applications

  8. Experiments and Simulations of the Use of Time-Correlated Thermal Neutron Counting to Determine the Multiplication of an Assembly of Highly Enriched Uranium

    Energy Technology Data Exchange (ETDEWEB)

    David L. Chichester; Mathew T. Kinlaw; Scott M. Watson; Jeffrey M. Kalter; Eric C. Miller; William A. Noonan

    2014-11-01

    A series of experiments and numerical simulations using thermal-neutron time-correlated measurements has been performed to determine the neutron multiplication, M, of assemblies of highly enriched uranium available at Idaho National Laboratory. The experiments used up to 14.4 kg of highly-enriched uranium, including bare assemblies and assemblies reflected with high-density polyethylene, carbon steel, and tungsten. A small 252Cf source was used to initiate fission chains within the assembly. Both the experiments and the simulations used 6-channel and 8-channel detector systems, each consisting of 3He proportional counters moderated with polyethylene; data was recorded in list mode for analysis. 'True' multiplication values for each assembly were empirically derived using basic neutron production and loss values determined through simulation. A total of one-hundred and sixteen separate measurements were performed using fifty-seven unique measurement scenarios, the multiplication varied from 1.75 to 10.90. This paper presents the results of these comparisons and discusses differences among the various cases.

  9. Use of helium-neon laser for the prevention of acute radiation reaction of the skin in neutron-beam therapy of head and neck tumors

    International Nuclear Information System (INIS)

    Popovich, V.I.; Musabaeva, L.I.; Kitsmanyuk, Z.D.; Lavrenkov, K.A.

    1991-01-01

    Preliminary data on helium-neon laser usage to prevent acute radiation skinresponse in patients with head and neck neoplasm were presented in case of fast neutrons therapy with average energy of ≅ 6.3 MeV. Irradiation was performed by 2 fractions a week with single absorbed focal dose of 1.2-1.4 Gy and the dose for the skin was 2-2.2 Gy. RBE of the fast neutrons comprised ∼ 3. Some patients were subjected to neutron therapy in combination with helium-neon laser treatment, the others underwent only neutron therapy. Combination of neutron and helium-neon laser therapy increased skin resistance to neutron irradiation. Combined treatment with neutrons and helium-neon laser decreased development of humid epidermitis by half than in case of neutron treatment alone

  10. Development of the JAERI computational dosimetry system (JCDS) for boron neutron capture therapy. Cooperative research

    Energy Technology Data Exchange (ETDEWEB)

    Kumada, Hiroaki; Yamamoto, Kazuyoshi; Torii, Yoshiya; Uchiyama, Junzo [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment; Matsumura, Akira; Yamamoto, Tetsuya; Nose, Tadao [Tsukuba Univ., Tsukuba, Ibaraki (Japan); Nakagawa, Yoshinobu [National Sanatorium Kagawa-Children' s Hospital, Kagawa (Japan); Kageji, Teruyoshi [Tokushima Univ., Tokushima (Japan)

    2003-03-01

    The Neutron Beam Facility at JRR-4 enables us to carry out boron neutron capture therapy with epithermal neutron beam. In order to make treatment plans for performing the epithermal neutron beam BNCT, it is necessary to estimate radiation doses in a patient's head in advance. The JAERI Computational Dosimetry System (JCDS), which can estimate distributions of radiation doses in a patient's head by simulating in order to support the treatment planning for epithermal neutron beam BNCT, was developed. JCDS is a software that creates a 3-dimentional head model of a patient by using CT and MRI images, and that generates a input data file automatically for calculation of neutron flux and gamma-ray dose distributions in the brain with the Monte Carlo code MCNP, and that displays these dose distributions on the head model for dosimetry by using the MCNP calculation results. JCDS has any advantages as follows; By using CT data and MRI data which are medical images, a detail three-dimensional model of patient's head is able to be made easily. The three-dimensional head image is editable to simulate the state of a head after its surgical processes such as skin flap opening and bone removal in the BNCT with craniotomy that are being performed in Japan. JCDS can provide information for the Patient Setting System which can support to set the patient to an actual irradiation position swiftly and accurately. This report describes basic design of JCDS and functions in several processing, calculation methods, characteristics and performance of JCDS. (author)

  11. In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.

    Science.gov (United States)

    Dewi, Novriana; Mi, Peng; Yanagie, Hironobu; Sakurai, Yuriko; Morishita, Yasuyuki; Yanagawa, Masashi; Nakagawa, Takayuki; Shinohara, Atsuko; Matsukawa, Takehisa; Yokoyama, Kazuhito; Cabral, Horacio; Suzuki, Minoru; Sakurai, Yoshinori; Tanaka, Hiroki; Ono, Koji; Nishiyama, Nobuhiro; Kataoka, Kazunori; Takahashi, Hiroyuki

    2016-04-01

    A more immediate impact for therapeutic approaches of current clinical research efforts is of major interest, which might be obtained by developing a noninvasive radiation dose-escalation strategy, and neutron capture therapy represents one such novel approach. Furthermore, some recent researches on neutron capture therapy have focused on using gadolinium as an alternative or complementary for currently used boron, taking into account several advantages that gadolinium offers. Therefore, in this study, we carried out feasibility evaluation for both single and multiple injections of gadolinium-based MRI contrast agent incorporated in calcium phosphate nanoparticles as neutron capture therapy agent. In vivo evaluation was performed on colon carcinoma Col-26 tumor-bearing mice irradiated at nuclear reactor facility of Kyoto University Research Reactor Institute with average neutron fluence of 1.8 × 10(12) n/cm(2). Antitumor effectivity was evaluated based on tumor growth suppression assessed until 27 days after neutron irradiation, followed by histopathological analysis on tumor slice. The experimental results showed that the tumor growth of irradiated mice injected beforehand with Gd-DTPA-incorporating calcium phosphate-based nanoparticles was suppressed up to four times higher compared to the non-treated group, supported by the results of histopathological analysis. The results of antitumor effectivity observed on tumor-bearing mice after neutron irradiation indicated possible effectivity of gadolinium-based neutron capture therapy treatment.

  12. Neutron field characterization and dosimetry at the TRIUMF proton therapy facility

    International Nuclear Information System (INIS)

    Mukherjee, B.

    2002-01-01

    Full text: In 1972 the 500 MeV H' Cyclotron of the TRIUMF (Tri University Meson Factory) located in Vancouver, Canada became operational. Beside Meson Physics, high-energy protons of various energy and beam current levels from the TRIUMF Cyclotron are used for scientific research and biomedical applications. Recently, a 500 MeV proton beam from the cyclotron was used as the booster beam for the radioactive ion beam facility, ISAC (Isotope Separator Accelerator) and a second beam as primary irradiation source for the Proton Irradiation Facility (PIF). The major commercial applications of the PIF are the provision of high-energy proton beams for radiation hardness testing of electronic components used in space applications (NASA) and proton therapy of ocular tumors (British Columbia Proton Therapy Facility). The PIF vault was constructed within the main accelerator hall of the TRIUMF using stacks of large concrete blocks. An intense field of fast neutrons is produced during the interaction of high-energy proton beam with target materials, such as, beam stops, collimators and beam energy degraders. The leakage of such neutrons due to insufficient radiological shielding or through the shielding discontinuities may constitute a major share of the personnel radiation exposure of the radiation workers. The neutron energy distribution and dose equivalent near a lead beam stopper bombarded with 116 MeV and 65 MeV collimated proton beams at the Ocular Tumor irradiation facility were evaluated using a Bonner-Sphere Spectrometer and a REM counter respectively. The results were utilized to investigate efficacy of the existing radiological shielding of the PIF. This paper highlights experimental methods to analyze the high-energy accelerator produced neutron beam and basic guideline for the radiological shielding designs of irradiation vault of Proton Therapy facilities

  13. Application of generalized perturbation theory to sensitivity analysis in boron neutron capture therapy

    Energy Technology Data Exchange (ETDEWEB)

    Garcia, Vanessa S. [Universidade Federal Fluminense (EEIMVR/UFF-RJ), Volta Redonda, RJ (Brazil). Escola de Engenharia Industrial e Metalurgica. Programa de Pos-Graduacao em Modelagem Computacional em Ciencia e Tecnologia; Silva, Fernando C.; Silva, Ademir X., E-mail: fernando@con.ufrj.b, E-mail: ademir@con.ufrj.b [Coordenacao dos Programas de Pos-Graduacao de Engenharia (PEN/COPPE/UFRJ), Rio de Janeiro, RJ (Brazil). Programa de Engenharia Nuclear; Alvarez, Gustavo B. [Universidade Federal Fluminense (EEIMVR/UFF-RJ), Volta Redonda, RJ (Brazil). Escola de Engenharia Industrial e Metalurgica. Dept. de Ciencias Exatas

    2011-07-01

    Boron neutron capture therapy - BNCT - is a binary cancer treatment used in brain tumors. The tumor is loaded with a boron compound and subsequently irradiated by thermal neutrons. The therapy is based on the {sup 10}B (n, {alpha}) {sup 7}Li nuclear reaction, which emits two types of high-energy particles, {alpha} particle and the {sup 7}Li nuclei. The total kinetic energy released in this nuclear reaction, when deposited in the tumor region, destroys the cancer cells. Since the success of the BNCT is linked to the different selectivity between the tumor and healthy tissue, it is necessary to carry out a sensitivity analysis to determinate the boron concentration. Computational simulations are very important in this context because they help in the treatment planning by calculating the lowest effective absorbed dose rate to reduce the damage to healthy tissue. The objective of this paper is to present a deterministic method based on generalized perturbation theory (GPT) to perform sensitivity analysis with respect to the {sup 10}B concentration and to estimate the absorbed dose rate by patients undergoing this therapy. The advantage of the method is a significant reduction in computational time required to perform these calculations. To simulate the neutron flux in all brain regions, the method relies on a two-dimensional neutron transport equation whose spatial, angular and energy variables are discretized by the diamond difference method, the discrete ordinate method and multigroup formulation, respectively. The results obtained through GPT are consistent with those obtained using other methods, demonstrating the efficacy of the proposed method. (author)

  14. Application of generalized perturbation theory to sensitivity analysis in boron neutron capture therapy

    International Nuclear Information System (INIS)

    Garcia, Vanessa S.; Silva, Fernando C.; Silva, Ademir X.; Alvarez, Gustavo B.

    2011-01-01

    Boron neutron capture therapy - BNCT - is a binary cancer treatment used in brain tumors. The tumor is loaded with a boron compound and subsequently irradiated by thermal neutrons. The therapy is based on the 10 B (n, α) 7 Li nuclear reaction, which emits two types of high-energy particles, α particle and the 7 Li nuclei. The total kinetic energy released in this nuclear reaction, when deposited in the tumor region, destroys the cancer cells. Since the success of the BNCT is linked to the different selectivity between the tumor and healthy tissue, it is necessary to carry out a sensitivity analysis to determinate the boron concentration. Computational simulations are very important in this context because they help in the treatment planning by calculating the lowest effective absorbed dose rate to reduce the damage to healthy tissue. The objective of this paper is to present a deterministic method based on generalized perturbation theory (GPT) to perform sensitivity analysis with respect to the 10 B concentration and to estimate the absorbed dose rate by patients undergoing this therapy. The advantage of the method is a significant reduction in computational time required to perform these calculations. To simulate the neutron flux in all brain regions, the method relies on a two-dimensional neutron transport equation whose spatial, angular and energy variables are discretized by the diamond difference method, the discrete ordinate method and multigroup formulation, respectively. The results obtained through GPT are consistent with those obtained using other methods, demonstrating the efficacy of the proposed method. (author)

  15. Evaluation of the criticality constant from Pulsed Neutron Source measurements in the Yalina-Booster subcritical assembly

    International Nuclear Information System (INIS)

    Bécares, V.; Villamarín, D.; Fernández-Ordóñez, M.; González-Romero, E.M.; Berglöf, C.; Bournos, V.; Fokov, Y.; Mazanik, S.; Serafimovich, I.

    2013-01-01

    Highlights: ► New methodology proposed to determine the reactivity of subcritical systems. ► Methodology tested in PNS experiments at the Yalina-Booster subcritical assembly. ► The area-ratio and the prompt decay constant methods have been used for validation. ► The absolute reactivity of the system is determined in spite of large spatial effects. - Abstract: The prompt decay constant method and the area-ratio (Sjöstrand) method constitute the reference techniques for measuring the reactivity of a subcritical system using Pulsed Neutron Source experiments (PNS). However, different experiments have shown that in many cases it is necessary to apply corrections to the experimental results in order to take into account spectral and spatial effects. In these cases, the approach usually followed is to develop different specific correction procedures for each method. In this work we discuss the validity of prompt decay constant method and the area-ratio method in the Yalina-Booster subcritical assembly and propose a general correction procedure based on Monte Carlo simulations

  16. A CONCEPTUAL DESIGN OF NEUTRON COLLIMATOR IN THE THERMAL COLUMN OF KARTINI RESEARCH REACTOR FOR IN VITRO AND IN VIVO TEST OF BORON NEUTRON CAPTURE THERAPY

    Directory of Open Access Journals (Sweden)

    Nina Fauziah

    2015-03-01

    Full Text Available Studies were carried out to design a collimator which results in epithermal neutron beam for IN VITRO and IN VIVO of Boron Neutron Capture Therapy (BNCT at the Kartini research reactor by means of Monte Carlo N-Particle (MCNP codes. Reactor within 100 kW of thermal power was used as the neutron source. The design criteria were based on recommendation from the International Atomic Energy Agency (IAEA. All materials used were varied in size, according to the value of mean free path for each material. MCNP simulations indicated that by using 5 cm thick of Ni as collimator wall, 60 cm thick of Al as moderator, 15 cm thick of 60Ni as filter, 2 cm thick of Bi as γ-ray shielding, 3 cm thick of 6Li2CO3-polyethylene as beam delimiter, with 1 to 5 cm varied aperture size, epithermal neutron beam with maximum flux of 7.65 x 108 n.cm-2.s-1 could be produced. The beam has minimum fast neutron and γ-ray components of, respectively, 1.76 x 10-13 Gy.cm2.n-1 and 1.32 x 10-13 Gy.cm2.n-1, minimum thermal neutron per epithermal neutron ratio of 0.008, and maximum directionality of 0.73. It did not fully pass the IAEA’s criteria, since the epithermal neutron flux was below the recommended value, 1.0 x 109 n.cm-2.s-1. Nonetheless, it was still usable with epithermal neutron flux exceeding 5.0 x 108 n.cm-2.s-1. When it was assumed that the graphite inside the thermal column was not discharged but only the part which was going to be replaced by the collimator, the performance of the collimator became better within the positive effect from the surrounding graphite that the beam resulted passed all criteria with epithermal neutron flux up to 1.68 x 109 n.cm-2.s-1. Keywords: design, collimator, epithermal neutron beam, BNCT, MCNP, criteria   Telah dilakukan penelitian tentang desain kolimator yang menghasilkan radiasi netron epitermal untuk uji in vitro dan in vivo pada Boron Neutron Capture Therapy (BNCT di Reaktor Riset Kartini dengan menggunakan program Monte

  17. Template mediated protein self-assembly as a valuable tool in regenerative therapy.

    Science.gov (United States)

    Kundu, B; Eltohamy, M; Yadavalli, V K; Reis, R L; Kim, H W

    2018-04-11

    The assembly of natural proteinaceous biopolymers into macro-scale architectures is of great importance in synthetic biology, soft-material science and regenerative therapy. The self-assembly of protein tends to be limited due to anisotropic interactions among protein molecules, poor solubility and stability. Here, we introduce a unique platform to self-immobilize diverse proteins (fibrous and globular, positively and negatively charged, low and high molecular weight) using silicon surfaces with pendant -NH 2 groups via a facile one step diffusion limited aggregation (DLA) method. All the experimental proteins (type I collagen, bovine serum albumin and cytochrome C) self-assemble into seaweed-like branched dendritic architectures via classical DLA in the absence of any electrolytes. The notable differences in branching architectures are due to dissimilarities in protein colloidal sub-units, which is typical for each protein type, along with the heterogeneous distribution of surface -NH 2 groups. Fractal analysis of assembled structures is used to explain the underlying route of fractal deposition; which concludes how proteins with different functionality can yield similar assembly. Further, the nano-micro-structured surfaces can be used to provide functional topographical cues to study cellular responses, as demonstrated using rat bone marrow stem cells. The results indicate that the immobilization of proteins via DLA does not affect functionality, instead serving as topographical cues to guide cell morphology. This indicates a promising design strategy at the tissue-material interface and is anticipated to guide future surface modifications. A cost-effective standard templating strategy is therefore proposed for fundamental and applied particle aggregation studies, which can be used at multiple length scales for biomaterial design and surface reformation.

  18. Secondary neutron doses received by patients of different ages during intracranial proton therapy treatments

    International Nuclear Information System (INIS)

    Sayah, R.

    2012-01-01

    Proton therapy is an advanced radiation therapy technique that allows delivering high doses to the tumor while saving the healthy surrounding tissues due to the protons' ballistic properties. However, secondary particles, especially neutrons, are created during protons' nuclear reactions in the beam-line and the treatment room components, as well as inside the patient. Those secondary neutrons lead to unwanted dose deposition to the healthy tissues located at distance from the target, which may increase the secondary cancer risks to the patients, especially the pediatric ones. The aim of this work was to calculate the neutron secondary doses received by patients of different ages treated at the Institut Curie-centre de Protontherapie d'Orsay (ICPO) for intracranial tumors, using a 178 MeV proton beam. The treatments are undertaken at the new ICPO room equipped with an IBA gantry. The treatment room and the beam-line components, as well as the proton source were modeled using the Monte Carlo code MCNPX. The obtained model was then validated by a series of comparisons between model calculations and experimental measurements. The comparisons concerned: a) depth and lateral proton dose distributions in a water phantom, b) neutron spectrometry at one position in the treatment room, c) ambient dose equivalents at different positions in the treatment room and d) secondary absorbed doses inside a physical anthropomorphic phantom. A general good agreement was found between calculations and measurements, thus our model was considered as validated. The University of Florida hybrid voxelized phantoms of different ages were introduced into the MCNPX validated model, and secondary neutron doses were calculated to many of these phantoms' organs. The calculated doses were found to decrease as the organ's distance to the treatment field increases and as the patient's age increases. The secondary doses received by a one year-old patient may be two times higher than the doses

  19. Metrology and quality of radiation therapy dosimetry of electron, photon and epithermal neutron beams

    Energy Technology Data Exchange (ETDEWEB)

    Kosunen, A

    1999-08-01

    In radiation therapy using electron and photon beams the dosimetry chain consists of several sequential phases starting by the realisation of the dose quantity in the Primary Standard Dosimetry Laboratory and ending to the calculation of the dose to a patient. A similar procedure can be described for the dosimetry of epithermal neutron beams in boron neutron capture therapy (BNCT). To achieve the required accuracy of the dose delivered to a patient the quality of all steps in the dosimetry procedure has to be considered. This work is focused on two items in the dosimetry chains: the determination of the dose in the reference conditions and the evaluation of the accuracy of dose calculation methods. The issues investigated and discussed in detail are: a)the calibration methods of plane parallel ionisation chambers used in electron beam dosimetry, (b) the specification of the critical dosimetric parameter i.e. the ratio of stopping powers for water to air, (S I ?){sup water} {sub air}, in photon beams, (c) the feasibility of the twin ionization chamber technique for dosimetry in epithermal neutron beams applied to BNCT and (d) the determination accuracy of the calculated dose distributions in phantoms in electron, photon, and epithermal neutron beams. The results demonstrate that up to a 3% improvement in the consistency of dose determinations in electron beams is achieved by the calibration of plane parallel ionisation chambers in high energy electron beams instead of calibrations in {sup 60}Co gamma beams. In photon beam dosimetry (S I ?){sup water} {sub air} can be determined with an accuracy of 0.2% using the percentage dose at the 10 cm depth, %dd(10), as a beam specifier. The use of %odd(10) requires the elimination of the electron contamination in the photon beam. By a twin ionisation chamber technique the gamma dose can be determined with uncertainty of 6% (1 standard deviation) and the total neutron dose with an uncertainty of 15 to 20% (1 standard deviation

  20. Metrology and quality of radiation therapy dosimetry of electron, photon and epithermal neutron beams

    International Nuclear Information System (INIS)

    Kosunen, A.

    1999-08-01

    In radiation therapy using electron and photon beams the dosimetry chain consists of several sequential phases starting by the realisation of the dose quantity in the Primary Standard Dosimetry Laboratory and ending to the calculation of the dose to a patient. A similar procedure can be described for the dosimetry of epithermal neutron beams in boron neutron capture therapy (BNCT). To achieve the required accuracy of the dose delivered to a patient the quality of all steps in the dosimetry procedure has to be considered. This work is focused on two items in the dosimetry chains: the determination of the dose in the reference conditions and the evaluation of the accuracy of dose calculation methods. The issues investigated and discussed in detail are: a)the calibration methods of plane parallel ionisation chambers used in electron beam dosimetry, (b) the specification of the critical dosimetric parameter i.e. the ratio of stopping powers for water to air, (S I ?) water air , in photon beams, (c) the feasibility of the twin ionization chamber technique for dosimetry in epithermal neutron beams applied to BNCT and (d) the determination accuracy of the calculated dose distributions in phantoms in electron, photon, and epithermal neutron beams. The results demonstrate that up to a 3% improvement in the consistency of dose determinations in electron beams is achieved by the calibration of plane parallel ionisation chambers in high energy electron beams instead of calibrations in 60 Co gamma beams. In photon beam dosimetry (S I ?) water air can be determined with an accuracy of 0.2% using the percentage dose at the 10 cm depth, %dd(10), as a beam specifier. The use of %odd(10) requires the elimination of the electron contamination in the photon beam. By a twin ionisation chamber technique the gamma dose can be determined with uncertainty of 6% (1 standard deviation) and the total neutron dose with an uncertainty of 15 to 20% (1 standard deviation). To improve the accuracy

  1. Characterization of the Caliban and Prospero Critical Assemblies Neutron Spectra for Integral Measurements Experiments

    Science.gov (United States)

    Casoli, P.; Authier, N.; Jacquet, X.; Cartier, J.

    2014-04-01

    Caliban and Prospero are two highly enriched uranium metallic core reactors operated on the CEA Center of Valduc. These critical assemblies are suitable for integral experiments, such as fission yields measurements or perturbation measurements, which have been carried out recently on the Caliban reactor. Different unfolding methods, based on activation foils and fission chambers measurements, are used to characterize the reactor spectra and especially the Caliban spectrum, which is very close to a pure fission spectrum.

  2. Advanced plutonium assembly (apa): evolution of the concept, neutron and thermal-mechanic constraints

    International Nuclear Information System (INIS)

    Porta, J.; Gastaldi, B.; Krakowiak-Aillaud, C.; Buffe, L.

    2002-01-01

    The APA concept was developed with the aim of increasing the PWR capacity to burn plutonium emerging from the recycling of irradiated fuels in the French park of nuclear power plants. At first, a concept using annular pins was optimised to allow a good consumption of plutonium while preserving an acceptable neutron control. To cope with the technological problems and those posed by the manufacture of these annular pins, an alternative concept is presented here. It poses as initial conditions the conservation of both the plutonium balance and the respect of the reactivity control. (authors)

  3. Basic and clinical study of boron neutron capture therapy for malignant brain tumor

    Energy Technology Data Exchange (ETDEWEB)

    Nose, Tadao; Matsumura, Akira; Nakai, Kei; Nakagawa, Kunio; Yoshii, Yoshihiko [Tsukuba Univ., Ibaraki (Japan). Inst. of Clinical Medicine; Shibata, Yasushi; Yamamoto, Tetsuya; Hayakawa, Yoshinori; Yamada, Takashi

    1998-01-01

    Rat malignant cells (9L glioma cell) were exposed to neutron radiation after culturing with boron compounds; BSH and STA-BX909, and cell growing ability after the exposure was determined by colony forming assay. The effects of in vivo radiation were examined by measuring neutron flux levels in rat brain and skin aiming to use neutron radiation in clinical study. STA-BX909 was found to show a dose-dependent cell toxicity, which was higher than that of BSH. The radiation induced G2/M block in 9L-glioma cells and their cell cycles recovered thereafter in low-dose radiated cells, but high-dose radiated cells became aneuploidy. Furthermore, boron neutron capture therapy (BNCT) was applied in two patients, 41-year old woman with glioma grade 3 recurred and 45-year old man with glioblastoma multiforme. The former died from systemic deterioration due to ileus, but BNCT was made only one time although conventional radiotherapy is carried out for a relatively long period. Therefore, BNCT was thought to be beneficial from an aspect of `quality of life` and the effects to repress a recurrence of cancer also seemed larger than the conventional one. (M.N.)

  4. Basic and clinical study of boron neutron capture therapy for malignant brain tumor

    International Nuclear Information System (INIS)

    Nose, Tadao; Matsumura, Akira; Nakai, Kei; Nakagawa, Kunio; Yoshii, Yoshihiko; Shibata, Yasushi; Yamamoto, Tetsuya; Hayakawa, Yoshinori; Yamada, Takashi

    1998-01-01

    Rat malignant cells (9L glioma cell) were exposed to neutron radiation after culturing with boron compounds; BSH and STA-BX909, and cell growing ability after the exposure was determined by colony forming assay. The effects of in vivo radiation were examined by measuring neutron flux levels in rat brain and skin aiming to use neutron radiation in clinical study. STA-BX909 was found to show a dose-dependent cell toxicity, which was higher than that of BSH. The radiation induced G2/M block in 9L-glioma cells and their cell cycles recovered thereafter in low-dose radiated cells, but high-dose radiated cells became aneuploidy. Furthermore, boron neutron capture therapy (BNCT) was applied in two patients, 41-year old woman with glioma grade 3 recurred and 45-year old man with glioblastoma multiforme. The former died from systemic deterioration due to ileus, but BNCT was made only one time although conventional radiotherapy is carried out for a relatively long period. Therefore, BNCT was thought to be beneficial from an aspect of 'quality of life' and the effects to repress a recurrence of cancer also seemed larger than the conventional one. (M.N.)

  5. FiR 1 reactor in service for boron neutron capture therapy (BNCT) and isotope production

    International Nuclear Information System (INIS)

    Auterinen, I.; Salmenhaara, S.E.J. . Author

    2004-01-01

    The FiR 1 reactor, a 250 kW Triga reactor, has been in operation since 1962. The main purpose for the existence of the reactor is now the Boron Neutron Capture Therapy (BNCT), but FiR 1 has also an important national role in providing local enterprises and research institutions in the fields of industrial measurements, pharmaceuticals, electronics etc. with isotope production and activation analysis services. In the 1990's a BNCT treatment facility was built at the FiR 1 reactor located at Technical Research Centre of Finland. A special new neutron moderator material Fluental TM (Al+AlF3+Li) developed at VTT ensures the superior quality of the neutron beam. Also the treatment environment is of world top quality after a major renovation of the whole reactor building in 1997. Recently the lithiated polyethylene neutron shielding of the beam aperture was modified to ease the positioning of the patient close to the beam aperture. Increasing the reactor power to 500 kW would allow positioning of the patient further away from the beam aperture. Possibilities to accomplish a safety analysis for this is currently under considerations. Over thirty patients have been treated at FiR 1 since May 1999, when the license for patient treatment was granted to the responsible BNCT treatment organization, Boneca Corporation. Currently three clinical trial protocols for tumours in the brain as well as in the head and neck region are recruiting patients. (author)

  6. D-T neutron generator development for cancer therapy. 1980 annual progress report

    International Nuclear Information System (INIS)

    Bacon, F.M.; Walko, R.J.; Bickes, R.W. Jr.; Cowgill, D.F.; Riedel, A.A.; O'Hagan, J.B.

    1980-05-01

    This report summarizes the work completed during the first year of a two-year grant by NCI/HEW to investigate the feasibility of developing a D-T neutron generator for use in cancer therapy. Experiments have continued on the Target Test Facility (TTF) developed during a previous grant to investigate high-temperature metal hydrides for use as target materials. The high voltage reliability of the TTF has been improved so that 200 kV, 200 mA operation is now routine. In recent target tests, the D-D neutron production rate was measured to be > 1 x 10 11 /s, a rate that corresponds to a D-T neutron production rate of > 1 x 10 13 /s - the desired rate for use in cancer therapy. Deuterium concentration depth profiles in the target, measured during intense ion beam bombardment, show that deuterium is depleted near the surface of the target due to impurities implanted by the ion beam. Recent modifications of the duopigatron ion source to reduce secondary electron damage to the electrodes also improved the ion source efficiency by about 40%. An ultra high vacuum version of the TTF is now being constructed to determine if improved vacuum conditions will reduce ion source impurities to a sufficiently low level that the deuterium near the surface of the target is not depleted. Testing will begin in June 1980

  7. Interim assessment of the experience of fast neutron therapy in Edinburgh

    International Nuclear Information System (INIS)

    Duncan, W.; Arnott, S.J.

    1982-01-01

    Clinical studies of fast neutron therapy were started in Edinburgh in March 1977. The treatment facility has an isocentric machine and a fixed horizontal beam. The neutron beam is produced by 15 MeV deuterons on a thick beryllium target. Six hundred and forty-one patients have been included in these studies in the four-year period to March 1981. Randomly controlled trials have been conducted since May 1977 and 376 patients have been recruited in this period. The local tumor response rates and morbidity observed is given for trials of patients with cerebral gliomass, squamous carcinoma of the head and neck region, transitional cell carcinoma of the bladder and adenocarcinoma of the rectum. This interim evaluation does not demonstrate any advantage of fast neutron radiotherapy as compared with photon therapy. However, greater numbers of patients require to be studied and followed-up for longer intervals. A definitive assessment of the randomly controlled clinical trials in Edinburgh should be possible at the end of 1982

  8. MONDO: A tracker for the characterization of secondary fast and ultrafast neutrons emitted in particle therapy

    Science.gov (United States)

    Mirabelli, R.; Battistoni, G.; Giacometti, V.; Patera, V.; Pinci, D.; Sarti, A.; Sciubba, A.; Traini, G.; Marafini, M.

    2018-01-01

    In Particle Therapy (PT) accelerated charged particles and light ions are used for treating tumors. One of the main limitation to the precision of PT is the emission of secondary particles due to the beam interaction with the patient: secondary emitted neutrons can release a significant dose far from the tumor. Therefore, a precise characterization of their flux, production energy and angle distribution is eagerly needed in order to improve the Treatment Planning Systems (TPS) codes. The principal aim of the MONDO (MOnitor for Neutron Dose in hadrOntherapy) project is the development of a tracking device optimized for the detection of fast and ultra-fast secondary neutrons emitted in PT. The detector consists of a matrix of scintillating square fibres coupled with a CMOS-based readout. Here, we present the characterization of the detector tracker prototype and CMOS-based digital SPAD (Single Photon Avalanche Diode) array sensor tested with protons at the Beam Test Facility (Frascati, Italy) and at the Proton Therapy Centre (Trento, Italy), respectively.

  9. CT densimetry for graduating subcutaneous fibrosis after photon/neutron therapy

    International Nuclear Information System (INIS)

    Eich, H.T.; Eich, P.D.; Mueller, R.D.; Stuschke, M.; Sack, H.

    1999-01-01

    Background: To evaluate alternative treatment regimen e.g. neutron therapy determination of treatment efficacy as well as side effects is important. Sensitivity of computed tomography (CT) in detecting changes of connective tissue after neutron therapy was examined. Patients and Methods: In the course of their follow-up period (median 45 months) 12 patients with malignant salivary gland tumors who had postoperatively received neutron (1/12) or photon/neutron therapy (11/12) were examined by means of CT densimetry on 3 representative scans in the area of radiotherapy. In 3 ROI (regions of interest) in subcutaneous fatty tissue the density at the irradiated and the non-irradiated side was determined according to Hounsfield units (HU) and the average density was calculated. The average density of both sides was compared and correlated with the clinical grade of fibrosis according to LENT SOMA. Results: All CT measurements (216 ROI, 18 ROI per patient) showed higher density levels on the irradiated side than on the non-irradiated side. The average density on the irradiated side was -57.7±4.7 HU and on the non-irradiated side -69.4±5.8 HU (p=0.002). In 3/12 patients a clinical fibrosis was not seen; however, the relative density measured on the irradiated and non-irradiated side deviated by up to 8%. This could have been caused by minimal changes not being noticed by either patient and examiner. In patients with determined fibrosis Grade 1 (8/12) the relative density deviation was 4 to 39%. In 1/12 patients with determined fibrosis Grade 2 the relative density deviation was 50%. Fibrosis Grade 3 and 4 did not occur. Conclusions: Fibrosis is correlated with an increasing value of HU of the tissue density in CT. With the described method it is possible to graduate radiation induced subcutaneous fibrosis in correlation to the clinical fibrosis grade according to LENT SOMA. In the patients we examined subcutaneous fibroses after photon/neutron therapy were moderate

  10. A novel approach to the microdosimetry of neutron capture therapy. Part I. High-resolution quantitative autoradiography applied to microdosimetry in neutron capture therapy

    International Nuclear Information System (INIS)

    Solares, G.R.; Zamenhof, R.G.

    1995-01-01

    A novel approach to the microdosimetry of neutron capture therapy has been developed using high-resolution quantitative autoradiography (HRQAR) and two-dimensional Monte Carlo simulation. This approach has been applied using actual cell morophology (nuclear and cytoplasmic cell structures) and the measured microdistribution of boron-10 in a transplanted murine brain tumor (GL261) containing p-boronophenylalanine (BPA) as the boron compound. The 2D Monte Carlo transport code for the α and 7 Li charged particles from the 10 B(n,α) 7 Li reactions has been developed as a surrogate to a full 3D approach to calculate a variety of different microdosimetric parameters. The HRQAR method and the surrogate 2D Monte Carlo approach are described in detail and examples of their use are presented. 27 refs., 11 figs., 1 tab

  11. A design study on hyper-thermal neutron irradiation field for neutron capture therapy at Kyoto University Reactor

    International Nuclear Information System (INIS)

    Sakurai, Y.; Kobayashi, T.

    2000-01-01

    A study about the installation of a hyper-thermal neutron converter to a clinical collimator was performed, as a series of the design study on a hyper-thermal neutron irradiation field at the Heavy Water Neutron Irradiation Facility of Kyoto University Reactor. From the parametric-surveys by Monte Carlo calculation, it was confirmed that the practical irradiation field of hyper-thermal neutrons would be feasible by the modifications of the clinical collimator and the bismuth-layer structure. (author)

  12. Influence of fuel assembly loading pattern and fuel burnups upon leakage neutron flux spectra from light water reactor core (Joint research)

    International Nuclear Information System (INIS)

    Kojima, Kensuke; Okumura, Keisuke; Kosako, Kazuaki; Torii, Kazutaka

    2016-01-01

    At the decommissioning of light water reactors (LWRs), it is important to evaluate an amount of radioactivity in the ex-core structures such as a reactor containment vessel, radiation shieldings, and so on. It is thought that the leakage neutron spectra in these radioactivation regions, which strongly affect the induced radioactivity, would be changed by different reactor core configurations such as fuel assembly loading pattern and fuel burnups. This study was intended to evaluate these effects. For this purpose, firstly, partial neutron currents on the core surfaces were calculated for some core configurations. Then, the leakage neutron flux spectra in major radioactivation regions were calculated based on the provided currents. Finally, influence of the core configurations upon the neutron flux spectra was evaluated. As a result, it has been found that the influence is small on the spectrum shapes of neutron fluxes. However, it is necessary to pay attention to the facts that intensities of the leakage neutron fluxes are changed by the configurations and that intensities and spectrum shapes of the leakage neutron fluxes are changed depending on the angular direction around the core. (author)

  13. Design and optimization of a beam shaping assembly for BNCT based on D-T neutron generator and dose evaluation using a simulated head phantom.

    Science.gov (United States)

    Rasouli, Fatemeh S; Masoudi, S Farhad

    2012-12-01

    A feasibility study was conducted to design a beam shaping assembly for BNCT based on D-T neutron generator. The optimization of this configuration has been realized in different steps. This proposed system consists of metallic uranium as neutron multiplier, TiF(3) and Al(2)O(3) as moderators, Pb as reflector, Ni as shield and Li-Poly as collimator to guide neutrons toward the patient position. The in-air parameters recommended by IAEA were assessed for this proposed configuration without using any filters which enables us to have a high epithermal neutron flux at the beam port. Also a simulated Snyder head phantom was used to evaluate dose profiles due to the irradiation of designed beam. The dose evaluation results and depth-dose curves show that the neutron beam designed in this work is effective for deep-seated brain tumor treatments even with D-T neutron generator with a neutron yield of 2.4×10(12) n/s. The Monte Carlo Code MCNP-4C is used in order to perform these calculations. Copyright © 2012 Elsevier Ltd. All rights reserved.

  14. Neutron spectra measurement and calculations using data libraries CIELO, JEFF-3.2 and ENDF/B-VII.1 in iron benchmark assemblies

    Science.gov (United States)

    Jansky, Bohumil; Rejchrt, Jiri; Novak, Evzen; Losa, Evzen; Blokhin, Anatoly I.; Mitenkova, Elena

    2017-09-01

    The leakage neutron spectra measurements have been done on benchmark spherical assemblies - iron spheres with diameter of 20, 30, 50 and 100 cm. The Cf-252 neutron source was placed into the centre of iron sphere. The proton recoil method was used for neutron spectra measurement using spherical hydrogen proportional counters with diameter of 4 cm and with pressure of 400 and 1000 kPa. The neutron energy range of spectrometer is from 0.1 to 1.3 MeV. This energy interval represents about 85 % of all leakage neutrons from Fe sphere of diameter 50 cm and about of 74% for Fe sphere of diameter 100 cm. The adequate MCNP neutron spectra calculations based on data libraries CIELO, JEFF-3.2 and ENDF/B-VII.1 were done. Two calculations were done with CIELO library. The first one used data for all Fe-isotopes from CIELO and the second one (CIELO-56) used only Fe-56 data from CIELO and data for other Fe isotopes were from ENDF/B-VII.1. The energy structure used for calculations and measurements was 40 gpd (groups per decade) and 200 gpd. Structure 200 gpd represents lethargy step about of 1%. This relatively fine energy structure enables to analyze the Fe resonance neutron energy structure. The evaluated cross section data of Fe were validated on comparisons between the calculated and experimental spectra.

  15. In vitro and in vivo studies in boron neutron capture therapy of malignant melanoma

    International Nuclear Information System (INIS)

    Allen, B.J.

    1982-01-01

    A multidisciplinary research project in boron neutron capture therapy of malignant melanoma is under consideration by the Australian Atomic Energy Commission. This paper reviews the biochemistry of melanoma and the properties of some melanoma-affined radiopharmaceuticals and their boron analogues. Human cell lines are being used for in vitro tests of uptake and incorporation of some of these compounds, and selected lines will then be implanted in nude mice for in vivo distribution studies. The fidelity of human melanoma xenografts in nude mice has been well studied, and results are reviewed in this paper. Boron concentration will be measured directly by plasma arc emission spectroscopy or liquid scintillation counting with 14 C-labelled boron analogues. Track-etch techniques will be used for the microscopic determination of boron in tumor sections. Neutron irradiation and radiobiology experiments are outlined

  16. The Idaho Power Burst Facility/Boron Neutron Capture Therapy (PBF/BNCT) Program overview

    International Nuclear Information System (INIS)

    Dorn, R.V. III; Griebenow, M.L.; Ackermann, A.L.; Miller, L.G.; Miller, D.L.; Wheeler, F.J.; Bradshaw, K.M.; Wessol, D.E.; Harker, Y.D.; Nigg, D.W.; Randolph, P.D.; Bauer, W.F.; Gavin, P.R.; Richards, T.L.

    1992-01-01

    The Power Burst Facility/Boron Neutron Capture Therapy (PBF/BNCT) Program has been funded since 1988 to evaluate brain tumor treatment using Na 2 B 12 H 11 SH (borocaptate sodium or BSH) and epithermal neutrons. The PBF/BNCT Program pursues this goal as a comprehensive, multidisciplinary, multiorganizational endeavor applying modern program management techniques. The initial focus was to: (1) establish a representative large animal model and (2) develop the generic analytical and measurement capabilities require to control treatment repeatability and determine critical treatment parameters independent of tumor type and body location. This paper will identify the PBF/BNCT Program elements and summarize the status of some of the developed capabilities

  17. Establishment of optimal thermal neutron capture therapy for 5 types of human malignant melanoma

    International Nuclear Information System (INIS)

    Mishima, Yutaka

    1993-03-01

    A series of boron neutron capture therapy (BNCT) studies has already germinated in 1972, with a view to establishing the BNCT particularly suited for the treatment of various types of malignant melanoma, and has been succeeded by research teams comprised of multi-disciplinary members. Twelve patients (7 men and 5 women, aged from 50 to 85 years) with malignant melanoma have been treated with BNCT; among them, six patients were completely cured, four had extremely reduced tumors, and two were still in the clinical process. The present Progress Report is a compilation of 39 research presentations for the recent two years. In this report, three patients are described. Of these, one patient had deep-seated lesions in right and left lymph nodes. These lesions were cured by the use of D 2 O that allowed neutron beams to reach them. Application of positron emission tomography to the diagnosis of melanoma is a highlight in this Report. (N.K.)

  18. Analysis of MCNP simulated gamma spectra of CdTe detectors for boron neutron capture therapy.

    Science.gov (United States)

    Winkler, Alexander; Koivunoro, Hanna; Savolainen, Sauli

    2017-06-01

    The next step in the boron neutron capture therapy (BNCT) is the real time imaging of the boron concentration in healthy and tumor tissue. Monte Carlo simulations are employed to predict the detector response required to realize single-photon emission computed tomography in BNCT, but have failed to correctly resemble measured data for cadmium telluride detectors. In this study we have tested the gamma production cross-section data tables of commonly used libraries in the Monte Carlo code MCNP in comparison to measurements. The cross section data table TENDL-2008-ACE is reproducing measured data best, whilst the commonly used ENDL92 and other studied libraries do not include correct tables for the gamma production from the cadmium neutron capture reaction that is occurring inside the detector. Furthermore, we have discussed the size of the annihilation peaks of spectra obtained by cadmium telluride and germanium detectors. Copyright © 2017 Elsevier Ltd. All rights reserved.

  19. Synthesis and biological evaluation of boronated polyglycerol dendrimers as potential agent for neutron capture therapy

    International Nuclear Information System (INIS)

    Silva, Gerald S.; Camillo, Maria A.P.; Higa, Olga Z.; Pugliesi, Reynaldo; Fermamdes, Edson G.R.; Queiroz, Alvaro A.A. de

    2005-01-01

    In this work, the polyglycerol dendrimer (PGLD) generation 5 was used to obtain a boronated macromolecule for boron neutron capture therapy. The PGLD dendrimer was synthesized by the ring opening polymerization of deprotonated glycidol using polyglycerol as core functionality in a step-growth processes denominated divergent synthesis. The PGLD dendritic structure was confirmed by gel permeation chromatography, nuclear magnetic resonance ( 1 H-NMR, 13 C-NMR) and matrix assisted laser desorption/ionization techniques. The synthesized dendrimer presented low dispersion in molecular weights (M w /M n = 1.05) and a degree of branching of 0.82, which characterize the polymer dendritic structure. Quantitative neutron capture radiography was used to investigate the boron-10 enrichment of the polyglycerol dendrimer. The in vitro cytotoxicity to Chinese hamster ovary cells of 10 B-PGLD dendrimer indicate lower cytotoxicity, suggesting that the macromolecule is a biocompatible material. (author)

  20. Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Haapaniemi, Aaro, E-mail: aaro.haapaniemi@hus.fi [Department of Otorhinolaryngology–Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki (Finland); Kankaanranta, Leena [Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki (Finland); Saat, Riste [Department of Radiology, Helsinki University Hospital and University of Helsinki, Helsinki (Finland); Koivunoro, Hanna; Saarilahti, Kauko [Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki (Finland); Mäkitie, Antti; Atula, Timo [Department of Otorhinolaryngology–Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki (Finland); Joensuu, Heikki [Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki (Finland)

    2016-05-01

    Purpose: To investigate the safety and efficacy of boron neutron capture therapy (BNCT) as a larynx-preserving treatment option for patients with recurrent laryngeal cancer. Methods and Materials: Six patients with locally recurrent squamous cell laryngeal carcinoma and 3 patients with persistent laryngeal cancer after prior treatment were treated with BNCT at the FiR1 facility (Espoo, Finland) in 2006 to 2012. The patients had received prior radiation therapy with or without concomitant chemotherapy to a cumulative median dose of 66 Gy. The median tumor diameter was 2.9 cm (range, 1.4-10.9 cm) before BNCT. Boron neutron capture therapy was offered on a compassionate basis to patients who either refused laryngectomy (n=7) or had an inoperable tumor (n=2). Boronophenylalanine-fructose (400 mg/kg) was used as the boron carrier and was infused over 2 hours intravenously before neutron irradiation. Results: Six patients received BNCT once and 3 twice. The estimated average gross tumor volume dose ranged from 22 to 38 Gy (W) (mean; 29 Gy [W]). Six of the 8 evaluable patients responded to BNCT; 2 achieved complete and 4 partial response. One patient died early and was not evaluable for response. Most common side effects were stomatitis, fatigue, and oral pain. No life-threatening or grade 4 toxicity was observed. The median time to progression within the target volume was 6.6 months, and the median overall survival time 13.3 months after BNCT. One patient with complete response is alive and disease-free with a functioning larynx 60 months after BNCT. Conclusions: Boron neutron capture therapy given after prior external beam radiation therapy is well tolerated. Most patients responded to BNCT, but long-term survival with larynx preservation was infrequent owing to cancer progression. Selected patients with recurrent laryngeal cancer may benefit from BNCT.

  1. Supplementary neutron-flux calculations for the ORNL Pool Critical Assembly Pressure Vessel Facility

    International Nuclear Information System (INIS)

    Maudlin, P.J.; Maerker, R.E.

    1982-01-01

    A three-dimensional Monte Carlo calculation using the MORSE code was performed to validate a procedure previously adopted in the ORNL discrete ordinate analysis of measurements made in the ORNL Pool Critical Assembly Pressure Vessel Facility. The results of these flux calculations agree, within statistical undertainties of about 5%, with those obtained from a discrete ordinate analysis employing the same procedure. This study therefore concludes that the procedure for combining several one- and two-dimensional discrete ordinate calculations into a three-dimensional flux is sufficiently accurate that it does not account for the existing discrepancies observed between calculations and measurements in this facility

  2. Supplementary neutron-flux calculations for the ORNL Pool Critical Assembly Pressure Vessel Facility

    Energy Technology Data Exchange (ETDEWEB)

    Maudlin, P.J.; Maerker, R.E.

    1982-01-01

    A three-dimensional Monte Carlo calculation using the MORSE code was performed to validate a procedure previously adopted in the ORNL discrete ordinate analysis of measurements made in the ORNL Pool Critical Assembly Pressure Vessel Facility. The results of these flux calculations agree, within statistical undertainties of about 5%, with those obtained from a discrete ordinate analysis employing the same procedure. This study therefore concludes that the procedure for combining several one- and two-dimensional discrete ordinate calculations into a three-dimensional flux is sufficiently accurate that it does not account for the existing discrepancies observed between calculations and measurements in this facility.

  3. Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy

    International Nuclear Information System (INIS)

    Pérez-Andújar, Angélica; Zhang, Rui; Newhauser, Wayne

    2013-01-01

    Purpose: Stray neutron radiation is of concern after radiation therapy, especially in children, because of the high risk it might carry for secondary cancers. Several previous studies predicted the stray neutron exposure from proton therapy, mostly using Monte Carlo simulations. Promising attempts to develop analytical models have also been reported, but these were limited to only a few proton beam energies. The purpose of this study was to develop an analytical model to predict leakage neutron equivalent dose from passively scattered proton beams in the 100-250-MeV interval.Methods: To develop and validate the analytical model, the authors used values of equivalent dose per therapeutic absorbed dose (H/D) predicted with Monte Carlo simulations. The authors also characterized the behavior of the mean neutron radiation-weighting factor, w R , as a function of depth in a water phantom and distance from the beam central axis.Results: The simulated and analytical predictions agreed well. On average, the percentage difference between the analytical model and the Monte Carlo simulations was 10% for the energies and positions studied. The authors found that w R was highest at the shallowest depth and decreased with depth until around 10 cm, where it started to increase slowly with depth. This was consistent among all energies.Conclusion: Simple analytical methods are promising alternatives to complex and slow Monte Carlo simulations to predict H/D values. The authors' results also provide improved understanding of the behavior of w R which strongly depends on depth, but is nearly independent of lateral distance from the beam central axis

  4. Application of drug delivery system for boron neutron capture therapy. Basic research toward clinical application

    International Nuclear Information System (INIS)

    Yanagie, Hironobu; Takahashi, Hiroyuki

    2010-01-01

    Tumour cell destruction in boron neutron-capture therapy (BNCT) is due to the nuclear reaction between 10 B and thermal neutrons ( 10 B+ 1 n → 7 Li+ 4 He (α) +2.31 MeV (93.7%)/2.79 MeV (6.3%)). The resulting lithium ions and αparticles are high linear energy transfer (LET) particles which give high biological effect. Their short range in tissue (5-9 μm) restricts radiation damage to those cells in which boron atoms are located at the time of neutron irradiation. BNCT has been applied clinically for the treatment of malignant brain tumors, malignant melanoma, head and neck cancer and hepatoma etc, recently. Sodium borocaptate (Na 2 10 B 12 H 11 SH; BSH) and borono-phenylalanine ( 10 BPA) are currently being used in clinical treatments. To achieve the selective delivery of boron atoms to cancer cells, drug delivery system (DDS) becomes an attractive intelligent technology as targeting and controlled release of drugs. We have firstly reported that 10 B atoms delivered by immunoliposomes are cytotoxic to human pancreatic carcinoma cells (AsPC-1) after thermal neutron irradiation in vitro. The intra-tumoural injection of boronated immunoliposomes can increase the retention of 10 B atoms in tumour cells, causing suppression of tumour growth in vivo following thermal neutron irradiation. We prepared polyethylene-glycol binding liposomes (PEG-liposomes) as an effective 10 B carrier to obviate phagocytosis by reticuloendotherial systems. We had prepared 10 BSH entrapped Water-in-Oil-in-Water (WOW) emulsion. The 10 B concentration in VX-2 tumour after intra-arterial injection of 10 BSH entrapped WOW emulsion was superior to the groups of 10 BSH entrapped conventional Lipiodol mix emulsion. 10 Boron entrapped WOW emulsion is one of the most useful for intra-arterial boron delivery carrier on BNCT to hepatocellular carcinoma. (author)

  5. Dosimetry boron neutron capture therapy in liver cancer (hepatocellular carcinoma) by means of MCNP-code with neutron source from thermal column

    International Nuclear Information System (INIS)

    Irhas; Andang Widi Harto; Yohannes Sardjono

    2014-01-01

    Boron Neutron Capture Therapy (BNCT) using physics principle when B 10 (Boron-10) irradiated by low energy neutron (thermal neutron). Boron and thermal neutron reaction produced B 11m (Boron-11m) (t 1/2 =10 -2 s). B 11m decay emitted alpha, Li 7 (Lithium-7) particle and gamma ray. Irradiated time needed to ensure cancer dose enough. Liver cancer was primary malignant who located in liver (Hepatocellular carcinoma). Malignant in liver were different to metastatic from Breast, Colon Cancer, and the other. This condition was Metastatic Liver Cancer. Monte Carlo method used by Monte Carlo N-Particle (MCNP) Software. Probabilistic approach used for probability of interaction occurred and record refers to characteristic of particle and material. In this case, thermal neutron produced by model of Collimated Thermal Column Kartini Research Nuclear Reactor, Yogyakarta. Modelling organ and source used liver organ that contain of cancer tissue and research reactor. Variation of boron concentration was 20, 25, 30, 35, 40, 45, and 47 µg/g cancers. Output of MCNP calculation were neutron scattering dose, gamma ray dose and neutron flux from reactor. Neutron flux used to calculate alpha, proton and gamma ray dose from interaction of tissue material and thermal neutron. Variation of boron concentration result dose rate to every variation were 0,059; 0,072; 0,084; 0,098; 0.108; 0,12; 0,125 Gy/sec. Irradiation time who need to every concentration were 841,5 see (14 min 1 sec); 696,07 sec(11 min 36 sec); 593.11 sec (9 min 53 sec); 461,35 sec (8 min 30 sec); 461,238 sec (7 min 41 sec); 414,23 sec (6 min 54 sec); 398,38 sec (6 min 38 sec). Irradiating time could shortly when boron concentration more high. (author)

  6. Single photon image from PET with insertable collimator for boron neutron capture therapy

    International Nuclear Information System (INIS)

    Jung, Jooyoung; Suh, Tae Suk; Hong, Key Jo

    2014-01-01

    Boron neutron capture therapy (BNCT) is a radiation therapy technique for treating deep-seated brain tumors by irradiation with a thermal neutron in which boron-labelled low molecular weight compounds. Once completed, a single photon emission computed tomography (SPECT) scan is conducted to investigate for the region of therapy using an isotope exclusive to SPECT. In the case of an existing PET/SPECT combination system, at least two types of isotopes should be used for each scan with their purposes. Recently, researchers examined the effects of PET/SPECT dual modality on animal imaging systems. They reported that the PET/SPECT combination system was effective for simultaneous achievement of a single event and coincidence. The aim of our proposed system is to confirm the feasibility of extraction of two types of images from one PET module with an insertable collimator for brain tumor treatment during the BNCT. We attempted to acquire the PET and SPECT images simultaneously using only PET without an additional isotope. Single photon images were acquired using an insertable collimator on a PET detector

  7. Clinical treatment planning for subjects undergoing boron neutron capture therapy at Harvard-MIT

    International Nuclear Information System (INIS)

    Zamenhof, R.G.; Palmer, M.R.; Buse, P.M.

    2001-01-01

    Treatment planning is a crucial component of the Harvard-MIT boron neutron capture therapy (BNCT) clinical trials. Treatment planning can be divided into five stages: (1) pre-planning, based on CT and MRI scans obtained when the subject arrives at the hospital and on assumed boron-10 distribution parameters; (2) subject set-up, or simulation, in the MITR-II medical therapy room to determine the boundary conditions for possible set-up configurations; (3) re-planning, following the subject simulation; (4) final localization of the subject in the medical therapy room for BNCT; and (5) final post facto recalculation of the doses delivered based on firm knowledge of the blood boron-10 concentration profiles and the neutron flux histories from precise online monitoring. The computer-assisted treatment planning is done using a specially written BNCT treatment planning code called MacNCTPLAN. The code uses the Los Alamos National Laboratory's Monte Carlo n-particle radiation transport code MCNPv.4b as the dose calculation engine and advanced anatomical model simulation based on an automatic evaluation of CT scan data. Results are displayed as isodose contours and dose-volume histograms, the latter correlated precisely with corresponding anatomical CT or MRI image planes. Examples of typical treatment planning scenarios will be presented. (author)

  8. Evaluation of the harmonics and neutronic coupling in the sub-cores of the Brazilian `RESUCO` subcritical assembly; Avaliacoes dos harmonicos e do acoplamento neutronico entre dois subnucleos do conjunto subcritico `RESUCO`

    Energy Technology Data Exchange (ETDEWEB)

    Aquino Bezerra, A.F. de

    1991-05-01

    The present study evaluates the importance of the harmonic components in the thermal neutron flux distribution and evaluates as well the separation required for attaining neutronic decoupling in sub-cores in subcritical assemblies. The theoretical results are compared to experimental ones performed at the Brazilian natural uranium, light water RESUCO subcritical assembly. It is observed that the harmonics have a very important contributions to neutron flux. Furthermore, the neutronic decoupling is attained with the removal of five rows of fuel elements, corresponding to 27,5 cm of light water. (F.E.). 23 refs, 18 figs, 9 tabs.

  9. Neutron Activation Foil and Thermoluminescent Dosimeter Responses to a Lead Reflected Pulse of the CEA Valduc SILENE Critical Assembly

    Energy Technology Data Exchange (ETDEWEB)

    Miller, Thomas Martin [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Celik, Cihangir [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Isbell, Kimberly McMahan [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Lee, Yi-kang [Commissariat a l' Energie Atomique et aux Energies Alternatives (CEA-Saclay), Gif-sur-Yvette (France); Gagnier, Emmanuel [Commissariat a l' Energie Atomique et aux Energies Alternatives (CEA-Saclay), Gif-sur-Yvette (France); Authier, Nicolas [Commissariat a l' Energie Atomique et aux Energies Alternatives (CEA-Saclay), Gif-sur-Yvette (France); Piot, Jerome [Commissariat a l' Energie Atomique et aux Energies Alternatives (CEA-Saclay), Gif-sur-Yvette (France); Jacquet, Xavier [Commissariat a l' Energie Atomique et aux Energies Alternatives (CEA-Saclay), Gif-sur-Yvette (France); Rousseau, Guillaume [Commissariat a l' Energie Atomique et aux Energies Alternatives (CEA-Saclay), Gif-sur-Yvette (France); Reynolds, Kevin H. [Y-12 National Security Complex, Oak Ridge, TN (United States)

    2016-09-01

    This benchmark experiment was conducted as a joint venture between the US Department of Energy (DOE) and the French Commissariat à l'Energie Atomique (CEA). Staff at the Oak Ridge National Laboratory (ORNL) in the US and the Centre de Valduc in France planned this experiment. The experiment was conducted on October 13, 2010 in the SILENE critical assembly facility at Valduc. Several other organizations contributed to this experiment and the subsequent evaluation, including CEA Saclay, Lawrence Livermore National Laboratory (LLNL), the Y-12 National Security Complex (NSC), Babcock International Group in the United Kingdom, and Los Alamos National Laboratory (LANL). The goal of this experiment was to measure neutron activation and thermoluminescent dosimeter (TLD) doses from a source similar to a fissile solution critical excursion. The resulting benchmark can be used for validation of computer codes and nuclear data libraries as required when performing analysis of criticality accident alarm systems (CAASs). A secondary goal of this experiment was to qualitatively test performance of two CAAS detectors similar to those currently and formerly in use in some US DOE facilities. The detectors tested were the CIDAS MkX and the Rocky Flats NCD-91. The CIDAS detects gammas with a Geiger-Muller tube, and the Rocky Flats detects neutrons via charged particles produced in a thin 6LiF disc, depositing energy in a Si solid-state detector. These detectors were being evaluated to determine whether they would alarm, so they were not expected to generate benchmark quality data.

  10. Slow-neutron capture therapy for malignant tumours: its history and recent development

    International Nuclear Information System (INIS)

    Hatanaka, H.

    1975-01-01

    Slow-neutron capture therapy was first suggested in 1936. The early clinical trials were performed at Brookhaven National Laboratory and Massachusetts Institute of Technology reactors. In the last series of treatments in 1960 and 1961, none of the 17 glioblastoma patients lived longer than a year and the clinical trial was discontinued, particularly because the was pathological evidence that normal tissue had been seriously damaged. Hatanaka, who worked first with Sweet between 1964 and 1967, continued intensive basic research and organized a collaborating team of chemists, physicists and physicians in Japan where he resumed treatment of brain tumour patients in 1968. The rationale of the revised therapy included: (1) use of promising compounds such as mercaptoundecahydrododecaborate, which has a high tumour binding property, (2) use of adrenocorticoid to minimize vascular damage, (3) intra-arterial infusion of boron to obtain a higher concentration in the tumour, (4) restriction of excessive neutron intensity, (5) and some technical improvements. New research techniques were also introduced, such as alpha autoradiography, electron microscopy, and immunotherapy. With the mercaptoundecahydrododecaborate compound an absolute concentration of 30 μg per gram of tumour is easily attainable, while the blood level of the isotope can be lowered to at least half of the tumour concentration. Normal dog brains were able to tolerate this therapy. Among the 15 patients so far treated, 13 were treated at the Hitachi Training Reactor. Patients, who had undergone repeated surgery as well as excessive irradiation before they came for the therapy, could not recover their full activities, but proved they could enjoy a significant prolongation of their lives. The only two fresh cases of glioblastoma responded so well to the therapy that one has been working as an engineer and the other as a farmer for 3 years without neurological deficits. Recent progress and future potentials of the

  11. PEMODELAN KOLIMATOR DI RADIAL BEAM PORT REAKTOR KARTINI UNTUK BORON NEUTRON CAPTURE THERAPY

    Directory of Open Access Journals (Sweden)

    Bemby Yulio Vallenry

    2015-03-01

    Full Text Available Salah satu metode terapi kanker adalah Boron Neutron Capture Therapy (BNCT. BNCT memanfaatkan tangkapan neutron oleh 10B yang terendapkan pada sel kanker. Keunggulan BNCT dibandingkan dengan terapi radiasi lainnya adalah tingkat selektivitas yang tinggi karena tingkatannya adalah sel. Pada penelitian ini dilakukan pemodelan kolimator di radial beamport reaktor Kartini sebagai dasar pemilihan material dan manufature kolimator sebagai sumber neutron untuk BNCT. Pemodelan ini dilakukan dengan simulasi menggunakan perangkat lunak Monte Carlo N-Particle versi 5 (MCNP 5. MCNP 5 adalah suatu paket program untuk memodelkan sekaligus menghitung masalah transpor partikel dengan mengikuti sejarah hidup neutron semenjak lahir, bertranspor pada bahan hingga akhirnya hilang karena mengalami reaksi penyerapan atau keluar dari sistem. Pemodelan ini menggunakan variasi material dan ukurannya agar menghasilkan nilai dari tiap parameter-parameter yang sesuai dengan rekomendasi I International Atomic Energy Agency (IAEA untuk BNCT, yaitu fluks neutron epitermal (Фepi > 9 n.cm-2.s-1, rasio antara laju dosis neutron cepat dan fluks neutron epitermal (Ḋf/Фepi 0,7. Berdasarkan hasil optimasi dari pemodelan ini, material dan ukuran penyusun kolimator yang didapatkan yaitu 0,75 cm Ni sebagai dinding kolimator, 22 cm Al sebagai moderator dan 4,5 cm Bi sebagai perisai gamma. Keluaran berkas radiasi yang dihasilkan dari pemodelan kolimator radial beamport yaitu Фepi = 5,25 x 106 n.cm-2s-1, Ḋf/Фepi =1,17 x 10-13 Gy.cm2.n-1, Ḋγ/Фepi = 1,70 x 10-12 Gy.cm2.n-1, Фth/Фepi = 1,51 dan J/Фepi = 0,731. Berdasarkan penelitian ini, hasil optimasi 5 parameter sebagai persyaratan kolimator untuk BNCT yang keluar dari radial beam port tidak sepenuhnya memenuhi kriteria yang direkomendasikan oleh IAEA sehingga perlu dilakukan penelitian lebih lanjut agar tercapainya persyaratan IAEA. Kata kunci: BNCT, radial beamport, MCNP 5, kolimator   One of the cancer therapy methods is

  12. Neutronics benchmark of a MOX assembly with near-weapons-grade plutonium

    International Nuclear Information System (INIS)

    Difilippo, F.C.; Fisher, S.E.

    1998-01-01

    One of the proposed ways to dispose of surplus weapons-grade plutonium (Pu) is to irradiate the high-fissile material in light-water reactors in order to reduce the Pu enrichment to the level of spent fuels from commercial reactors. Considerable experience has been accumulated about the behavior of mixed-oxide (MOX) uranium and plutonium fuels for plutonium recycling in commercial reactors, but the experience is related to Pu enrichments typical of spent fuels quite below the values of weapons-grade plutonium. Important decisions related to the kind of reactors to be used for the disposition of the plutonium are going to be based on calculations, so the validation of computational algorithms related to all aspects of the fuel cycle (power distributions, isotopics as function of the burnup, etc.), for weapons-grade isotopics is very important. Analysis of public domain data reveals that the cycle-2 irradiation in the Quad cities boiling-water reactor (BWR) is the most recent US destructive examination. This effort involved the irradiation of five MOX assemblies using 80 and 90% fissile plutonium. These benchmark data were gathered by General Electric under the sponsorship of the Electric Power Research Institute. It is emphasized, however, that global parameters are not the focus of this benchmark, since the five bundles containing MOX fuels did not significantly affect the overall core performance. However, since the primary objective of this work is to compare against measured post-irradiation assembly data, the term benchmark is applied here. One important reason for performing the benchmark on Quad Cities irradiation is that the fissile blends (up to 90%) are higher than reactor-grade and, quite close to, weapons-grade isotopics

  13. (n,xn cross section measurements for Y-89 foils used as detectors for high energy neutron measurements in the deeply subcritical assembly “QUINTA”

    Directory of Open Access Journals (Sweden)

    Bielewicz Marcin

    2017-01-01

    Full Text Available Study of the deep subcritical systems (QUINTA using relativistic beams is performed within the project “Energy and Transmutation of Radioactive Wastes” (E&T – RAW. The experiment assembly was irradiated by deuteron/proton beam (Dubna NUCLOTRON. We calculated the neutron energy spectrum inside the whole assembly by using threshold energy (n,xn reactions in yttrium (Y-89 foils. There are almost no experimental cross section data for those reactions. New Y-89(n,xn cross section measurements were carried out at The Svedberg laboratory (TSL in Uppsala, Sweden in 2015. In this paper we present preliminary results of those experiments.

  14. In situ and real-time small-angle neutron scattering studies of living anionic polymerization process and polymerization-induced self-assembly of block copolymers

    International Nuclear Information System (INIS)

    Tanaka, H.; Yamauchi, K.; Hasegawa, H.; Miyamoto, N.; Koizumi, S.; Hashimoto, T.

    2006-01-01

    We have studied a simultaneous living anionic polymerization process of isoprene and deuterated styrene in deuterated benzene with sec-buthyl lithium as an initiator into polyisoprene-block-poly(styrene-d 8 ) and the polymerization-induced self-assembling process. This polymerization-induced self-assembling process was directly observed by an in situ and real-time small-angle neutron scattering (SANS) experiment. The time-resolved SANS studies enabled us to explore a time evolution of hierarchical structures induced by a time evolution of the primary structure (linear sequential connection of two monomers)

  15. Boron Neutron Capture Therapy at European research reactors - Status and perspectives

    International Nuclear Information System (INIS)

    Moss, R.L.

    2004-01-01

    Over the last decade. there has been a significant revival in the development of Boron Neutron Capture Therapy (BNCT) as a treatment modality for curing cancerous tumours, especially glioblastoma multiforme and subcutaneous malignant melanoma. In 1987 a European Collaboration on BNCT was formed, with the prime task to identify suitable research reactors in Europe where BNCT could be applied. Due to reasons discussed in this paper, the HFR Petten was chosen as the test-bed for demonstrating BNCT. Currently, the European Collaboration is approaching the start of clinical trials, using epithermal neutrons and borocaptate sodium (BSH) as the 10 B delivery agent. The treatment is planned to start in the first half of 1996. The paper here presents an overview on the principle of BNCT, the requirements imposed on a research reactor in order to be considered for BNCT, and the perspectives for other European materials testing reactors. A brief summary on the current status of the work at Petten is given, including: the design, construction and characterisation of the epithermal neutron beam: performance and results of the healthy tissue tolerance study; the development of a treatment planning programme based on the Monte Carlo code MCNP; the design of an irradiation room; and on the clinical trials themselves. (author)

  16. 1013/second 14 MeV neutron generator for cancer therapy

    International Nuclear Information System (INIS)

    Walko, R.J.; Bacon, F.M.; Bickes, R.W. Jr.; Cowgill, D.F.; Boers, J.E.; Riedel, A.A.; O'Hagan, J.B.

    1980-01-01

    A high output D-T neutron generator is being developed at Sandia National Laboratories as a cancer therapy tool. Preliminary results have been obtained with a high vacuum deuterium accelerator consisting of a duopigatron ion source, single stage accelerator and a scandium occluder target. The ion source and accelerating system have been optimized to reliably focus a 200 mA, 200 kV deuterium ion beam onto the scandium target 1.5 m away with a beam spot size of 10 -3 m 2 . The scandium target degrades due to implantation of impurities from the unbaked vacuum system. A UHV accelerator is being fabricated which will permit a 450 0 C bakeout to alleviate the impurity problem. This system will also be compatible with the use of tritium, a necessary component of the therapy machine

  17. Boron neutron capture therapy as new treatment for clear cell sarcoma: Trial on different animal model

    International Nuclear Information System (INIS)

    Andoh, Tooru; Fujimoto, Takuya; Sudo, Tamotsu; Suzuki, Minoru; Sakurai, Yoshinori; Sakuma, Toshiko; Moritake, Hiroshi; Sugimoto, Tohru; Takeuchi, Tamotsu; Sonobe, Hiroshi; Epstein, Alan L.; Fukumori, Yoshinobu; Ono, Koji; Ichikawa, Hideki

    2014-01-01

    Clear cell sarcoma (CCS) is a rare malignant tumor with a poor prognosis. In our previous study, the tumor disappeared under boron neutron capture therapy (BNCT) on subcutaneously-transplanted CCS-bearing animals. In the present study, the tumor disappeared under this therapy on model mice intramuscularly implanted with three different human CCS cells. BNCT led to the suppression of tumor-growth in each of the different model mice, suggesting its potentiality as an alternative to, or integrative option for, the treatment of CCS. - Highlights: • BNCT with the use of L-BPA was applied for three human clear cell sarcoma (CCS) cell lines. • BNCT trial was performed on a newly established intramuscularly CCS-bearing animal model. • A significant decrease of the tumor-volume was seen by single BNCT with the use of L-BPA. • A multiple BNCT application would be required for controlling the growth of any residual tumors

  18. Boron neutron capture therapy. Synthesis of boronated amines- and DNA intercalating agents for potential use in cancer therapy

    International Nuclear Information System (INIS)

    Ghaneolhosseini, H.

    1998-01-01

    Boron Neutron Capture Therapy is a binary cancer treatment modality, involving the delivery of a suitable boron compound to tumour cells followed by irradiation of the tumour by thermal neutrons. Boronated agents can selectively be delivered to tumour cells either directly with tumour-specific boron compounds, or by use of targeting strategies. However, the efficacy of this method would increase if the boron agents are localised in the cell nucleus rather than in the cell cytoplasm when neutron irradiation takes place. With these considerations in mind, some boronated DNA intercalating/interacting agents such as phenanthridine- acridine- spermidine- and naphthalimide derivatives were synthesised. Aminoalkyl-o-carboranes were synthesised in order to be used both for coupling to macromolecules and also for halogenation of their corresponding nido-derivatives. The amino groups were introduced using the Gabriel reagent N, N-dibenzyl iminodicarboxylate to provide 1-(aminomethyl)- and 1-(2-aminoethyl)-o-carboranes. The first attempt to achieve the possibility to accumulate a higher concentration of boron atoms in the cell nucleus was to synthesize carboranyl phenanthridinium analogues by reacting a p- or o-carboranyl moiety with phenanthridine, a chromophore with a planar aromatic ring system as DNA intercalator. Boronated acridine-spermidine, boronated diacridine, and boronated dispermidine were obtained in order to increase water solubility to avoid the interaction of these agents with non-DNA sides of the cell, especially membranes; and to enhance the feasibility of a higher DNA-binding constant and also decrease the DNA-drug dissociation rate. Finally, the synthesis of a boronated naphthalimide derivative was carried out by nucleophilic reaction of a primary aminoalkyl-p-carborane with naphthalic anhydride. Biological evaluations on DNA-binding, toxicity, and cellular binding with carboranyl phenanthridinium analogues, boronated acridine- and spermidine are described

  19. Neutron Activation and Thermoluminescent Detector Responses to a Bare Pulse of the CEA Valduc SILENE Critical Assembly

    Energy Technology Data Exchange (ETDEWEB)

    Miller, Thomas Martin [ORNL; Isbell, Kimberly McMahan [ORNL; Lee, Yi-kang [French Atomic Energy Commission (CEA), Centre de Saclay, Gif sur Yvette; Gagnier, Emmanuel [French Atomic Energy Commission (CEA), Centre de Saclay, Gif sur Yvette; Authier, Nicolas [French Atomic Energy Commission (CEA), Centre de Valduc, Is-sur-Tille; Piot, Jerome [French Atomic Energy Commission (CEA), Centre de Valduc, Is-sur-Tille; Jacquet, Xavier [French Atomic Energy Commission (CEA), Centre de Valduc, Is-sur-Tille; Rousseau, Guillaume [French Atomic Energy Commission (CEA), Centre de Valduc, Is-sur-Tille; Reynolds, Kevin H. [Y-12 National Security Complex

    2016-09-01

    This benchmark experiment was conducted as a joint venture between the US Department of Energy (DOE) and the French Commissariat à l'Energie Atomique (CEA). Staff at the Oak Ridge National Laboratory (ORNL) in the US and the Centre de Valduc in France planned this experiment. The experiment was conducted on October 11, 2010 in the SILENE critical assembly facility at Valduc. Several other organizations contributed to this experiment and the subsequent evaluation, including CEA Saclay, Lawrence Livermore National Laboratory (LLNL), the Y-12 National Security Complex (NSC), Babcock International Group in the United Kingdom, and Los Alamos National Laboratory (LANL). The goal of this experiment was to measure neutron activation and thermoluminescent dosimeter (TLD) doses from a source similar to a fissile solution critical excursion. The resulting benchmark can be used for validation of computer codes and nuclear data libraries as required when performing analysis of criticality accident alarm systems (CAASs). A secondary goal of this experiment was to qualitatively test performance of two CAAS detectors similar to those currently and formerly in use in some US DOE facilities. The detectors tested were the CIDAS MkX and the Rocky Flats NCD-91. These detectors were being evaluated to determine whether they would alarm, so they were not expected to generate benchmark quality data.

  20. Trial production of hyper-thermal neutron generator for Neutron Capture Therapy (NCT) and its radiation properties

    International Nuclear Information System (INIS)

    Sakurai, Yoshinori; Kobayashi, Toru

    1999-01-01

    In NCT, it was at first important to give a cancer portion to radiation dose required for its recovery. By finding out that whole cross-section of water comprising of a living body decreased monotonously with increase of neutron energy from about 100 barn against thermal neutron, became about 40 barn at about 0.5 eV and kept constant to 40 barn till at about 100 eV, application of thermal neutron shifted to higher temperature side, called Hyper thermal neutron, to NCT is proposed. The Hyper thermal neutron radiation can be expected to have similar controllability to that of the thermal neutron radiation. In 1977 fiscal year, a trial Hyper thermal neutron generator was produced on a base of up-to-date investigation results. As a part of property evaluation of the generator, evaluation of energy spectra in the Hyper thermal neutron generated at LINAC by TOF was conducted to confirm shift of the spectra to high temperature side. And, a Fantom experiment at KUR heavy water neutron radiation facility was also conducted to confirm effect of improvement in deep portion dose distribution. (G.K.)

  1. Measurement of neutron dose equivalent outside and inside of the treatment vault of GRID therapy

    Energy Technology Data Exchange (ETDEWEB)

    Wang, Xudong; Charlton, Michael A.; Esquivel, Carlos; Eng, Tony Y.; Li, Ying; Papanikolaou, Nikos [University of Texas Health Science Center, San Antonio, Texas 78229 (United States)

    2013-09-15

    Purpose: To evaluate the neutron and photon dose equivalent rates at the treatment vault entrance (H{sub n,D} and H{sub G}), and to study the secondary radiation to the patient in GRID therapy. The radiation activation on the grid was studied.Methods: A Varian Clinac 23EX accelerator was working at 18 MV mode with a grid manufactured by .decimal, Inc. The H{sub n,D} and H{sub G} were measured using an Andersson–Braun neutron REM meter, and a Geiger Müller counter. The radiation activation on the grid was measured after the irradiation with an ion chamber γ-ray survey meter. The secondary radiation dose equivalent to patient was evaluated by etched track detectors and OSL detectors on a RANDO{sup ®} phantom.Results: Within the measurement uncertainty, there is no significant difference between the H{sub n,D} and H{sub G} with and without a grid. However, the neutron dose equivalent to the patient with the grid is, on average, 35.3% lower than that without the grid when using the same field size and the same amount of monitor unit. The photon dose equivalent to the patient with the grid is, on average, 44.9% lower. The measured average half-life of the radiation activation in the grid is 12.0 (±0.9) min. The activation can be categorized into a fast decay component and a slow decay component with half-lives of 3.4 (±1.6) min and 15.3 (±4.0) min, respectively. There was no detectable radioactive contamination found on the surface of the grid through a wipe test.Conclusions: This work indicates that there is no significant change of the H{sub n,D} and H{sub G} in GRID therapy, compared with a conventional external beam therapy. However, the neutron and scattered photon dose equivalent to the patient decrease dramatically with the grid and can be clinical irrelevant. Meanwhile, the users of a grid should be aware of the possible high dose to the radiation worker from the radiation activation on the surface of the grid. A delay in handling the grid after the beam

  2. Design and optimization of a beam-shaping assembly (BSA) for BNCT based on a neutron generator located at CEADEN, Havana, Cuba

    International Nuclear Information System (INIS)

    Padilla Cabal, F.; Martin, G; Abrahantes, A.

    2007-01-01

    A monoenergetic neutron beam simulation study is carried out to determine the most suitable neutron energy for treatment of shallow and deep-seated brain tumors in the context of Boron Neutron Capture Therapy (BNCT). Two figures-of-merit, i.e. the absorbed dose for healthy tissue and the absorbed tumor dose at a given depth in the brain are used to measure the neutron beam quality. Also irradiation time, therapeutic gain and the power generated in the target are utilized as beam assessment parameters. Moderators, reflectors and delimiters are designed and optimized to moderate the high-energy neutrons from the fusion reactions 2 H(d;n) 3 He and 3 H(d;n) 4 He down to a suitable energy spectrum. Metallic uranium and manganese are successfully tested for fast-to-epithermal neutron moderation as well as Fluental TM for the neutron spectrum shifting. A semispherical target is proposed in order to dissipate twice the amount of power generated in the target, and decrease all the dimensions of the BSA. The cooling system of the target is also included in the calculations. Calculations are performed using the MCNP code. After the optimization of our beam-shaper a study of the dose distribution in the head had been made. The therapeutic gain is increased in 9% while the current required for one hour treatment is decreased in comparison with the trading prototypes of NG used for BNCT. (Author)

  3. Design and optimization of a beam-shaping assembly (BSA) for BNCT based on a neutron generator located at CEADEN, Havana, Cuba

    International Nuclear Information System (INIS)

    Padilla Cabal, F.; Martin, G.; Abrahantes, A.

    2007-01-01

    A monoenergetic neutron beam simulation study is carried out to determine the most suitable neutron energy for treatment of shallow and deep-seated brain tumors in the context of Boron Neutron Capture Therapy (BNCT). Two figures-of-merit, i.e. the absorbed dose for healthy tissue and the absorbed tumor dose at a given depth in the brain are used to measure the neutron beam quality. Also irradiation time, therapeutic gain and the power generated in the target are utilized as beam assessment parameters. Moderators, reflectors and delimiters are designed and optimized to moderate the high-energy neutrons from the fusion reactions 2 H(d;n) 3 He and 3 H(d;n) 4 Hedown to a suitable energy spectrum. Metallic uranium and manganese are successfully tested for fast-to-epithermal neutron moderation as well as Fluental TM for the neutron spectrum shifting. A semi spherical target is proposed in order to dissipate twice the amount of power generated in the target, and decrease all the dimensions of the BSA. The cooling system of the target is also included in the calculations. Calculations are performed using the MCNP code. After the optimization of our beam-shaper a study of the dose distribution in the head had been made. The therapeutic gain is increased in 9% while the current required for one hour treatment is decreased in comparison with the trading prototypes of NG used for BNCT. (Author)

  4. A case of malignant melanoma of the maxilla treated by adoptive immunotherapy after fast neutron therapy

    International Nuclear Information System (INIS)

    Morifuji, Masayo; Ohishi, Masamichi; Higuchi, Yoshinori; Ozeki, Satoru; Tashiro, Hideo

    1992-01-01

    A 77-year-old male patient with malignant melanoma was treated by fast neutron therapy and immunotherapy. Total dose of fast neutron applied to the primary lesion was 1905 cGy per 21 fractionation for 46 days. For adoptive immunotherapy, lymphocytes were collected from the peripheral blood drawn from the patient 2 days after the injection of cyclophosphamide. T cells were further purified by passing the lymphocytes through nylon wool. Cytotoxic T cells were induced by incubating the T cells mixed with allogeneic malignant melanoma cells and a small number of patient's adherent cells, and activated with recombinant interleukin-2 (γ IL-2). Our patient and the patient from whom stimulating melanoma cells were derived shared A locous 24 and B locous 51 of MHC class I antigens in common. Thus prepared cytotoxic T cells were inoculated to the patient via the maxillary artery, 3 to 4 times a week for one month. Total amount of cells transferred was 5.6 x 10 8 (97% lymphocytes). Primary lesion reduced markedly by the therapies. During adoptive immunotherapy, increase in natural killer cells and decrease in both suppressor/inducer T-cells and macrophages were observed. However, lung metastases appeared 3 months after adoptive immunotherapy. While the nonspecific immunotherapy (OK-432 injection) was being conducted thereafter, growth of the metastatic lesions of the lung was kept gentle but became obvious after the suspension of the treatment. (author)

  5. Water-Insoluble Photosensitizer Nanocolloids Stabilized by Supramolecular Interfacial Assembly towards Photodynamic Therapy

    Science.gov (United States)

    Liu, Yamei; Ma, Kai; Jiao, Tifeng; Xing, Ruirui; Shen, Guizhi; Yan, Xuehai

    2017-02-01

    Nanoengineering of hydrophobic photosensitizers (PSs) is a promising approach for improved tumor delivery and enhanced photodynamic therapy (PDT) efficiency. A variety of delivery carriers have been developed for tumor delivery of PSs through the enhanced permeation and retention (EPR) effect. However, a high-performance PS delivery system with minimum use of carrier materials with excellent biocompatibility is highly appreciated. In this work, we utilized the spatiotemporal interfacial adhesion and assembly of supramolecular coordination to achieve the nanoengineering of water-insoluble photosensitizer Chlorin e6 (Ce6). The hydrophobic Ce6 nanoparticles are well stabilized in a aqueous medium by the interfacially-assembled film due to the coordination polymerization of tannic acid (TA) and ferric iron (Fe(III)). The resulting Ce6@TA-Fe(III) complex nanoparticles (referenced as Ce6@TA-Fe(III) NPs) significantly improves the drug loading content (~65%) and have an average size of 60 nm. The Ce6@TA-Fe(III) NPs are almost non-emissive as the aggregated states, but they can light up after intracellular internalization, which thus realizes low dark toxicity and excellent phototoxicity under laser irradiation. The Ce6@TA-Fe(III) NPs prolong blood circulation, promote tumor-selective accumulation of PSs, and enhanced antitumor efficacy in comparison to the free-carrier Ce6 in vivo evaluation.

  6. An Accelerator Neutron Source for BNCT

    International Nuclear Information System (INIS)

    Blue, Thomas E.

    2006-01-01

    The overall goal of this project was to develop an accelerator-based neutron source (ABNS) for Boron Neutron Capture Therapy (BNCT). Specifically, our goals were to design, and confirm by measurement, a target assembly and a moderator assembly that would fulfill the design requirements of the ABNS. These design requirements were (1) that the neutron field quality be as good as the neutron field quality for the reactor-based neutron sources for BNCT, (2) that the patient treatment time be reasonable, (3) that the proton current required to treat patients in reasonable times be technologically achievable at reasonable cost with good reliability, and accelerator space requirements which can be met in a hospital, and finally (4) that the treatment be safe for the patients

  7. An Accelerator Neutron Source for BNCT

    Energy Technology Data Exchange (ETDEWEB)

    Blue, Thomas, E

    2006-03-14

    The overall goal of this project was to develop an accelerator-based neutron source (ABNS) for Boron Neutron Capture Therapy (BNCT). Specifically, our goals were to design, and confirm by measurement, a target assembly and a moderator assembly that would fulfill the design requirements of the ABNS. These design requirements were 1) that the neutron field quality be as good as the neutron field quality for the reactor-based neutron sources for BNCT, 2) that the patient treatment time be reasonable, 3) that the proton current required to treat patients in reasonable times be technologially achievable at reasonable cost with good reliability, and accelerator space requirements which can be met in a hospital, and finally 4) that the treatment be safe for the patients.

  8. Intraoperative boron neutron capture therapy for malignant gliomas. First clinical results of Tsukuba phase I/II trial using JAERI mixed thermal-epithermal beam

    International Nuclear Information System (INIS)

    Matsumura, A.; Yamamoto, T.; Shibata, Y.

    2000-01-01

    Since October 1999, a clinical trial of intraoperative boron neutron capture therapy (IOBNCT) is in progress at JRR-4 (Japan Research Reactor-4) in Japan Atomic Energy Research Institute (JAERI) using mixed thermal-epithermal beam (thermal neutron beam I: TNB-I). Compared to pure thermal beam (thermal neutron beam II: TNB-II), TNB-I has an improved neutron delivery into the deep region than TNB-II. The clinical protocol and the preliminary results will be discussed. (author)

  9. SERA -- An advanced treatment planning system for neutron therapy and BNCT

    International Nuclear Information System (INIS)

    Nigg, D.W.; Wemple, C.A.; Wessol, D.E.; Wheeler, F.J.; Albright, C.; Cohen, M.; Frandsen, M.; Harkin, G.; Rossmeier, M.

    1999-01-01

    Detailed treatment planning calculations on a patient-specific basis are required for boron neutron capture therapy (BNCT). Two integrated treatment planning systems developed specifically for BNCT have been in clinical use in the United States over the past few years. The MacNCTPLAN BNCT treatment planning system is used in the clinical BNCT trials that are underway at the Massachusetts Institute of Technology. A second system, BNCT rtpe (BNCT radiation therapy planning environment), developed independently by the Idaho national Engineering and Environmental Laboratory (INEEL) in collaboration with Montana State University (MSU), is used for treatment planning in the current series of BNCT clinical trials for glioblastoma at Brookhaven National Laboratory (BNL). This latter system is also licensed for use at several other BNCT research facilities worldwide. Although the currently available BNCT planning systems have served their purpose well, they suffer from somewhat long computation times (2 to 3 CPU-hours or more per field) relative to standard photon therapy planning software. This is largely due to the need for explicit three-dimensional solutions to the relevant transport equations. The simplifying approximations that work well for photon transport computations are not generally applicable to neutron transport computations. Greater computational speeds for BNCT treatment planning must therefore generally be achieved through the application of improved numerical techniques rather than by simplification of the governing equations. Recent efforts at INEEL and MSU have been directed toward this goal. This has resulted in a new paradigm for this type of calculation and the subsequent creation of the new simulation environment for radiotherapy applications (SERA) treatment planning system for BNCT. SERA is currently in initial clinical testing in connection with the trials at BNL, and it is expected to replace the present BNCT rtpe system upon general release

  10. Proton Neutron Gamma-X Detection (PNGXD): An introduction to contrast agent detection during proton therapy via prompt gamma neutron activation

    Science.gov (United States)

    Gräfe, James L.

    2017-09-01

    Proton therapy is an alternative external beam cancer treatment modality to the conventional linear accelerator-based X-ray radiotherapy. An inherent by-product of proton-nuclear interactions is the production of secondary neutrons. These neutrons have long been thought of as a secondary contaminant, nuisance, and source of secondary cancer risk. In this paper, a method is proposed to use these neutrons to identify and localize the presence of the tumor through neutron capture reactions with the gadolinium-based MRI contrast agent. This could provide better confidence in tumor targeting by acting as an additional quality assurance tool of tumor position during treatment. This effectively results in a neutron induced nuclear medicine scan. Gadolinium (Gd), is an ideal candidate for this novel nuclear contrast imaging procedure due to its unique nuclear properties and its widespread use as a contrast agent in MRI. Gd has one of the largest thermal neutron capture cross sections of all the stable nuclides, and the gadolinium-based contrast agents localize in leaky tissues and tumors. Initial characteristics of this novel concept were explored using the Monte Carlo code MCNP6. The number of neutron capture reactions per Gy of proton dose was found to be approximately 50,000 neutron captures/Gy, for a 8 cm3 tumor containing 300 ppm Gd at 8 cm depth with a simple simulation designed to represent the active delivery method. Using the passive method it is estimated that this number can be up to an order of magnitude higher. The thermal neutron distribution was found to not be localized within the spread out Bragg peak (SOBP) for this geometrical configuration and therefore would not allow for the identification of a geometric miss of the tumor by the proton SOBP. However, this potential method combined with nuclear medicine imaging and fused with online CBCT and prior MRI or CT imaging could help to identify tumor position during treatment. More computational and

  11. MCNP6 model of the University of Washington clinical neutron therapy system (CNTS).

    Science.gov (United States)

    Moffitt, Gregory B; Stewart, Robert D; Sandison, George A; Goorley, John T; Argento, David C; Jevremovic, Tatjana

    2016-01-21

    A MCNP6 dosimetry model is presented for the Clinical Neutron Therapy System (CNTS) at the University of Washington. In the CNTS, fast neutrons are generated by a 50.5 MeV proton beam incident on a 10.5 mm thick Be target. The production, scattering and absorption of neutrons, photons, and other particles are explicitly tracked throughout the key components of the CNTS, including the target, primary collimator, flattening filter, monitor unit ionization chamber, and multi-leaf collimator. Simulations of the open field tissue maximum ratio (TMR), percentage depth dose profiles, and lateral dose profiles in a 40 cm × 40 cm × 40 cm water phantom are in good agreement with ionization chamber measurements. For a nominal 10 × 10 field, the measured and calculated TMR values for depths of 1.5 cm, 5 cm, 10 cm, and 20 cm (compared to the dose at 1.7 cm) are within 0.22%, 2.23%, 4.30%, and 6.27%, respectively. For the three field sizes studied, 2.8 cm × 2.8 cm, 10.4 cm × 10.3 cm, and 28.8 cm × 28.8 cm, a gamma test compari